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ABSTRACT 
 
     From the yeast genome completed in 1996 to the 12 Drosophila genomes published 
earlier this year; little more than a decade has provided an incredible amount of genomic 
data. Yet even with this mountain of genetic information the regulatory networks that 
control gene expression remain relatively undefined. In part, this is due to the enormous 
amount of non-coding DNA, over 98% of the human genome, which needs to be made 
sense of.  It is also due to the large number of transcription factors, potentially 2,000 such 
factors in the human genome, which may contribute to any given network directly or 
indirectly.  Certainly, one of the central limitations has been the paucity of transcription 
factor (TF) specificity data that would aid in the prediction of regulatory targets 
throughout a  
genome.   
 
     The general lack of specificity data has hindered the prediction of regulatory targets 
for individual TFs as well as groups of factors that function within a common regulatory 
pathway.  A large collection of factor specificities would allow for the combinatorial 
prediction of regulatory targets that considers all factors actively expressed in a given 
cell, under a given condition.  Herein we describe substantial improvements to a previous 
bacterial one-hybrid system with increased sensitivity and dynamic range that make it 
amenable for the high-throughput analysis of sequence-specific TFs. Currently we have 
characterized 108 (14.3%) of the predicted TFs in Drosophila that fall into a broad range 
 ix  
of DNA-binding domain families, demonstrating the feasibility of characterizing a large 
number of TFs using this technology.  
 
     To fully exploit our large database of binding specificities, we have created a 
GBrowse-based search tool that allows an end-user to examine the overrepresentation of 
binding sites for any number of individual factors as well as combinations of these factors 
in up to six Drosophila genomes (veda.cs.uiuc.edu/cgi-bin/gbrowse/gbrowse/Dmel4).  
We have used this tool to demonstrate that a collection of factor specificities within a 
common pathway will successfully predict previously validated cis-regulatory modules 
within a genome.  Furthermore, within our database we provide a complete catalog of 
DNA-binding specificities for all 84 homeodomains in Drosophila.  This catalog enabled 
us to propose and test a detailed set of recognition rules for homeodomains and use this 
information to predict the specificities of the majority of homeodomains in the human 
genome.   
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CHAPTER I: INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
Summary 
     From the yeast genome completed in 1997 to the 12 Drosophila genomes published 
earlier this year; little more than a decade has provided an incredible amount of genomic 
data (Cherry et al., 1997; Drosophila 12 Genomes Consortium, 2008). Yet even with this 
mountain of genetic information the regulatory networks that control gene expression 
remain relatively undefined. In part, this is due to the enormous amount of non-coding 
DNA, over 98% of the human genome, which needs to be made sense of (Lander et al, 
2001).  It is also due to the large number of transcription factors, potentially over 2,000 
such human factors, which may contribute to any given network directly or indirectly 
(Wilson et al., 2008; Tupler et al., 2001).  Certainly, one of the central limitations has 
been the paucity of transcription factor specificity data that would aid in the prediction of 
regulatory targets throughout a genome.  The general lack of specificity data has not only 
hindered the prediction of regulatory targets for an individual transcription factor but also 
how it may function within a set of complimentary factors. A large collection of factor 
specificities would allow for the combinatorial prediction of gene regulation that 
considers all factors actively expressed in a given cell, under a given condition.  
Furthermore, the amount of effort required for the characterization of a transcription 
factor’s specificity, at least until recently, has resulted in the sporadic characterization of 
factors with mostly coincidental common themes or similarities.  A comprehensive 
catalog of specificities for a given DNA-binding domain family from a metazoan would 
provide a detailed understanding of that domain’s interaction at the protein-DNA 
interface.  Such a catalog might allow the prediction of DNA-binding specificity for like 
3 
factors in other genomes which may alleviate or limit the need to characterize every 
factor in every genome. 
 
Transcription  
     To understand the regulation of transcription it must first be understood how 
transcription works and at what points might its mechanism be encouraged or retarded.  
A very basic understanding of transcription begins with RNA polymerase being able to 
find and bind the core promoter of a specific gene.  Binding the DNA is followed by 
separation of the strands of a short sequence of DNA where one of these strands will be 
used as the template for the polymerase to copy.  The actual duplication of this “template 
strand” is accomplished by base pairing with complimentary ribonucleotides, which is 
catalyzed by the polymerase, adding to the growing RNA molecule one nucleotide at a 
time.  Though the polymerase may struggle initially, once the RNA molecule reaches 
beyond roughly 10 bases the reaction becomes favorable.  At this point the 
polymerization becomes more efficient and the polymerase clears the promoter 
transitioning to the elongation stage (Mooney and Landick, 1999; Cramer 2004).  There 
are many influences that can promote this transition from initiation to elongation and 
those that stabilize and enhance elongation itself.  For example, in the development of the 
Drosophila embryo it appears that RNA polymerase may be loaded but stalled at many 
promoters and it is the repression of elongation that is regulating transcription (Wang et 
al., 2007).  However, for the purposes of this discussion we will focus primarily on the 
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first step where much of regulation occurs; how the polymerase gets to a specific 
promoter to initiate transcription. 
 
     In prokaryotes, RNA polymerase is able to engage the promoter and initiate 
transcription with only a small number of essential subunits (Borukhov and Nudler, 
2003).  The core polymerase, which is able to catalyze the polymerization reaction, is 
made up of two α subunits, the β and β’ subunits (Vassylyev et al, 2002; Sweester, et al, 
1987).  However, the core polymerase is capable of initiating transcription from 
essentially any sequence.  It is the addition of a fifth subunit, the σ subunit, that provides 
the promoter specificity that allows for initiation to begin at an appropriate sequence 
(Gross et al, 1998).  Though there are several σ subunits, most genes are transcribed with 
σ70 during exponential growth and σ38 while in stationary phase (Lonetta et al, 1992).  
These five subunits comprise the minimal holoenzyme that is capable of initiating 
transcription from a given promoter though there are several other nonessential subunits 
that play varying roles.  Essentially, the two factors influencing prokaryotic transcription 
are the local concentration of the polymerase near a promoter and strength of the 
interaction between the holoenzyme and the specific promoter sequence. 
 
     Eukaryotic transcription is quite complex in comparison to the prokaryotic system. 
There are three eukaryotic polymerases that transcribe DNA into RNA, each with a 
separate purpose.  RNA polymerase II is responsible for the transcription of protein 
coding genes and will therefore be the focus of this discussion.  Like its prokaryotic 
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counterpart, the core 12 subunit RNA polymerase II is able to initiate transcription on 
special transcripts in vitro but is not able to recognize a promoter sequence (Armache et 
al., 2003). Several proteins, the general transcription factors (GTFs), must assemble at the 
promoter before transcription is initiated (Green 2005; Roeder 1980).  These GTFs 
include RNA polymerase II and the auxiliary protein complexes TFIIA, TFIIB, TFIID, 
TFIIE, TFIIF, and TFIIH.  The first to assemble is TFIID which contains the TATA-
binding protein (TBP) and the TBP-associated factors (TAFs) (Maldonado et al, 1990; 
Smale and Kadonaga, 2003).  TBP has been shown to bind in vitro to the core A-T rich 
sequence of the promoter, the TATA box, creating a major distortion in the DNA, around 
which the remaining GTFs assemble (Patikoglou et al. 1999).  TFIID binding is assisted 
by the binding of TFIIA and TFIIB (Maldonado et al, 1990).  Once this complex is 
formed, RNA polymerase II along with TFIIF assembles followed by TFIIE and TFIIH.  
TFIIH contains a helicase that melts the promoter which not only marks the beginning of 
initiation but creates a much more stable open complex of polymerase and the DNA. 
 
     In addition to the TATA-box, there are other conserved sequence elements in 
eukaryotic promoters that subunits of RNA polymerase II interact with.  In fact, the 
TATA-box is found in only 20% of eukaryotic promoters (Bucher, 1990).  It appears that 
at many of these TATA-less promoters TBP does not make base specifying contacts 
(Coleman and Pugh, 1995).  Rather, TBP simply acts as a scaffold for other proteins to 
assemble upon, the first of which may be tissue specific TAFs, thereby providing the first 
example of specific regulation of transcription.  Other elements that encourage 
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transcription initiation are the TFIIB regulatory element (BRE), the initiator sequence 
(Inr) and the downstream promoter element (DPE) (Smale and Kadonaga, 2003).  The 
BRE is the only element recognized by a GTF other than TFIID.  TFIIB will bind 
cooperatively with TBP at the BRE when a TATA-box is present and appears to provide 
directionality to the TBP (Tsai and Sigler, 2000).  Inr is the most conserved of these 
elements with roughly 70% of the genes in Drosophila containing such a sequence 
(Smale and Kadonaga, 2003).  Typically 30 base pairs downstream of where the TATA 
box would be, this Inr marks the spot where initiation will begin and is recognized by 
TAFs.  Finally, found in roughly 40% of eukaryotic promoters the TAF recognized DPE 
functions cooperatively with the Inr and is usually found in promoters that lack a TATA-
box.  Any given promoter may have a unique combination of these sequences as well as 
their relative match to their consensus.  Therefore, the unique combination of promoter 
elements and available TAFs in a given cell, is the first level of sequence specific 
regulation of transcription.   
 
     The core RNA polymerase II and the GTFs are sufficient to initiate transcription in 
vitro.  However, in vivo an approximately 25-30 subunit complex, the Mediator, also 
assembles with the GTFs (Conaway et al., 2005).  The subunits of the Mediator, thought 
to be the target of many transcription activators, acts by integrating the signals of these 
trans-activating factors and stimulating the assembly of the GTFs (Maston et al, 2006).  
This understates the importance of the Mediator.  For example, while TFIID is only 
required for activation from 16% of yeast promoters, the Mediator protein Srb4 is 
7 
required in 93% (Holstege et al, 1999).  It is clear that subunits of the Mediator are 
absolutely necessary for transcription at most promoters in vivo therefore it is now 
commonly considered an additional GTF.  Together these subunits, the core RNA 
polymerase II, the additional GTFs, and the Mediator form the preinitiation complex 
(PIC) at the promoter where TFIIH will separate the stands of DNA to initiate 
transcription. 
 
Regulation 
     The first step in the regulation of transcription is to regulate the ability of the PIC to 
assemble at a given promoter.  Therefore, the most straightforward way to regulate 
transcription might be to simply control the availability of a given promoter.  In fact, the 
most common mode of gene regulation in prokaryotes is for a repressor protein to bind 
the promoter region of a target gene and by doing so make it inaccessible to RNA 
polymerase (Thiel et al, 2004).  Of course, this also implies that the natural state of a 
given promoter in a prokaryote is active, which is not all too surprising considering the 
relatively minimal polymerase components that are required for transcription.  However 
this is not necessarily the case.  Activation in prokaryotes often requires recruitment of 
the holoenzyme to the target promoter by a transactivating factor.   
 
     Activation of transcription by recruitment of the holoenzyme is accomplished through 
the binding of the transcriptional activator to a specified sequence that neighbors its 
target promoter.  An additional domain will contact a subunit of the holoenzyme and 
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either recruit the enzyme to the promoter or stimulate the transition to an open complex 
and promoter clearance.  Therefore, stimulation of transcription is mediated by a protein-
protein interaction between the transcription factor and a subunit of the polymerase.  The 
contact is often made with C-terminal domain of the α subunit (Hochschild and Dove, 
1998).  This may be due to the presence of two α subunits, the accessibility of the C-
terminal domain or simply the DNA-binding properties of the α subunit.  Stabilizing the 
interaction between the α subunit and the DNA might be an efficient way for a 
transcription factor to stabilize the polymerase-DNA interaction and therefore stimulate 
transcription.  Moreover, the σ subunit which also binds DNA, is another common target 
of activators.  However, it is certainly possible that different activators utilize interactions 
with any of the subunits of the holoenzyme or even a nonessential domain.  In fact, a 
transcription factor expressed as a direct fusion to the nonessential ω subunit was able to 
stimulate transcription by 70 fold (Dove and Hochschild, 1998).  Also, alternative 
protein-protein interactions can stimulate transcription if one protein is fused to a DNA-
binding domain and the other is fused to either the α or ω subunits (Dove et al, 1997; 
Dove and Hochschild,1998).  In this case, when the target sequence of the DNA-binding 
domain is placed upstream of the promoter, the alternative protein-protein interaction 
mediates the recruitment of RNA polymerase through the fusion to one of its subunits.  
Furthermore, the Hochschild lab also demonstrated that multiple contacts lead to a 
synergistic activation of transcription (Joung et al, 1993; Joung et al. 1994).  First, they 
demonstrated that two factors that are able to contact different subunits of the polymerase 
will result in a much greater level of transcription than either interaction independently.  
9 
Secondly, they demonstrated that if a 2nd, artificial interaction is engineered into a single 
factor, this too results in a synergistic activation of transcription in comparison to the 
natural and artificial interaction alone.  Therefore, transcription can be influenced by 
multiple factors that each make a different contact with the polymerase resulting in a 
synergistic activation of transcription.  
 
     In contrast to prokaryotic systems, eukaryotic promoters might be thought of as 
naturally inactive because of the inability of RNA polymerase II to transcribe without the 
assembly of many times more proteins and the organization of DNA in chromatin, 
making any given promoter at least to some degree inaccessible.  One way in which 
promoter accessibility is controlled in chromatin is by influencing the strength of the 
DNA-chromatin interaction.  The basic subunit of chromatin is the histone, the core of 
which is composed 2 sets of the H2A, H2B, H3, and H4 subunits (Widom J, 1998; 
Woodhead and Johns, 1976).  Roughly 150 base pairs wrap around each histone which 
are linked by short sequences of DNA.  The N-terminal tails of the histone domains are 
the targets of the chromatin modifying enzymes.  The strength of the DNA-histone 
interaction can be influenced by acetylation or methylation of lysines, and sometimes 
arginines, of these N-terminal tails (Wade et al., 1997; Ng and Bird, 2000; Martinowich 
et al. 2003).  For example, acetylation decreases the net positive charge of the histone and 
therefore weakens the interaction with the negatively charged DNA and making it more 
accessible (Wade et al, 1997).   
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     Inducing higher order structure in chromatin, such as the densely packed 
heterochromatin, will also have a large impact on promoter accessibility.  This is 
primarily induced by methylation of the lysine 9 residue of the H3 subunit (Rea et al., 
2000; Jenuwein T, 2001; Grewal and Elgin, 2002).  This methylated residue is the target 
of heterochromatin protein 1 (HP1) which can dimerize.  It is the dimerization of the 
bound HP1 that leads to an expanding compaction of the DNA (Nielsen et al., 2001; 
Grewal and Elgin, 2002 ).  Therefore it is the extent of methylation at lysine 9 and the 
availability of HP1 that controls the transition to heterochromatin. 
 
     Based on the concept of an inaccessible promoter, it might seem likely that activation 
of transcription is as simple as remodeling the chromatin.  However activation is not that 
simple. There are several lines of evidence that argue for the required recruitment of 
factors that will stimulate the assembly of the PIC for transcription to be activated (Kuras 
and Struhl, 1999; Ptashne and Gann, 1997).  Perhaps the most convincing work came out 
of the Ptashne lab in the late 1980’s and 1990’s.  The Ptashne lab eloquently 
demonstrated the fundamental concept of recruitment and its contribution to activation of 
transcription.  They were able to demonstrate that a DNA-binding and activating domain 
were sufficient to stimulate transcription at a specified promoter but only in the presence 
of that DNA-binding domain’s target sequence (Giniger et al, 1985; Brent and Ptashne, 
1985; Ma and Ptashne, 1987).  Furthermore, if the DNA-binding domain is fused directly 
to a component of the PIC, transcription at a specific promoter can be activated when its 
target sequence has been installed upstream of that promoter (Barberis, et al, 1995).  By 
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comparison, when the same type of fusion is made with a chromatin modifying protein, 
transcription is only weakly activated (Georgakopoulous et al, 1995).  This demonstrates 
that recruitment of the PIC to a promoter appears sufficient to activate transcription while 
localized chromatin remodeling is not.   
 
     Through these and other studies, the general mode of transcriptional activation has 
been relatively well outlined for some time now.  The DNA-binding domain of an 
activator binds its target sequence which is within some proximity of the promoter it 
regulates.  In yeast, this distance is typically within a few hundred base pairs (Levine and 
Tjian, 2003).  In humans, this distance can span tens of thousands of base pairs.  No 
matter the distance, once bound to its target sequence the activator uses an additional 
domain, the activation domain (AD), to contact some component of the PIC.  The contact 
between the activator and the component of the PIC stimulates the assembly of the PIC at 
the target promoter.  In other words, through its contact with a PIC component, the 
activator recruits RNA polymerase II to a specific promoter and thus stimulates 
transcription of a specific gene.  Ptashne demonstrated that the Gal4 activation domain 
was able to interact specifically with a mutated form of the Mediator subunit Gal11 
(Gal11P) to stimulate PIC assembly and transcription at a specified promoter (Barberis et 
al, 1995).  It has since been shown that Gal4 naturally interacts with Tra1, a component 
of the SAGA complex (Bhaumik et al., 2004).   SAGA in turn interacts with the Mediator 
and leads to the TAF independent recruitment of TBP to the promoter.  Both contacts 
demonstrate interactions with the Mediator, direct and indirect, that lead to assembly of 
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the PIC.  Of course, there are activators that influence chromatin structure or regulate 
elongation such as in the Drosophila embryo but stimulating PIC assembly appears to be 
a common mode of site directed transcriptional activation and certainly the most 
documented.   
 
DNA-binding domains 
Overview 
     Trans acting activators and repressors are referred to as sequence specific transcription 
factors because their effect on transcription is dependant on the availability of a specific 
sequence of DNA.  These transcription factors are able to recognize their genomic targets 
by utilizing a specialized subdomain, their DNA-binding domain.  These domains are 
able to interact with a small degenerative set of DNA sequences which at least partially 
determines which genomic sequences it interacts with and therefore, which gene’s 
transcription the factor may regulate.  Several different strategies for such protein-DNA 
interactions have evolved but the most common theme is the DNA-binding domain is 
able to position an alpha helix into the major groove where the side chains of its amino 
acids can make direct contact with the base pairs.  However, this is an over simplification 
of the interaction at the protein-DNA interface.  The local sequence of DNA influences 
the depth, width and flexibility of the double helix (Klug A, 1995).  A given domain may 
not only recognize a pattern of chemical groups in the major or minor groove but also the 
unique shape and local environment which that sequence provides.  Therefore, these 
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secondary influences on specificity may play a powerful role in a domains ability to 
discriminate one sequence from another.   
 
     A great number of domains have evolved for the purpose of specifying DNA 
sequences but most transcription factors utilize one of a small number of domain 
families.  In fact, 84% of the transcription factors in the human genome use one of only 
the 7 different domains that follow (Wilson et al., 2008; Tupler et al., 2001).  Though all 
of these domains bring a unique element to specificity determination, they can be broadly 
clustered in two catagories: those that are able to bind DNA independently and those that 
require dimerization.  Below, a brief description of the 7 most common DBDs in the 
human genome is provided as well as their relative abundance. 
 
Monomers 
     These classes of DBDs are considered monomers because not only are they able to 
bind DNA independently, but they are able to carry out their mode of action 
independently.  Whether the TF’s function is to recruit other TFs, stimulate PIC 
formation, or modify chromatin, these factors are able to do that as a single protein.  In 
contrast, there is some evidence that dimers may initially bind DNA as monomers but 
they require dimerization to carry out the function of the TF that encodes them.  Of 
course, the DBD families listed in this category might also function as dimers.  The most 
obvious example is the homeodomain that is often thought of as forming a dimer to 
provide extended specificity and therefore determine which genomic targets will be 
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regulated (Ryoo and Mann, 1999; Joshi et al., 2007).  However, this is primarily based on 
evidence that the HOX factors are able to dimerize with extradenticle and perhaps other 
homeodomains that fall into the atypical subfamily of this domain. This dimerization 
does indeed extend and modify the specificity of the HOX monomer.  Still, outside of the 
HOX factors there is very little evidence that homeodomains function as dimers and there 
are several examples of monomeric regulation even by members of the HOX family (see 
discussion Chapter 4).  An interesting wrinkle in the dimerization discussion is the ability 
of the winged helix DBD families, the Forkhead and Ets families, to form heterotypic 
dimers, which are dimers formed between two factors from different DBD families 
(Amoutzias et al, 2008).  Both the Forkhead and Ets families have the ability to dimerize 
with hormone receptors and some homeodomains.  Again, these factors are indeed able to 
bind DNA and function independently though dimerization, both homotypic and 
heterotypic, may be an important component of their regulatory repertoire. For the 
purposes of this discussion I will focus on their monomeric binding.  
 
 Cys2His2 Zinc fingers  
     When only considering the longest transcripts for each coding sequence and therefore 
ignoring any relevant splice variants, there are approximately 750 transcription factors in 
the human genome that utilize Cys2His2 zinc fingers making this by far the most common 
DBD (Wilson et al, 2008; Tupler et al, 2001).   These factors represent roughly 50% of 
the sequence specific transcription factors in the human genome and regulate a diverse 
set of cellular functions.  This DBD was first noticed as 9 tandem repeats in the coding 
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sequence of TFIIIA of Xenopus (Brown et al, 1985; Miller et al, 1985) and as more and 
more Cys2His2 zinc fingers have been characterized, their alignments have shown that the 
domain can be described by the consensus sequence: (F/Y)-X-C-X2-5-C-X3-(F/Y)-X5- -
X2-H-X3-5-H, where X can be any residue and   is a hydrophobic residue.  The domain 
utilizes tetrahedral zinc coordination by its two cysteines and two histidines to stably fold 
the polypeptide into a ββα structure (Pavletich and Pabo, 1991; Elrod-Erickson et al, 
1996).  This zinc coordination provides stability to these roughly 30 amino acid domains 
that are not large enough to form a stable hydrophobic core and therefore are not able to 
fold in the absence of the zinc ion. 
 
     Zinc finger transcription factors typically contain multiple fingers that each bind 
adjacent 3bp subsites (Wolfe et al, 2000; Elrod-Erickson et al, 1996).  Hypothetically, 
this means that a two fingered protein will bind a 6bp site and each additional finger will 
add 3 bases of specificity.  The base specifying contacts of each finger are then made 
with the DNA by positioning the helix in the major groove where positions -1, 2, 3, and 6 
of the helix will most often provide the specificity for each finger (Elrod-Erickson et al, 
1996; Luscombe et al, 2000). These factors will typically function as monomers and can 
bind with sufficient specificity and affinity to regulated sets of genes independently of 
other factors.  In fact, three finger proteins will often bind with nM to pM affinities 
(Elrod-Erickson and Pabo, 1999; Greismann and Pabo, 1997) and provide excellent 
discrimination between target sequences.   
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      In practice, zinc finger binding is not so straight forward.  These factors in the human 
genome have an average of 12 fingers per protein (Wilson et al, 2008; Huntley et al, 
2006).  If each finger were to bind as proposed, the average transcription factor would be 
specifying 36 bases.  But the proposition that each additional finger will bind an adjacent 
3bp sequence assumes that those fingers are canonically linked and function 
cooperatively.  That is to say that the linker between two fingers is 5 amino acids from 
the last histidine of one finger to the first hydrophobic residue of the following finger, the 
linker sequence is similar to TGEKP, and the binding of each finger is at least partially 
dependent on the binding of the other.  This may be the case for a significant portion of 
fingers but certainly not all of them.  Out of the over 10,000 estimated individual zinc 
fingers coded by the human genome, approximately 4,200 of them are canonically linked 
(Letunic et al, 2006).  Many more fingers have short linkers, but noncanonical in 
sequence, that are likely restricted in their flexibility.  Still, many other fingers have large 
insertions between them.  Since a given transcription factor will often have all of these 
various linker types, its possible that these large insertions are acting as spacers or even 
barriers that separate the functions of sets of canonically linked fingers within the same 
protein.  Each set may act as a functional unit and therefore provide diversity in the 
functions that a single protein might perform.  
 
Homeodomains 
 In humans, as well as many other metazoans, homeodomains comprise the second 
largest class of sequence-specific transcription factors with an estimated 233 such factors 
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(Wilson et al, 2008; Tupler et al, 2001).  Homeodomains were first identified as 
Homeotic genes in D. melanogaster where the altered activity of a particular gene can 
lead to the morphological transformation of one segment into that of its neighbor, leading 
to dramatic phenotypes such as the appearance of a second pair of wings (Lewis, 1978) .  
Cloning of these genes and analysis of their products led to the observation that they 
contain a common sequence motif that encodes a DNA binding domain (Gehring et al., 
1994a).   
 
The homeodomain consists of approximately 60 amino acids that fold into a stable 3-
helix bundle preceded by a flexible N-terminal arm. Interactions with a 4 to 7 basepair 
DNA binding site are formed by positioning the third helix, the recognition helix, in the 
major groove and the N-terminal arm in the minor groove. Despite a common DNA 
binding architecture, there is significant variation in the sequence composition within the 
homeodomain family; for example the two superclasses of homeodomains, denoted as 
typical and atypical (Banerjee-Basu and Baxevanis, 2001; Gehring et al., 1994a; 
Mukherjee and Burglin, 2007), share low sequence identity and generally recognize 
substantially different DNA sequences. Nonetheless, the docking of typical and atypical 
homeodomains with the DNA is nearly identical (Kissinger et al., 1990; Wolberger et al., 
1991), likely facilitated by common sets of contacts to the phosphodiester backbone.  
Though the vast majority of homeodomains appear to function as monomers, there 
are several examples of dimerization between members of the Hox and TALE families of 
homeodomains (Ryoo and Mann, 1999; Joshi et al., 2007).  This dimerization appears to 
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be mediated by a YPWM motif that is encoded N-terminal to the homeodomain in the 
Hox factor and the three amino acid loop extension (TALE) that connects helix 1 and 
helix 2 of the TALE factor.  The dimerization of these homeodomains not only increases 
the size of the core recognition sequence to eight or more bases, but it also modifies the 
specificity contributed by each of the individual homeodomains.  However, it must be 
noted there is also evidence that these same homeodomains are able to function and 
regulate transcription as homo-oligomers (Galant et al, 2002; Lohmann et al, 2002). 
 
Forkhead domains 
     Forkhead domains represent the fifth most common family of DBDs in the human 
genome with 49 representative members and they are the first of two families that utilize 
a “winged helix” motif to bind DNA (Tupler et al, 2001).  The common architecture of 
this domain includes 3 β-sheets, 3 α-helices, and two loops or “wings” in the following 
order: α1 - β1 - α2 - α3 - β2-W1- β3-W2.  The 2nd and 3rd helix form a helix-turn-helix 
motif that positions the 3rd helix in the major groove where the base specifying contacts 
are made (Luscombe et al, 2000).  However, this 3rd helix is highly conserved which may 
contribute to the fact that all Forkhead domains characterized to date bind a core 
sequence of (A/C)AA(C/T)A sequence element (Wijchers et al, 2006).  This 5bp 
sequence is required but not sufficient for binding which implies there are other base 
specifying contacts.  These additional contacts are thought to come from the less 
conserved turn immediately N-terminal to the 3rd helix and from contacts made in the 
minor groove by the second wing.  These additional contacts may lead to the extended 
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specificities that are required for a given subfamily of Forkhead domains.  For example, 
the FoxO family specifies a (T/C)(G/A)AAACAA sequences (core sequence element is 
underlined).   
 
     For the most part Forkhead proteins function as monomers; however, there are 
exceptions.  The FoxP subfamily requires dimerization to function.  Also, as previously 
noted, the Forkhead family can form heterotypic dimers with other DBD families.  For 
example, members of the FoxO family are able to interact with the androgen, 
glucocorticoid, and retinoic acid receptors.  Foxa2 has been shown to interact with 
several homeodomains including PITX2, HOXA10, and engrailed (Foucher et al, 2003; 
Marshak et al, 2000).  It is not clear how these heterotypic interactions are forming and 
their influences on function are inconsistent.  Some interactions enhance while others 
interfere with the regulation of the binding partner’s target.  It is also unclear whether 
these interactions modify the specificity of either DBD and thus revise the regulatory 
targets of either domain, or if they alter the regulatory activity of their partner at their 
common set of targets. 
 
Ets domains 
     Ets domains were first identified by homology to the v-ets oncogene from the E26 
avian erythroblastosis virus (E-Twenty-Six) (Sharrocks et al, 1997).  There are 28 
members in the human genome, representing the 7th largest family (Wilson et al, 2008).  
Structurally they are very similar to the Forkhead domain in that both domains utilize a 
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winged helix motif.  In fact, the only major difference appears to be that most Ets 
domains only have a single wing compared to the common two wings of the Forkhead 
domain (Luscombe et al, 2000).  The main difference appears to lie in the specificity.  
While the Forkhead domain requires a (A/C)AA(C/T)A core sequence for DNA binding, 
the Ets domain requires a GGA(A/T) motif (Oikawa and Yamada, 2002). These 
differences in core specificity appear to be determined by different residues on the 3rd 
helix, the recognition helix.  Also, like the Forkhead domain, the Ets domain requires 
subfamily dependent sequences that flank the core motif binding.  These typically result 
in 7-9bp elements and are thought to be specified by the residues adjacent to the 
recognition helix.   
 
     Also like the Forkhead domain, Ets domains primarily function as monomers though 
recent structural data indicates it is possible for some members to homodimerize.  
However, a more striking similarity is that members of both of these domains are able to 
form heterotypic dimers with both hormone receptors and homeodomains.  There are a 
handful of examples for each partnering domain but a very interesting example is 
demonstrated between the Ets-1 factor and the vitamin D receptor (VDR) (Tolon et al, 
2000).  Like most hormone receptors, ligand binding to VDR (in this case vitamin D) 
induces a conformational change that allows the receptor to function as a transcription 
factor.  Remarkably, the interaction between Ets-1 and VDR appears to produce the same 
conformational change, relieving the receptor of its vitamin D dependance and 
stimulating its regulatory activity.  The Forkhead and Ets domains seem so similar in 
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structure and function that one might think of them as two superclasses of one master 
DNA-binding domain family, the winged helix family, but thus far their classification has 
remained separate.   
 
Dimers 
     Dimeric DNA-binding domains add an additional level of complexity to gene 
regulation.  Because one monomer can potentially bind with several partners, that same 
monomer is able to regulate different genes and networks.  Functionally, a specific 
partner might modify the DNA-binding specificity of the dimer and therefore lead to the 
regulation of a unique set of genomic targets (Ryoo and Mann, 1999; Amoutzias et al, 
2008). On the other hand, different partners might simply provide different auxiliary 
domains, leading to different outcomes at the same group of targets.  For example, the 
basic helix-loop-helix domain Max can dimerize with either Myc or Mad. However, Myc 
and Mad are not able to dimerize with one another (Luscher, 2001).  If Max is bound to 
Myc it recruits SWI/SNF, a histone acetyl transferase, to its genomic targets.  If Max is 
bound to Mad it recruits histone deacetylases, leading to the exact opposite result as the 
Myc-Max dimer at a targeted promoter (Grandori et al, 2000).  Therefore, the ability of a 
dimer to regulate a target sequence is dependant on additional influences: the 
concentration of both monomers, the affinity the monomers have for one another, and the 
affinity that the dimer then has for the target sequence.  These influences provide 
additional interactions that can be regulated and therefore provided tighter control than 
might be possible with monomeric factors. 
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     Another advantage of dimeric transcription factors is that they provide potential 
diversity in their targets with a minimal number of parts.  For example, if we assume that 
all monomers of a given DBD family are able to form functional dimers, the 51 basic 
leucine zipper (bZip) domains in the human genome (Wilson et al, 2008) would provide 
1,326 dimer combinations, close to 150% of all the Cys2His2 zinc finger proteins.  
However, it is estimated that there are actually only 350 unique dimers in the human 
genome that are functional because of the dimerization specificity between bZip 
monomers (Grigoryan and Keating, 2006; Newman and Keating, 2003).  In fact, dimeric 
DBD families often have “hub” proteins that are able to dimerize with many partners 
while the peripheral monomers bind with relatively few.  For example, the E2A bHLH 
domain and the RXR hormone receptor are predicted to have 38 and 24 partners, 
respectively (Armoutzias et al, 2004; Amoutzias et al, 2007).  The dimerization 
specificity obviously limits the number of potential combinations but still, 350 unique 
bZip combinations is 50% more than all of the monomeric homeodomains and it implies 
that each bZip monomer has on average 7 different dimer combinations.  Below, the 
DNA binding properties of the three most common dimeric DBD families are briefly 
described.  When we consider all the homodimeric and heterodimeric combinations of 
these three domains and then add into the equation that some factors, such as Ets factors, 
are able to form heterotypic multimers with other DBD families, it becomes clear that the 
protein-protein interactions between site-specific transcription factors are every bit as 
important as the protein-DNA interactions that they govern.  
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Basic Leucine Zippers 
     The basic Leucine Zipper (bZip) consists of a single α-helix, roughly 60 amino acids 
long (Luscombe et al, 2000).  The helix is made of two parts; the C-terminal dimerization 
domain and the N-terminal basic region .  The 30 amino acid C-terminal domains have a 
leucine, or similar residue, positioned roughly every 7 amino acids or two turns of the 
helix.  These hydrophobic side chains from each helix utilize hydrophobic contacts to 
pack together side by side and “zipper” the helices together, forming a coiled-coil.  The 
leucine zipper is a very common dimerization domain utilized by DBDs.  Subfamilies of 
the bHLH family use one and sometimes two leucine zippers to specify potential 
dimerization partners (Amoutzias et al, 2008).  There are also a few examples of zinc 
fingers and homeodomains that utilize Leucine zippers for dimerization. 
 
     In the context of the basic leucine zipper, the basic region provides the DNA-binding 
specificity.  The basic region is simply an extension of the helix that is positioned into the 
major groove where its side chains make base specifying contacts with ½ of  the dimer’s 
target sequence.  However, it must be noted the basic region is not ordered in the absence 
of DNA.  It is presently unclear whether the mode of action is for the dimers to form 
independently and the basic regions of both monomers will then be ordered once in 
contact with the entire target sequence or if the monomers bind DNA independently and 
dimerize when they come in contact with a potential partner (Kohler and Schepartz, 
2000).  It is known that dimers are able to form in the absence of DNA.  However, there 
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is evidence that the presence of DNA speeds up the dimerization process implying that by 
binding the DNA first, monomers are better able to dimerize.     
 
Basic Helix-Loop-Helix 
     The basic helix-loop-helix (bHLH) domain is the third most common DBD family in 
the human genome with 118 members (Wilson et al, 2008; Tupler et al, 2001).  The 
bHLH domain dimerizes by forming a 4 helix bundle on the DNA where each monomer 
is contributing a helix-loop-helix (Amoutzias et al, 2008).  The basic region is an 
extension of the first helix of the helix-loop-helix motif and, like the bZip domain, is 
disordered in solution but forms an alpha helix when contacting DNA (Jones, 2004). 
Contacts are made between this basic alpha helix and bases in the major groove. In 
contrast to the bZip domain, the loop between helices in the bHLH domain provides more 
flexibility in positioning the helices in the major groove.  The resulting 4 helix bundle is 
then centered on the E-box sequence CANNTG. 
 
Hormone Receptors 
     The hormone receptor family of DBD’s function by binding their ligand in the 
cytoplasm and then translocating to the nuclease where they regulate a subset of genes in 
response to this environmental cue.  The vast majority of this domain family members 
function as a dimer with each monomer having a ligand binding, DNA-binding, and 
transcriptional regulatory domain (Amoutzias et al, 2007).  The canonical domain 
architecture is loop-helix-loop-helix, the fold of which is stabilized by the coordination of 
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two zinc ions, one by the 4 cysteines in each loop leading to its designation as a C4 zinc 
finger (Luscombe et al, 2000).  Contact is made with the DNA by both of the helices.  
The first helix provides the base specifying contacts in the major groove.  The second 
helix positions itself perpendicular to the first helix and makes nonspecific contacts with 
the DNA backbone.  Dimerization is mediated by the second loop which positions the 
two monomers so that each of their six base pair half sites are separated by 3-6 base pairs.  
One exception to the hormone receptor family is the knirps, and knirps-like, protein.  
These factors function as monomers utilizing the same C4 zinc finger architecture but 
instead of relying on dimerization to provide additional specificity and/or affinity, knirps 
contains an additional DBD known as the “knirps box” (Rothe et al, 1989).  It is not clear 
how the knirps box makes contact with the DNA but truncation analysis has 
demonstrated that it is necessary for DNA binding.  Because of the lack of three 
dimensional structure or quality specificity data for the knirps protein, it is difficult to say 
whether the knirps box provides specificity, affinity, or both.   
 
Regulatory Networks 
     A single transcription factor is able to influence transcription of its regulatory targets 
by binding to a sequence or set of sequences in a genome and influencing the 
transcription of neighboring genes, positively or negatively as previously detailed.  
However, in higher eukaryotes genes regulated by a single protein are less common 
(Spiegelman and Heinrich, 2004; Harbison et al., 2004; Kim and Kim, 2006).  Rather, the 
transcription of a given gene is the result, or the sum, of all the combinatorial inputs of 
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the factors that are available and able to influence initiation of transcription at that gene’s 
promoter.  Therefore, transcription may be the result of a network of regulatory 
influences rather than a one to one relationship between a transcription factor and its 
target.  Since each transcription factor holds a different piece of information (e.g. Is a 
hormone present?  Is the cell dividing or stationary?) the cell, or more appropriately a 
given promoter, must be able to decode this information in order to determine what is the 
proper outcome.  The units that decipher all of this information are the DNA sequence 
elements that all the relevant transcription factors are able to bind to and that neighbor a 
given gene’s promoter (Davidson, 2001).  These sequence elements are most often 
thought of as enhancers but might include enhancers, silencers or insulators.  Together, 
these elements are referred to as “cis-regulatory modules” (CRMs).   Each CRM is 
typically greater than 300bp in length and contains roughly 10 binding sites for four or 
more transcription factors (Levine and Tjian, 2003).  However, because the promoters 
each CRM regulates can be tens of thousands of base pairs away, and not always the 
nearest promoter, it is rather difficult to pinpoint what sequence elements and promoters 
are functional pairs.       
 
Yeast Regulatory Networks 
     Since the sequencing of the yeast genome (Cherry et al., 1997), an enormous effort 
has been made to map the regulatory networks in this organism, providing a great deal of 
what is now understood about these systems.  This effort has been aided by several 
advantages provided by this organism.  First, it is relatively straight forward to site 
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specifically modify a genomic sequence in yeast by homologous recombination.  Second, 
there are few introns and the intergenic sequence space is compact in comparison to 
higher eukaryotes such as humans.  Together, this allowed the Young lab to create knock-
ins for most of the transcriptional regulators in yeast with the addition of a C-terminal 
epitope tag (Lee et al., 2002).  This allowed for tagged versions of each regulator to be 
expressed under its natural physiological control.  A tagged version of each regulator 
could then be chromatin-immunoprecipitated (ChIP) under rich growth conditions, or an 
alternative condition, to recover potentially all of the genomic regions that a given factor 
was able to bind to.  DNA microarrays were used to determine which genomic sequences 
were enriched by a given factor.  This approach was referred to as a genome-wide 
location analysis (Ren et al., 2000). 
 
     The first pass at a large scale genome-wide location analysis provided several insights 
into the fundamental workings of eukaryotic networks (Lee et al., 2002).  Analysis of 106 
yeast factors demonstrated an average factor bound 38 different promoter regions.  
Conversely, it was found that roughly 37% of the promoter regions were bound by at 
least one transcription factor.  Furthermore, more than a third of these promoter were 
bound by two or more factors.  Within this data set, a number of network motifs were 
described that form the building blocks of higher network structure.  There are several 
examples of motifs such as autoregulation, feedforward loops, and single or multiple-
input loops.  However, this analysis was limited in that it provided which promoter a 
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factor or set of factors might bind but not how many times they might bind or how 
multiple factors might influence the binding of one another within a given promoter.  
 
      A second pass by the Young lab included more factors (203), 84 of which were tested 
at multiple growth conditions, and a comparison of the phylogenetic conservation 
between related yeast species at an enriched genomic region to predict the binding site 
specificity for a given factor (Harbison, et al., 2004).   This analysis allowed for the 
prediction of how many binding sites a given factor might have within a specific 
promoter.  Promoters that contained single binding sites, repeating binding sites, and sites 
for multiple different factors were all common.  Furthermore, multiple growth conditions 
provided insight into how sets of factors respond differently to external cues.  For 
example, some factors were termed ‘condition-invariant’ because the same sets of 
promoters were recovered under multiple conditions.  Others were only active once the 
conditions were modified, in other words they were ‘condition enabled’.  Still, other sets 
demonstrated an expansion of the promoters they bound under new conditions.  This 
global analysis of the yeast regulatory network provides a powerful foundation to expand 
upon in higher eukaryotes. 
 
A Metazoan Development Network 
     Much of what we know about metazoan regulatory networks comes from decades of 
genetic studies that detail the development of the Drosophila body plan and the genes 
that control it (Carroll, 1990; Ingham, 1988).  Remarkably, execution of the adult body 
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plan begins extremely early in development where the fate of a given nucleus is 
determined by its position in the embryo and the patterned distribution of critical 
transcription factors (Gaul and Jackle, 1987; Ingham 1988; Small et al., 1991).  Even 
before fertilization the body plan is being organized in the embryo by the distribution of 
maternal mRNA.  These maternal morphogens, such as bicoid, are arranged in a broad 
gradient across the embryo.  Upon fertilization, it is the concentration of these maternal 
factors and the number of binding sites that neighbor their regulatory targets that will 
determine which zygotic genes are initially expressed.   
 
     The Drosophila embryo has provided an excellent platform to investigate how various 
concentrations of multiple transcription factors and numbers of binding sites are 
processed to result in discrete outputs.  This is at least partially because of the unique, 
rapid expansion of nuclei that takes place soon after fertilization.  The syncytial 
blastoderm, also referred to as the pre-cellular blastoderm, that is formed contains 
thousands of nuclei across the embryo, none of which are separated by cell membranes.  
This provides for an almost seamless flow of information (the expression and availability 
of transcription factors) between nuclei across the embryo.  It is therefore the discrete 
position of each nucleus within the embryo that determines the concentration of maternal 
factors that will influence the expression of a unique set of genes.  Neighboring nuclei 
will then have similar expression patterns and therefore set up secondary gradients of 
transcription factor expression.  It is this cascade of transcription that leads to the more 
and more refined regions with unique portfolios of gene expression and ultimately the 
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morphology that will develop from that region of the embryo (Carroll, 1990; Arnosti, 
2003; Arnosti et al., 1996).     
 
     The factors that determine the anterior-posterior segmentation of the Drosophila 
embryo form a hierarchy of groups of transcription factors; the Maternal, Gap, Pair-ruled 
and Segment polarity groups (St Johnston and Nusslein-Volhard, 1992; Schroeder et al., 
2004) (Figure 1.1).  Their function can be described as a regulatory cascade where the 
expression of one group regulates the expression of the proceeding group and so on (Peel 
et al., 2005; Pick, 1998).  Activated by the unique, local concentration of Maternal 
factors, the first set of activated zygotic genes are the gap factors.  These are expressed in 
broad bands and, in concert with the maternal factors they regulate the expression of the 
pair-ruled genes.  Expressed in 7 stripes roughly perpendicular to the anterior-posterior 
axis, the pair-rule gene expression gives the first glimpse at the developing segmented 
body plan of the Drosophila.  The pair-ruled factors then regulate 14 stripes of segment  
polarity gene expression, providing the foundation for the segmented adult body.  
Members of all of these groups may participate in the regulation of the downstream 
homeotic factors that influence the further development of each segment. 
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Figure 1.1. 
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Figure 1.1.  Transcription factors involved in A-P patterning. TFs involved in A-P 
patterning function in a hierarchical network to subdivide the embryo into 14 segments.  
The early maternal factors are expressed in broad gradients, with subsequent TF groups 
expressed in patterns that are increasingly refined. TFs involved in early segmentation or 
expressed in early patterns that were characterized in this study are grouped according to 
their initial stage of expression and they are color-coded to indicate the type of DBD 
(Cys2His2 Zinc fingers = Blue, homeodomains = Green, bHLH = Gray, bZip = Red, 
Winged helix = Pink, Nuclear Hormone Receptor = Orange, POU motif= light Blue, 
Paired motif = Yellow, and HMG = lavender. Runt is black and was characterized as an 
alpha fusion (Meng et al., 2005)).  
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Early expression of even-skipped 
     Perhaps the best characterized example of the combinatorial control of a gene’s 
expression is demonstrated by the early expression of Even-skipped (eve) in the 
Drosophila embryo.  Like the other Pair-ruled genes, eve is initially expressed as 7 
stripes that transverse the pre-cellular embryo, each of which is 5-6 nuclei wide (Small et 
al., 1991).  These 7 stripes are controlled by 5 different CRM’s that sit in a roughly 16kb 
region that surrounds the eve gene (Goto et al, 1989; Harding et al, 1989).  Three of these 
CRM’s control the expression of a single stripe (1, 2, and 5) while two others are 
responsible for two stripes each (3+7 and 4+6).  Therefore, there are at least 5 different 
combinations of transcription factors that can lead to the expression of eve and it is the 
unique availability and discreet positioning these factors along the anterior-posterior axis 
that leads to the striped pattern.    
      
     The stripe 2 CRM is the best characterized of the 5 and is perhaps the absolute classic 
example of a single CRM’s combinatorial control of gene expression in a metazoan.  This 
CRM is roughly 500 bp in length and its regulation can be described by 3 gap and 1 
maternal factors: Giant (Gt), Kruppel (Kr), Bicoid (Bcd), and Hunchback (Hb) (Small et 
al., 1991; Small et al., 1992). The CRM sequence contains 3 Giant binding sites, 3 
Kruppel sites, 5 bicoid sites and 1 Hunchback site (Figure 1.2 top).  Giant and Kruppel 
act as repressors while Bicoid and Hunchback act as activators and it is the unique pattern 
of these factors across the embryo that leads to the unique stripe of eve expression 
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Figure 1.2 
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Figure 1.2.  Schematic of the CRM and the transcription factors that control the second 
stripe of eve’s early expression.  Top. The roughly 16kb genomic sequences that include 
the eve gene and control elements of eve’s early expression are depicted.  Each stripe 
CRM has been placed in its approximate position relative to eve’s start site.  The 480bp 
stripe 2 element is blown up to show the binding sites for the four critical transcription 
factors.  These factors and binding sites are color coded as follows: Kruppel is dark blue, 
Hunchback is light blue, Bicoid is green, and Giant red.  Cartoon depictions of each 
factor are shown in the key and what their binding might look like under stripe 2 
activating conditions are shown.   Bottom. The expression patterns of all four 
transcription factors are displayed from anterior to posterior, color coded as in A.  The 
region that should lead to expression of the eve gene from stripe two is boxed.  Notice the 
relatively low level of Bicoid.  It is apparently Bicoid’s ability to act synergistically with 
Hunchback that leads to stripe two activation. 
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controlled by this CRM.  Both Bicoid and Hunchback are present as a gradient along the 
anterior-posterior axis with their highest concentration at the anterior pole (Myasnikova 
et al., 2001), though Hb has another band of expression at the posterior pole (Figure 1.2 
bottom).  Certainly, both activators are present in the relatively anterior position of eve’s 
second stripe though Bicoid is tailing off.  The repressors, Giant and Kruppel, are 
expressed in wide bands along the axis with Giant expressed more anterior and Kruppel 
expressed in the central embryo.  Therefore, any nuclei too anterior or too central in the 
embryo will not be able to express eve from the stripe 2 CRM since these repressors will 
be present.  Moreover, it is the location of the repressors, Giant on the anterior border and 
Kruppel on the posterior border, which sets the boundaries of where eve is able to be 
expressed by this CRM.  With this in mind, it might seem possible that eve would be 
expressed in the posterior portion of the embryo from this CRM since both repressors are 
absent.  However, the lack of just a single factor, Bicoid results in no expression from the 
CRM in the posterior embryo (Small et al., 1992).  In fact, disruption of any of these 
genes will change the morphology of the 2nd stripe of eve expression.  For example, in a 
Giant mutant embryo, stripes 1 and 2 are fused while in a Hunchback mutant, stripe 2 is 
gone or reduced.   
 
     In contrast to the stripe 2 CRM, the 3+7 and 4+6 CRMs appear to be predominantly 
controlled by repression.  In fact, though activation from the stripe 3+7 CRM appears to 
be at lest partly dependant on the ubiquitously expressed dSTAT92E, additional 
activators for this and the 4+6 CRM are unknown (Small et al, 1996; Clyde et al., 2003).  
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Regardless of the activator, the borders of these stripes appear to be completely 
controlled by the availability of the repressors Knirps and Hunchback.  Hunchback in this 
case is likely to act as a repressor through the recruitment of coregulators discussed 
below.  Knirps is found in a gradiant band of the embryo roughly in the range of stripes 
4-6 with its highest concentration centered on stripe 5 (Figure 1.3 Top).  Hunchback, as 
mentioned previously, is found in gradients that are at their highest concentration near the 
poles and decrease towards the center of the embryo with a broader concentration near 
the anterior side.  The internal borders of the stripes controlled by these two CRMs 
(posterior side of stripes 3 and 4; anterior side of stripes 6 and 7) are then set by knirps 
repression.  The external borders of these stripes (anterior side of stripes 3 and 4; 
posterior side of stripes 6 and 7) are set by Hunchback repression.  
 
     An interesting comparison between the functional activity of a transcription factor and 
DNA-binding, both the number and strength of these events, is demonstrated by these 
two CRMs.  Both CRMs are able to control the sharp borders of eve expression necessary 
to define their associated stripes yet both do this with drastically different concentrations 
of the repressors.  This is demonstrated by the different positions of the stripes in relation 
to the gradients of both hunchback and knirps expression (Clyde et al, 2003).  The  
internal borders of stripes 3 and 7 are set at much lower concentrations of knirps than 
stripes 4 and 6 (Figure 1.3 Bottom).  This appears to be due to the greater number (12 vs 
4) and quality of knirps binding sites found in the 3+7 CRM (quality is determined by 
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Figure 1.3 
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Figure 1.3.  Schematic of eve’s early expression regulated by the 3+7 and 4+6 CRMs.   
Top.  The expression patterns of Hunchback and Knirps are depicted from anterior to 
posterior, Hunchback = light blue, Knirps = orange.  Bottom. The expression of these two 
factors in the more central region of the embryo is magnified.  Relative positions of the 
stripes 3 and 4 are indicated by green boxes.  Notice the posterior border of stripe 3 is at a 
relatively low concentration of Knirps.  The 3+7 CRM contains a greater number of high 
quality Knirps sites in comparison to the 4+6 CRM (12 vs 4) presumably to 
accommodate this low concentration.  Likewise, the anterior border of stripe 4 is at a 
relatively low concentration of Hunchback.  This CRM (4+6) contains a greater number 
of high quality Hunchback sites.   
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how well the site matches a position weight matrix (PWM) of sites created for knirps by 
comparison to the known in vivo knirps binding sites.  The composition of bases at each 
position within a set of binding sites can be connected to the free energy of binding, 
discussed below).  Likewise, the external borders of stripes 4 and 6 are set at lower 
concentrations of Hunchback in comparison to stripes 3 and 7.  This also appears to be 
due to a greater number of high affinity hunchback sites (10 vs 6) in the 4+6 CRM.  In 
both cases lower repressor concentration has been compensated for with greater number 
and/or affinity binding sites in the corresponding CRM.  This may also explain in part 
how bicoid is able to contribute to the activation of stripe 2 at relatively low 
concentrations.  A close inspection of the stripe 2 CRM (Small et al., 1992) shows that 3 
of the 5 bicoid sites are perfect matches to bicoid’s consensus sequence (TAATCC).  The 
other two sites differ by only one base (TAATC(G/T)) which should also be high affinity 
sites (see Chapter 4).  Its possible that the low concentration of bicoid has been 
compensated for with 5 high affinity binding sites.   
 
          The relative quality of a binding site for a given transcription factor (e.g. bicoid, 
hunchback, knirps) can be approximated because the fractional composition of bases 
observed at each position in a set of sequences infer the relative energetic contribution of 
each base at each position in the binding site when compared to a reference sequence 
(Stormo and Fields, 1998; Stormo 1998).  The reference sequence is typically the 
consensus sequence which we can assume is the high affinity site if each position of the 
binding site contributes independently to the free energy of binding.  Under this 
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assumption, the contribution to the equilibrium constant (K) for a specific base (b) at a 
specific position (l) should be proportional to the fraction (f) with which that base occurs 
in the set of sites divided by the probability (p) of that base occurring in the specific 
genome (not all genomes have an equal distribution of bases and therefore the 
background probability can be different for each Watson-Crick pair).  In other words, the 
“weight” of a specific base can be calculated as W(b,l) = ln f(b,l)/p(b).  A partial equilibrium 
constant can then be calculated as Ka ≈ eW/Σb,l e
W.  Since, ΔG = -RT ln Keq, this base 
frequency at position “l” can be related to free energy by the equation ΔG(b,l) = RT ln 
Ka(b,l)/Ka(ref,,l), where Ka(ref,,l) is calculated from the base at position “l” in the consensus 
sequence.  When considering an entire binding site (α), the term becomes ΔG(α) = RT 
Σ(b,l) ln Ka(b,l)/Ka(ref,l).  This calculation of ΔG(α) will estimate a relative change in free 
energy in comparison to the consensus sequence.  However, for hard numbers the binding 
constant of the consensus sequence would have to be experimentally determined. 
 
     The conflict between hunchback’s activity as an activator in one instance and a 
repressor in others brings up an additional layer of regulation, the availability of 
coregulators.  As an activator, Hunchback works together with Bicoid to express eve in 
the second stripe.  The loss of either of these factors leads to the loss or reduction in the 
stripe 2 expression of eve.  It appears that these factors have a synergistic effect on 
transcription.  It has been demonstrated that a second bicoid site upstream of a reporter 
gene will increase the transcription by 10 fold in comparison to one bicoid site (Sauer et 
al., 1995a; Sauer et al., 1995b).  A third bicoid binding site has little impact but a third 
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bicoid site and a Hunchback site leads to a 65 fold increase in transcription.  This appears 
to be due to the fact that hunchback and bicoid are able to interact with different TAF’s 
of the TFIID complex.  Bicoid is able to interact with both TAFII110 and TAFII60 using 
two separate domains (Sauer et al., 1995a).  Hunchback is able to bind to TAFII60 (Sauer 
et al., 1995b).  When any of these interactions are disrupted the synergy is lost.  
Therefore, it appears that different combinations of hunchback and bicoid recruit multiple 
compontents of the TFIID complex and this leads to the synergistic assembly of the PIC 
at the neighboring promoter.  It is likely that the activation of eve from the stripe 2 CRM, 
even at a low concentration of bicoid, is due to the synergistic recruitment of the PIC by 
the 3 potential pairs of factors on the CRM’s 6 high affinity binding sites (5 bicoid and 1 
Hb). 
 
     By contrast, the repressor activity of hunchback may be due to its interaction with 
another coregulator, dMi-2 (Tautz 1988).  Hunchback is able to bind dMi-2 with a 
conserved D domain and this domain is required for its activity as a repressor.  In 
addition, in the absence of dMi-2 Hunchback’s repression of downstream HOX factors 
has been shown to be derepressed.  In Drosophila, dMi-2 has been shown to interact with 
the Polycomb Group Proteins (Kehle et al, 1998) that lead to gene silencing by chromatin 
remodeling.  In Xenopus, Mi-2 has been found associated with a histone deacetylase 
complex (Wade et al, 1999).  Therefore, it is likely that Hunchback acts as a repressor 
through its interaction with dMi-2 and potentially other coregulators.  It is unclear how it 
is determined which partner Hunchback will interact with.  At least early in the embryo 
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dMi-2 is ubiquitously expressed (Khattak et al, 2002), so the availability of dMi-2 is not 
the limiting factor in the central embryo where hunchback acts as an activator.  There are 
likely to be other cofactors that are influencing where and when Hunchback will interact 
with dMi-2 or TAFII60.   
 
     Thus far this discussion has focused on the regulatory networks involved in the 
expression of a single gene at a single time in development.  However, this is just a small 
step in the program of development and the outcome of this network’s control of eve’s 
expression becomes just a single input in downstream networks.  For example, one of 
eve’s primary roles is to indirectly regulate the expression of engrailed, a segment-
polarity gene, that will establish rigid borders between the stripes (Manoukian and 
Krause 1993; Kuhn et al, 2000).  This regulation is dictated by the further refinement of 
eve’s expression to the more anterior region of each stripe and the expression of fushi 
tarazu (ftz) in the more posterior (Manoukian and Krause, 1992).  This results in14 
narrow parasegments, 7 alternating eve and ftz stripes, that will coincide with the 14 
segments of the adult body plan.  The graded expression of eve, a repressor, from anterior 
to posterior will help to maintain engrailed as off.  In the 7 alternating posterior segments 
the expression of engrailed will be activated by ftz.  However, even this expression is 
only in the very posterior nuclei of each stripe, creating a stark contrast between the 
parasegments.  In summary, the expression of a single gene is the result of a vast network 
of influences.  The CRMs that regulate expression decode all of the available temporal 
and spacial information in order to determine a given outcome.  However, it must not be 
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lost that this is just a node, a single piece of information, in a higher network that may 
coordinate a cell’s matabolism, a cell to cell signal, or even the development of an entire 
organism. 
 
Identifying regulatory elements in metazoans 
     The identification of cis-regulatory sequences throughout the genome and their 
complementary transcription factors is obviously a powerful step in deconstructing the 
mechanism of spatial and temporal gene regulation.  This has been eloquently 
demonstrated in the early segmentation of the Drosophila embryo.  For the investigation 
of the TF-CRM relationship in other pathways, the majority of sequence-specific 
transcription factors in a genome can be readily identified by sequence homology to 
members of previously identified families of DBDs. This type of identification has 
revealed that typically 5 to 10 percent of the protein coding genes within a eukaryotic 
genome are TFs, with more complex organisms containing a higher proportion of TFs, 
presumably due to the requirement for more elaborate regulatory networks to control 
greater cellular complexity (Levine and Tjian, 2003). However, the number of CRMs 
within a genome that contain binding sites for these factors is hard to define due to the 
difficulty in identifying these elements based on sequence features alone (Ludwig et al., 
1998)  and, for more complex organisms, because this number presumably far exceeds 
the number of genes within the genome (Siepel et al., 2005).  Therefore, defining the 
subset of functional interactions between these two groups - TFs and CRMs - is a 
complex problem in higher eukaryotes, where the vast majority of DNA is non-coding 
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sequence. For example, the regulatory network that controls the anterior-posterior 
segmentation of the Drosophila embryo utilizes less than 40 transcription factors and 
took several decades of meticulous genetic study to deconvolute.  By comparison, the 
human genome contains potentially 2,000 TFs or more that are involved in countless 
overlapping regulatory networks presenting an enormous challenge to the decoding of the 
networks that define gene expression in higher eukaryotes. 
 
     Fortunately, biochemical and computational methods for the identification of CRMs 
within the genome have been developed that are beginning to fulfill this goal, yet 
limitations remain.  Biochemical methods based on genome-wide location analysis or 
“ChIP-chip” (Harbison et al., 2004; Lee et al., 2002; Zeitlinger et al., 2007), nuclease 
hypersensitive sites (Crawford et al., 2004; Sabo et al., 2004) and 5C (Dostie and Dekker, 
2007; Dostie et al., 2006) allow the identification of functional elements throughout the 
genome.  However, these techniques are limited typically to cell types that can be 
obtained in sufficient quantities for each protocol and, with the exception of ChIP-chip, 
cannot associate specific TFs with an identified CRM.  The ChIP-chip approach, though 
able to make the TF-CRM association, requires an antibody specific to the TF of interest 
limiting the breadth of this protocols potential application.  Furthermore, identification of 
genomic binding sites by ChIP-chip does not reveal whether those sites are functional; 
binding sites that are occupied in vivo may not contribute to organismal fitness, as long as 
they do not have negative consequences (Gao et al., 2004; Zeitlinger et al., 2007).  An 
alternative is to take a gene centered approach whereby a set of genomic sequences can 
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be used to screen a pool of TFs by a yeast one-hybrid assay (Deplancke et al, 2004; 
Deplancke et al, 2006).  Because the yeast one-hybrid assay requires activation of a 
reporter gene, functional pairs determined by this method are likely to be representative 
of the functional interactions in vivo.  However, how a TF is binding within a genomic 
sequence may be difficult to ascertain.  
 
     Computational methods to identify CRMs have focused primarily on two types of 
approaches: Phylogenetic footprinting and Binding site cluster analysis.  Phylogenetic 
footprinting, where short conserved sequence blocks in non-coding sequence between 
species are used as surrogates for TF binding sites (McCue et al., 2002; Lenhard et al., 
2003; Grad et al., 2004), can identify regions of a genome between closely related species 
that may be under stabilizing selection, a property of CRMs. However, this approach 
does not a priori associate TFs with identified CRMs.  CRMs can also be 
computationally identified by searching for binding site clusters, groups of binding sites 
for TFs that function in a common transcriptional regulatory network, within sequence 
windows on the order of 500 bp (Berman et al., 2002; Lifanov et al., 2003; Markstein et 
al., 2002; Rajewsky et al., 2002; Sosinsky et al., 2003).. The accuracy of these predictions 
can be improved by incorporating phylogenetic comparisons between species separated 
by moderate evolutionary distances (Schroeder et al., 2004; Sinha et al., 2004).   
 
     The prediction of CRMs and their cognate factors via binding site cluster analysis has 
been most thoroughly studied in the context of the regulatory cascade driving anterior-
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posterior segmentation of the Drosophila embryo.  The detail with which this pathway 
has been documented allows for a level of validation in the predictions a given method is 
able to make.  However, even for this carefully studied regulatory network the 
architecture of CRMs neighboring genes within this regulatory cascade and the binding 
sites for the controlling factors are incompletely defined (Arnosti, 2003; Arnosti et al., 
1996). The DNA-binding specificity of many prominent TFs involved in this process is 
imprecisely defined (e.g. Slp1, Kni, D & Tll), and though the majority of TFs can be 
identified by sequence homology alone, their DNA-binding specificities typically cannot 
be directly inferred based on amino acid sequence unless a direct homolog of the factor 
has been characterized. This dearth of DNA-binding specificities for factors involved in 
this regulatory cascade, has limited the scope of binding site cluster analysis for the 
identification of novel CRMs. Nonetheless, position weight matrices (PWMs) for subsets 
of the TFs involved in this regulatory network have been successfully utilized to identify 
novel CRMs (Berman et al., 2002; Berman et al., 2004; Rajewsky et al., 2002; Schroeder 
et al., 2004).  A more complete set of specificities for factors in this pathway should 
provide a powerful database for the prediction of CRMs utilized by these early 
embryonic regulators.   
 
      Binding site cluster analyses followed by a phylogenetic filter will no doubt become a 
more and more powerful methodology as additional genomes are sequenced, but this 
approach is only possible if the DNA-binding specificities for the set of TFs of interest 
are defined.  Therefore, the limited number of available TF DNA-binding specificities is 
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clearly a major hurdle to deconstructing the network of TF-CRM pairings in a genome.  
This limitation could be addressed by the implementation of a high throughput system for 
determining TF specificity.  Furthermore, the determination of specificities that require a 
biological activation are likely to be a closer representation of a TF functional in vivo 
specificity in comparison to purely in vitro methods.  These “functionally” determined 
specificities could be used to filter which ChIP-recovered sequences are likely to be 
functional in a genome-wide location analysis.  In addition, specificities for large sets of 
factors within a common DBD family might allow for the generation of a recognition 
code for that domain family.  Such a code could allow for the prediction of specificities 
in other genomes that alleviate the need to experimentally characterize every like factor 
in other genomes.  The combination of expression data, genome-wide location analysis 
and TF specificities would provide a powerful combination of data for the prediction of 
CRMs.  A high throughput method for the determination of DBD specificities would 
therefore make a great contribution to our understanding of regulatory networks. 
 
Characterizing Transcription Factor Specificity 
     The small proportion of TFs with well-characterized DNA-binding specificities is not 
limited to Drosophila; this state of knowledge is representative of the majority of 
eukaryotic genomes.  This void reflects the absence of a readily accessible high-
throughput method for characterizing the specificity of factors. Various methods have 
been developed for the characterization of sequence-specific DNA-binding domains.  
Traditional in vitro methods such as DNase I footprinting (Bergman et al., 2005) and 
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SELEX (Ellington and Szostak, 1990; Roulet et al., 2002; Tuerk and Gold, 1990; Wright 
and Funk, 1993), are cumbersome to employ at a genome-wide level for TFs in a 
complex eukaryotic genome such as Drosophila, which contains ~750 sequence specific 
TFs.  Other methods such as ChIP-chip and DIP-chip have been employed on a case-by-
case basis, but have not yet been scaled for high-throughput analysis of protein-DNA 
interactions (Harbison et al., 2004; Lee et al., 2002; Lieb et al., 2001; Zeitlinger et al., 
2007).  Protein binding microarrays provide one potential approach for characterizing a 
wide-variety of TFs (Berger et al., 2006; Bulyk et al., 2001; Linnell et al., 2004; 
Mukherjee et al., 2004).  This platform, while powerful, has certain barriers that may 
limit its widespread adoption as a technology: it requires protein purification of each 
factor that is being characterized and the synthesis of custom microarrays used in the 
analysis.   
 
     Previous studies have demonstrated that bacteria provide an attractive platform to 
assay protein-DNA interactions that would not require protein purification.  The 
Hochschild lab demonstrated that a reporter gene could be activated in bacteria by the 
DBD-mediated recruitment of the RNAP holoenzyme to a specified promoter (Joung et 
al., 1993; Joung et al., 1994; Dove et al., 1997; Dove and Hochschild, 1998).  They also 
demonstrated that this recruitment could be mediated by a direct fusion to the omega 
subunit (one-hybrid interaction; Dove and Hochschild, 1998) or an indirect contact 
through an alternative protein-protein interaction such as the GAL4-GAL11P interaction 
(two-hybrid interaction; Dove et al., 1997; Dove and Hochschild, 1998) (Figure 1.4A, B).  
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Figure 1.4 
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Figure 1.4.  Schematic of bacterial one and two-hybrid systems.  A. One-hybrid 
activation.  The Hochschild lab demonstrated that a transcription factor fused directly to a 
subunit of RNAP (here an omega fusion is shown) could activate transcription of a 
reporter gene if the recognition sequence for that TF was placed in an appropriate 
position upstream of the promoter.  B.  Two-hybrid activation.  The Hochshild lab also 
demonstrated this same type of activation can be mediated by a protein-protein 
interaction such as the GAL4-GAL11P interaction.  Here the TF is fused to GAL11P and 
the C-terminal domain of the alpha subunit has been replaced by the dimerization domain 
of GAL4.  C. Two-hybrid selection.  The Pabo lab was able to show that zinc fingers with 
novel specificity could be selected from pools of randomized zinc fingers through the 
GAL4-GAL11P mediated activation (the rainbow color indicates a library of random 
clones).  D.  One-hybrid binding site selection.  The Wolfe lab demonstrated that 
activation mediated by the direct fusion of a transcription factor of interest to the alpha 
subunit could be utilized to select functional sequences from a library of randomized 
DNA upstream of a reporter.   
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Later, the Pabo lab demonstrated that DNA-binding domains with novel specificities 
could be selected from large libraries using a similar system (Joung et al., 2000) (Figure 
1.4C).  This later system demonstrates the advantages that the high transformation 
efficiency and fast growth rate of bacteria provide for the selection of library members 
with unique attributes from a large randomized pool.  In addition, this bacterial two-
hybrid system introduced the yeast HIS3 gene as the reporter.  In cells that have the 
bacterial hisB gene knocked out, this reporter makes survival dependant on its activation 
when plated on media that lacks histidine.  This allows for the screening of libraries 
greater than 108 on a single petri dish.  Finally, the system was modified by Meng et al. to 
determine DNA-binding specificities of different DBDs by selecting binding sites from a  
library of DNA sequences upstream of the promoter (Meng et al, 2005) (Figure 1.4D).  
Here, the DNA-binding domain of interest was expressed as a direct fusion to the α 
subunit of RNA polymerase.  In addition, a second reporter, the yeast URA3 gene, was 
installed downstream of the HIS3 gene.  This was necessary because the large library of 
DNA sequences could easily contain a large number self-activating sequence such as 
“up-elements”.  The URA3 gene allows for a counter-selection in the presence of 5-
fluoroorotic acid and therefore removal of sequences that activate independently of a 
DNA-binding domain. 
    
     We have previously described a bacterial one-hybrid (B1H) system for the rapid 
characterization of transcription factor specificity (Meng et al., 2005; Meng and Wolfe, 
2006).  This technology has certain attributes that make it suitable as a platform for the 
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genome-wide analysis of DNA-binding domain specificities.  The bacterial selection 
precludes the need to purify any given factor.  Binding sites for a factor are isolated in a 
single round of selection where multiple selections can be performed in parallel, which 
provides an avenue for the high-throughput analysis of factors.  Standard molecular 
biology and sequencing technologies are employed, making the technology accessible to 
most laboratories. 
 
     Herein we describe substantial improvements to the B1H system that increase its 
sensitivity and dynamic range, which make it amenable for the high-throughput analysis 
of sequence-specific TFs. Currently we have characterized 108 (14.3%) of the predicted 
TFs in Drosophila, demonstrating the feasibility of characterizing a large number of TFs 
using this technology. These characterized factors fall into a broad range of DBD families 
that are commonplace in eukaryotic genomes, including the five most common found in 
humans: Cys2His2 zinc finger, homeodomains, bHLH, bZip and Forkhead domains.  Our 
overall success rate for characterization of individual factors using this system is 
currently >95%.   
 
    One of our groups of characterized factors is focused around those that play important 
roles in early A-P patterning with previously uncharacterized or poorly defined 
specificities.  This dataset dramatically expands the set of defined specificities for these 
factors. In individual tests, the PWMs for the set of maternal, gap and terminal factors, 
for which a large number of target CRMs have already been identified, show strong 
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correlations between the expression pattern of the TF and the enrichment of their binding 
sites in CRMs that regulate gene expression in neighboring or overlapping positions 
within the embryo. To fully exploit this large database of binding specificities, we have 
created a GBrowse-based search tool (Stein et al., 2002) that allows an end-user to 
examine the overrepresentation of binding sites for any number of individual factors as 
well as combinations of these factors in up to six Drosophila genomes 
(veda.cs.uiuc.edu/cgi-bin/gbrowse/gbrowse/Dmel4).  Peaks of significant binding site 
overrepresentation for combinations of gap and maternal TFs are found in the majority of 
characterized CRMs regulated by these factors.  This search tool has also been enabled to 
allow the end-user to search the fly genome for the most significant peaks of 
overrepresentation for combinations of factors. Using this tool with the PWMs for 
anteriorly expressed TFs, we find a remarkable correlation between the strongest hits in 
the genome and previously characterized anterior stripe CRMs, as well as a number of 
interesting predictions of potential novel CRMs neighboring genes with confirmed 
anterior expression patterns. Fundamental questions of how combinations of factors act at 
individual enhancers to produce diverse patterns of gene expression during development 
can potentially be addressed within the framework of this system. Thus, the combination 
of this tool and the dataset provided by our high throughput B1H system can be used as a 
test-bed for dissection of the TF/CRM combinations that control gene expression during 
fly development.  As more PWMs for factors are added to the dataset, this should provide 
a framework for efforts to computationally map CRMs in the fly on a comprehensive 
scale. 
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    To demonstrate the feasibility of characterizing an entire class of DBDs, we also 
characterized all of the independent homeodomains within the fly genome.  This subset 
of factors provides a powerful basis set for predicting the specificities of homeodomains 
throughout eukaryotic genomes.  Herein we provide a complete catalog of specificities 
for all 84 homeodomains in Drosophila that are not associated with an additional DNA-
binding domain and use the rich experimental history of homeodomain studies in 
Drosophila to help interpret this dataset. The binding specificities of these factors can be 
clustered broadly into eleven specificity groups that encompass the majority of these 
factors.  Homeodomains within these clusters typically share common recognition 
residues; coupled with previous structural and biochemical work on the homeodomain 
family, this data provides a global perspective on the specificity determinants within this 
family.  Based on these observations we propose and test a detailed set of recognition 
rules for homeodomains and use this information to predict the specificities of the 
majority of homeodomains in the human genome.  Furthermore, the Drosophila PWMs 
and the human homeodomain predictions are made available at 
http://ural.wustl.edu/flyhd/.  The user is also able to input any homeodomain sequence 
from any genome and a specificity prediction will be made if by comparison to 
Drosophila factors in our set it is found similar enough with regards to both overall 
sequence similarity and the identity at key recognition residues.  These predictions will 
become more robust as diverse homeodomain specificities from other genomes are 
characterized and as the number sequences from a given selection are increased.  This 
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could be done by deep sequencing pools of selected clones to provide a potential 10 to 
100 fold increase in the number of sequences currently used in each PWM. 
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CHAPTER II:  CHARACTERIZATION OF A BACTERIAL ONE-
HYBRID SYSTEM FOR THE DETERMINATION OF DNA-
BINDING SPECIFICITY 
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Introduction 
 
The identification of cis-regulatory sequences throughout the genome and the 
complementary sequence-specific trans-acting factors that bind within these modules is 
an important step in deciphering the mechanism of spatial and temporal gene regulation 
in metazoans. The majority of sequence-specific transcription factors (TFs) in a 
eukaryotic genome can be readily identified by sequence homology to previously 
identified families of DNA-binding domains, where complex organisms usually contain a 
higher proportion of TFs (~5 to 10%) due to the requirement for more elaborate 
transcriptional regulatory networks (Levine and Tjian, 2003). However, identifying cis-
regulatory modules (CRMs) within a genome is difficult due to the more dynamic nature 
of these sequences relative to coding sequences (Ludwig et al., 1998) and the fact that the 
vast majority of DNA in higher eukaryotes is non-coding sequence (Siepel et al., 2005).  
CRMs have been computationally identified by searching for overrepresented clusters of 
binding sites within the genome for groups of TFs that function in a common 
transcriptional regulatory network (Berman et al., 2002; Lifanov et al., 2003; Markstein 
et al., 2002; Rajewsky et al., 2002; Sosinsky et al., 2003). The accuracy of these 
predictions can be improved by incorporating phylogenetic comparisons between species 
separated by moderate evolutionary distances (Schroeder et al., 2004; Sinha et al., 2004).  
However, this approach is hindered by the general lack of transcription factor specificity 
data. 
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The small proportion of TFs with well-characterized DNA-binding specificities is not 
limited to D. melanogaster. This incomplete state of knowledge is representative of the 
majority of eukaryotic genomes and reflects the absence of high-throughput studies of 
factor specificities. in vitro methods for characterizing specificity include DNaseI 
footprinting (Bergman et al., 2005), SELEX (Ellington and Szostak, 1990; Roulet et al., 
2002; Tuerk and Gold, 1990; Wright and Funk, 1993), and protein binding microarrays 
(Berger et al., 2006; Bulyk et al., 2001; Linnell et al., 2004; Mukherjee et al., 2004).  All 
of these techniques require protein purification, limiting their application as a high-
throughput methodology.  To date, these methods have not been widely adopted for 
large-scale analysis of TF specificities. In addition, it remains unclear whether the off-
rate measurements obtained via some of these in vitro methods are representative of the 
in vivo recognition properties of these factors (Berger et al., 2006).  
 
TF specificities can also be identified as overrepresented motifs within DNA 
sequences identified in genome-wide TF ChIP datasets (Harbison et al., 2004; Lee et al., 
2002; Lieb et al., 2001; Zeitlinger et al., 2007). When applied to the comparatively 
simple yeast genome, this approach successfully identified high confidence motifs for 65 
of 203 (32%) TFs (Harbison et al., 2004). The inability to determine specificities for the 
majority of these factors may reflect the difficulty in identifying motifs within the larger 
sequence segments defined by ChIP experiments and the complications associated with 
TFs that bind DNA in complexes with one or more other TFs.  
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We have previously described a bacterial one-hybrid (B1H) system for the rapid 
characterization of TFs (Meng et al., 2005; Meng and Wolfe, 2006).  This technology has 
certain attributes that make it suitable as a platform for the genome-wide analysis of 
DNA-binding domain specificities.  Selections are performed in vivo, which precludes 
the need to purify any given factor. Moreover, binding sites are isolated based on their 
ability to activate a biological response in the context of competition from a pool of 
potential sites in the E. coli genome, which simulates the functional requirements in a 
eukaryotic genome. Binding sites for a factor are isolated in a single round of selection 
using standard molecular biology and sequencing technologies, making it accessible to 
most laboratories.  Here, we describe substantial improvements to the B1H system that 
increase its sensitivity and dynamic range, and make it amenable for the high-throughput 
analysis of sequence-specific TFs (Figure 2.1). Using this system, we have determined 
specificities for 108 (14.3%) of the predicted TFs in D. melanogaster. These factors 
represent a broad range of DNA-binding domain families that are commonplace in 
eukaryotic genomes. Thus far, we have focused on two groups of factors. One group 
represents all of the independent homeodomains within the fly genome, which provides a 
basis for predicting the specificities of homeodomains throughout the eukaryotic 
kingdom (see Chapter 4).  Members of the other group play prominent roles in early A-P 
patterning (see Chapter 3).  Our dataset dramatically expands the set of defined 
specificities for these factors and these motifs are good predictors of CRMs throughout 
the genome.  
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Figure 2.1 
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Figure 2.1.  Overview of the omega-based B1H system.  A.) Cartoon depicting 
recruitment of direct omega fusions (left) and omega-Zif12-HD fusions (right) to the 
weak promoter driving the HIS3 and URA3 reporters used in this system.  The 28 base 
pair library is positioned 7 bases upstream of the -35 box allowing the TF to bind to a 
recognition element up to 3 turns upstream of the promoter.  The ZF10 library has the 
binding site for Zif12 (TGGGCGG) positioned 21 bases upstream of the promoter and 
the 10 base pair randomized region is located immediately 5’ to this site.  B.) Overview 
of Bait and Prey plasmids used in this system.  Bait plasmids are constructed by cloning 
the TF of interest as a C-terminal fusion to omega (omega-TF hybrid).  Homeodomains 
are cloned into a modified bait plasmid (pB1H2ω2-12) that results in their expression as 
an omega-ZF12-HD hybrid.  C.)  Binding site selection procedure.  A bait plasmid and 
the appropriate prey plasmid are transformed into the selection strain.  Transformants are 
grown on minimal media lacking histidine and challenged with various concentrations of 
3-AT.  Surviving colonies represent a complementary interaction between the bait 
plasmid (TF) and a single member of the prey library.  The library region from 
approximately 20-25 surviving colonies are amplified by colony PCR and sequenced.  
The resulting sequences are analyzed by MEME (Bailey and Elkan, 1994) to recover the 
TF’s recognition motif.  
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Results 
 
Our original B1H system for characterizing DNA-binding specificity utilized TF 
fusions to the alpha-subunit of RNA polymerase (alpha-TF) (Meng et al., 2005; Meng 
and Wolfe, 2006).  This system contained three components:  the alpha-TF expression 
vector, a tandem HIS3-URA3 reporter cassette in a low copy number plasmid (pH3U3), 
and the selection strain with the bacterial homologs of the reporter genes inactivated 
(ΔhisB, ΔpyrF). The HIS3-URA3 reporter cassette is regulated by a weak promoter and 
consequently these genes, which provide a direct method for auxotrophic selection, are 
only weakly transcribed.  However, when a functional binding site for the alpha-linked 
TF is present upstream of the weak promoter, RNA polymerase can be actively recruited 
to stimulate transcription of the reporter cassette (Dove et al., 1997).  Thus, bacteria 
harboring a complementary interaction between the TF and reporter DNA can be selected 
under appropriate growth conditions, which permits binding sites complementary to a TF 
to be isolated from a randomized library introduced into the reporter vector. Our alpha-
based system, while suitable for characterizing factors such as Cys2His2 zinc finger 
proteins, proved ineffective with several basic helix-loop-helix proteins (bHLH) and 
homeodomains. The origin of this limitation was unclear, but one potential source was 
insufficient sensitivity: Alpha is an essential gene, and as such, alpha-TF fusions are in 
competition with endogenous alpha for incorporation into RNA polymerase complexes.  
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Omega is the only conserved component of bacterial RNA polymerase (α2ββ’ω) that 
is not required for viability under laboratory growth conditions (Gentry and Burgess, 
1989). Hochschild and colleagues demonstrated that in artificial interactions between a 
sequence-specific TF and the omega-subunit of RNA polymerase, like interactions with 
the alpha-subunit, could mediate activation of a nearby promoter (Dove and Hochschild, 
1998). Because Omega is not required for viability, Omega-fusions have the potential 
advantage that selections might be performed in an omega-knockout (ΔrpoZ) strain, 
where omega-fusions could be uniformly incorporated into RNA polymerase without 
competition.  Under these conditions the selection system should be more sensitive due to 
the higher cellular concentration of RNAP-TF complexes, allowing weaker protein-DNA 
interactions to be characterized. 
 
To test this hypothesis we knocked-out the rpoZ gene in our selection strain (Figure 
2.2) and examined the activity of an omega-Zif268 fusion with a reporter vector 
containing a Zif268 binding site. The fusion was expressed using three promoter 
strengths:  the dual promoter used in the original alpha-based system (lppC-lacUV5), a 
lacUV5 promoter and a mutant lacUV5 promoter (lacUV5m) (Figure 2.3). Omega-Zif268 
expressed via the weakest (lacUV5m) promoter displayed robust activity, allowing cells 
to survive at higher 3-AT concentrations than was tolerated by the alpha-Zif268 fusion 
under optimal expression conditions.  Surprisingly, omega-Zif268 constructs expressed 
with either the dual promoter or the lacUV5 promoter proved toxic. However, for other  
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Figure 2.2 
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Figure 2.2.  PCR products of rpoZ locus.  These loci were disrupted by knock-in or 
knockout following the recombination method detailed by Wanner (Datsenko and 
Wanner, 2000).  The PCR products generated from genomic DNA of our rpoZ cell types 
run on a 1.5% agarose gel.  Above each lane the insertion at the rpoZ locus of the 
particular cell type is listed.  Wt is the wild type rpoZ gene, Kan is the kanamycin 
cassette, Zeo is the zeocin cassette, and KO has the antibiotic cassette removed resulting 
in a complete removal of the rpoZ locus.  On the left side of the gel are the PCR products 
from the rpoZ 5’ primer and an internal omega primer (omega int 3’) that should only 
amplify the wt gene.  On the right side of the gel are PCR products using the two external 
primers described in the text, rpoZ 5’ and rpoZ 3’.  These give an indication of the 
relative size of the insertion/deletion at the rpoZ locus. 
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Figure 2.3 
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Figure 2.3.  Maps of the bait plasmids used in the omega-B1H system.  The maps of the 
bait plasmids used to characterize the TF reported here are displayed with key features 
annotated.  The plasmids allow a TF to be characterized at 3 different promoter strengths 
as direct fusions to omega or as fusions mediated by Zif268 fingers 1 and 2 (Zif12) by 
simply subcloning between the unique Kpn1 and Xba1 sites in each plasmid.  The linkers 
between the omega subunit or Zif12 and the TF are indicated below the plasmid sets.   
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factors (Paired, Hunchback and Giant) higher expression levels achieved through the 
stronger promoters were required to fully activate the reporter system (Figure 2.4). The 
difference in promoter strengths used to drive expression of each factor was reflected in 
the relative protein expression levels of each factor within the cell (Figure 2.5).  Thus, the 
availability of three different promoter strengths provides flexibility to characterize a 
wide variety of TFs that may differ in affinity, specificity and level of expression.  
 
The omega-based B1H system is sensitive to changes in the strength of the interaction 
between a DNA-binding domain and its target site.  The activity of omega-Zif268 with its 
consensus sequence was compared to three different variants of the binding site that have 
four to twenty-fold reduced affinity(Miller and Pabo, 2001). A clear correlation is 
observed between colony size and number with the quality of the binding site: cells 
containing the consensus sequence within the reporter displayed the highest rates of 
survival and the largest colonies relative to the survival rates and colony sizes for other 
sites with decreased affinity (Figure 2.6). Based on these results we expect that the 
distribution of sequences that are recovered from a binding site selection will be a 
function of the difference in affinity of the protein for these sites.  As a result the 
recognition motif constructed from the selected sites should accurately reflect the 
specificity of the factor.. The optimal position of the Zif268 binding site was determined 
by examining the activity of reporters harboring sites positioned in various registers 
relative to the promoter. Two peaks of maximal activity were observed for sites 
positioned either 10 bp or 21 bp upstream of the -35 box (Figure 2.7). 
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Figure 2.4 
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Figure 2.4.  Comparison of the activity of three different factors at three different 
promoter strengths. The activity of three different TFs (Paired, Hunchback and Giant) 
that represent three different families of DNA-binding domains (a Paired motif, a 
Cys2His2 zinc finger protein, and basic leucine zipper motif, respectively) were 
characterized on consensus binding sites for each factor at three different promoter 
strengths.  The optimal window of activity varied depending on the factor. Paired 
displays good activity when expressed from all three promoters (nearly 100% at 10 mM 
3-AT), with the lacUV5 promoter slightly superior to the other two.  Hunchback 
displayed weaker activity than Paired at all three promoter strengths, with the strongest 
activity again with the lacUV5 promoter. Giant displayed almost no activity when 
expressed under the lacUV5m promoter, which was optimal for Zif268, but strong 
activity when expressed from the other two promoters, with the dual promoter perhaps 
slightly superior. The reporter pH3U3 plasmids used in each case had the consensus 
binding site for each factor positioned at the most highly represented position relative to 
the -35 box based on B1H binding site selections.    The activity of the omega-TF hybrids 
with these reporters was examined on minimal media plates containing 3 different 
concentrations of 3-AT where the 2xYT rich media plate serves as a control for the 
number of cells plated in each set.  Each combination of expression plasmid and reporter 
plasmid was plated in duplicate, where each spot represents a 10-fold serial dilution of 
cells from left to right. 
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Figure 2.5 
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Figure 2.5.  Western blots of 3 ω-TF’s at 3 different promoter strengths.  Three factors, 
Prd, Hb, and Gt, each at 3 different promoter strengths were grown under inducing 
conditions (10 µM IPTG).  For each lane on the gel a normalized amount of each 
bacterial culture was created based on its OD600 and these cells were solubilized in SDS-
loading buffer.  A identical fraction of this sample was run on an SDS gel and the flag tag 
in each construct was visualized by Western blot.  Each factor is shown from left to right 
with decreasing promoter strength (lppC, lacUV5, and lacUV5m).  The approximate 
molecular weights of the omega-TF constructs are: Prd = 41.58kDa, Hb = 25.74kDa, Gt 
= 29.7kDa. 
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Figure 2.6a 
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Figure 2.6b 
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Figure 2.6.  Comparison of ω-Zif268 activity with 4 different binding sites.   A. Cells 
harboring the pB1H2ω2-Zif268 plasmid and one of 4 different pH3U3 plasmids were 
challenged at several 3-AT concentrations.  The pH3U3 plasmids contained one of 4 
Zif268 binding sites (GCGTGGGCG) placed 10 bp upstream of the -35 box with 
modifications in the finger 1 binding sequence.  The finger 1 sequence is listed to the left 
of each row and their previously determined relative Kds are GAG=4.9-fold over GCG, 
GCA=4.7-fold over GCG, and GGG=20.3-fold over GCG.  Cells were plated in triplicate 
and a representative plate is displayed here with the mean and standard deviation colony 
count is listed below.  B. A histogram displays the percentage of colonies that survive at 
each 3-AT concentration in comparison to non-selective conditions (0mM 3-AT) in 
green.  In yellow is the percentage OD600 that was measured from the cells pooled in 
liquid 2xYT media from each plate of different stringency. 
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Based on this analysis, a new 28 bp randomized binding site library was constructed to 
complement the omega-based B1H system.  This library encompasses the region 8 to 35 
bp upstream of the -35 box of the promoter, which spans these two peaks of activity.  The 
constructed library contains ~2 x 108 unique clones, and though this clearly does not 
cover the hypothetical complexity of a randomized 28 bp region (7.2 x 1016), it should 
encode nearly all of the possible 12 bp sites in each frame of the binding site window. 
Like the previously described 18 bp randomized library (Meng et al., 2005), a small 
proportion of the 28 bp randomized library consists of self-activating sequences.  The 
population of self-activating sequences was reduced by performing a URA3 based 5-
FOA counter-selection (Meng et al., 2006), which reduced the number of self-activating 
sequences to 1 in 106 at a typical selection stringency (10 mM 3-AT).   
 
The utility of the 28 bp library in the omega-B1H system was assessed by 
determining the DNA-binding specificity of three well-characterized DNA-binding 
domains: Zif268, Mig1 and Rap1. Complementary sequences within the 28 bp 
randomized library to each TF were isolated under selective conditions (10 mM 3-AT).  
Each factor yielded a significant increase (>10-fold) in the number of surviving colonies 
over background when compared to a negative control (omega without a fusion partner). 
The recognition motif for each factor generated from approximately 20 selected 
sequences matches well with previously described specificities for these factors (Figure 
2.8).  Thus, the omega-based B1H system and the new 28-bp binding site library can be 
used to rapidly determine the DNA-binding specificity of a TF. 
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Figure 2.7 
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Figure 2.7.  The omega subunit and the positions utilized by omega-TF hybrids.  A.  The 
structure of RNA Polymerase bound to DNA.  Top.   An upstream view of the RNAP 
shows the relative positions of the C-termini of both alpha subunits (green and avocado) 
and the omega subunit (yellow).  The position of the omega subunit is rotated about the 
DNA by about 30 degress relative to the nearest alpha subunit.  Bottom.  Measurements 
from the nearest alpha subunit and omega subunit C-termini to the DNA roughly one turn 
upstream of the -35 box reveals that the omega subunit is approximately 20Å closer to 
the DNA.  B.  The survival frequency of cells under stringent conditions harboring the 
pB1H2ω2-Zif268 plasmid and a reporter pH3U3 plasmid with the Zif268 consensus 
binding site placed at various distances from the -35 box reveals two clear peaks of 
activity at approximately 10 and 21 bp upstream. Ostermeier and colleagues observed a 
peak of activity for a site positioned 14 bp away from -35 box of the alpha-B1H system, 
which could be the result of differences in the positions of the polymerase subunits 
relative to the DNA (Durai et al., 2006) C.  A comparison of the binding site positions of 
four factors characterized with the omega-B1H system.  Some factors have a clear 
preference for a specific distance from the -35 box (Zif268, Hb, and Odd) and these 
distances differ from one factor to another (Hb sequences are centered 9 or 10 bp from 
the -35 box while Odd sequences are centered almost exclusively 16 or 17 bp away).   
There are other factors such as Hairy that utilize almost the entire library window.  
(*sequences that came through 27 and 28 basepair from the -35 box are utilizing a fixed 
region of the pH3U3 plasmid and could be a reason for the peak here.  These sequences 
were not used for the construction of the Hairy logo).   
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Figure 2.8 
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Figure 2.8.  Comparison of Zif268, Mig1 and Rap1 logos. The DNA-binding domains of 
all three factors were expressed (lacUV5m) as C-terminal fusions to the omega subunit. 
Approximately 20 reporters were sequenced from each binding site selection and binding 
sites were determined by identifying overrepresented motifs within these sequences using 
MEME (Bailey and Elkan, 1994).  The logos identified for each factor as an omega-TF 
fusion are compared to logos generated for these factors by other methods.  The 
TRANSFAC logos were generated from the available PWMs at TRANSFAC (Matys et 
al., 2003).  The Zif268 logo is compared to the logos from characterization as an alpha-
Zif268 hybrid (Meng et al., 2005) and from in vitro SELEX data (Wolfe et al., 1999).   
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Despite these successes, binding site selections with Engrailed, a member of the 
homeodomain family, did not yield a motif.  Since homeodomains represent the second 
largest family of TFs in the genomes of higher eukaryotes (Tupler et al., 2001), this 
failure represented a significant limitation for a comprehensive analysis of factor 
specificities.  Because Engrailed recognizes a modest 6 bp element, we reasoned that 
competitive binding to the thousands of perfect recognition sequences that are present in 
the E. coli genome could act as a sink reducing the free pool of omega-Engrailed fusions.  
To increase the specificity of the homeodomain fusion protein we found inspiration in the 
studies by Pabo and colleagues, which demonstrated that increases in specificity are 
obtained when two DNA-binding domains are joined by a short linker (Klemm and Pabo, 
1996).  They developed synthetic a transcription factor - ZFHD1, a chimera of fingers 1 
and 2 of Zif268 (Zif12) and the homeodomain of Oct1. This fusion displays superior 
specificity to either of its component parts (Pomerantz et al., 1995).  Correspondingly, 
B1H binding site selections using an omega-Zif12-Oct1 hybrid yielded a pair of motifs 
consistent with the specificity of both DNA-binding domains (Figure 2.9).  Thus, the 
omega-Zif12 scaffold can be used to select binding sites for homeodomains and 
presumably other factors with smaller recognition sequences. Since the Zif12 component 
would be constant in all selections using this scaffold, a complementary randomized 
library was constructed with the recognition motif for the Zif12 module positioned 
neighboring a 10 bp randomized library (Figure 2.1a). The “ZF10” library contains ~8 x 
106 unique clones and is of adequate length to encompass the recognition sequence of a 
standard homeodomain with extra sequence diversity (unselected flanking sequence) to  
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Figure 2.9 
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Figure 2.9.  The ZFHD1 model.  A. (left) Cartoon depicting the omega-ZFHD1 construct 
interaction with a reporter with a 18 bp randomized window and (right) one that has a 
fixed binding site for the Zif12 DBD.  B and C.  The logos resulting from the ZFHD1 
selection using the 28 bp library as determined by MEME (B. searches for one motif) and 
by BioProspector (Liu et al., 2001) (C. searching for 2 separate motifs).  D.  
Chromatogram of the ZF10 library, the 10bp randomized region and the Zif12 binding 
sites are indicated.  E.  The logo resulting from the ZFHD1 selection on the ZF10 library. 
5x107 bacteria containing the ZF-10 library and the omega-Zif12-Oct1 expression vector 
were selected on minimal medium lacking histidine and containing 10 mM 3-AT.  
Approximately 2000 colonies survived the selection, which represented a > 100-fold 
increase over the number of surviving clones in the omega-Zif12 negative control. 
MEME analysis of 22 unique sequenced clones recovered a motif consistent with the 
specificity of Oct1 from 22 of 22 sequences (Verrijzer et al., 1992).    
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allow unique clones containing the same core binding site to be identified.  Selections 
with omega-Zif12-Oct1 and the ZF10 library yielded a motif consistent with the 
specificity of Oct1 ((Verrijzer et al., 1992); Figure 2.9).   
 
Large-scale analysis of D. melanogaster TFs 
To demonstrate that this technology is sufficiently rapid and simple to perform a 
comprehensive characterization of the TFs we focused on two groups of factors from the 
D. melanogaster genome:  all of the factors from a certain DNA-biding domain family 
(84 homeodomains, see Chapter 4) and all of the factors in a common regulatory network 
(36 A-P embryonic patterning, see Chapter 3).  The former set provides a survey of the 
breadth of specificities that are observed for a particular family, while the later provides a 
basis set for testing the utility of B1H-generated PWMs for the prediction of CRMs 
throughout the genome.  
 
Discussion 
 
We have developed an omega-based B1H system that allows the high throughput 
determination of TF DNA-binding specificity.  This system has several advantages over 
other techniques for characterizing DNA-binding specificity.   First, the use of E. coli as 
our platform allows the isolation of complementary TF - binding site combination in vivo 
in a single round of selection using relatively simple techniques.  Because E. coli 
demonstrate an extremely high transformation efficiency, randomized binding site 
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libraries with complexity greater than 10^8 members can be utilized. Perhaps the greatest 
advantage realized by this system is the flexibility provided by utilizing omega-TF 
hybrids, as the absence of competition from endogenous omega has resulted in an 
extremely sensitive selection system with a much greater dynamic range than previous 
systems (Durai et al., 2006; Meng et al., 2005). This sensitivity has allowed us to 
successfully characterize TFs that failed to generate motifs in the alpha-based B1H 
system.   
 
Using this system we have determined recognition motifs for ~14% of the predicted 
D. melanogaster TFs. For comparison the FlyREG database contains motifs for 53 TFs 
constructed from 5 or more identified binding sites (Bergman et al., 2005); thus our 
database doubles the number of specificities that are available, and in cases where these 
databases overlap, our data is typically of higher quality. The rate of successful TF 
characterization within this system (101 of 102) makes it amenable to perform 
comprehensive surveys of TF specificity in complex organisms: once cloned, ten or more 
factors can be analyzed in parallel in the B1H system in a matter of days. Our current 
dataset is focused primarily on monomeric DNA-binding domains, but also includes 
homodimers and heterodimers.  This reductionist approach overlooks the potential for 
sets of factors to cooperatively recognize motifs that are not a simple composite sites 
formed from their individual motifs, such as the Exd-Hox combinations that play critical 
roles in specification during development (Pearson et al., 2005; Ryoo and Mann, 1999; 
Wilson and Desplan, 1999).  These types of combinations can potentially be 
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characterized using the B1H system, as complementary vectors for the characterization of 
heterodimers have been developed (Meng et al., 2005; Meng and Wolfe, 2006).  
However, some criteria for choosing sets of factors to be evaluated must be applied 
because of the combinatorial issues involved with testing all possible pair-wise 
combinations.  
 
Experimental Procedures 
 
Construction and genotype of the ΔrpoZ Selection Strain 
     The omega selection strain was created by knocking out the rpoZ gene from the 
selection strain used with the alpha-based B1H system (Meng et al., 2006): 
SB3930 lac-, ΔhisB463, ΔpyrF [F´ proAB lacIqZ M15 Tn10 (TetR)]. Gene inactivation 
was accomplished using the method detailed by Datse55nko and Wanner.  To avoid using 
the Kanamycin or Chloramphenicol resistance markers for gene knock-outs that was 
developed by Datsenko and colleagues (Datsenko and Wanner, 2000), which are already 
utilized in the B1H system plasmids, we created a Zeocin resistant version of the pKD4 
plasmid.  This template has the Zeocin resistance cassette flanked by FRT sites with the 
P1 and P2 priming sequences 5’ and 3’, respectively, to the FRT flanked cassette.  The 
following primers were used to amplify both the Zeocin and the Kanamycin 
recombination cassette using the P1 and P2 sites: 
 
rpoZ 5’ (genomic homology italics, P1 site is bold) 
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5’ATGCCCAGTCATTTCTTCACCTGTGGAGCTTTTTAAGTATGGCACGCGTAACTGT
TCATGTGTAGGCTGGAGCTGCTTCG-3’ 
rpoZ 3’ (genomic homology italics, P2 site is bold) 
5’ACAAGGGCGACCCGCTTTGTGATTAACGACGACCTTCAGCAATAGCGGTAACGG
CCATATGAATATCCTCCTTAGTTCCT-3’ 
The resulting PCR products were introduced as recombination donors in conjunction with 
lambda red recombinase to inactivate the rpoZ locus.  The resistance marker was 
removed following isolation of a confirmed knockout strain by FLP recombinase. PCR 
primers were designed to prime approximately 100 basepairs upstream and downstream 
from the rpoZ locus to confirm insertion of the resistance marker and its removal from 
this locus.   
rpoZ 5’ PCR primer 
5’-GCAGCGTCATGACGCTTTAA-3’ 
rpoZ 3’ PCR primer 
5’-GATTTGGTCTTCCGGCAGG-3’ 
Following amplification of this locus, the PCR products were run on a 1.5% agarose gel 
to confirm the change in mobility of the products that should be associated with insertion 
of antibiotic resistance marker and their removal (Supplementary figure 1).  These PCR 
products were sequenced to verify rpoZ replacement and deletion.   The resulting strain 
containing the Zeocin insertion into the rpoZ gene,  SB3930 lac-, ΔhisB463, ΔpyrF, 
ΔrpoZ::Zeo [F´ proAB lacIqZ M15 Tn10 (TetR)], was used in all of the B1H selections 
because it provides an additional selectable marker for identification and maintenance of 
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the selection strain that is orthogonal to all of the plasmid-based markers and it 
demonstrated the same activity when compared to the complete rpoZ knockout.   
 
Omega Constructs  
 
Direct Omega fusions 
     The coding sequences for the wt omega subunit contains a BamHI and KpnI site, both 
of which are potential cloning candidates in our expression vectors.  Therefore, the 
following primers were used to PCR amplify the omega subunit from E. coli genomic 
DNA in two fragments that would remove these target sequences.  
Omega 5’ (introduces a NcoI site at 5’ end of gene) 
5’-GCGGAATTCCATGGCACGCGTAACTGTTCAG-3’ 
Omega int 3’ (introduces two silent mutations, removing restriction sites) 
5’-TTCTTCCGGTACGAGCGGGTCCTTTCCGCC-3’ 
Omega int 5’ (compliment to Omega int 5’) 
5’-GGCGGAAAGGACCCGCTCGTACCGGAAGAA-3’ 
Omega 3’  (removes R91 and stop codon, introduces NotI site)   
5’-TGCGCGGCCGCACGACCTTCAGCAATAGCGGT-3’ 
The first fragment was amplified using Omega 5’ and Omega int 3’.  This fragment 
introduced an NcoI site at the 5’ end of the gene which contains the ATG start site that 
will be used for expression of the omega-TF hybrid.  The second fragment was amplified 
with Omega int 5’ and Omega 3’ which removed the stop codon and the last residue 
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(R91) of the omega protein while introducing a NotI site.  The two internal primers 
introduced two silent mutations that removed the BamHI and KpnI target sites.  The final 
PCR was done using an equal molar mix of the first two fragments as templates for the 
external Omega 5’ and Omega 3’ primers.  The resulting PCR product was recovered and 
digested with NcoI and NotI.  The digestion product was ligated into the previously 
described pB1H2 expression plasmid (Meng et al., 2005).  This resulted in a plasmid that 
could express omega-TF hybrids with exactly the same promoter and linker that had been 
used in the alpha system.  This plasmid for expressing a transcription factor as a fusion to 
the C-terminus of omega was named pB1H2ωL where the L signifies the lppC lacUV5 
dual promoter that is driving expression of the omega-TF hybrid (Hu et al., 2000).  The 
pB1H2ω2 and pB1H2ω5 expression plasmids were created by replacing a fragment of 
the pB1H2ωL plasmid that contains the promoter (EcoRI to NcoI) with a fragment that 
contains either the lacUV5 promoter (pB1H2ω5) or a mutant version of the lacUV5 
promoter (lacUV5m) that has two mutations in the -10 box (pB1H2ω2).  Once the three 
primary expression plasmids (pB1H2ω2, pB1H2ω5, and pB1H2ωL) had been 
constructed, a TF could be introduced into any of these plasmids for expression by 
designing a KpnI site in frame into the 5’ primer and a stop codon and XbaI site into the 
3’ primer used to amplify the TF from a DNA template (genomic DNA or cDNA).  The 
PCR product could then be digested with KpnI and XbaI and ligated into the pB1H2ω 
backbone DNA with the desired promoter strength (Supplementary figure 2).  This 
universal cloning strategy allowed a TF to be easily moved between the plasmids by sub-
cloning to examine the impact of changing the promoter strength.  The linker between the 
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omega-subunit and the TF was identical to the linker previously described in pB1H2, 
which contains a flag-tag allowing the expression of a TF to be verified by Western blot.  
 
Omega-Zif12 fusions (Homeodomain constructs) 
     Homeodomains were expressed as omega fusions in combination with fingers one and 
two of Zif268 (Zif12) under control of the lacUV5m promoter plasmid (pB1H2ω2-12HD; 
Supplementary Figure 2).  The KpnI site at the 5’ end of TF construct (the beginning of 
Zif268 finger 1) was inactivated by converting the sequence from GGTACC to 
GGCACG, both sequences coding for Gly, Thr.  A new KpnI site was then created 3’ to 
Thr codon that is the first amino acid of the linker between fingers 2 and 3 of Zif268.  
Two additional amino acids were added after the Kpn1 site.  The first amino acid was 
always glycine.  In the majority of the homeodomains, the second amino acid was the -1 
amino acid of the specific homeodomain being assayed, however for a subset we used the 
-1 residue of Oct1, arginine for purely historical reasons.  The KpnI site and the inserted 
residues created a 5 amino acid linker between the 2nd His of Zif268 finger 2 and the 
beginning of the HD (Zif12-TGTGN-HD).  Each homeodomain (with the additional two 
residues) was cloned between the KpnI site, which encodes the first set of TG residues, 
and the Xba1 site downstream with a stop codon introduced just prior to the Xba1 site.  
The lacUV5 version of the Zif12-HD construct (pB1H2ω5-12HD) was created by 
moving the entire fragment encoding the linker-Zif12-HD fragment via NotI to XbaI 
digestion into the corresponding region of the pB1H2ω5 plasmid.  All new expression 
constructs were sequence verified.  
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Library Construction 
 
28 Basepair Library 
     The 28 basepair library was constructed in pH3U3 as previously described by Meng, 
Brodsky and Wolfe except that it was introduced between the NotI and EcoRI sites using 
the following oligonucleotides: 
28 bp library oligonucleotide: 
5’GGCGCGAATTCGNNNNNNNNNNNNNNNNNNNNNNNNNNNNGCGGCCGCA
AGGTAGCTGATTCCGTTCTCGC-3’ 
Library extension primer: 
5’-GCGAGAACGGAATCAGCTACCTT-3’ 
This library places the randomized region 7 bp away from the 5’ edge of the -35 box of 
the weak promoter that controls expression of the HIS3/URA3 reporter genes.  The 28 bp 
raw library contains  ~2 x 108 independent clones based on titration of the initial 
transformants following electroporation of the ligated library after a 1 hour recovery in 
SOC medium.  
 
ZF10 Library 
     The ZF10 library was created by annealing oligonucleotides with complimentary ends 
to the library oligonucleotide to make duplex DNA with a gap spanning the randomized 
region and appropriate overhangs for cloning into the pH3U3 plasmid between the NotI 
and EcoRI sites upstream of the promoter controlling the HIS3 and URA3 genes.   
93 
ZF10 library oligonucleotide: 
5’-GGCCGCCATGGATCCNNNNNNNNNNTGGGCGGCTGATAGGCGCGCCG-3’, 
5 prime complimentary oligonucleotide: 
5’-GGATCCATGGC-3’  
3 prime complimentary oligonucleotide:  
5’-AATTCGGCGCGCCTATCAGCCGCCCA-3’  
The oligonucleotides were 5’ phosphorylated as a mixture by combining 200 pmol of 
each oligonucleotide in 100µl of 1xT4 polynucleotide kinase buffer (NEB) with 1mM 
ATP and 20 Units T4 polynucleotide kinase (NEB).  This reaction was incubated at 37οC 
for 30 minutes and then boiled for 5 minutes before annealing by a gradual reduction in 
temperature to 4οC. 1 µl of the phosporylated, annealed oligonucleotides (2µM) was 
ligated into 1 µg of gel purified pH3U3 plasmid backbone that had been digested with 
NotI and EcoRI in a 30 µl reaction containing 1xT4 DNA Ligase buffer and 1 µl of T4 
DNA Ligase (400 units, NEB) overnight at 16 οC.  Following completion, the ligation 
reaction was ethanol precipitated, and the DNA pellet was resuspended in 2 µl of H20, 
and transformed into 80 µl of electrocompetent XLI-Blue cells.  The transformed cells 
were recovered in 50 ml SOC for 1 hour at 37οC.  Following the recovery, a 200ul 
sample was titrated by 10-fold serial dilution on 2xYT plates containing 25 µg/ml 
Kanamycin to determine the total number of transformants. The number of transformants 
in a dilution normalized to the fraction of library culture should reflect the constructed 
library size.  Kanamycin (25 µg/ml) was then added to the remaining culture and the cells 
were expanded for an additional hour at 37οC.  After expansion, the cells were plated on 
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10 large 2xYT plates (150mm round) containing 25 µg/ml kanamycin and grown 
overnight at 37 οC.  200µl of the culture was again titrated by 10-fold dilutions on 2xYT 
plates containing kanamycin to determine the degree of expansion that occurred during 
the additional hour of growth.  After these large plates had grown overnight, cells were 
harvested from these plates by resuspending the colonies in 10ml 2xYT per plate.  The 
resuspensions were pooled and cells pelleted by centrifugation for 15 minutes at 3000 
rpm.  The plasmid DNA was recovered from this pellet by scaling 20-fold the procedure 
for DNA isolation using the QIAGEN plasmid Miniprep Kit. 
 
Counterselection of the libraries 
     Counterselections were performed on each library to remove self-activating 
sequences.  250 ng (28bp) or 1 µg (ZF10) of raw library material was transformed into 
80 µl of the rpoZ positive version of the selection strain (US0 ΔhisB, ΔpyrF).  These cells 
were recovered in SOC for 1 hour at 37οC while rotating.  The cells were then pelleted by 
centrifugation for 15 minutes at 3000 rpm and the resulting pellet was resuspended in 5 
ml of YM medium (a type of minimal medium).  The cells were acclimated to the YM 
medium for 1 hour at 37οC while rotating.  Following recovery the cells were pelleted, 
washed 2 times with YM medium (by pelleting and resuspension) and then resuspended 
in a final volume of 1ml YM medium.  20 µl of this final resuspension was titrated by 10-
fold serial dilution on rich media plates (2xYT + 25 µg/ml Kanamycin) to determine the 
total transformants.  The titration plates were grown overnight at 37οC while the 
remaining 980 µl cell resuspension was stored at 4 οC.  The following day cells were 
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counted from the rich media titrations and approximately 5x106 transformants were 
plated on each of the 150mm round YM plates containing 2.5mM 5-FOA (27 plates used 
for the 28bp library, 10 plates for the ZF10 library).  The plates were wrapped with 
parafilm and incubated at 37οC for 24 to 36 hours.  The cells were then harvested from 
the plates and the plasmid DNA recovered as described for the ZF10 library construction.  
A second round of counterselection was performed on the 28 basepair library to further 
reduce the background of self-activating clones, which remained higher than desired 
following the first counterseleciton.  This additional counterselection was performed as 
described above except that approximately 2.5x108 transformed cells were split over 20 
5-FOA/YM plates. 
 
Selection Overview (Figure 2.1) 
     Two different libraries were constructed to assess the specificity of each TF: a 28 bp 
randomized library for general use in characterizing factors, and a 10 bp library 
containing a neighboring binding site for fingers 1 and 2 of Zif268 (ZF10), which is for 
characterizing factors with low affinity or specificity.  The 28 bp library, which was 
constructed for the characterization of direct omega-TF fusions has a relatively high 
background of false positive clones when compared to the previously described 18 pair 
library.  The majority of this background results from a population of self-activating 
sequences in the randomized region that are coupled to a deactivated URA3 reporter gene 
that allows these clones to persist even under stringent counterselection.  This 
subpopulation is sensitive to the absence of uracil during the positive selection of binding 
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sites, and consequently uracil was omitted from binding site selections using this library 
in the description of general procedure that follows.  The false positive rate within the 
ZF10 library following counterselection was quite low and did not change significantly 
when uracil was omitted, consequently all selections using the ZF10 library were 
performed in the presence of uracil (200 µM uracil was added to each NM selection 
plate), which provides slightly greater growth rates under selective conditions. 
 
General selection procedure (Figure 2.1c)  
     Approximately 2 µg of the bait plasmid (pB1H2ω2/5/L or pB1H2ω2/5-12HD) and 50 
ng of the library plasmid were electroporated into 80 µl of the selection strain.  The cells 
and the two plasmids were mixed on ice and moved to a pre-chilled 1 mm cuvette.  The 
cell and plasmid suspension was electroporated at 4οC and immediately resuspended in 
10 ml pre-warmed SOC.  The cells were then recovered while rotating at 37 οC for 1 
hour.  Next, the cells were pelleted by centrifugation at 3000 rpm for 15 minutes and 
resuspended in 5 ml NM medium that was supplemented with 200 µM uracil, and 0.1% 
histidine.  These cells were acclimated to the NM medium while rotating for 1 hour at 
37οC.  Cells were pelleted, washed 4 times in NM medium (no supplement) by sequential 
pelleting and resuspension and then resuspended to a final volume of 1 ml NM medium.  
20 µl of this final resuspention was titrated by 10-fold serial dilutions on rich media 
plates (2xYT + 25 µg/ml Kanamycin, and 100 µg/ml Carbenicillin) to determine the total 
number of transformants.  The titration plates were grown overnight at 37 οC while the 
remaining 980 µl cell culture was stored at 4 οC.  The following day cell counts were 
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determined from the rich media titrations and based on the total number of transformants, 
between 1x107 and 1x108 cells were placed on one 5 mM 3-AT and one 10mM 3-AT NM 
selective plate (150mm diameter rounds). Cells were spread on the plates with sterile 
glass beads and allowed to dry.  The plates were then wrapped individually with parafilm 
and grown at 37οC for 36 to 48 hours. Typically five to fifteen binding site selections 
were performed in parallel with positive and negative controls included to allow a 
qualitative assessment of the success of each experiment. Surviving colonies on each 
plate were counted and the fraction of surviving clones was determined based on the 
number of cells that were plated.  A 10-fold increase in the fraction of surviving clones 
compared to the negative control (omega without a tethered TF) was highly correlated 
with a successful selection.  Selections with ratios lower than a 10-fold increase were 
successful in many instances, but in this range there was more variability in the number 
of sequenced clones that contained binding sites.   
 
Failed Selections 
      A low fold increase (or no increase) in the number of surviving clones on selective 
media relative to the background when normalized to the number of cells plated was a 
reliable indicator of a failed selection.  This outcome was predominantly the result of 
improper expression of the TF (too low or too high).  Factors that had too high an 
expression level displayed toxicity on rich media plates (reduced colony number relative 
to selections performed with other factors in parallel and/or extreme variability in colony 
size), which allowed us to gauge whether the expression level of a TF from a failed 
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selection should be increased or decreased.  If the expression plasmid for a particular 
factor appeared toxic, the TF was moved to a version of the pB1H2ω plasmid that 
contains a weaker promoter (lacUV5m or lacUV5) and the selections were repeated. If the 
expression plasmid for a particular factor did not appear to be toxic to cells based on the 
rich media titrations but the selection failed, the TF was moved to a version of the 
pB1H2ω plasmid with a stronger promoter (lacUV5 or lppC) and reselected. This 
approach proved successful in almost every example.  In principle the concentration of 
the inducer IPTG could also be increased or decreased to further modify the expression 
levels, but we found adjusting the overall promoter strengths on the expression plasmid to 
be the most reliable path to success. In the case of one homeodomain, Eve, where our 
initial selections failed, we found that the removal of a small string of hydrophobic 
residues from the C-terminus of the protein just after the end of the homeodomain 
resulted in a significant improvement in activity.  Hydrophobic residues at the C-terminus 
of a protein can lead to lower levels of functional expression in bacteria (Parsell et al., 
1990). Croc is the single example of a TF that did not generate a binding site motif using 
the omega-based B1H system.  This factor produced colony numbers following selection 
that were between 20 and 100-fold over the background when expressed form either a 
lacUV5 and lppC promoter at either 5 or 10mM 3-AT, however computational analysis of 
the selected binding sites was unable to identify a significantly overrepresented motif 
within this population.  It is not clear why Croc was able to achieve a high fold over the 
background without selecting a specific binding site; one possible explanation is 
recognition of a binding site present in a fixed region of the pH3U3 plasmid outside the 
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library window, which would return sequences that were not related to sequence-specific 
binding.   
 
Medium for Selection procedure 
 
SOB medium 
Purchased from Becton, Dickinson and  Company, cat. No 244310.  Add 28.086g SOB 
powder to 1L purified water.  Heat while stirring.  Allow to boil for 1 minute.  Autoclave 
at 121oC for 15 minutes.  The SOB medium contains the following components per liter: 
Typtone………………………………20.000g 
Yeast Extract…………………………..5.000g 
Sodium Chloride………………………0.500g 
Magnesium Sulfate, anhydrous……….2.400g 
Potassium Chloride……………………0.186g 
 
SOC medium 
Contains a final concentration of 0.5% filter sterilized glucose in autoclaved SOB 
(above). 
 
 
 
2xYT medium 
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Purchased from Becton, Dickinson and  Company, cat. No 244020.  Add 31.0g 2xYT 
powder to 1L purified water.  Heat while stirring.  Allow to boil for 1 minute.  Autoclave 
at 121oC for 15 minutes.  The 2xYT medium contains the following components per liter: 
Pancreatic Digest of Casein………….16.0g 
Yeast Extract………………………...10.0g 
Sodium Chloride………………………5.0g 
 
YM medium 
Prepare the following solution: 1xM9 Salts, 4 mg/ml glucose, 200µM Uracil, 0.1% 
Histidine, 0.01% Yeast Extract, 1 mM MgSO4, 10 µg/ml thiamine, 10 µM ZnSO4, 
100 µM CaCl2, 25ug/ml kanamycin, and 10 µM IPTG.  Filter sterilize through a 0.22 µm 
filter.   
 
NM medium 
Prepare the following solution: 1xM9 Salts, 4 mg/ml glucose, 200 µM adenine-HCl, 1x 
Amino acid mixture (below), 1 mM MgSO4, 10 µg/ml thiamine, 10 µM ZnSO4, 100 µM 
CaCl2, 25ug/ml kanamycin, 100 µg/ml carbenicillin, and 10 µM IPTG.  Filter sterilize 
through a 0.22 µm filter.   
 
 
 
YM counter-selective plates 
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Conter-selective plates contain: 1.5% autoclaved agar, 1xM9 Salts, 4 mg/ml glucose, 
200µM Uracil, 0.1% Histidine, 0.01% Yeast Extract, 1 mM MgSO4, 10 µg/ml thiamine, 
10 µM ZnSO4, 100 µM CaCl2, 25ug/ml kanamycin, and 10 µM IPTG and the desired 
concentration of 5-FOA.   
 
NM selective plates 
Selective plates contain: 1.5% autoclaved agar, 1xM9 Salts, 4 mg/ml glucose, 200 µM 
adenine-HCl, 1x Amino acid mixture (below), 1 mM MgSO4, 10 µg/ml thiamine, 10 µM 
ZnSO4, 100 µM CaCl2, 25 µg/ml kanamycin, 100 µg/ml carbenicillin, 10 µM IPTG and 
the desired concentration of 3-AT.   
 
Amino acid mixture (33.3x) 
Contains 17 of the 20 amino acids, omitting His, Met, and Cys. 
Prepare the following six solutions (all percentages are wt/vol): 
Solution I (200x): dissolve 0.99g Phe (0.99%), 1.1g Lys (1.1%) and 2.5g Arg (2.5%) in 
water to a final volume of 100ml. 
Solution II (200x): dissolve 0.2 g Gly (0.2%), 0.7 g Val (0.7%), 0.84 g Ala (0.84%) and 
0.41 g Trp (0.41%) in water to a final volume of 100ml. 
Solution III (200x): dissolve 0.71g Thr (0.71%), 8.4 g Ser (8.4%), 4.6 g Pro (4.6%) and 
0.96 g Asn (0.96%) in water to a final volume of 100ml. 
Solution IV (200x): add 1.04g Asp (1.04%) and 18.7g potassium-Glu (18.7%) to water, 
bring to a final volume of 100ml. 
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Solution V (200x):  add 14.6g Gln (14.6%) and 0.36g Tyr (0.36%) to roughly 90ml of 
water.  Add solution V to solution IV.  Add NaOH pellets slowly until all amino acids go 
into solution.  Bring final volume to 200ml. 
Solution VI (200x): dissolve 0.79 g Ile (0.79%) and 0.77 g Leu (0.77%) in water to a final 
volume of 100ml.   
Mix solutions I to VI together and filter sterilize through a 0.22 µm filter and store at 4C.  
This results in a 33.3x amino acid mixture. 
 
Colony PCR and Sequencing 
     The binding sites from successful selections were recovered by PCR amplification of 
the corresponding pH3U3 Library window from individual surviving colonies picked 
from each selection plate.  These PCR products were sequenced to generate the desired 
data for computational analysis. PCR reactions were done in a 96-well plate format where 
25µl of the PCR mix (1µM HU100 primer, 1µM OK181 primer, 300µM Denville dNTP 
mix, 1x NEB ThermoPol Buffer and 1 unit of NEB Taq polymerase) was added to each 
well of the plate.  For each of the 96 wells, a single colony was picked from a selection 
plate with an autoclaved toothpick to inoculate the 25ul PCR mix.  For each set of PCRs 
from a given selection plate a negative control reaction (no inoculation) was run in 
parallel in one well to insure that the appearance of an amplified product was not due a 
contaminating DNA source. Once each well had been inoculated, the plate was covered 
with aluminum film and placed in the thermocycler.  The PCR reaction initiated with a 
single, 2 minute denaturation step at 94oC.  This was followed by 35 reaction cycles 
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consisting of one minute denaturation at 94oC, a 1.5 minute annealing step at 56oC, and a 
2 minute extension at 68oC.  After these 35 cycles were complete, there was a final 
extension for 5 minutes at 68oC.  The plate was held at 4oC from that point until being 
removed from the block.  To confirm successful PCR reactions, 5µl of each 25µl PCR 
reaction was run out on a 1.5% agarose gel and the mobility of product in each well was 
compared to a DNA ladder standard (NEB).  Successful reactions were sequenced 
(Agencourt) using HU100 as the sequencing primer. 
HU100 
5’-GAAATATGTATCCGCTCATGAC-3’ 
OK181 
5’-CCAGAGCATGTATCATATGGTCCAGAAACCC-3’ 
Motif discovery and alignment 
     The chromatogram from each sequence read was inspected for quality and accuracy, 
and if judged interpretable, the sequence between the NotI site and the EcoRI site (the 
library window) was confirmed by visual inspection of the peaks.  The group of all 
unique library sequences recovered for a TF was then analyzed using MEME motif 
discovery tool (http://meme.sdsc.edu/meme/intro.html). Overrepresented motifs were 
recovered using the following settings in MEME. Selections employing the 28 bp library: 
zero or one motif per sequence could be discovered, a motif could be discovered on either 
strand of the DNA and the search width for a motif was set from 3 to 28 bases. Selections 
employing the ZF10 library were identical except that the search width for a motif was 
set from 3 to 10 bases.  In all instance where a binding site motif was successfully 
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identified, it was the top hit recovered from the MEME search and had an expectation 
value that was <e-5.  The aligned sequences that compose each motif recovered by 
MEME were used to generate a Sequence logo using the WebLogo tool 
(http://weblogo.berkeley.edu/logo.cgi).   
 
Omega-TF activity assays 
 
Target sites in pH3U3 for Zif268, Paired, Giant and Hunchback 
     The following binding sites were designed for the promoter strength activity assays 
based on the preferred consensus sequence and the preferred position of that site relative 
to the promoter that were determined for each factor from an omega-B1H binding site 
selection. For the Zif268 mutant sites, mutant target sequences were designed based on 
previously determined binding constants for variants of the finger 1 binding site.  
Giant 
5’-GGCCGCAGACCGGAGATTACGTAACTATAAGACACG-3’ 
Hunchback 
5’-GGCCGCCTACCGGAGCGATACACAAAAAAACATGCG-3’ 
Paired 
5’-GGCCGCGAGTCTCACATACATCCGTCACGCTACCCG-3’ 
Zif268-F1 wt (GCG) 
5’-GGCCGCTGCGTGGGCGGGACG-3’ 
Zif268-F1 GAG 
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5’-GGCCGCTGCGTGGGAGGGACG-3’ 
Zif268-F1 GGG 
5’-GGCCGCTGCGTGGGGGGGACG-3’ 
Zif268-F1 GCA 
5’-GGCCGCTGCGTGGGCAGGACG-3’ 
These oligonucleotides were annealed to a complementary oligonucleotide that contains a 
5’ AATT overhang and were truncated by four bp on the 3’ end to leave a GGCC 
overhang on the complementary strand.  These overhangs are complimentary to the 
overhangs created by a NotI/EcoRI digestion of pH3U3. Each complementary pair of 
oligonucleotides were annealed and ligated between the Not1 and EcoR1 site of the 
pH3U3 plasmid.  Cloned binding sites were verified by sequencing. 
Zif268 activity on mutant finger 1 binding sites 
     100 ng of pB1H2ω2-Zif268 and 50 ng of a reporter pH3U3 plasmid containing one of 
four different Zif268 finger 1 binding sites (GCG, GCA, GAG, or GGG) were 
transformed into 80 µl of the selection strain by electroporation.   The cells were 
recovered in 1 ml of SOC for 1 hour at 37 οC.  After recovery, the cells were plated on 
rich media plates (2xYT + 25 µg/ml Kanamycin, and 100 µg/ml Carbenicillin) and grown 
overnight at 37 οC.  A single colony was selected from each plate and a 5 ml 2xYT 
culture with Kanamycin and Carbenicillin was grown overnight at 37 οC.  The following 
day, a second 5 ml culture in identical medium was inoculated with 50 µl of the 
overnight, saturated culture and grown to an OD600 of approximately 0.2 to 0.4.  The 
cells in each culture were pelleted by centrifugation at 3000 rpm for 15 minutes.  The 
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pellet was then resuspended in 5 ml NM media supplemented with 200 µM uracil.  The 
cells were acclimated to NM media for 1 hour at 37 οC while rotating.  This cells in this 
culture were pelleted by centrifugation at 3000 rpm for 15 minutes.  The cells were then 
washed 4 times by sequential pelleting and resuspension in NM media supplemented with 
200 µM uracil and finally resuspended in a volume of 1ml.  20 µl of this final 
resuspension was titrated by 10-fold serial dilutions on rich media plates (2xYT + 
25 µg/ml Kanamycin, and 100 µg/ml Carbenicillin) to determine the total number of 
cells.  The titration plates were grown overnight at 37 οC while the remaining 980 µl cell 
culture was stored at 4 οC.  The following day cell counts were determined from the rich 
media titrations and a fraction of the culture was diluted to roughly 500 cells per 750 µl.  
Next, 750 µl of each diluted culture was spread on small NM selective plates with 
various concentrations of 3-AT.  Each 3-AT concentration challenge was performed in 
triplicate for each binding site.  Plates were wrapped in parafilm and grown at 37 οC for 
36 hours.  The number of surviving colonies was counted on each plate.  Next, the 
colonies on each plate were resuspended in 5 ml of 2xYT and the cell suspension from 
the three duplicate plates for each 3-AT concentration were pooled.  These cells were 
pelleted by centrifugation at 3000 rpm for 15 minutes and then the pellet was 
resuspended in 100 ml of 2xYT and an OD600 reading was measured in triplicate to 
determine the approximate number of cells recovered form each group of selection plates. 
For easy interpretation, the mean colony counts from each condition for each binding site 
were normalized by the colony count from non-selective conditions (NM medium with 
no 3-AT and 0.1% Histidine) to provide a fractional colony count.  This fractional colony 
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count for each binding site at each stringency describes  the percentage of surviving 
colonies relative to the number observed at non-selective conditions (maximum survival 
rate).  The measured OD600’s were normalized by colony count to provide quantitative 
basis for evaluating the colony size that was recovered for each binding site at each 
stringency. To remove the complication of the number of colonies contributing to the 
OD600 at a stringency, the mean OD600 measurement at each stringency was multiplied 
by the fraction of the non-selective colony count divided by the colony count at a that 
specific stringency.  This product represents OD600’s at equivalent cell densities. Once 
the OD600’s were normalized by colony count, the percentage of the OD600 from non-
selective conditions (0mM 3-AT with 0.1% Histidine) was calculated for each binding 
site, 3-AT combination. 
 
Paired, Giant and Hunchback Activity Assay 
     100 ng of pB1H2ω2, 5, and L versions of each TF was cotransformed with 50 ng of a 
reporter pH3U3 plasmid containing the optimal binding site for the corresponding TF 
into 80 µl of the selection strain by electroporation.   The cells were recovered in 1ml of 
SOC for 1 hour at 37 οC.  After recovery, the cells were plated on rich media plates 
(2xYT + 25 µg/ml Kanamycin, and 100 µg/ml Carbenicillin) and grown overnight at 
37οC.  The following day, a single colony was selected from each plate and a 5ml 2xYT 
culture with Kanamycin and Carbenicillin was grown overnight at 37 οC.  A second 5 ml 
culture in identical medium was inoculated with 50 µl of this overnight, saturated culture 
and grown to an OD600 of approximately 0.2 to 0.4.  The cells in this culture were 
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pelleted by centrifugation at 3000 rpm for 15 minutes.  The pellet was resuspended in 5 
ml NM medium supplemented with 200 µM uracil, and 0.1% histidine. The cells were 
acclimated to NM media for 1 hour at 37 οC while rotating.  This culture was pelleted by 
centrifiugation at 3000 rpm for 15 minutes.  The cells were then washed 4 times by 
sequential pelleting and resuspension in NM medium supplemented with 200 µM uracil 
and then resuspended in a final volume of 1ml.  20 µl of this final resuspention was 
titrated by 10-fold serial dilution on rich media plates (2xYT + 25 µg/ml Kanamycin and 
100 µg/ml Carbenicillin) to determine the total number of cells.  The titration plates were 
grown overnight at 37 οC while the remaining 980 µl cell culture was stored at 4 οC.  The 
following day cell counts were determined from the rich media titrations.  The cell 
concentration in each sample was normalized based on the titration results to achieve 
uniform cell densities at each cell dilution.  The normalized cell cultures were then 
titrated by 10-fold serial dilution on rich media and NM selective plates supplemented 
with 200µM uracil and various 3-AT concentrations.  The NM selective plates were 
wrapped with parafilm and grown at 37 οC for 36 hours whereas the rich media plates 
were grown overnight at 37 οC. 
 
 
 
Western blot assay 
     100 ng of pB1H2ω2, 5, and L versions of each TF assayed was cotransformed with 50 
ng of a reporter pH3U3 plasmid containing the optimal binding site for the corresponding 
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TF into 80 µl of the selection strain by electroporation.   The cells were recovered in 1ml 
of SOC for 1 hour at 37 οC.  After recovery, the cells were plated on rich media plates 
(2xYT + 25 µg/ml Kanamycin, and 100 µg/ml Carbenicillin) and grown overnight at 
37οC.  The following day, a single colony was selected from each plate and a 5ml 2xYT 
culture with Kanamycin and Carbenicillin was grown overnight at 37 οC.  A second 5 ml 
culture in identical medium with the addition of 10µM IPTG was inoculated with 50 µl 
of this overnight, saturated culture and grown to an OD600 of approximately 0.4 to 0.6.  
1.5ml of each culture was pelleted by centrifugation at 18,000g for 2 minutes.  The 
pellets were resuspended in a volume of 1xSDS loading buffer that was normalized by 
the OD600 of each sample in comparison to the sample with the lowest OD600, which 
was resuspended in 50µl.  The samples were promptly boiled for 10 minutes.  After 
boiling, the samples were then centrifuged briefly to pellet debris and diluted 1:10 in 
1xSDS loading buffer. 10µl of each of the diluted samples were loaded on to a 14% SDS-
polyacrylamide gel along with 5µl of Kaleidoscope Prestained Standard (BioRad).   The 
samples were run on the gel for approximately 2.5 hours.  The gel was then transferred to 
0.45 micron polyvinylidene difluoride (PVDF) membrane and the membrane was 
blocked overnight with gentle rocking in binding buffer (5% nonfat dry milk resupended 
in wash buffer).  After blocking the membrane was washed four times in wash buffer 
(20mM Tris, 150mM NaCl, and 0.05% Tween 20).  The membrane was then labeled for 
2 hours with 2.5µl of anti-FLAG per 10ml of binding buffer.  The membrane was again 
washed four times with wash buffer.  The secondary labeling was done for 2 hours with 
1ml anti-murine-hc-HRP per 15ml binding buffer.  The membrane was washed four 
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times with wash buffer.  Finally, the HRP was reacted using the Millipore Immobolin 
reagents for HRP substrates.  The membrane was bathed with this Peroxide 
Solution/Luminol Reagent, 1:1 mix for 1 minute before exposing film.  Film exposures 
were taken from 2 seconds to 5 minutes. 
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CHAPTER III:  THE SYSTEMATIC CHARACTERIZATION OF 
DNA-BINDING SPECIFICITIES FOR FACTORS INVOLVED IN 
THE ANTERIOR – POSTERIOR SEGMENTATION OF THE 
DROSOPHILA EMBRYO 
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Introduction 
 
The identification of cis-regulatory sequences throughout the genome and the 
complementary sequence-specific trans-acting factors that bind within these modules is 
an important step in deciphering the mechanism of spatial and temporal gene regulation 
in metazoans. The majority of sequence-specific transcription factors (TFs) in a 
eukaryotic genome can be readily identified by sequence homology to previously 
identified families of DNA-binding domains, where complex organisms usually contain a 
higher proportion of TFs (~5 to 10%) due to the requirement for more elaborate 
transcriptional regulatory networks (Levine and Tjian, 2003). However, identifying cis-
regulatory modules (CRMs) within a genome is difficult due to the more dynamic nature 
of these sequences relative to coding sequences (Ludwig et al., 1998) and the fact that the 
vast majority of DNA in higher eukaryotes is non-coding sequence (Siepel et al., 2005).  
 
Biochemical and computational methods for the identification of CRMs within the 
genome have been developed, yet limitations remain.  Biochemical methods based on 
ChIP-chip (Harbison et al., 2004; Lee et al., 2002; Zeitlinger et al., 2007), nuclease 
hypersensitive sites (Crawford et al., 2004; Sabo et al., 2004) and 5C (Dostie and Dekker, 
2007; Dostie et al., 2006) allow the identification of functional elements throughout the 
genome.  However, these techniques are limited typically to cell types that can be 
obtained in sufficient quantities for each protocol.  A second limitation is that 
identification of genomic binding sites by ChIP does not reveal whether those sites are 
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functional; binding sites that are occupied in vivo may not contribute to organismal 
fitness, as long as they do not have negative consequences (Gao et al., 2004; Zeitlinger et 
al., 2007). CRMs can be computationally identified by searching for overrepresented 
clusters of binding sites within the genome for groups of TFs that function in a common 
transcriptional regulatory network (Berman et al., 2002; Lifanov et al., 2003; Markstein 
et al., 2002; Rajewsky et al., 2002; Sosinsky et al., 2003). The accuracy of these 
predictions can be improved by incorporating phylogenetic comparisons between species 
separated by moderate evolutionary distances (Schroeder et al., 2004; Sinha et al., 2004).  
In combination with ChIP experiments, computational analysis of evolutionary 
conservation provides an approach to identify functional TF binding sites. 
 
The prediction of CRMs and their cognate factors via binding site cluster analysis has 
been most thoroughly studied in the context of the regulatory cascade driving anterior-
posterior (A-P) pattern formation during embryogenesis in D. melanogaster.  A hierarchy 
of genes responsible for the systematic subdivision of the embryo into 14 segments has 
been defined through exhaustive genetic studies (Jaeger and Reinitz, 2006; Peel et al., 
2005; Pick, 1998).  These genes are expressed in four sequential cascades - maternal, gap, 
pair-rule and segment polarity - with genes in each tier of the hierarchy cooperating with 
the previous group of factors to coordinate expression of the next set.  This cascade also 
activates the homeotic genes in distinct zones that define the initial body plan (Figure 
3.1). The majority of genes within this regulatory cascade are TFs that coordinate 
patterned expression of the next tier of genes by binding to clusters of sites within their  
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Figure 3.1 
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Figure 3.1.  Transcription factors involved in A-P patterning. TFs involved in A-P 
patterning function in a hierarchical network to subdivide the embryo into 14 segments.  
The early maternal factors are expressed in broad gradients, with subsequent TF groups 
expressed in patterns that are increasingly refined. TFs involved in early segmentation or 
expressed in early patterns that were characterized in this study are grouped according to 
their initial stage of expression and they are color-coded to indicate the type of DBD 
(Cys2His2 Zinc fingers = Blue, homeodomains = Green, bHLH = Gray, bZip = Red, 
Winged helix = Pink, Nuclear Hormone Receptor = Orange, POU motif= light Blue, 
Paired motif = Yellow, and HMG = lavender. Runt is black and was characterized as an 
alpha fusion (Meng et al., 2005)).  
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CRMs; the unique expression patterns of the activators and repressors that bind each 
CRM determine its spatial activity (Arnosti, 2003; Arnosti et al., 1996). However, even 
within this carefully studied network, the location and number of CRMs that regulate 
many genes within this segmentation cascade are unknown. One major obstacle is the 
limited specificity data that is available for even some of the central factors involved in 
this process (e.g. Gt & Kni) despite their identification about 20 years ago (Berman et al., 
2004; Schroeder et al., 2004; St Johnston and Nusslein-Volhard, 1992). Position weight 
matrices (PWMs) for subsets of these TFs have been utilized to identify new CRMs 
(Berman et al., 2002; Berman et al., 2004; Rajewsky et al., 2002; Schroeder et al., 2004), 
but a more complete description of specificities would provide a powerful tool to predict 
CRMs in this transcriptional regulatory network. A comprehensive characterization of D. 
melanogaster TF specificities would provide an invaluable tool for the systematic 
prediction of CRMs in all regulatory networks.  
 
Here, we describe substantial improvements to a B1H system that increase its 
sensitivity and dynamic range, and make it amenable for the high-throughput analysis of 
sequence-specific TFs (see Chapter 2). Using this system, we have determined 
specificities for 108 (14.3%) of the predicted TFs in D. melanogaster. These factors 
represent a broad range of DNA-binding domain families that are commonplace in 
eukaryotic genomes. Members of one of the groups that we’ve focused on are those 
factors that play prominent roles in early A-P patterning.  Our dataset dramatically 
expands the set of defined specificities for these factors and these motifs are good 
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predictors of CRMs throughout the genome. To facilitate utilization of these specificities, 
we have created a GBrowse-based visualization tool (Stein et al., 2002) that allows an 
end-user to examine the overrepresentation of binding sites for any number of individual 
factors as well as combinations of these factors throughout the D. melanogaster genome 
(veda.cs.uiuc.edu/cgi-bin/gbrowse/gbrowse/Dmel4). The genome browser interface is 
coupled to a genome-wide search tool to identify the most significant peaks of binding 
site overrepresentation for any combination of factors.  The combination of a large 
database of factor specificities coupled with web-based tools for the rapid analysis of any 
combination of transcription factors provides the community with a readily accessible 
tool to analyze and discover CRMs genome-wide. Eventually, the combination of 
computational predictions and experimental techniques for genome-wide CRM 
identification (e.g. ChIP-chip) should allow a comprehensive annotation of the CRMs 
throughout the genome and the TFs that function through these elements.  
 
Results 
 
Large-scale analysis of D. melanogaster TFs 
To demonstrate that this technology is sufficiently rapid and simple to perform a 
comprehensive characterization of the TFs we focused on two groups of factors from the 
D. melanogaster genome:  all of the factors from a certain DNA-biding domain family 
(homeodomains, see Chapter 4) and all of the factors in a common regulatory network 
(A-P embryonic patterning).  The former set provides a survey of the breadth of 
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specificities that are observed for a particular family, while the later provides a basis set 
for testing the utility of B1H-generated PWMs for the prediction of CRMs throughout the 
genome.  
.  
The early anterior-posterior patterning network in the D. melanogaster embryo 
contains representative members of a wide variety of DNA-binding domain families that 
are present in higher eukaryotes (Schroeder et al., 2004).  Included within this set of 
factors are members of the five most represented DNA-binding domain families (Tupler 
et al., 2001): Cys2His2 zinc fingers, homeodomains, bHLH, bZIP and winged helix as 
well as other less represented domains (Figure 3.1).  All told, ~80% of the sequence 
specific TF’s in the fly genome utilize one of the DNA-binding domains represented in 
this group (Adryan and Teichmann, 2006). Some of these TFs, such as the gap gene 
Kruppel (Kr), have very well defined genetic roles and DNA-binding specificities.  
Others, such as the gap genes Giant (Gt) and Knirps (Kni) have well defined genetic 
roles, but their specificities are only roughly described by a handful of binding sites 
mapped by DNaseI footprinting (Bergman et al., 2005).  Therefore, this set of factors 
provides an opportunity not only to supplement and improve the existing specificity data 
for this network but also to assess the ability of our technology to characterize a wide 
variety of DNA-binding domain families.   
 
We characterized the specificity of 35 different factors involved in the A-P pathway, 
which represent 9 different DNA-binding domain families (Figure 3.2 and see appendix 
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Table A.1).  The specificity determined for these factors using the omega-based B1H 
system is in most cases consistent with previously determined specificity data, where 
available.  For example the existing DNase-based specificities of Bicoid (Bcd), Kr and 
Tailless (Tll), which represent 3 different families of DNA-binding domains, are quite 
similar to the specificities obtained from the B1H system (Figure 3.3). Moreover, the 
stringency of the selection can be varied to recover binding sites with different ranges in 
affinity as demonstrated by motifs generated for Bcd from sites collected at two different 
selection stringencies (5 and 10 mM 3-AT, see Chapter 4). Both of these motifs display 
the same core DNA-binding specificity that is consistent with previously published data 
(Bergman et al., 2005; Wilson et al., 1996), but the higher stringency selection yielded a 
more constrained motif, due to a greater enrichment of the highest affinity sites. Thus, 
where good specificity data previously exists, there is excellent concordance between the 
B1H data and other datasets for these factors. 
 
There are also a number of factors in the dataset with previously poorly defined 
specificity.  Some of these factors, such as Caudal (Cad), Gt and Kni, were originally 
identified described ~ 20 years ago and play critical early roles in segmentation (St 
Johnston and Nusslein-Volhard, 1992), yet have poorly defined specificity (Figure 3.3).  
For example, our data recognition motif for Cad is similar, but much better defined, than 
the specificity of Cad determined by Dearolf and colleagues (TTTATG) based on sites in  
the ftz zebra stripe element (Dearolf et al., 1989) or than SELEX data available on the 
Chicken Cad homolog, CdxA (Margalit et al., 1993).  The existing DNaseI footprinting 
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Figure 3.2 
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Figure 3.2.  Specificities of the 35 TF in the A-P regulatory pathway characterized by the 
omega-B1H system. These TFs are grouped by DNA-binding domain family and color 
coded as described in Figure 3.1. 
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Figure 3.3 
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Figure 3.3.  Comparison of B1H-generated recognition motifs to previously published 
data.  (Left panels) The B1H recognition motifs for Bcd, Kr and Tll are very similar to 
the motifs generated from DNase footprinting data (FlyREG) (Bergman et al., 2005).  In 
the case of Bcd, the high stringency data (10 mM 3-AT) is most similar to the previously 
described SELEX data (Wilson et al., 1996), whereas the lower stringency data is more 
similar to the FlyREG data. (Right panels) The B1H recognition motifs for Cad, Gt and 
Kni differ significantly from the FlyREG data.  For Cad, the B1H-generated data is 
similar to SELEX data on the chicken homolog (Margalit et al., 1993), but provides 
better definition of the overall sequence preference. 
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data for Cad appears to misrepresent its specificity in the 3’ end of its recognition 
sequence (Bergman et al., 2005). Two other notable examples are Gt and Kni.  The 
existing DNase motifs for both of these factors contain only limited information about 
their sequence preferences.  By comparison the B1H data for these factors provides a 
detailed description of their recognition motifs.  
 
In total, we successfully determined the specificity of 101 D. melanogaster TFs 
between this and the homeodomain sets.  Data for these factors is available at 
labs.umassmed.edu/WolfeLab. Only a single factor (Croc) attempted within these sets of 
factors failed to produce a recognition motif using the omega-B1H system, resulting in a 
99% success rate (101/102).  This flexibility suggests that the system will be suitable for 
the high-throughput characterization of the majority of sequence specific transcription 
factors present in the D. melanogaster as well as other eukaryotic genomes.   
 
Assessing the predictive value of the B1H-generated motifs 
As an initial assessment of the utility of our binding site motifs for identifying CRMs, 
we examined the correlation between the expression profile of each transcription factor 
(TF) and the occurrence of its binding sites in 48 CRMs from D. melanogaster that drive 
patterned gene expression in the early embryo as previously described (Schroeder et al., 
2004). When a TF functions as an activator, one would expect an overrepresentation of 
its binding sites in CRMs that drive gene expression in the same spatial and temporal 
domains. Conversely, when a TF functions as a repressor that defines a spatial boundary 
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for the expression of a CRM, there should be an anticorrelation between the expression 
profile of the TF and of CRMs that contain its binding sites. We focused on a set of eight 
TFs that play prominent roles in early patterning for which we could compare our 
characterized recognition motifs (“B1H”) with existing motifs previously utilized for 
CRM discovery (“DNaseI”) (Schroeder et al., 2004). We used Stubb (Sinha et al., 2003) 
to calculate, for each CRM, a “Motifcount” score that describes the number of binding 
sites for each TF and their quality based on its PWM.  The average of the Motifcount 
scores for all of the CRMs contributing to gene expression at each position along the A-P 
axis was plotted along with the expression profile of each TF (Figure 3.4). Strong 
correlations or anticorrelations are observed within these plots.  For some TFs, such as 
Bcd and Kr, we find that there are very similar Motifcount profiles for both the DNaseI 
and B1H PWMs, which is consistent with the similarity between their motifs (Figure 
3.3).  Bcd displays a strong correlation between its Motifcount and expression profile, as 
would be anticipated for an activator, whereas Kr displays a strong anticorrelation 
between its Motifcount and expression profile, as would be anticipated for a repressor. 
For the majority of these comparisons, the significance of the observed correlation or 
anticorrelation is greater for the B1H PWMs (indicated by the P-value; Figure 3.4). The 
most striking difference is observed for Kni, where the P-value improves from 0.2 to e-14. 
Cad is the one exception; although the B1H motif is more consistent with the existing  
specificity data, the DNaseI recognition motif displays a somewhat better correlation with 
the expression data.  The improved correlations observed for most of the B1H motifs are 
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Figure 3.4 
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Figure 3.4.  Motifcount plots over 48 CRMs from D. melanogaster that drive early 
patterned expression.  Comparison of the Motifcount plots based on the DNase 
(Schroeder et al., 2004)and B1H PWMs for Bcd, Cad,  Hb, Hkb, Gt, Kni, Kr & Tll. In 
each plot the red line indicates the TF expression profile over the embryo length (x-axis, 
0 = anterior pole; y-axis, arbitrary units).  The average number of binding sites for each 
factor over the CRMs that drive expression in each region (the Motifcount) is indicated 
by a blue line plotted as a function of the z-score, where 0 is the genome-wide mean 
(indicated by the magenta line). Solid bars at the top of each graph indicate the window 
regions over which correlations between the factor expression profile and the Motifcount 
profile were calculated with the exception of Bcd and Cad, which were calculated over 
the entire region. P-values for strongest correlation/anticorrelation between the TF 
expression profile and its Motifcount along the A-P axis are listed to the right of the plots 
where the bold value indicates the most significant correlation. 
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particularly noteworthy given that the majority of the DNaseI data is obtained from 
bindings sites footprinted within these CRMs. 
 
One other observation from these plots is noteworthy.  For some of the repressors, 
e.g. Gt, Hb and Hkb, there is a strong underrepresentation of binding sites in CRMs that 
have overlapping expression profiles.  Selective pressure against the presence of these 
binding sites may play an important role in shaping the sequence composition of the 
CRM just as there is selective pressure to maintain binding sites for factors that 
participate in gene regulation (Ludwig et al., 2000). Overall these results suggest that our 
B1H-generated PWMs have favorable properties for the prediction of CRMs, and for 
many factors our motifs appear to be superior to the previously employed PWMs for 
CRM discovery (Berman et al., 2004; Schroeder et al., 2004).  A Motifcount analysis on 
syntenic regions to these CRMs within the D. pseudoobscura and D. mojanvensis 
genomes generates similar plots indicating that our PWMs should have utility for the 
prediction of CRMs within related species (Figure 3.5). 
 
Genome Surveyor: a new tool for identifying CRMs 
We developed a new genome analysis tool, Genome Surveyor, to rapidly search for 
putative CRMs based on the presence of overrepresented binding sites for a combination  
of TFs.  A simple scoring function was chosen based on its ability to readily identify 
known CRMs amongst a large population of random intergenic sequences (Table 3.1):  
Putative CRMs are identified by computing the average of the overrepresentation score 
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Figure 3.5 
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Figure 3.5. Motifcount plots for the DNase and B1H PMWs over syntenic regions for the 
48 CRMs within the D. pseudoobscura and D. mojavensis genomes.  Overall these plot 
look similar to the D. melanogaster plots in Figure 5, although some of the feature are 
more poorly defined. The p-values are significant for a number of factors and in most 
cases superior for the B1H PWMs. Otherwise, these plots have the same features as 
described in Figure 5. 
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 (z-score) for a group of TFs over 500 bp windows tiled across the genome. Using our 
PWMs, this scoring function distinguishes CRMs in our test set with an accuracy that is 
similar to that of Stubb (Sinha et al., 2003).  Importantly, this scoring function provides 
an enormous advantage in speed over Stubb, as the z-scores for each factor can be 
calculated once across the genome and then this stored information may then be used in 
all combination searches that include a particular TF. Our method differs from that of 
ecis-analyst (Berman et al., 2004) in that we value each site according to its PWM score, 
which allows both strong and weak sites to contribute to the overall score for each 500 bp 
window. Then, a z-score is determined for each TF to reflect how the score in that 
window compares to the overall genomic distribution. By contrast ecis-analyst employs a 
user-defined threshold (P-value) to determine if a site will be scored as present, and if 
defined as present, all sites contribute equally to the score.   
 
We developed a flexible user interface that operates through the GBrowse software 
package (Stein et al., 2002) to allow a user to utilize our scoring function and library of 
PWMs to search for CRMs in the D. melanogaster genome (Figure 3.6).  This interface 
allows gene-specific browsing or genome-wide searching for CRMs.  For gene-specific 
browsing, tracks that indicate the scores for individual factors, along with their 
significance values, can be displayed across a genomic region of interest (up to 500 kb).   
Combination tracks can also be generated to identify peaks of binding site 
overrepresentation for any collection of factors. For example, in the genomic region 
134 
Table 3.1  Evaluation of CRM scoring function using 48 defined CRMs and 4800 
random regions. 
 
 Number of CRMs of 48 sampled above threshold 
Scoring Function P≤0.005 P≤0.01 P≤0.05 
Stubb, all PWMs together 13 14 24 
Sum-of-PWMs, dict 9 15 23 
Sum-of-PWMs, dict, z,  13 17 25 
Sum-of-PWMs, dict, z + 
thresholding 16 19 29 
Sum-of-PWMs, dict, z + 
thresholding, Mel-Pse  17 20 33 
Sum-of-PWMs, dict, z + 
thresholding, Mel-Moj (43 
CRMs) 16 20 31 
    Above values 
extrapolated to 48 CRMs* 
18 22 35 
Sum-of-PWMs, dict, z + 
thresholding, Mel-Pse-Moj 
(43 CRMs) 14 21 28 
    Above values 
extrapolated to 48 CRMs* 16 23 31 
*Syntenic regions for only 43 CRMs are available in D. mojavensis 
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Figure 3.6 
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Figure 3.6.  Genome Surveyor display interface.  A 20 kb region surrounding the eve 
locus is displayed.  Annotations for the D. melanogaster genome are shown at the top of 
the browser window.  The predicted transcripts and genes in the D. melanogaster genome 
are indicated within the genomic region.  Immediately below is a line indicating the 
regions where a high confidence alignment with the D. pseudoobsura genome has been 
assembled onto the melanogaster scaffold. Annotations for identified CRMs 
(downloaded from REDfly (Gallo et al., 2006)) can also be displayed within this region.  
The user-configurable tracks for individual factors or groups of factors are displayed 
below the annotations.  Multiple different factor combination tracks can be displayed 
simultaneously.  These tracks represent the average of the z-scores for each factor plotted 
over this genomic region for the combination of TFs selected by the user, where the 
factors included are indicated above each track (i.e. Kr, Bcd, Hkb, Tll and Hb, which 
were the anterior factor search set used to generate the list of hits in Table 1).  The 
numbers in the upper left hand corner indicate the maximum value (z-scores) for each 
plot, the genome-wide mean and the mean plus two standard deviations, respectively. 
The positions of the genome-wide mean and the mean plus two standard deviations are 
also indicated on the plot by horizontal lines of the same color that transect the plot.  In 
this view the two combination tracks (red) for the anterior factor search set are shown 
across D. melanogaster genome (mel) and the average over the D. melanogaster and D. 
pseudoobsura genomes (melpse).  Both of these factor combinations contain a strong 
peak within the eve stripe 1 CRM.  Two other Combination tracks for other groups of 
factors (a different gap set and a pair-rule set) are also shown.  These groups display  
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Figure 3.6 cont. 
significant peaks that overlap with other CRMs.  Below the five Combination tracks are a 
number of tracks for individual factors.  These tracks provide a rapid assessment of the 
individual factors that are potentially contributing to each combination track.  For 
example significant peaks for Bcd, Hkb, Kr and Tll all overlap with the stripe 1 CRM 
(blue box). 
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surrounding eve the tracks for individual maternal and gap factors (e.g. Bcd, Hkb, Hb, Kr 
and Tll) display small peaks indicating overrepresentation of sites at various positions, 
but when certain groups of these factors are combined, strong peaks of binding site 
overrepresentation are evident that correspond to known eve pair-rule stripe CRMs 
(Figure 3.6). The accuracy of these CRM predictions can be increased by cross-species 
comparisons to identify peaks that are present in the D. melanogaster genome and in a 
syntenic region of the D. pseudoobscura genome (Berman et al., 2004; Sinha et al., 
2004). Using our scoring function, the identification of CRMs in a population of 
intergenic sequences is improved if scores from two genomes are combined (Table 3.1).  
These comparisons are implemented in Genome Surveyor by calculating z-scores for 
each TF within the D. pseudoobscura genome and mapping the homologous regions onto 
the D. melanogaster genome.  The Gbrowse window can be used to display individual 
and combination tracks for TFs in the D. pseudoobscura genome as well as “two-species 
tracks” that average the z-scores of each factor or group of factors between the two 
genomes (Figure 3.6).  This cross-species analysis over syntenic windows evaluates the 
total number of sites in each window, not the conservation of individual sites, as 
individual sites in a CRM may not be conserved but the entire element should be under 
stabilizing selection (Ludwig et al., 2000). These features allow a user to define 
significant clusters of binding sites for a group of factors in each genome independently, 
as well as within both genomes. 
We also created a Genome Search Tool within Genome Surveyor that allows a user to 
perform genome-wide searches for the highest scoring windows using any combination 
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of factors.  This page can be accessed via a link in the Gbrowse webpage wherein users 
can select the combination of factors that they want to employ in their search, the number 
of top hits that they want returned, and the option to search in the D. melanogaster 
genome alone, or in combination with the D. pseudoobscura genome. To avoid 
recovering peaks that are primarily the result of a strong peak for a single factor, an 
additional filter can be enabled that requires the combination peak score to be composed 
of a certain number of factors with individual scores above a desired significance 
threshold.  Each search returns a table of positions within the D. melanogaster genome 
with the highest average z-scores listed in descending order (Table 3.2).  The z-scores for 
each hit are listed in the D. melanogaster and D. pseudoobscura genomes as well as the 
combination score across both genomes.  The output also includes a list of factors that are 
contributing significantly to the score within each region, as well as the nearest 
neighboring genes and their distances from the center of the binding site cluster.  The 
location of each hit is linked back to the Gbrowse tool to enable visualization of the 
surrounding genomic region for more detailed inspection of the contributing factors.   
 
The effectiveness of these tools and database is evident in the top hits that are 
returned from a combined D. melanogaster and D. pseudoobscura genome search using  
TFs that are involved in anterior patterning (Bcd, Hb, Hkb, Kr & Tll; Table 3.2 and 
Figure 3.7a-d).  
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Table 3.2  Top twenty matches in a genome-wide search with Bcd, Hb, Hkb, Kr & Tll.  
Rank Location Dmel Dpse DmelDpse Motifs gene 
known 
CRM expression 
1 2R 5498250 5.3 3.59 4.44 bcd, hkb, tll, kr eve eve_stripe1 stripe1 
2 3L 8645450 5.65 1.6 3.62 bcd, hkb, tll, kr h h_stripe1 stripe1 
3 2L 3611150 2.51 4.22 3.31 bcd, tll kr odd odd_-5 ant+post 
4 3R 2694100 3.47 3.07 3.24 bcd, tll, kr ftz ftz_ftzDE stripe1+5 
5 3L 20630500 3.33 2.93 3.13 tll, kr kni kni_KD ant+post 
6 X 20534450 3.28 2.98 3.11 hkb, tll, kr run  stripes 
7 X 9535750 3.35 2.73 3.04 bcd, tll, kr btd btd_Ss-Bg head 
8 2L 12682100 3.29 2.66 2.91 hkb, kr, hb pdm2  stripes 
9 3R 4527100 2.73 2.96 2.78 kr, hb hb hb_HZ526 post 
10 3R 675650 1.81 3.47 2.64 bcd, tll, hb opa  stripes 
11 2L 12689800 2.85 2.43 2.61 hkb, kr, hb pdm2  stripes 
12 2L 3834050 3.22 2.09 2.59 bcd, kr slp2 slp2_-3 ant 
13 3R 15955950 2.32 2.99 2.58 bcd, tll    
14 X 7500350 3.2 1.89 2.54 tll, kr, hb cut  CNS 
15 2R 20730400 2.19 3 2.52 bcd Kr Kr_CD1 ant + central 
16 X 20462750 2.85 2.38 2.52 tll, kr    
17 3L 14138800 2.65 2.33 2.49 bcd, hkb, kr D D_(+5) central 
18 2R 20744500 1.99 2.89 2.44 kr, hb Kr  stripes 
19 2R 5490050 2.25 2.53 2.38 bcd, tll, kr eve eve_stripe2 stripe 2 
20 3L 6090300 2.16 2.76 2.37 hkb, tll, kr, hb Ets65A  CNS 
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Table 3.2  Top twenty matches in a genome-wide search for sequences with 
overrepresented binding sites for TFs that regulate anterior gene expression during early 
embryogenesis (Bcd, Hb, Hkb, Kr & Tll). Genomic sites were ranked based on dual 
genome z-scores (DmelDpse; where genome-wide mean + 2*stdev = 0.74). TF motifs 
with significant individual scores (>mean + 2*stdev) are shown for each segment. 
Flanking genes and overlapping CRMs with anterior-posterior specific expression are 
shown. Because several of the factors are also expressed during CNS development, two 
flanking genes with CNS specific expression are also indicated. 
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Figure 3.7a  Hairy 
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Figure 3.7b  Odd 
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Figure 3.7c  Ftz 
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Figure 3.7d  knirps 
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Figure 3.7.   Hits two through five from the anterior TF search.  Loci surrounding hits 
neighboring A) hairy, B) odd, C) ftz and D) knirps.  Strong peaks of binding site 
overrepresentation are observed in all four of these loci and they overlap with previously 
identified CRMs that control patterned gene expression in the early embryo.  For the 
three pair-rule genes, these peaks overlap with CRMs that control expression of the most 
anterior stripe (stripe 1) in their patterned expression.  Otherwise the tracks displayed in 
these images are identical to those in Figure 3.6. 
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This search produces a remarkable number of strong hits that neighbor genes with early 
anterior expression patterns: 13 of the 15 top hits are in genes that display early anterior 
expression and 8 of these 13 are in previously annotated CRMs.  The top hit from this 
search falls within eve stripe 1 (Figure 3.6).  Bcd, Hkb, Kr, and Tll all contribute robustly 
to the composite peak at this position as is evident from their individual factor traces, 
which are all well in excess of 2 standard deviations above the genomic mean.  The next 
four hits within this search neighbor genes with gap or pair-rule patterns of expression (h, 
odd, ftz & kni; Table 3.2).  The three hits neighboring the pair-rule genes are all in known 
CRMs that control expression of “stripe 1”, as might be anticipated for the anterior TFs 
set (Figure 3.7).  Performing the search using two genomes significantly increased the 
number of top hits near genes that are involved in early segmentation.  A search with the 
same set of factors using only the D. melanogaster genome yielded a subset of the CRMs 
that were found in the two-species search (8 of the top 15 hits neighbor genes that display 
anterior expression, as opposed to 13 of 15 with the “two-species” scores).  Thus the dual 
genome search has enriched the validated positives recovered by the genomic search 
consistent with previous studies that have utilized of cross-species comparisons in CRM 
identification (Berman et al., 2004; Sinha et al., 2004).  
 
Discussion 
 
We have developed an omega-based B1H system that allows the high-throughput 
determination of TF DNA-binding specificity.  This system has several advantages over 
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other techniques for characterizing DNA-binding specificity.   First, the use of E. coli as 
our platform allows the isolation of complementary TF - binding site combination in vivo 
in a single round of selection using relatively simple techniques.  Because E. coli 
demonstrate an extremely high transformation efficiency, randomized binding site 
libraries with complexity greater than 10^8 members can be utilized. Perhaps the greatest 
advantage realized by this system is the flexibility provided by utilizing omega-TF 
hybrids, as the absence of competition from endogenous omega has resulted in an 
extremely sensitive selection system with a much greater dynamic range than previous 
systems (Durai et al., 2006; Meng et al., 2005). This sensitivity has allowed us to 
successfully characterize TFs that failed to generate motifs in the alpha-based B1H 
system.   
 
Using this system we have determined recognition motifs for ~14% of the predicted 
D. melanogaster TFs. For comparison the FlyREG database contains motifs for 53 TFs 
constructed from 5 or more identified binding sites (Bergman et al., 2005); thus our 
database doubles the number of specificities that are available, and in cases where these 
databases overlap, our data is typically of higher quality. The rate of successful TF 
characterization within this system (101 of 102) makes it amenable to perform 
comprehensive surveys of TF specificity in complex organisms: once cloned, the DBDs 
of ten or more factors can be analyzed in parallel in the B1H system in a manner of days. 
Our current dataset is focused primarily on monomeric DNA-binding domains, but also 
includes homodimers and heterodimers.  This reductionist approach overlooks the 
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potential for sets of factors to cooperatively recognize motifs that are not a simple 
composite sites formed from their individual motifs, such as the Exd-Hox combinations 
that play critical roles in specification during development (Pearson et al., 2005; Ryoo 
and Mann, 1999; Wilson and Desplan, 1999).  These types of combinations can 
potentially be characterized using the B1H system, as complementary vectors for the 
characterization of heterodimers have been developed (Meng et al., 2005; Meng and 
Wolfe, 2006).  However, some criteria for choosing sets of factors to be evaluated must 
be applied because of the combinatorial issues involved with testing all possible pair-wise 
combinations.  
 
The PWMs generated from our B1H data when used in combination with Genome 
Surveyor provide a fast, flexible and accessible platform for user-guided prediction of 
CRMs in the fly genome. This type of PWM-guided CRM discovery has been previously 
accomplished with a set of maternal and gap TFs by several groups (Berman et al., 2002; 
Berman et al., 2004; Rajewsky et al., 2002; Schroeder et al., 2004) using different 
computational approaches.  Both demonstrated that known CRMs and novel CRMs could 
be successfully identified within the genome based on the presence of clusters of binding 
sites for factors that function in a common regulatory pathway.  These studies 
demonstrated that even relatively crude representations of the DNA-binding specificity of 
a TF, typically constructed from DNaseI footprinting on a limited number of sites 
(Adryan and Teichmann, 2006), could help identify CRMs and that these predictions 
could be improved by using two related fly genomes (Berman et al., 2004; Sinha et al., 
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2004).  These computational approaches, as well as an additional method (Sosinsky et al., 
2003), differ in the tactics used for CRM identification, but share a common strategy with 
Genome Surveyor of identifying clusters of overrepresented binding sites.  
 
The key features of Genome Surveyor are that it evaluates the quality of each binding 
site as well as over-representation of binding sites relative to the genome average, but is 
still rapid enough to allow genome-wide searches to be performed on a web-server.  
Thus, CRM Surveyor, which is integrated within the GBrowse software interface, 
provides a particularly powerful platform for gene-specific or genome-wide searches for 
CRMs regulated by a combination of factors.  Users can rapidly perform genome-wide 
searches with any combination of 100 factors over the D. melanogaster and D. 
pseudoobscura genomes and then investigate the locations of peaks of interest within the 
genome using the GBrowse tools.  Peaks that overlap with previously identified CRMs 
can be easily identified by uploading annotations for these elements from the REDfly 
website (redfly.ccr.buffalo.edu)(Gallo et al., 2006). The number and quality of PWMs 
available for these searches will increase with the adoption of new, high-depth 
sequencing and barcoding technologies such 454 (Hoffmann et al., 2007; Margulies et al., 
2005) and SOLEXA-based sequencing (Barski et al., 2007; Johnson et al., 2007) for the 
analysis of the B1H-selected binding sites. 
 
As the number of factors with high quality PWMs increases, it should be feasible to 
annotate most potential CRMs using combinations of factors that function in common 
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regulatory networks. Cooperating TFs could be identified based on common expression 
patterns, phenotypes, or  physical interactions. Because Genome Surveyor is built into the 
GBrowse webtool format (Stein et al., 2002), it will also be possible to incorporate other 
corroborating datasets into these tools, such as genome wide ChIP analysis of TF binding 
or chromatin structure. The combination of these experimental and computation 
approaches for the identification of CRMs should provide the most robust method for the 
functional annotation of these elements throughout eukaryotic genomes.  
 
Experimental Procedures: 
 
Factor information 
The amino acid sequence for each factor used and all of the sequences of the binding 
sites recovered in the individual selections are provided in appendix Table A.1 with the 
exception of the majority of the homeodomain sequences and selected binding sites, 
which are available in appendix Table A.2 and described in detail in Chapter 4.   
Sequence logos (Schneider and Stephens, 1990) for each factor were created by 
WebLogo (Crooks et al., 2004) using the aligned motifs defined by MEME (Bailey and 
Elkan, 1994) identified within the B1H-selected sequences. 
 
Motifcount analysis 
First, the “expression profile” of a TF is determined from available data on the in situ 
hybridization of the TF’s mRNA (Schroeder et al., 2004; Tomancak et al., 2007), which 
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is a real-valued measurement of the TF’s expression level in each of 100 equally-spaced 
intervals (“bins”) along the anterior-posterior axis of the Stage 4-6 (blastoderm) embryo. 
Then calculate the “discrete expression profile” for a set of 48 CRMs that drive anterior-
posterior gene expression in a defined pattern in the blastoderm embryo (Schroeder et al., 
2004). For each CRM, determine whether it drives gene expression in each of the 100 
bins along the A-P axis by imposing a fixed threshold on the real-valued expression 
levels. For each CRM, “count” the number of binding sites for the TF, using its PWM 
and Stubb (Sinha et al., 2003) as described in (Sinha et al., 2006). Then for each of the 
100 bins along the A-P axis, collect the set of CRMs that are “expressed” in that bin, and 
compute the average of the binding site counts for these CRMs (from Step 3). This 
average is the TF’s “MOTIFCOUNT”, which is plotted along with the TF’s expression 
profile along the A-P axis. 
 
P-values for this analysis were computed as follows: 
1. For a repressor, regions of influence were chosen around the boundaries of its 
domain of expression, and for each such region of influence the correlation coefficient 
between the TF expression profile and its MOTIFCOUNT was tested by calculating the 
Pearson correlation coefficient (rho). We tested the null hypothesis of rho = 0 (with the 
alternative hypothesis rho < 0, which represents anticorrelation). 
2. For an activator, CRMs were classified as either “positive” or “negative” 
depending on whether the CRM’s region of expression overlapped predominantly with 
the TF’s expression domain, or not. A two-sample t-test was performed on the 
153 
MOTIFCOUNT in these classes of CRMs to test for a difference of means in these two 
classes. 
 
Gbrowser web tool 
Single motif tracks: For each PWM, scan the genome with a sliding window of 500 
bp, in shifted in 50 bp increments, and count the number of occurrences of the PWM in 
each window, using the Stubb program (Sinha et al., 2003) and the method described in 
(Sinha et al., 2006) to generate the “DICT” score. The resulting profile of DICT scores is 
then plotted as a “track” in GBrowse (Stein et al., 2002). These tracks are shown for each 
PWM in D. melanogaster and D. pseudoobscura in genomic coordinates of the former. A 
“two-species” track is also plotted, combining the DICT scores of homologous windows 
from the two genomes. For this, each species’ DICT score is first converted to a “z-
score”, by subtracting the genome-wide mean and then dividing by the genome-wide 
standard deviation, and the z-scores of the homologous windows are averaged. For 
D.melanogaster windows in which the syntenic region could not be properly defined 
using the “liftover” tool (genome.ucsc.edu), the D. melanogaster z-score is halved.  
 
Motif combination tracks: Any combination of two or more PWMs can be used to 
create a “motif combination track” that is dynamically plotted as follows: For each 500 
bp window, the z-score of each PWM’s DICT score is computed as above, set to zero if it 
is negative, and an average over the chosen combination of PWMs is regarded as the 
score of this window. The resulting score profile is plotted as a track. Such tracks may be 
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created for each of the two genomes separately. A “two-species” motif combination track 
may also be created by averaging the scores from homologous windows. The mean and 
standard deviation of a combination track is computed from 1 Mbp sequence on either 
side of the region currently displayed by the browser. 
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Introduction 
 
In humans, as well as many other metazoans, homeodomains comprise the second 
largest class of sequence-specific transcription factors (TFs) (Tupler et al., 2001). 
Homeotic genes were first identified in D. melanogaster where the altered activity of a 
particular gene can result in the morphological transformation of one segment into that of 
its neighbor, leading to dramatic phenotypes such as the appearance of a second pair of 
wings (Lewis, 1978).  Cloning of these genes led to the landmark observation that they 
contain a common sequence motif that encodes a DNA-binding domain (Gehring et al., 
1994a). Subsequent studies have identified a large number of additional homeodomain 
proteins in Drosophila that regulate diverse processes including appendage formation, 
organogenesis and cell fate determination. A remarkable number of these genes have 
mammalian homologs with conserved developmental functions and biochemical 
properties, contributing to the now widespread appreciation of the conserved molecular 
mechanisms that regulate signaling and development in metazoans (Banerjee-Basu and 
Baxevanis, 2001; Mukherjee and Burglin, 2007).  
 
Insights into the mechanisms of sequence-specific DNA binding by homeodomains 
have been provided by the three-dimensional structures of individual protein-DNA 
complexes coupled with directed mutagenesis and biochemical analysis (Ades and Sauer, 
1995; Gehring et al., 1994b; Wolberger, 1996).  The homeodomain consists of 
approximately 60 amino acids that fold into a stable 3-helix bundle preceded by a flexible 
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N-terminal arm. Interactions with a 5 to 7 base pair DNA binding site are formed by 
positioning a single “recognition” helix in the major groove and an N-terminal arm in the 
minor groove (Figure 4.1, A and B). Despite a common DNA-binding architecture, there 
is significant variation in the sequence composition within the homeodomain family; for 
example the two superclasses of homeodomains, denoted as typical and atypical 
(Banerjee-Basu and Baxevanis, 2001; Gehring et al., 1994a; Mukherjee and Burglin, 
2007), share low sequence identity and generally recognize substantially different DNA 
sequences. Nonetheless, the docking of typical and atypical homeodomains with the 
DNA is nearly identical, (Kissinger et al., 1990; Wolberger et al., 1991) likely facilitated 
by common sets of contacts to the phosphodiester backbone. This conserved binding 
geometry allows differences in amino acids sequence and DNA-binding specificity for 
various homeodomains to be interpreted within a common structural framework. 
Residues at positions 2, 3 and 5-8 on the N-terminal arm and at positions 47, 50, 51, 54 
and 55 on the recognition helix can all contribute to DNA-binding specificity (Ades and 
Sauer, 1995; Damante et al., 1996; Ekker et al., 1994; Fraenkel et al., 1998; Hanes and 
Brent, 1989; Hovde et al., 2001; Passner et al., 1999; Percival-Smith et al., 1990; Piper et 
al., 1999; Treisman et al., 1989; Wolberger et al., 1991) (Figure 4.1, B and C).  The roles 
of some of these residues in specificity are clear; for example, in the vast majority of 
homeodomains, Asn is present at position 51 and defines a preference for Ade at binding 
site position 3 through a bidentate interaction with the N6 and N7 positions of the base. 
However, at other recognition positions, a precise role in DNA-binding specificity is 
more difficult to define.  For example, Gln is present at position 50 in most 
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homeodomains, but extensive biochemical and structural studies have not defined an 
obvious role for Gln50 in DNA recognition (Ades and Sauer, 1994; Fraenkel et al., 1998; 
Grant et al., 2000).   
 
How variations in homeodomain sequence result in differences in binding site 
specificity has been defined for a number of specific residues. Seminal experiments 
demonstrated the importance of Lys50 in the recognition of TAATCC by the Bicoid class 
of homeodomains instead of TAAT(T/G)(A/G) by the Antp and En classes (Hanes and 
Brent, 1989; Percival-Smith et al., 1990; Treisman et al., 1989).  Beachy and colleagues 
mapped differences in binding site position 2 specificity of the posterior HOX protein 
Abd-B (TTATGG) and more anterior HOX family members (TAATGG) to amino acids 
at positions 3, 6 and 7 in the N-terminal arm (Ekker et al., 1994).  Interestingly, 
substitutions at overlapping amino acid positions (6-8) are sufficient to switch the 
specificity of an NK-2 type homeodomain (CAAGTG) to the specificity of an Antp-type 
homeodomain (TAAGTG) at the neighboring base, binding site position 1 (Damante et 
al., 1996). This complexity is not limited to the N-terminal arm, as artificial combinations 
of residues at positions 50 and 54 in the recognition helix fail to interact with anticipated 
binding sites (Pellizzari et al., 1997).  Moreover, residues at different amino acid 
positions can contact the same base pair.  For example, residues at positions 47 and 54 
can both interact with complementary bases at binding site position 4, which could create 
competition between these amino acids to define alternate specificities (Fraenkel et al., 
1998; Gruschus et al., 1997; Wolberger et al., 1991).  This recognition complexity may  
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Figure 4.1  
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Figure 4.1.  DNA recognition by the homeodomain family.  A) The structure of Msx-1 
bound to DNA is representative of homeodomain-DNA interactions (Hovde et al., 2001). 
The N-terminal arm (orange) wraps around the 5’ end of the DNA recognition sequence 
(magenta) interacting through the minor groove while additional contacts to the 3’ end of 
the sequence are achieved by the recognition helix (yellow) through the major groove.  
Residues involved in base-specific interactions are shown (red).  B) Detailed view of the 
recognition contacts, where residues at positions 2 and 5 interact with bases in the minor 
groove and residues at positions 47, 50, 51 and 54 are positioned to make contacts in the 
major groove.  C) (Top) Sequence logo representation of the diversity in our set of 84 
homeodomains (TALE insertion in atypical homeodomains omitted for clarity). (Bottom) 
Windows corresponding to the DNA-recognition regions - the N-terminal arm (red) and 
recognition helix (yellow) – have been expanded to highlight the diversity or 
conservation at the key DNA-recognition positions (indicated with asterisks).  For 
reference a schematic representation of homeodomain-DNA recognition is shown to the 
left of the logo.   
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have hindered some efforts to reengineer homeodomain binding specificity.  For 
example, an attempt to convert the specificity of Matα2 (TTACA) to the specificity of 
Engrailed (TAATTA) through directed substitutions failed (Mathias et al., 2001). 
 
Likewise, more unbiased approaches to establish alternate specificities, such as 
selection via phage display, have enjoyed little success (Connolly et al., 1999). 
Consequently, while roles for specific homeodomain residues in binding site recognition 
have been defined, a comprehensive description of the determinants of homeodomain 
DNA-binding specificity remains an important goal.   
 
A comprehensive survey of DNA-binding specificity on a large, diverse family of 
DNA-binding domains has not been previously attempted. We have recently described a 
bacterial one-hybrid (B1H) system that allows the specificities of a DNA-binding domain 
to be rapidly characterized with sufficient ease that multiple factors can be characterized 
in parallel (Meng et al., 2005; Meng and Wolfe, 2006).  We have made further 
modifications to this selection system that facilitate the characterization of DNA-binding 
domains, such as homeodomains, that bind short recognition elements. Using this system, 
we analyze the DNA-binding specificities for all 84 homeodomains in D. melanogaster 
that are not associated with an additional DNA-binding domain. We use the rich 
experimental history of homeodomain studies in D. melanogaster to help interpret this 
dataset. Our analysis reveals that homeodomain proteins exhibit a diverse array of DNA-
binding specificities, with eleven specificity groups in D. melanogaster that encompass 
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the majority of these factors.  Certain specificities are highly represented, with fifty-one 
percent of the members falling in the En and Antp groups. The remaining forty-nine 
percent display subtle to drastic differences in specificity from the common En and Antp 
groups.  Homeodomains within a given specificity group typically share common 
recognition residues.  Combining this data with previous structural and biochemical work 
on the homeodomain family, we propose and evaluate a detailed set of recognition 
determinants for homeodomains and use this information to broadly and accurately 
predict the specificities of homeodomains in the human genome.   
 
Results 
 
Analysis of homeodomains using a modified bacterial one-hybrid (B1H) system 
We have made two modifications to our B1H system for characterizing the DNA-
binding specificity of a homeodomain (Meng et al., 2005; Meng and Wolfe, 2006): one-
hybrid fusions are made to the omega subunit of RNA-polymerase instead of the alpha 
subunit (Dove and Hochschild, 1998) and homeodomains are expressed as fusions to an 
accessory DNA-binding domain (Figure4.2A). Omega is not required for viability under 
laboratory growth conditions (Gentry and Burgess, 1989). Consequently, omega-based 
one-hybrid selections performed in an omega knockout strain are more sensitive than the 
corresponding alpha-based system due to the absence of competition from the 
endogenous subunit (Noyes, Meng, Wakabayashi, Brodsky and Wolfe, unpublished 
results). However, even this more sensitive selection system is unable to determine a 
164 
recognition motif for several homeodomains. Since homeodomains may recognize a 
modest 4 to 6 bp element, this failure is likely the result of competitive binding to the 
thousands of perfect recognition sequences in the E. coli genome.  Therefore, 
homeodomains were characterized as fusions to fingers 1 and 2 of the zinc finger protein 
Zif268 (Zif12; Figure 4.2A). ZFHD1, a fusion between Zif12 and the homeodomain of 
Oct1, displays superior specificity compared to either of its component parts (Pomerantz 
et al., 1995). Omega-based binding site selections performed on ZFHD1 yielded two 
motifs separated by variable spacing consistent with the specificity of both DNA-binding 
domains (Figure 4.2). A library with10 randomized basepairs adjacent to a Zif12 binding 
site (ZF10) was created to analyze the DNA-binding specificity of homeodomains fused 
to Zif12 (Figure 4.2D).  
 
This system was used to determine DNA-binding specificities for all 84 of the 
homeodomains in the D. melanogaster genome that are not associated with an auxiliary 
DNA-binding domain (Figure 4.3 and appendix Table A.2). The specificity of each 
homeodomain was obtained in the absence of any other domains present in the 
endogenous protein.  These fly homeodomains cluster into previously described families 
(Banerjee-Basu and Baxevanis, 2001; Mukherjee and Burglin, 2007) based on their 
amino acid similarity (Figure 4.4), where homeodomains falling in the typical superclass 
represent the largest fraction of the population (71 of the 84). A diverse set of amino 
acids are present at previously defined DNA-recognition positions, implying that a range 
of DNA-binding specificities may be represented within this population (Figure 4.1C).  
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Figure 4.2 
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Figure 4.2.  The ZFHD1 framework for determining DNA-binding specificity.  A. (left) 
Cartoon depicting the interaction of the omega-ZFHD1 construct with a reporter with a 
18 bp randomized window and (right) one that has a fixed binding site for the Zif12 
DNA-binding domain in the context of the ZF10 library.  B and C.  The logos resulting 
from the ZFHD1 selection using the 28 bp library as determined by MEME (B. searching 
for one motif) and by BioProspector (Liu et al., 2001) (C. searching for 2 separate 
motifs).  The discovered motifs in the BioProspector analysis are consistent with the 
specificity of Zif12 and Oct1 (Pomerantz et al., 1995).  D.  Sequence chromatogram of 
the ZF10 library prior to selection with a transcription factor where the 10 bp randomized 
region and the Zif12 binding sites are indicated.  E.  The logo resulting from the ZFHD1 
selection on the ZF10 library. 5x107 bacteria containing the ZF-10 library and the omega-
Zif12-Oct1 expression vector were selected on minimal medium lacking histidine and 
containing 10 mM 3-AT.  Approximately 2000 colonies survived the selection, which 
represented a > 100-fold increase over the number of surviving clones in the omega-
Zif12 negative control. MEME analysis of 22 unique sequenced clones recovered a motif 
consistent with the specificity of Oct1 from 22 of 22 sequences (Pomerantz et al., 1995; 
Verrijzer et al., 1992).  F. The maps of the bait plasmids used to characterize the 
homeodomains as omega-Zif12 fusions with key features annotated.  These plasmids 
allow a homeodomain to be characterized at two different promoter strengths: either 
expressed under control of the lacUV5 or a mutant lacUV5 (lacUV5mut) promoter.  
Homeodomains were introduced by simply subcloning between the unique KpnI and 
XbaI sites in each plasmid.  The linker between Zif12 and the TF is indicated below. 
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Figure 4.3 
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Figure 4.3. Sequence logos for 84 homeodomains determined in this study. Binding site 
alignments for each of the 84 homeodomains were extracted from the master alignment 
of sites.  We generated Sequence logos (Schneider and Stephens, 1990) for each of these 
alignments using WebLogo version 2.8 (Crooks et al., 2004).  WebLogo converts 
alignments to count matrices.  Gaps are treated as missing data and ignored, thus not all 
column count totals are equal.  There are no gaps in the core portion of the master 
alignment, however (columns 4 through 8, see Experimental Procedures). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
170 
Figure 4.4  
 
171 
Figure 4.4. ClustalW alignment of the homeodomain motifs from the 84 homeodomains 
examined in this study.  The position of each amino acid in the canonical homeodomain 
numbering scheme is indicated at the top of the alignment, along with cylinders that 
indicate the position of the three alpha helices in the structure.  The homeodomains can 
be divided into two broad superclasses: the Atypical (top) and Typical (bottom), which 
have distinguishing sequence features and recognition motifs.  One of the most prominent 
sequence differences is the presence of a three amino acid loop extension (TALE) 
between helix 1 and 2 within the majority of the atypical homeodomains (Banerjee-Basu, 
2001; Mukherjee, 2007).  Where clearly defined, the classes that the homeodomains fall 
within are indicated to the left of their names (Banerjee-Basu, 2001; Harvey, 1996).  
Colored residues at each position within the alignment indicate a high frequency of 
occurrence of residues with similar properties, with the exception of Gly and Pro, which 
are highlighted throughout these sequences.  Filled circles above the sequences indicate 
positions that make phosphate contacts in the structures of both typical and atypical 
homeodomain-DNA complexes (Wolberger, 1991; Fraenkel, 1998; Joshi, 2007).  Red 
circles indicate positions where an amino acid type capable of making a phosphate 
contact is conserved in all Asn51 containing homeodomains.  At these seven common 
phosphate-contacting positions 95% (79 of 83) have an appropriate residue for this 
interaction at 6 of the 7 positions.  In the case of position 31, the absence of a Lys or Arg 
can be compensated by one at position 46, as either position can contact a common 
phosphate (Grant, 2000).  Not surprisingly, two of the outliers with regards to conserved 
phosphate contacts are Cut and Onecut, which display unique specificities.  
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One notable exception to this diversity is Asn at position 51 of the recognition helix, 
which is present in all but one of these homeodomains.  
 
Several observations indicate that the motifs obtained by the B1H method accurately 
reflect the DNA-binding specificities of homeodomains. Some of the most thoroughly 
characterized homeodomains within D. melanogaster are members of the homeotic 
(HOX) gene family (Gehring et al., 1994a; Pearson et al., 2005).  These factors provide a 
benchmark for assessing the quality of the B1H-generated specificity data.  All of our 
determined specificities for the HOX factors share a common consensus – 
T(A/T)AT(T/G)(A/G), which is consistent with the previously described binding site 
selection data on these factors (Figure 4.5). Previous in vitro binding site selections and 
gel shift assays revealed subtle differences in the specificity of Ubx, Dfd and Abd-B 
(Ekker et al., 1994; Ekker et al., 1992); these factors exhibit similar preferences in our 
data, such as the preference of Abd-B for Thy over Ade at binding site position 2 (Ekker 
et al., 1994). Thus, even subtle differences in homeodomain specificity can be captured 
by the B1H analysis. Other examples where the B1H dataset is supported by previously 
identified binding sites in D. melanogaster or mammals are described for individual 
specificity groups below. To further assess the accuracy of our B1H-generated data, 
competition gel mobility shift assays were performed for 9 factors that display different 
specificities using binding sites representing 8 different specificity groups; these results 
are consistent with the B1H specificities (Figure 4.6). 
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Figure 4.5.  Binding site logos for the eight D. melanogaster HOX factors displayed in 
order of anterior to posterior expression (top to bottom).  Potential specificity 
determinants for each position of the binding site are indicated above the logos. There are 
subtle differences between the specificity of each HOX factor that are highlighted when 
they are arranged according to their regional expression pattern within the embryo. For 
example, at binding site position 2, the specificity shifts from a strong preference for Ade 
in more anterior factors toward an increasing tolerance for Thy in the most posterior 
factors, with Abd-B displaying a significant preference for Thy over Ade as was 
previously noted in the study by Beachy and colleagues(Ekker et al., 1994). This change 
in base preference was ascribed to residues at position 3, 6 and 7 in the N-terminal arm of 
Abd-B(Ekker et al., 1994).  A second trend is the increasing preference for Thy at 
position 0 in the more posterior factors.  This observation is consistent with a greater 
preference for Thy in Ubx and Abd-B compared to Dfd in in vitro binding site 
selections(Ekker et al., 1994; Ekker et al., 1992).  Another notable difference previously 
observed for Dfd and Ubx was a stronger preference of Dfd for Gua over Thy at binding 
site position 5, whereas Ubx did not display an obvious preference for Gua over Thy at 
this position(Ekker et al., 1992).   
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Figure 4.6.  Competitive gel shift assays for nine different fly homeodomains 
representing nine different specificity groups.  The sequence logo for the factor used in 
each assay is shown on the left of each row.  Radiolabeled DNA containing the consensus 
binding site for each factor was challenged with excess cold competitor DNA containing 
sequences from the various specificity groups.  Each lane represents a different 
competition, where the cold competitor and protein are at constant concentrations, with 
the exceptions of the far left (no protein) and far right (no competitor) lanes.  The 
sequence of the homeodomain binding site used in each competition is indicated at the 
top of the page, where they are at identical positions in each assay.  A yellow arrow 
indicates the competitor that is identical in sequence to the radiolabeled probe.  The 
quantification of the change in percent shift as a function of the concentration of cold 
competitor is shown on the right where these values are normalized to the percent shift in 
the no competitor lane. A yellow arrow indicates the competitor that is identical in 
sequence to the radiolabeled probe.  The neighboring 5' constant region of each binding 
site is CAG with the exception of the indicated site (*), which contains an additional T 
(CAGT).  The reverse complement of this element with a portion of the binding site 
creates an element “TAACTG” which may compete somewhat effectively with some of 
the typical homeodomains.   
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Figure 4.7. Determining the orientation of the homeodomain on a selected site.  To 
correlate differences in homeodomain specificity with differences in their amino acids, it 
is also critical to determine the orientation of the homeodomain with respect to the motif. 
For example, if the consensus sequence for a factor defined from a selection is TCATTA, 
the N-terminal arm might either specify the TC at the 5’ end of this sequence or the TA at 
the 5’ end of the complimentary sequence TAATGA. In this study, base positions 
predicted to interact with the N-terminal arm are at the 5’ positions of the motif (Figure 
1). Previous structural and mutagenesis studies of well-characterized homeodomain 
proteins such as En, Ubx, and Bcd have defined the orientation of the homeodomain on 
its binding site (Ades and Sauer, 1994; Ekker et al., 1992; Fraenkel et al., 1998; Hanes 
and Brent, 1989; Percival-Smith et al., 1990; Treisman et al., 1989). For factors, such as 
En, that can bind a pseudo-C2 symmetric binding sequence (e.g. TAATTA), it is not 
immediately obvious from the binding site logo alone how the sequence motif should be 
orientated. Fortunately, the short tether between the omega-Zif12 module used for the 
B1H selection and the homeodomain biases the location of binding sites recovered from 
the randomized library. Homeodomain binding sites that neighbor the fixed Zif12 binding 
site are preferentially recovered on the DNA strand complementary to the Zif12 binding 
site. In contrast, more distant homeodomain sites are generally recovered on the same 
strand as the Zif12 binding site.  This positional bias is most easily observed in the 
selected binding sites of a factor such as Bcd, which binds a clearly asymmetric binding 
sequence (TAATCC, Supplementary Table 2).  This site bias can be used to define the  
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orientation of the homeodomain on the consensus sequence, which facilitates the 
comparison of recognition sequences for each homeodomain in a common register.  
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Table 4.1 
 
Bicoid selected sequences 
>bcd1 
TGTTAATCCG 
>bcd2 
ATGGATTAGA 
>bcd3 
CGTTAATCTC 
>bcd4 
GGTTTAATCC 
>bcd5 
TCTATAATCC 
>bcd6 
TCTTAATCCC 
>bcd7 
GCTTAATCCG 
>bcd8 
GGGTTAATCC 
>bcd9 
GAGATAATCC 
>bcd10 
AGCTTATCC 
>bcd11 
CGGGTAATCC 
>bcd13 
TGTTAATCC 
>bcd14 
TGGGATTATA 
>bcd15 
GCGTAATCCA 
>bcd16 
GGCTTAAGCC 
>bcd17 
GGTTATCCG 
>bcd18 
TGTTAATCCC 
>bcd20 
CGCTTAATCC 
>bcd21 
TTACTAATCC 
>bcd22 
GTCCTAATCC 
>bcd23 
GGTTAATCCG 
>bcd24 
ATGGATTAGA 
 
Deformed selected sequences  
>dfd1 
CTTCATTAAG 
>dfd2 
GGTCATTAAT 
>dfd3 
TATCATTAAA 
>dfd4 
GGTCATTAAT 
>dfd5 
GTCATTAACA 
>dfd6 
CCTAATTAAG 
>dfd7 
GATAATTAAT 
>dfd8 
CCTAATTAAG 
>dfd9 
CCCCATTAAT 
>dfd10 
TTTTTAATGA 
>dfd11 
AGCTATTAAA 
>dfd12 
GCACTAATGA 
>dfd13 
TCGTAATGA 
>dfd14 
TGCTTAATGG 
>dfd15 
ATCGTAATTA 
>dfd16 
CTCATTACT 
>dfd17 
CTTCATTAAG 
>dfd18 
AGTCATTAGG 
>dfd19 
TACCTAATGA 
>dfd20 
TGGATAATGA 
>dfd21 
CGACTAATGA 
>dfd22 
TATCATTAAC 
>dfd23 
CCGTTAATGA 
>dfd24 
CAATTAATGA 
 
Engrailed selected sequences 
>En1A1 
CGCAATTAGA 
>En1A2 
GACTTAATGA 
>En1A3 
CTACTAATTG 
>En1A4 
CCAATTATTT 
>En1A5 
CCAATTACC 
>En1A6 
CATAATTAAA 
>En1A7 
CACAATTAAC 
>En1A8 
AGTAATTACC 
>En1A9 
CTAATTAGAG 
>En1A10 
TTAATTAGAC 
>En1A11 
TTAATTAGGT 
>En1A12 
CCAATTATGT 
>En1B2 
TTAATTAGTA 
>En1B3 
TTTTTAATTA 
>En1B4 
ATAATTAGTG 
>En1B5 
TCCAATTAAG 
>En1B6 
CCAATTAGAT 
>En1B7 
TAATTAACA 
>En1B8 
GGTAATTAAA 
>En1B9 
GGTAATTAAC 
>En1B10 
TCAATTAAGG 
>En1B11 
GCTAATTAAT 
>En1*A1 
GTGTTAATGA 
>En1*A4 
GCATAATTA 
>En1*A5 
ACAATTATAA 
>En1*A6 
ATAATTAAAA 
>En1*A8 
ATCATTAACC 
>En1*A9 
GATAATTATC 
>En1*A10 
TATCAACCCC 
>En1*A11 
CCTCATTAAA 
>En1*B2 
ATTAATTATC 
>En1*B3 
GTAATTAGG 
>En1*B4 
AGCAATTAAG 
>En1*B5 
TGTAATTAGA 
>En1*B7 
TTTAATTAAG 
>En1*B8 
TAGTTAATTA 
>En1*B9 
ATCAATTAAG 
>En1*B10 
CTCATTAAGA 
>En1*B11 
CTCATTAGTG
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Table 4.1.  Selected sequences for Bicoid, Deformed and En.  All sequences are listed in 
the same orientation relative to the promoter of the reporter genes (toward the 3’ side).  
Yellow highlight indicates the position of a binding site in the positive strand, magenta 
indicates the position of a binding site in the negative strand, and green indicates a 
palidromic site (orientation unknown).  “Yellow” sites trend toward the 3’ end of the 
sequence whereas “magenta” sites trend toward the 5’ end of the sequence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
183 
Global alignment and clustering of homeodomain binding sites  
Remarkable diversity exists in the B1H-determined DNA-binding specificities for the 
entire set of homeodomains (Figure 4.3). The almost absolute conservation of Asn51, 
which specifies Ade at binding site position 3 (Fraenkel et al., 1998; Grant et al., 2000; 
Wolberger et al., 1991), in combination with our ability to infer the orientation of each 
homeodomain on its binding site (Figure 4.7 and Table 4.1) provides a basis for aligning 
all of these recognition sequences.  Using this master alignment (Appendix Table A.3), 
hierarchical clustering of the D .melanogaster homeodomains was performed based on 
the similarity of their DNA-binding specificities (Figure 4.8).  Based on this analysis the 
majority of these factors can be organized into eleven different specificity groups (Figure 
4.8). We determined the average specificity of each group for the purposes of comparison 
(Group recognition motif, Figure 4.8B).  In this calculation, we utilized the core 6 base 
pair element recognized by these factors, although some individual factors recognize 
larger motifs. Slightly more than half (43) of the homeodomains fall into the Antp or En 
specificity groups.  There are also a number of specificity groups, such as the Abd-B and 
NK-1 group, which differ in sequence preference from the Antp or En groups at only one 
or two positions. Other groups, such as the TGIF-Exd group, differ at four or five 
positions relative to the Antp or En groups. Outside of these specificity groupings are five 
factors, such as CG11617, that exhibit unique specificities. This diversity of specificities 
reveals the adaptability of the homeodomain architecture for the recognition of a variety 
of DNA sequences.   
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Figure 4.8. Specificity-based clustering of the 84 Drosophila homeodomains. (A) Based 
on the sequence similarity between the clustered recognition motifs, these factors can be 
organized into eleven different specificity groups.  Oct1 (Oct) was also included this 
analysis, but was not included in a specificity group. (B) The typical and atypical 
homeodomains are distributed into different groups, with the typical groups listed at the 
top. The average specificity of each group is indicated under the Group recognition motif, 
and to the right is the Sequence logo of the key homeodomain recognition positions for 
each group. (C) The specificity groups (colored rectangles) are mapped onto the 
homeodomain amino acid sequence similarity tree. In instances where highly similar 
neighbors have been assigned into different specificity groups (10 pairs indicated by red 
brackets) any difference in residue type at a key recognition position (5, 47, 50, 54 or 55) 
is noted (ND = No difference). 
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Homeodomains that share strong sequence similarities are not always found in the 
same specificity group.  We mapped the specificity group assignments onto an amino 
acid neighbor-joining tree to examine the correlation between overall sequence similarity 
and DNA-binding specificity within the homeodomain family (Figure 4.8C).  As 
expected, when there is a strong similarity in amino acid sequence for two factors they 
usually share a common specificity.  However, in 10 instances, two factors share strong  
sequence similarity, but fall into different specificity groups.  In eight of these 
comparisons, this difference can be explained by the presence of a different residue at  
one or more of the key DNA-recognition positions (5, 47, 50, 51, 54 and 55, see below).  
Pairs of factors with high overall sequence similarity, but different specificities due to 
changes in their specificity determinants, may represent recently diverged gene 
duplications where one factor has acquired new target genes and a different in vivo 
function. 
 
Distinguishing features of homeodomain specificity groups 
Clear correlations exist between the specificity of each group and the amino acid 
distributions that are present at the key DNA recognition positions (Figure 4.8B). Below, 
we compare and contrast these amino acid distributions to highlight distinguishing 
features of the different homeodomain specificity groups. In some cases, the contribution 
of specific residues toward specificity for one or more group members has been 
demonstrated in previous mutagenesis or structural studies. This dataset allows the 
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categorization of these determinants in the context of the full range of Drosophila 
homeodomain specificities.  
  
Typical superclass 
Antp and En groups:  The largest and most extensively-studied groups of homeodomains 
provide our benchmark for describing how differences in amino acid sequence correlate 
with DNA-binding specificity. The Antp and En groups share very similar recognition 
motifs and corresponding similarities in their amino acid distributions at the key 
recognition positions.  One difference in specificity is at binding site position 5: the En 
class prefers Thy, whereas the Antp class tolerates either Gua or Thy.  There is a 
corresponding difference between these groups in the most common residue at position 
54: Ala for the En group and Met for the Antp group. In the Antp-DNA structure, the side 
chain of Met54 is close (4.25Å) to binding site position 5, which could directly influence 
the preferred base (Fraenkel and Pabo, 1998). This correlation is not absolute, as a small 
number of factors with Ala at position 54 are found in the Antp class.  
 
Bcd group:  Typical homeodomains containing Lys50 (Bcd, Oc, Gsc and Ptx1) prefer 
Cyt at binding site positions 5 and 6. The importance of Lys in defining this preference is 
well-established (Hanes and Brent, 1989; Percival-Smith et al., 1990; Treisman et al., 
1989) and is a consequence of a direct contact between Lys50 and the complementary 
guanines at binding site positions 5 and 6 (Tucker-Kellogg et al., 1997). These factors  
 
188 
Figure 4.9 
 
 
189 
Figure 4.9.  Secondary effects influence recognition for Thr47 containing 
homeodomains.  A) Schematic of the potential interactions between the Thr47 containing 
homeodomains and their binding sites. When the eight typical homeodomains that 
contain Thr at position 47 are considered together, they display a clear reduction in 
specificity at binding site positions 4 and 5 of their as assessed by the information content 
at these positions. B) This set of Thr47-containing factors can be divided into two sub-
sets with regards to the degree of preference for Thy at position 4 of their binding site.  
Factors that contain a β-branched amino acid at position 43 (Bsh, CG11085 & CG34031) 
display a strong preference for Thy at position 4, while the remaining five factors (Lbe, 
Lbl, B-H1, B-H2 & C15) display only a weak preference The difference between these 
two motifs is statistically significant (p-value = 2.48e-4). Because amino acids at 
positions 43 and 47 are on the same face of the recognition helix and are in van der Waals 
contact in some crystal structures (Piper et al., 1999), it is plausible that the type of 
residue at position 43 could bias the preferred conformation of Thr47 and thereby 
influence its binding site preference. The Sequence logos of the recognition helices for 
each subgroup (not corrected for small sample size) are shown to the right of their motifs.  
C) The combination of Thr47 and Thr54 leads to a preference for Gua over Ade at 
binding site position 6 for the factors within the Bar group.  Five of these factors (BH-1, 
BH-2, CG11085, CG34031 & C15) contain Thr at positions 47 and 54 of the recognition 
helix and a display a strong preference for Gua at binding site position 6, a preference 
that is not observed in any of the other homeodomain groups.  Ten other homeodomains 
(Bsh, Lbl, Lbe, NK7.1, CG7056, Slou, CG13424, Hgtx, E5 & Ems) that contain Thr at  
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either but not both positions, display a preference for an alternate base, typically A, at 
position 6.  This difference is statistically significant (p-value = 7.05e-18). 
Mechanistically, how the presence of Thr at positions 47 and 54 would create a 
preference for Gua at position 6 of the binding site is not obvious as these residues are 
separated by 2 helical turns and appear more appropriately positioned to influence 
specificity at binding site positions 4 and 5.  This combination could indirectly affect 
specificity at binding site position 6 through an influence on the sequence preference of 
Gln50.  
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prefer the classical TAAT motif at binding site positions 1 through 4 and correspondingly 
have canonical (En/Antp-like) recognition residues at most other recognition positions.  
 
NK-1, Bar and Ladybird groups: Many of these homeodomains are members of the NK 
or DL homeodomain classes (Banerjee-Basu and Baxevanis, 2001), which generally have 
Thr at position 47 or 54, and have specificities similar to the Antp and En groups. Those 
homeodomains with Thr47 generally display reduced specificity at binding site positions 
4 and 5 (Figure 4.9A) with the exception of homeodomains with a beta-branched amino 
acid at position 43. These homeodomains display a stronger preference for Thy at 
position 4 (Figure 4.9B). Within the Bar group, factors that contain both Thr47 and Thr54 
display a unique preference for Gua at binding site position 6 (Figure 4.9C).  
 
NK-2 group: The three members of this group display a unique preference for Gua at 
binding site position 4, due to an interaction between Tyr54 and the complementary Cyt 
in this base pair (Gruschus et al., 1997). Their specificities differ only at binding site 
position 1, which correlates with amino acid differences at positions 6 and 7 of the N-
terminal arm (Damante et al., 1996) (Figure 4.10).  
 
Abd-B group: These factors display a slight preference for Thy over Ade at binding site 
position 2.  A diverse set of amino acids is present at positions 2 and 3 of the N-terminal 
arm when compared with other groups of typical homeodomains, which frequently have 
Arg or Lys at both positions.  Although the preference for Thy at binding site position 2  
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Figure 4.10.  Residues at positions 6 and 7 of the N-terminal arm can influence the 
specificity at position 1 of the binding site.  A) The three NK-2 class family members that 
share Tyr at position 54 display very similar overall specificities with the exception of 
binding site position. Bap (NK3) prefers a TAAGTG sequence, while Tin (NK4) and 
Vnd (NK2) prefer CAAGTG. A vertebrate homolog of Bap, Nkx3.2 displays an identical 
consensus sequence TAAGTG (Kim et al., 2003). The modest preference for Cyt at 
binding site position 1 has been observed for homologs of Tin and Vnd in other species 
and has been particularly well characterized in bovine TTF-1, which recognizes 
CAAGTG(Damante et al., 1996). Damante and colleagues narrowed the residues 
responsible for the Cyt preference at position 1 to the residues at positions 6 through 8 
(VLF) in the N-terminal arm(Damante et al., 1996).  They demonstrated that when these 
residues are substituted for the QTY in the N-terminal arm of Antp, its specificity was 
altered from a strong preference for Thy at binding site position 1 to a tolerance for Cyt 
or Thy.  B) Consistent with this analysis, both Tin and Vnd have VLF motif at these 
positions in the N-terminal arm, while Bap contains an AAF motif.  Our results allow us 
to further narrow the key residues responsible for the alteration in the specificity 
observed in the NK-2 family at binding site position 1 to residues at positions 6 and 7 in 
the N-terminal arm, since F is shared between all three NK-2-type factors.  Only one 
other D. melanogaster homeodomain, Cut, has the VL motif at positions 6 and 7 of the 
N-terminal arm and it tolerates either Thy or Cyt at position 1 in the binding site, 
although there is a modest preference for Thy (Figure 4.4).  This Thy preference in Cut 
may be due to the presence of a contact to binding site position 2 by Arg55, which can  
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influence the preference for Thy at position 1 in the binding site as described in the text 
(Figure 4.11B). A structural explanation for this influence is unavailable, but it is possible 
that the packing of the VL motif against the homeodomain fold positions a backbone 
carbonyl to favorably interact with the N2 position of the complementary Gua in the 
minor groove.   
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Figure 4.11.  Correlations are observed within the atypical homeodomains between the 
presence of Arg at positions 54 and 55 and the preferred specificity at binding site 
positions 2 and 4.  A)  (Left) Sequence logos for the different types of atypical 
homeodomains (either groups or outliers). (Right) The amino acid sequences at the key 
DNA contact positions for each factor or group.  When Arg is present at position 54 
(magenta) there is usually a preference for Cyt at binding site position 4.  When Arg is 
present at position 55 (cyan) there is usually a preference for Gua at binding site position 
2. Notable exceptions are indicated by red circles.  B) Structural model of DNA 
recognition for atypical family members containing Arg at positions 54 and 55 
constructed from a superposition of the contacts observed in the MATα2-DNA 
(Wolberger et al., 1991) and Exd-Ubx-DNA structures (Passner et al., 1999). These 
arginines potentially specify not only the contacted Gua, but also the 5’ Thy due to the 
favorable van der Waals interaction (~4 Å) with the T-methyl group (silver sphere).   
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in Abd-B has been mapped to amino acid positions 3, 6 and 7 of the N-terminal arm 
(Ekker et al., 1994), the variability within this group at these positions prevents a 
straightforward correlation of binding site preference and amino sequence. 
 
Atypical homeodomains 
The atypical superclass is distinguished from the typical superclass by different 
amino acid preferences at a number of positions within the homeodomain fold and by the 
presence of a three amino acid loop extension (TALE) between helix 1 and 2 (Figure  
4.4). The D. melanogaster atypical homeodomains comprise three different specificity 
groups with additional outliers (e.g. Cut, Onecut and CG11617, Figure 4.11A).  
 
Overall, Recognition motifs for the atypical groups are distinguished by a tendency 
toward Gua at binding site position 2, and Cyt and Ade at positions 4 and 5 (Figures 4.8B 
and 4.11A). In CG11617 and the Iroquois and TGIF groups, the preference for Cyt and 
Ade at positions 4 and 5 correlates with the presence of Arg54, which is consistent with 
the contact between Arg54 and the complementary Gua and Thy at positions 4 and 5 
described in the MATα2 co-complex crystal structures (Wolberger et al., 1991) (Figure 
4.11B). The single exception to this correlation, Onecut, contains a unique specificity 
determinant (Met50), which may be responsible for its distinct recognition preference. 
Likewise, with the exception of the Iroquois group, homeodomains that contain Arg55 
prefer Gua at position 2, suggesting that the contact observed between this amino acid 
and base in the Exd and Pbx co-complex crystal structures (Passner et al., 1999; Piper et 
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al., 1999) is another general recognition feature (Figure 4.11B). Consistent with this 
model, CG11617, which has Lys55, has reduced specificity at position 2 (Figure 4.6).  
 
TGIF-Exd group: Our data is consistent with the described specificities for individual 
members of the TGIF - Exd group (Bertolino et al., 1995; Chang et al., 1996). 
 
Six group: All members of this group (So, Six4 and Optix) display a specificity that 
overlaps with the recognition motif TGATAC and share identical residues at the key 
DNA-recognition positions (47, 50, 51, 54 and 55). Our recognition motif is consistent 
with binding sites extracted from footprinting data for So ((T/C)GATAC) (Hazbun et al., 
1997), but is inconsistent with the specificity (TAAT) reported for murine Six3, an Optix 
homolog (Zhu et al., 2002). Both Six3 and Optix contain Arg55 and so would be 
expected to specificity G instead of A at position 2. This discrepancy is examined in more 
detail below. 
 
Iroquois group: Our motif (ACA) represents the specificity of a monomer, whereas the 
previous described specificity of a full-length protein (Mirr) revealed that it binds as a 
homodimer to the palindrome ACANNTGT (Bilioni et al., 2005). All three members of 
the Iroquois group (Caup, Mirr and Ara) exhibit a weak preference for Thy at position 1 
despite the presence of Arg5 in the N-terminal arm, which can specify this position in 
other homeodomains (Passner et al., 1999; Piper et al., 1999), and exhibit a weak 
preference for Ade or Thy instead of Gua at position 2 despite the presence of Arg55.   
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Figure 4.12.  The role of position 8 in organizing the N-terminal arm.  A) Most 
homeodomains have a large hydrophobic residue at position 8 that docks into a pocket 
formed by the three-helix bundle of the homeodomain fold.  This interaction anchors the 
N-terminal arm over the minor groove for DNA-recognition.  B) Surface rendering of the 
homeodomain (residues 9-60, recognition helix shown in yellow; Msx-1 structure (Hovde 
et al., 2001)). Phe8 (red) sits in a structural pocket and directs the N-terminal arm 
(orange) over the minor groove of the DNA.  C) Iroquois family members have Ala at 
position 8 and as a consequence the N-terminal arm is free to sample other conformations 
that reduce the specificity of the factor.  D) Reintroduction of the Phe at position 8 in 
Caup (A8F) dramatically alters the specificity of the protein at positions 1 and 2 of the 
binding site.   
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One striking difference between the Iroquois group and all other homeodomains (typicals 
and atypicals) is the presence of Ala instead of a large hydrophobic residue at position 8 
(Figure 4.4).  The large hydrophobic residue binds in a cleft against the homeodomain  
helices and appears to position the N-terminal arm over the 5’ end of the binding site 
(Figure 4.12). This residue can influence the efficiency of DNA-binding, as mutation of 
Phe8 to Ala in Bcd attenuates its DNA-binding affinity (Subramaniam et al., 2001). To 
test if the limited specificity of the Iroquois family at the 5’ end of their site is due to the 
absence of this interaction, a Ala8Phe mutation was introduced into Caup (Figure 4.12D). 
Remarkably, this single mutation increases Thy specificity at position 1 and Gua 
specificity at position 2. The relatively weak specificity for Gua at position 2 suggests 
that another feature within the homeodomain architecture may directly or indirectly mask 
the ability of Arg55 to specify this base; one potential confounding feature is Glu59,  
which could create a cationic trap in conjunction with the phosphodiester backbone 
(Figure 4.13). 
 
Overall, a comparison of the typical and atypical specificity groups suggests two 
overlapping, but distinct sets of protein-DNA interactions (Figure 4.8B and 4.11B). In 
both, Arg5 and Asn51 generally specify Thy and Ade at binding site positions 1 and 3. 
These contacts in conjunction with a common set of phosphate contacts that are shared by 
95% of the homeodomains in this set imply that the docking geometry of all of these 
homeodomains with the DNA will be similar (Figure 4.4). The specificity differences 
arise from different combinations of residues on this common recognition platform,  
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Figure 4.13.  Glu59 may influence the specificity imparted by Arg55 in Caup.  The 
presence of glutamate at position 59 of the homeodomain may also be influencing the 
degree of preference for Gua at position 2 of the binding site by capturing Arg55.  A) A 
“cationic trap” is present in the Antp structure where Lys55 is captured against the 
phosphate backbone by Glu59 (Fraenkel and Pabo, 1998).  Dotted lines indicate the 
distances between the lysine amino group and the negatively charged oxygens on the 
phosphodiester backbone and the acidic side-chain.  The Iroquois family has a conserved 
glutamate at this position that could potentially capture Arg55 against the phosphodiester 
backbone.  B) Mutation of Glu59 to Gln in the presence or absence of the A8F mutation 
results in an increase in the frequency of recovery of Gua at position 2 in the binding site.  
However, this change in specificity is modest when compared to the effect of the A8F 
mutation on specificity. 
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which can be analyzed as a set to elucidate how each position in the binding site is 
influenced by the homeodomain sequence. 
 
Common specificity determinants for homeodomain proteins 
We have undertaken both computational and qualitative approaches to decipher the 
common DNA-binding determinants for homeodomains. Our dataset provides an 
excellent resource for the computational identification of correlations between amino acid 
sequence and base preferences within the binding site, as it contains significantly more 
breadth (1860 different binding sites for 84 different proteins) than any previous catalog 
of homeodomain DNA-binding specificities. Mutual information (MI) analysis was used 
to identify potential specificity determinants by evaluating positions within our set of 
homeodomains that co-vary with changes at specific positions in the binding site (Gutell 
et al., 1992; Mahony et al., 2007). Protein and DNA positions that have high MI scores 
(i.e. their variation appears correlated) are candidates to interact either directly or 
indirectly. MI analysis identified a number of protein/DNA positions that appear to be 
correlated, some of which correspond to expected interactions based on previously 
identified DNA recognition positions (Appendix Table A.4). However, simple MI 
analysis is complicated by the limited variability at some individual positions (Figure 
4.14). In order to normalize the values over both columns and rows of the MI matrix, we 
transformed the MI matrix into a joint rank product matrix, which provides a more 
uniform landscape (Figure 4.15). Prominent features of this plot correspond to expected 
homeodomain-DNA interactions.  For example, strong MI is observed between  
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Figure 4.14 
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Figure 4.14.  Heat plot of Mutual Information (MI) analysis between the amino acid 
sequences of the homeodomain and the master alignment of their selected binding sites.  
A two-dimensional heat plot is shown where background levels of covariance are 
indicated in dark blue and positions with strong covariance are indicated in red.  The x-
axis indicates the position within the homeodomain (1 through 60), where the TALE 
insertions in the atypical family have been removed to achieve a common sequence 
framework. The amino acid diversity at each position is indicated by a Sequence logo 
above the plot.  Key DNA-recognition positions are indicated by asterisks above the 
amino acid sequence. The y-axis indicates the position within the binding site (5’ top, 3’ 
bottom).  The overall motif of all of the binding sites is represented as a Sequence logo to 
the right of the plot.  Overall the degree of covariation is higher at the 3’ end of the 
binding site than for the 5’ end of the site.  Positions with little diversity in sequence 
composition have lower MI values, which is highlighted by the trough in the plot at the 
position corresponding to the Ade at position 3, which is highly conserved among the 
population of binding sites.  Strong peaks are observed within the plot for expected base-
amino acid contacts, such as between position 50 of the homeodomain and positions 5 
and 6 of the binding site. 
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Figure 4.15  
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Figure 4.15. Heat plot of the joint-ranked Mutual Information (jrMI) analysis.  The 
background levels of covariance are indicated in dark blue and positions with strong 
covariation are indicated in red.  The x-axis indicates the position within the 
homeodomain alignment. Only positions 1 through 10 and 40 through 60 are shown to 
highlight the regions that are most likely involved in recognition. The amino acid 
diversity at each position is indicated by the Sequence logo above the plot.  Key DNA-
recognition positions are indicated by asterisks. The y-axis denotes the position within 
the binding site (5’ top, 3’ bottom, with positions 1-4 capitalized) where the overall motif 
of the aligned binding sites is represented by a Sequence logo.  
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recognition helix positions 50 and 54 and binding site positions 6 and 4, respectively.  
Both of these peaks correctly predict positions of interaction between the homeodomain 
and DNA.  Strong peaks are also observed between positions 6 and 47 of the  
homeodomain and binding site position 2. Position 6 on the N-terminal arm is expected 
to affect the specificity of binding site position 2 (Ekker et al., 1994). However, the 
correlation at position 47 is likely due to evolutionary linkage; the type of residue at 
position 47 is correlated to the superclass of the homeodomain (atypical or typical) where 
each superclass typically prefers different bases at binding site position 2. Although this 
evolutionary history complicates the MI analysis, a number of known homeodomain-
DNA interactions are recovered and other homeodomain positions are identified that may 
be new hallmarks for predicting specificity based on amino acid sequence.  
 
While the MI analysis can predict positions involved in determining DNA-binding 
specificity, it does not identify which amino acids lead to different binding site 
preferences. This information can be extracted from our dataset by examining the 
correlations between amino acid sequence and recognition preference in the context of 
the large body of reported structural and biochemical studies on homeodomain 
recognition. The keystone for this analysis is the Asn51-mediated recognition of Ade at 
binding site position 3.  In the presence of an alternate amino acid-base combination at 
this position, other inferences about the key specificity determinants may not be valid. 
Below, the residues that frequently contribute to specificity are summarized for each 
position in the binding site (Figure 4.16). 
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Figure 4.16  
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Figure 4.16. Catalog of common specificity determinants for Asn51-containing 
homeodomains. The specificity of a homeodomain for its binding site can be inferred 
from the amino acid sequence that is present at positions 2, 3, 5, 43, 47, 50, 51, 54 and 
55.  Amino acid positions that are most likely to influence the sequence preference of the 
homeodomain at a particular position in the binding site are indicated in boxes (solid line 
– major groove, dotted line – minor groove) surrounding the core 6 bp binding element. 
An arrow points from the box of potential interactions to the base within each base pair 
that it describes.  For simplicity some interactions, such as Lys50 with binding site 
positions 5 and 6, are described as influencing specificity on the primary strand of the 
DNA when in reality direct contacts are made to the complementary strand. The DNA 
base specified by a certain type of amino acid at each position is indicated in each box. 
Where multiple amino acid positions can influence specificity at a particular binding site 
position, the position of each amino acid is indicated as a superscript. The prediction of 
specificity of a homeodomain based on the amino acids at these recognition positions will 
not be perfect, as many factors can influence the sequence preference of these 
determinants.   
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BS Position 1: 89% of the aligned recognition sequences have Thy at this position.  
Consistent with this preference, the majority of homeodomains (94%) have Arg5 in the  
N-terminal arm, which specifies Thy (Ades and Sauer, 1995).  In the Six family, Thy is 
preferred in the absence of Arg5, which is potentially due to the favorable stacking of the 
T-methyl group over Arg55 as it interacts with Gua at position 2 of the binding site 
(Figure 4.11B). In the NK-2 class, Val6 and Leu7 promote a preference for Cyt over Thy 
(Damante et al., 1996).  
 
     BS Position 2: Preferences for Ade, Gua or Thy are observed among the different 
homeodomains. 83% of the aligned sequences have Ade at this position. Consistent with 
this preference, most typical homeodomains contain Arg2 or Arg3 within the N-terminal 
arm, which structural and biochemical studies have implicated in biasing specify toward 
Ade (Ades and Sauer, 1995; Hovde et al., 2001). However, both Lab and HGTX, which 
lack either arginine, strongly prefer Ade, which is consistent with reports of an additional 
unidentified specificity determinant (Ades and Sauer, 1995). Members of the Abd-B 
group display a preference for Thy over Ade, but the responsible specificity determinants 
are unclear. In atypical homeodomains Arg55 specifies Gua; however, several typical 
homeodomains contain Arg55, yet display a preference for Ade (e.g. Awh and Bcd), 
indicating that additional residues contribute to specification of Gua.   
 
BS Position 3: Asn51 specifies Ade at this position.  
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BS Position 4: Any base can be specified at this position.  Thy is the most common 
base (80%) and is strongly correlated with the presence of Ile or Val at position 47. The 
three exceptions that contain Val at position 47 - Bap, Tin and Vnd – are NK-2 class 
homeodomains, which prefer Gua due to a direct contact by Tyr54 to the complementary 
strand Cyt (Gruschus et al., 1997).  Cyt specificity is strongly correlated with the 
presence of Arg54, which interacts with the complementary Gua. Bcd is one notable 
exception; it contains both Ile47 and Arg54, yet displays strong preference for Thy, 
which suggests that the base preference of Ile47 may supercede Arg54 (explored below). 
Decreased specificity at position 4 is correlated with either Thr47 or Asn47, although the 
presence of a β-branched amino acid at position 43 modifies the degree of preference 
(Figure 4.9B).  Finally, Cut displays a unique preference for Ade at position 4; His50, 
which only occurs in this homeodomain, may be responsible. 
 
BS Position 5: For many specificity groups correlations exist between the residues at 
positions 47, 50 and 54 and certain base preferences. Specificity groups that have Gln50 
and either Ile47 or Val47 display preferences that correlate with the residue at position 
54.  When Met54 is present (Antp group) a tolerance is observed for either Gua or Thy, 
whereas when Ala54 (En group) or Tyr54 (NK-2 group) are present, a preference for Thy 
is observed. When Lys50 occurs with Ile47 or Val47 and Ala54 (Bcd group) a strong 
preference for Cyt is observed (Ades and Sauer, 1994; Hanes and Brent, 1989; Percival-
Smith et al., 1990; Treisman et al., 1989).  However, Lys50 in the presence of Asn47 and 
Gln54 (Six family) specifies Ade instead of Cyt.  An influence of position 54 on the 
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specificity mediated by Lys50 has also been observed in other contexts (Pellizzari et al., 
1997). Finally, when Arg54 is present in the absence of Ile47 or Val47 (Iroquois and 
TGIF groups) a preference for Ade is observed, which is likely due to preferential 
stacking of the complementary T-methyl group over the guanidinium group of Arg54 as 
it interacts with Gua at position 4 (Figure 4.11B). Typical homeodomains containing 
Thr47 display relaxed specificity at position 5. 
 
 BS Position 6: Like position 5, the determinants of specificity at this position appear 
influenced by the residues at positions 47, 50 and 54.  Ade is modestly preferred over 
Gua when Gln50 and Met54 (Antp group) or Ala54 (En group) are present.  Conversely, 
Gua is preferred over Ade when both Thr47 and Thr54 are present with Gln50 (Bar and 
NK-1 groups, or less exclusively when Tyr54 is present with Ile47 and Gln50 (NK-2 
group).  Finally, the presence of Lys50 provides a preference for Cyt at position 6 (Bcd 
and Six groups). The majority of atypical homeodomains with the exception of the Six 
group display no strong preference at this position. 
 
Competing contact residues in Bcd  
One complicating feature of these specificity determinants, as observed for other 
types of DNA-binding domains, is the absence of a one-to-one correlation between the 
presence of an individual residue at a certain position and the specificity at a particular 
binding site position; residues at different positions on the homeodomain can potentially  
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Figure 4.17  
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Figure 4.17. Exploring DNA-binding specificity through mutagenesis.  A) Mutational 
analysis of the specificity determinants for binding site position 4 in Bcd. Amino acids at 
three different positions (Ile47, Lys50 and Arg54) can potentially influence the base 
preference at position 4. The wild-type protein prefers Thy. Three different mutants 
(I47N, K50A and I47N with K50A) were characterized to determine the alteration in base 
preference at this position. The frequency that each base was recovered at position 4 is 
indicated to the right of the Sequence logo for each factor. B) Conversion of Engrailed 
(En) into a homeodomain with TGIF-like specificity.  (Top)  Schematic representation of 
the critical base contacts responsible for specificity in En and TGIF family members.  
(Bottom) Flow diagram of the mutations required to complete the specificity conversion.  
Two intermediate specificity conversions (EnV1 and EnV2) were obtained first, and these 
mutations were combined along with Q50A to produce TGIF-like specificity. 
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Figure 4.18 
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Figure 4.18.  Binding site selection data for Bicoid collected from a selection performed 
at 5mM 3-AT instead of the typical stringency of 10 mM.  The sequence preferences are 
preserved in this binding site selection except that Cyt and Thy are equally represented at 
position 6. There is increased tolerance for other bases at many positions, such as position 
4 where Thy and Gua are both acceptable, but Cyt is still excluded from the binding sites 
at this position. 
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interact with a common base pair to coordinately influence the base preference. For 
example, residues at positions 47 and 54 can both directly influence the base preference  
at binding site position 4 (Fraenkel et al., 1998; Gruschus et al., 1997; Wolberger et al., 
1991). When multiple determinants with different preferences for a single binding site 
position are present, it is possible that these potential interactions compete. Consequently, 
the overall specificity of a homeodomain may be a composite of more than one binding 
site motif.  
 
     We have used Bcd to explore whether competing interactions can contribute to 
binding site specificity. Bcd contains Ile47 and Arg54, which appear to respectively 
specify Thy and Cyt at binding site position 4 in other homeodomains. At this position 
Bcd displays a strong preference for Thy, a weak preference for Gua and no evidence of 
tolerance for Cyt (Figure 4.17A).  This hierarchy of preferences is also observed in a 
binding site selection performed at lower stringency (Figure 4.18).  A weak tolerance for 
Gua is consistent with previous SELEX-based characterization of Bcd (Wilson et al., 
1996) and is likely a consequence of Lys50. In the structure of the Engrailed Q50K 
mutant with the binding site TAATCC, this Lys has two different conformations: one 
conformation interacts with the O6 positions of Gua5’ and Gua6’ (’ indicates the 
complementary strand) while the other conformation interacts with the O4 of Thy4 and 
the O6 of Gua5’ (Tucker-Kellogg et al., 1997).  The latter interaction would likely be 
more favorable with the O6 positions of Gua4 and Gua5’ in the context of the sequence 
TAAGCC (e.g. see (Kim and Berg, 1996)).  In fact, Bcd has been previously shown to 
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bind specifically to the sequence TAAGCT (Dave et al., 2000), although the authors 
ascribed the preference for Gua at position 4 to Arg54, which appears unlikely given our 
mutational results (described below) and the fact that the Oc homeodomain protein, 
which also contains Lys50 but lacks Arg54, displays a weak preference for Gua at 
position 4 based on our data and previous SELEX data (Wilson et al., 1996).   
 
The absence of Cyt in the recognition motif suggests that Ile47 or Lys50 may prevent 
Arg54 from contributing to the base preference at position 4.  To help define the 
hierarchy of interactions that influence specificity, single and double mutations were 
examined at positions 47 and 50.  When Ile47 is mutated to Asn, a residue commonly 
found in atypical homeodomains that contain Arg54, the specificity of Bcd was modestly 
altered (Figure 7A).  In this mutant, the relative preference for Thy and Gua is preserved, 
but a tolerance for Cyt is also apparent, possibly due to the increased influence of Arg54.  
Moreover, every occurrence of Cyt is in the context of the sequence TAACAC (3 of 34), 
which is consistent with Arg54 specifying Cyt and Ade at positions 4 and 5, respectively 
(Figure 4.11B), and Lys50 specifying Cyt at position 6 as seen in the Six group.  When 
Lys50 is mutated to Ala, a complete shift to an En-like specificity (TAATTA) is 
observed with no evidence of other specificity determinants influencing position 4.  In the 
double mutant Ile47Asn and Lys50Ala, a preference for Cyt at position 4 - the base 
specified by Arg54 in most atypical homeodomains - is revealed. Thus, three different 
potential specificities are embedded within the Bcd scaffold as a consequence of the 
residues at positions 47, 50 and 54. Lys50 and Arg54 are less influential likely because 
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they have greater flexibility, which allows them to obtain other favorable interactions: 
Lys50 with bases at positions 5 and 6, and Arg54 with the phosphodiester backbone. 
 
Engineering the DNA-binding specificity of En  
To assess the utility of our catalog of specificity determinants, we attempted to shift 
the specificity of En, a typical homeodomain (TAATTA), to that of a TGIF-type atypical 
homeodomain (TGACA).  These homeodomains differ in sequence preference at four of 
the six recognition positions (Figure 4.17B), and share ~28% sequence identity overall.  
While small numbers of substitutions have been previously introduced into 
homeodomains to alter their specificity at one or two binding site positions, attempts to 
produce dramatic changes in specificity, such as grafting the specificity of a typical 
homeodomain onto an atypical homeodomain, have failed (Mathias et al., 2001).  
 
En was chosen as our scaffold for engineering because of its detailed biochemical and 
structural characterization (Ades and Sauer, 1994, 1995; Fraenkel et al., 1998; Grant et 
al., 2000; Tucker-Kellogg et al., 1997). Two partial specificity conversions were carried 
out in parallel (Figure 4.17B):  One conversion (variant EnV1) to alter specificity at 
position 2 (TGATTA), and another conversion (variant EnV2) to alter specificity at 
positions 4-6 (TAACA). Two mutations (R3K and K55R), which both influence the base 
preference at position 2 (Figure 4.16), were sufficient to generate a strong preference for 
Gua (Figure 4.17B). Likewise, two mutations (I47N and A54R), which influence 
specificity at the 3’ end of the recognition sequence (Figure 4.16 and 4.17A), were 
sufficient to promote the EnV2 specificity. Consistent with the Bcd mutagenesis data, 
222 
individual substitutions did not achieve the desired alteration in specificity.  It is 
noteworthy that the specificity of the EnV2 mutant (TAACA) was obtained in the 
presence of Gln50, which is not found in atypical homeodomains but is almost 
universally conserved among typical homeodomains.  In this particular context, the 
Arg54 specificity determinant is dominant, which is consistent with previous studies that 
found no evidence of a prominent role in specificity for Gln50 in En (Ades and Sauer, 
1994; Grant et al., 2000).   
 
The two pairs of mutations (R3K, I47N, A54R and K55R) present in EnV1 and EnV2 
were combined in anticipation that they would produce the desired composite specificity 
(TGACA).  However, this mutant displayed a 3’ specificity that is intermediate between 
an En-like and TGIF-like specificity (TGA(T/C)(T/A)(G/A); Figure 7B). Even though 
Gln50 appears passive in the EnV2 mutant, its potential influence on specificity in this 
context was examined by mutation; including Q50A provides an almost complete 
conversion to the desired TGACA specificity. When this motif is included with the other 
fly homeodomains to analyze the overall similarity of all of the recognition motifs, it 
clusters with the TGIF-Exd group (Figure 4.19). The less pronounced preference for Gua 
at binding site position 2 relative to a TGIF homeodomain suggests that additional 
residues in atypical homeodomains can contribute to specificity at this position. This 
nearly complete transformation of binding specificity demonstrates that En is a robust 
scaffold for engineering novel DNA-binding specificities while highlighting the  
complex interplay between residues at the recognition surface that can influence 
specificity of the entire motif.  
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Figure 4.19. Clustergram of engineered En homeodomain that has TGIF-like specificity 
(En_2_TGIF; R3K, I47N, Q50A, A54R, K55R) with the entire set of fly homeodomains.  
The specificity of this factor clusters with the other members of the TGIF-Exd specificity 
group (Vis, Achi, Hth & Exd), which is significantly removed from its original position 
in the clustergram (En) with the En-group. 
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Figure 4.20 
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Figure 4.20.  ClustalW alignment of the D. melanogaster and H. sapiens Iroquois family 
members.  The numbering scheme has been adjusted to ignore the presence of the TALE 
insertion in this atypical family.  Position 8 is indicated by an arrow, where all nine 
proteins have an alanine at this position.  It is noteworthy that the majority of sequence 
divergence that has occurred within this family during evolution is present in the N-
terminal arm, which in the context of alanine at position 8 may no longer play an 
important role in sequence-specific binding by this factor.  
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Predicting the specificity of the human homeodomain set  
Based on our complete description of the specificities of the fly homeodomains and 
our analysis of homeodomain recognition via mutagenesis, we predicted the specificity of 
the majority of independent homeodomains that are present in the human genome. This 
effort is facilitated by the large degree of evolutionary conservation within the family 
(e.g. Figure 20).  However, there are numerous instances in our analysis where pairs of 
homeodomains with the highest overall sequence similarity have different specificities, 
which are likely due to differences at their key recognition positions (Figure 4.8C). 
Therefore, three criteria were employed in making predictions for the independent human 
homeodomains: 1) the presence of Asn51, 2) the overall sequence similarity of each 
human homeodomain to each fly homeodomain, and for each of these comparisons 3) the 
number of identical residues at five key recognition positions (5, 47, 50, 54 and 55). 
Based on these criteria the recognition motif for 153 of 193 human homeodomains (79%)  
was constructed from the selected binding sites of up to three fly factors that share the 
highest overall sequence homology and the most similar DNA-recognition residues 
(Figure 4.21). A cross-validation test was performed on the fly homeodomain set to 
assess the accuracy of these predictions (Table 4.2). Based on this evaluation, the human 
predictions were binned into four confidence levels (Appendix Table A.5): 1 represents 
the highest confidence level and 4 the lowest confidence level.  113 (74%) of the 
predictions fall in the top two confidence levels and only 8 (5%) of our predictions fall in 
the lowest confidence level. The quality of these predictions was confirmed by 
determining the specificity of six human homeodomains representing different specificity 
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groups using the B1H system (Figure 4.22) and by comparing the predicted and defined 
specificities of the non-fly homeodomains in TRANSFAC (Matys et al., 2003)(Table 
4.3).  The predicted and defined specificities for the six human homeodomains were 
highly correlated (all P-values < 2x10-6). To make this predictive method accessible to 
the scientific community, we have created an interactive web-page where a user may 
enter the sequence of a homeodomain to be evaluated using our predictive criteria.  A 
recognition motif will be constructed for the input homeodomain sequence if fly 
homeodomains are present in our dataset that meet the user-defined criteria (Figure 4.23). 
Our specificity predictions for the human homeodomain set, their corresponding PWMs, 
and the interactive prediction tool are available at http://ural.wustl.edu/flyhd.   
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Figure 4.21  Sequence logos of the 153 predicted human homeodomains. 
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Table 4.2 
Crossvalidation analysis of fly homeodomains. 
Query ALLR Distanc
e 
p-value e-value Pred. 
Cons. 
Actual 
Cons. 
Combined 
Cons. 
Repo 9.9809 0.0512 7.90E-009 7.90E-009 TAATTa TAATTA TAATTa 
Rx 9.9038 0.1058 9.29E-009 9.29E-009 TAATTa TAATTR TAATTa 
Hbn 9.8023 -0.2713 1.15E-008 1.15E-008 TAATTa TAATTR TAATTa 
Al 9.7524 0.4103 1.28E-008 1.28E-008 TAATTR TAATTA TAATTa 
Ptx1 9.6421 0.6916 1.61E-008 1.61E-008 TAATCC TAATCC TAATCC 
Oc 9.6284 0.3647 1.65E-008 1.65E-008 TAATCC TAATCC TAATCC 
Pph13 9.5617 0.1223 1.90E-008 1.90E-008 TAATTA TAATTa TAATTA 
Gsc 9.5553 0.6155 1.93E-008 1.93E-008 TAATCC TAATCc TAATCC 
Dfd 9.4429 0.2754 2.44E-008 2.44E-008 TAATgA TAATGA TAATGA 
CG32532 9.4385 0.074 2.46E-008 2.46E-008 TAATTa TAATTR TAATTa 
CG11294 9.3819 0.3812 2.77E-008 2.77E-008 TAATTA TAATTA TAATTA 
Odsh 9.3406 0.2868 3.02E-008 3.02E-008 TAATTR TAATTR TAATTR 
Scr 9.2996 0.3014 3.29E-008 3.29E-008 TAATKA TAATGA TAATKA 
Ind 9.2047 0.2277 4.01E-008 4.01E-008 TAATKA TAATKA TAATKA 
Zen2 9.1465 0.6703 4.53E-008 4.53E-008 TAATGA TAATKA TAATKA 
Lab 9.1042 0.7574 4.95E-008 4.95E-008 TAATGA TAATKA TAATgA 
Inv 9.0763 0.3488 5.25E-008 5.25E-008 TAATTR TAATTa TAATTR 
En 9.0763 0.3488 5.25E-008 5.25E-008 TAATTa TAATTR TAATTR 
Unc4 9.0702 0.8337 5.32E-008 5.32E-008 TAATTa TAATTg TAATTR 
CG9876 9.067 0.3904 5.35E-008 5.35E-008 TAATTa TAATTa TAATTa 
Otp 9.0266 0.456 5.83E-008 5.83E-008 TAATTA TAATTA TAATTA 
Ftz 8.9761 0.0222 6.48E-008 6.48E-008 TAATKA TAATKA TAATKA 
Zen 8.9689 0.699 6.57E-008 6.57E-008 TAATKA TAATgA TAATKA 
Antp 8.8538 0.4076 8.37E-008 8.37E-008 TAATKA TAATKA TAATKA 
PhdP 8.8293 0.1977 8.81E-008 8.81E-008 TAATTA TAATTn TAATTa 
AbdA 8.7462 0.1147 1.05E-007 1.05E-007 TAATKA TAATtA TAATKA 
Dr 8.6782 2.0874 1.21E-007 1.21E-007 TAATTA TAATTG TAATTR 
Btn 8.6048 0.3618 1.41E-007 1.41E-007 TAATKA TAATgA TAATKA 
Vis 8.5718 1.0373 1.51E-007 1.51E-007 TGACAg TGACAn TGACA 
Achi 8.5718 1.0373 1.51E-007 1.51E-007 TGACAn TGACAg TGACA 
Unpg 8.5501 1.4249 1.58E-007 1.58E-007 TAATTA TAATTa TAATTA 
Ro 8.39 1.8609 2.21E-007 2.21E-007 YAATTA TAATTA tAATTA 
Eve 8.3891 0.4253 2.21E-007 2.21E-007 TAATKA TAATKA TAATKA 
CG33980 8.3842 0.9261 2.24E-007 2.24E-007 TAATTa TAATTA TAATTA 
CG4136 8.3842 0.9261 2.24E-007 2.24E-007 TAATTA TAATTa TAATTA 
Ubx 8.3467 0.5666 2.42E-007 2.42E-007 TAATKA TAATta TAATKA 
Hth 8.3339 1.5492 2.48E-007 2.48E-007 TGACAg TGACAg TGACA 
CG18599 8.325 1.2562 2.53E-007 2.53E-007 TAATKA TAATtA TAATKA 
Pb 8.2429 1.6834 3.01E-007 3.01E-007 TAATKA TAATKA TAATKA 
Awh 8.2022 1.0905 3.27E-007 3.27E-007 TAATtA TAATTA TAATTA 
Ap 8.2022 1.0905 3.27E-007 3.27E-007 TAATTA TAATtA TAATTA 
So 8.1879 2.4025 3.37E-007 3.37E-007 TGATAC TGATAC TGATAC 
Tin 8.0367 1.177 4.63E-007 4.63E-007 YAAGTR cAAGTG YAAGTg 
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Bap 7.8641 2.6081 6.64E-007 6.64E-007 CAAGTg TAAGTg YAAGTg 
Dll 7.8095 1.8343 7.45E-007 7.45E-007 YAATTA YAATTA YAATTA 
BH2 7.7818 1.3614 7.89E-007 7.89E-007 TAAWtG TAATtG TAAttG 
BH1 7.7818 1.3614 7.89E-007 7.89E-007 TAATtG TAAWtG TAAttG 
Optix 7.7705 2.0452 8.08E-007 8.08E-007 TGATAC TGATAn TGATAC 
CG34031 7.7609 1.7932 8.24E-007 8.24E-007 TAATtG TAATtG TAATtG 
CG13424 7.7235 0.9239 8.92E-007 8.92E-007 TAATtR TAATtR TAATtR 
Vnd 7.6846 1.9895 9.67E-007 9.67E-007 tAAGTG CAAGTR YAAGTg 
Slou 7.4995 1.1247 1.43E-006 1.43E-006 TAATtR TAATtR TAATtR 
Six4 7.4962 3.3833 1.44E-006 1.44E-006 TGATAC TGAnAC TGATAC 
Ems 7.4919 0.9041 1.45E-006 1.45E-006 TAATKA TAATKa TAATKA 
E5 7.4919 0.9041 1.45E-006 1.45E-006 TAATKa TAATKA TAATKA 
CG11085 7.4246 1.0618 1.67E-006 1.67E-006 TAAttG TAATtG TAAttG 
Hgtx 7.4223 1.6526 1.68E-006 1.68E-006 TAATtR TAATtA TAATtR 
NK7 7.376 1.4885 1.85E-006 1.85E-006 TAATtR TAATtR TAATtR 
Bsh 7.3414 1.302 1.98E-006 1.98E-006 TAATtR TAATKR TAATtR 
Exex 7.2781 4.8019 2.27E-006 2.27E-006 TAATKA TAATTA TAAT 
Lim1 7.1013 3.0796 3.28E-006 3.28E-006 TAATtA TAATTA TAATTA 
Mirr 6.8517 0.3406 5.53E-006 5.53E-006 taACAn WaACAn WaACA 
Ara 6.7625 0.493 6.67E-006 6.67E-006 WAACAn WaACAn WaACA 
Caup 6.6398 0.3492 8.62E-006 8.62E-006 WaACAn tAACAn WaACA 
Lbe 6.5811 1.563 9.75E-006 9.75E-006 TAATtA TAAYnA TAAtnA 
Lbl 6.5811 1.563 9.75E-006 9.75E-006 TAAYnA TAATtA TAAtnA 
Lim3 6.5461 2.1844 1.05E-005 1.05E-005 TWATTR TAATtA TaATTa 
C15 6.4381 2.6673 1.32E-005 1.32E-005 TAATtG TAAttR TAAttG 
CG32105 6.4272 2.9105 1.35E-005 1.35E-005 TWATTR TAATTA TWATTR 
CG4328 6.4272 2.9105 1.35E-005 1.35E-005 TAATTA TWATTR TWATTR 
Hmx 6.1889 4.7795 2.22E-005 2.22E-005 TAAKTR TAATTG TAAtTg 
H2 5.7098 1.9904 6.04E-005 6.04E-005 TWATKA TWATnA TWATnA 
AbdB 5.647 4.8563 6.89E-005 6.89E-005 TAATKA TTATga TAATKA 
CG12361 5.2354 5.7449 0.000163 0.000163 TAATTA TMATWA TAATtA 
Cad 5.0652 6.9451 0.0002328 0.0002328 TAATgA TtATtR TAATKA 
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Figure 4.22 
 
 
Similarity of predicted and determined recognition motifs for six human homeodomains 
Factor 
Comparison 
ALLR Distan
ce 
E value P value  predicted 
consensus 
actual 
consensus 
combined 
consensus 
BarHL1 7.8848 1.5896 8.48E-007 8.48E-007 TAAttG nTAAtTGn TAAtTG 
Nkx3-2 9.1699 0.6191 5.04E-008 5.04E-008 TAAGTg YTAAGTG TAAGTG 
PitX2 10.1543 0.114 5.50E-009 5.50E-009 TAATCC TAATCC TAATCC 
Six3 7.6043 0.962 1.27E-006 1.27E-006 TGATA nnSTGATA TGATA 
TGIF2 8.5538 1.3843 1.83E-007 1.83E-007 TGACAg ntTGACA TGACA 
Vsx1 9.5817 0.2637 2.13E-008 2.13E-008 TAATTa tTAATTA TAATTa 
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Figure 4.22.  Comparison of the predicted and actual recognition motifs for 6 human 
homeodomains.  The specificities of the human factors were predicted as described in the 
text.  Specificities for these factors were determined using the B1H system and the ZF10 
library.  Comparisons between the predicted and determined motifs were determined as 
described in the Supplementary Methods with the local alignments and similarity 
calculated by ALLR and the E value and P value calculated by Matalign.  Of particular 
note, the specificity of Six3 is consistent with other Six family members; it does not 
specify TAAT as previously described {Zhu, 2002}. 
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Table 4.3 Prediction of TRANSFAC homeodomains. 
Predicted Actual ALLR Dist E value P value Predicted 
Cons. 
Actual Cons. Combine
d Cons. 
T02970 
mouse 
Chx10 
M00437.co
ns.L8.c2.to
pMx1 
9.2938 4.15
72 
4.44E-
008 
4.44E-
008 
TAATTa GCTAATTA TAATTA 
T04139 
human 
Chx10 
M00437.co
ns.L8.c2.to
pMx1 
9.2938 4.15
72 
4.44E-
008 
4.44E-
008 
TAATTa GCTAATTA TAATTA 
T04142 
chick 
Chx10 
M00437.co
ns.L8.c2.to
pMx1 
9.2938 4.15
72 
4.44E-
008 
4.44E-
008 
TAATTa GCTAATTA TAATTA 
T08863 
mouse S8 
M00099.co
ns.L9.c2.to
pMx1 
8.8487 1.27
48 
1.27E-
007 
1.27E-
007 
TAATTa TAATTRRnt TAATTR 
T03978 
human 
Cart-1 
M00416.co
ns.L14.c2.t
opMx1 
7.836 7.87
14 
1.64E-
006 
1.64E-
006 
TAATTA SnTAATtRnATTAn TAATTA 
T03981 
clawed 
frog Cart-
1 
M00416.co
ns.L14.c2.t
opMx1 
7.836 7.87
14 
1.64E-
006 
1.64E-
006 
TAATTA SnTAATtRnATTAn TAATTA 
T03980 
rat Cart-1 
M00416.co
ns.L14.c2.t
opMx1 
7.836 7.87
14 
1.64E-
006 
1.64E-
006 
TAATTA SnTAATtRnATTAn TAATTA 
T08295 
mouse 
Nkx2-2 
M00485.co
ns.L9.c2.to
pMx1 
7.2991 5.26
62 
3.25E-
006 
3.25E-
006 
CAAGTR TAAGTRnTT YAAGTR 
T04337 
human 
Nkx2-2 
M00485.co
ns.L9.c2.to
pMx1 
7.2991 5.26
62 
3.25E-
006 
3.25E-
006 
CAAGTR TAAGTRnTT YAAGTR 
T04272 
chick 
Nkx2-2 
M00485.co
ns.L9.c2.to
pMx1 
7.2991 5.26
62 
3.25E-
006 
3.25E-
006 
CAAGTR TAAGTRnTT YAAGTR 
T04265 
golden 
Syrian 
hamster 
Nkx2-2 
M00485.co
ns.L9.c2.to
pMx1 
7.2991 5.26
62 
3.25E-
006 
3.25E-
006 
CAAGTR TAAGTRnTT YAAGTR 
T03489 
cattle Crx 
M00623.co
ns.L15.c2.t
opMx1 
6.4759 5.53
7 
3.04E-
005 
3.04E-
005 
TAATCC YnnnTAAtCnnMnnn TAATC 
T03458 
rat Crx 
M00623.co
ns.L15.c2.t
opMx1 
6.4759 5.53
7 
3.04E-
005 
3.04E-
005 
TAATCC YnnnTAAtCnnMnnn TAATC 
T03461 
mouse 
Crx 
M00623.co
ns.L15.c2.t
opMx1 
6.4759 5.53
7 
3.04E-
005 
3.04E-
005 
TAATCC YnnnTAAtCnnMnnn TAATC 
T02792 
human 
Crx 
M00623.co
ns.L15.c2.t
opMx1 
6.4759 5.53
7 
3.04E-
005 
3.04E-
005 
TAATCC YnnnTAAtCnnMnnn TAATC 
T00857 
human 
Nkx2-1 
M00432.co
ns.L8.c2.to
pMx1 
6.264 4.60
36 
2.52E-
005 
2.52E-
005 
CAAGTR ASTCAAGT CAAGT 
T00856 
rat Nkx2-
1 
M00432.co
ns.L8.c2.to
pMx1 
6.264 4.60
36 
2.52E-
005 
2.52E-
005 
CAAGTR ASTCAAGT CAAGT 
T02098 
dog 
Nkx2-1 
M00432.co
ns.L8.c2.to
pMx1 
6.264 4.60
36 
2.52E-
005 
2.52E-
005 
CAAGTR ASTCAAGT CAAGT 
T00859 
mouse 
Nkx2-1 
M00432.co
ns.L8.c2.to
pMx1 
6.264 4.60
36 
2.52E-
005 
2.52E-
005 
CAAGTR ASTCAAGT CAAGT 
T00856 
rat Nkx2-
M00794.co
ns.L9.c2.to
5.911 5.21
32 
5.95E-
005 
5.94E-
005 
CAAGTR cTcAAGnGY cAAGtg 
237 
1 pMx1 
T04271 
chick 
Nkx2-1 
M00794.co
ns.L9.c2.to
pMx1 
5.911 5.21
32 
5.95E-
005 
5.94E-
005 
CAAGTR cTcAAGnGY cAAGtg 
T00859 
mouse 
Nkx2-1 
M00794.co
ns.L9.c2.to
pMx1 
5.911 5.21
32 
5.95E-
005 
5.94E-
005 
CAAGTR cTcAAGnGY cAAGtg 
T00857 
human 
Nkx2-1 
M00794.co
ns.L9.c2.to
pMx1 
5.911 5.21
32 
5.95E-
005 
5.94E-
005 
CAAGTR cTcAAGnGY cAAGtg 
T02098 
dog 
Nkx2-1 
M00794.co
ns.L9.c2.to
pMx1 
5.911 5.21
32 
5.95E-
005 
5.94E-
005 
CAAGTR cTcAAGnGY cAAGtg 
T05157 
human 
RX 
M00623.co
ns.L15.c2.t
opMx1 
5.8299 7.26
43 
0.000117
4 
0.000117
4 
TAATTR YnnnTAAtCnnMnnn TAAT 
T00863 
fruit fly 
Ubx 
M00018.co
ns.L4.c2.to
pMx1 
5.7005 3.42
02 
4.11E-
005 
4.11E-
005 
TAATKA TAAT TAAT 
T03848 
red flour 
beetle 
Ubx 
M00018.co
ns.L4.c2.to
pMx1 
5.7005 3.42
02 
4.11E-
005 
4.11E-
005 
TAATKA TAAT TAAT 
T01481 
human 
Pbx1a 
M00124.co
ns.L9.c2.to
pMx1 
5.1275 11.4
862 
0.000306
6 
0.000306
5 
TGAcaa TTGATTGAT TGA 
T01481 
human 
Pbx1a 
M00096.co
ns.L9.c2.to
pMx1 
5.0303 11.8
509 
0.000375
7 
0.000375
7 
TGAcaa AAGCTTGAT TGA 
T01481 
human 
Pbx1a 
M00998.co
ns.L8.c2.to
pMx1 
4.0228 8.64
73 
0.002752 0.002749 TGAcaa tGATTGAT TGA 
T01992 
fruit fly 
Abd-A 
M01083.co
ns.L10.c2.t
opMx1 
2.4675 12.5
216 
0.08927 0.0854 TAATKA AARTaAWWWW TAAT 
T04367 
human 
NCX 
M00484.co
ns.L10.c2.t
opMx1 
1.9307 7.21
97 
0.2746 0.2401 TAAttR nngtAAntng TAA 
T04368 
mouse 
Ncx 
M00484.co
ns.L10.c2.t
opMx1 
1.9307 7.21
97 
0.2746 0.2401 TAAttR nngtAAntng TAA 
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Figure 4.23. A. Splash page of interactive web-based homeodomain specificity 
prediction tool at http://ural.wustl.edu/flyhd/. Given a set of homeodomain protein 
sequences entered as a FASTA file, the program returns a set of predicted sites, a count 
matrix and a sequence logo for each query protein, as well as the set of reference proteins 
used to make each prediction.  If the homology constraints are not met by any of the 
reference proteins, no prediction is made.  Users can change the default parameters to 
define alternate sets of key and critical residues and different homology score constraints. 
B.  Example of the information returned from the website upon entering the sequence of 
the Alx4 homeodomain.  The sites used to construct the LOGO can be accessed by 
clicking the “sites” link.  The quality score (1 to 4) under the MATRIX indicates the 
confidence level of the prediction where 1 is the highest confidence.  Under SOURCE, 
the REFERENCE indicates the fly homeodomains used to construct the predicted LOGO 
where SIM.= similarity score, #MAT= number of matches at the key recognition 
positions, RVQAK are the amino acids at the key recognition positions in the query, with 
the corresponding residues of the utilized fly factors listed below, #SITES = number of 
unique sequences used from each fly factor. 
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Discussion 
 
The DNA-binding specificity of 84 fly homeodomains, 6 human homeodomains and 
16 proteins with mutations in specificity determinants were characterized using the 
omega-based B1H system. This dataset dramatically increases the number of 
characterized fly homeodomains; for example, only 18 of the homeodomains in this study 
have any binding site information present in the FlyREG database (Bergman et al., 2005) 
and the specificity of two of these factors is described by only a single binding site. B1H 
binding site data is now available for all the independent homeodomains in D. 
melanogaster.  In addition to the ability to efficiently analyze a complete set of DNA-
binding domains, the B1H system offers two potential advantages for the analysis of 
transcription factor specificity. First, selected binding sites are assayed for the ability to 
activate a biological response in the context of competition from a pool of potential sites 
in the E. coli genome. For some factors, this assay may provide a more relevant measure 
of specificity than the off-rate measurements obtained in in vitro assays using 
oligonucleotides (Berger et al., 2006).  More importantly, the ability to determine the 
orientation of the homeodomain on each selected binding site allows even partially 
symmetric sites to be properly aligned when constructing recognition motifs (Figure 4.7). 
Correct alignment of selected sites is not only important for ranking predicted recognition 
sequences in genomic DNA sequences, but it is also required to construct an accurate 
catalog of specificity determinants. 
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In principal, technical factors such as the use of an N-terminal fusion partner or the 
number of selected sequences analyzed could limit the accuracy or precision of our 
dataset. However, several observations argue against these concerns. First, the ability to 
cluster factors based on their observed binding specificities and to identify correlations in 
DNA contact residues demonstrates a striking internal consistency within the dataset.  
The significance of these correlations is confirmed by the ability to subsequently use this 
data to rationally alter DNA-binding specificity in mutagenesis experiments. Second, 
validation of the specificities by gel shift for a subset of factors as well as comparisons 
with external data sources - the previously determined in vitro and in vivo specificity data 
for fly homeodomains - provides clear evidence of the accuracy of our data.  Combined 
with the advantages discussed above, this validation of the homeodomain dataset 
confirms the utility of the B1H system.  
 
This study provides the first global analysis of homeodomain specificities in an 
organism. We find that the homeodomain family displays a great range of specificities in 
which a wide variety of bases can be preferred at most positions within the core 6 bp 
binding site.  Overall, the majority of homeodomains (93%) in our dataset can be 
clustered into 11 different specificity groups. In addition to the 11 specificity clusters, 
there are 6 individual homeodomains with unique specificities.  In general, these orphan 
factors display different combinations of amino acids at the key DNA-recognition 
positions than are found in the specificity groups. Thus, while the 43 homeodomains in 
the Antp and En groups all have related binding specificities, we find evidence for at least 
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17 different-DNA binding specificities within the entire D. melanogaster homeodomain 
set.  
 
An important conclusion from our analysis is that the overall sequence similarity 
between two homeodomains is a useful, but sometimes misleading indicator of the degree 
of similarity in their DNA-binding specificities. Once factors are clustered into specificity 
groups, it is possible to compare binding specificity with their degree of sequence 
homology (Figure 4.8C). A substantial correlation between sequence similarity and 
preferred recognition motif is observed, which is expected since proteins with greater 
overall homology are also more likely to share similar residues at their DNA-recognition 
positions. However, we observed multiple examples where pairs of closely related 
homeodomains cluster into different specificity groups.  In both naturally-occurring and 
engineered homeodomains, single amino acid changes at putative DNA recognition 
positions are sufficient to significantly alter specificity. Alteration of only 5 recognition 
positions in Engrailed is sufficient to change its specificity to that of a TGIF family 
member, although these homeodomains only share 17 identical residues.  These 
observations illustrate the importance of defining the amino acid positions that contribute 
to variations in binding site specificity in order to make accurate specificity predictions. 
 
Among the specificity groups, there are clear correlations between amino acid 
sequence and specificity.  Using this data we have produced a catalog of common 
specificity determinants based on our computational and mutagenic analysis of specificity 
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combined with previous biochemical and structural data. The origin of specificity is 
clearer for residues that are found in the recognition helix.  Binding site positions 4, 5 and 
6 are specified primarily by the combination of residues at positions 47, 50 and 54. 
However, the influence of each of these residues does not map to a single position within 
the binding site and multiple residues can simultaneously affect specificity at a single 
binding site position. The mutational analysis of Bcd highlights this complexity, as 
residues at all three of these positions compete to define the nucleotide preference at 
position 4.  Consequently, our catalog of determinants indicates that the presence of 
specific residues can bias specificity towards a particular base or bases within the binding 
site, but that the actual specificity is dependent on a combination of primary and 
secondary effects at the protein-DNA interface. 
 
In addition to defining specificity determinants, this dataset provides an important 
resource for the prediction and interpretation of homeodomain binding sites in regulatory 
targets within the D. melanogaster genome.  The reductionist approach of analyzing the 
specificity of isolated homeodomains has resulted in a much more detailed understanding 
of monomeric DNA-recognition. The specificity of individual homeodomains has proven 
instrumental in the identification of functional regulatory sites utilized by these factors in 
vivo (a subset of examples in D. melanogaster are listed in Table 4.4) and in the 
computational identification of target genes with evolutionarily conserved binding sites 
(Berman et al., 2004; Kheradpour et al., 2007; Schroeder et al., 2004; Sinha et al., 2003).  
Comparisons with chromatin immunoprecipitation (ChIP) data confirm that Bicoid  
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Table 4.4  Examples of functional (in vivo) homeodomain binding sites consistent with 
their monomeric specificity 
HD Target gene References Notes enhancer 
element name* 
Cad ftz Dearolf, C.R., Topol, J., and Parker, 
C.S. (1989). Nature 341, 340-343. 
Activation of the ftz zebra stripe element is 
facilitated by cad binding sites where direct 
mutation of these sites abrogates activity.   
ftz zebra stripe 
Tin mef2 Gajewski, K., Kim, Y., Lee, Y.M., 
Olson, E.N., and Schulz, R.A. 
(1997). EMBO J 16, 515-522. 
A pair of tinman sites is required for enhancer 
function in myocyte precursors as demonstrated 
by loss of lacZ expression when the sites are 
mutated in report assay. 
Mef2_IIA237 
Tin beta3Tub60D Kremser, T., Gajewski, K., Schulz, 
R.A., and Renkawitz-Pohl, R. 
(1999). Dev biol 216, 327-339 
Identified 3 tinman sites, 2 are required for 
reporter transcription in dorsal vessel cells.  
Mutation of tin sites in enhancer disrupts 
expression.  
betaTub60D_ 
b3-lac333 
Bap beta3Tub60D Zaffran, S., and Frasch, M. (2002). 
Mech. Dev. 114, 85-93. 
Identifies single pair of overlapping bap sites that 
are responsible for tissue specific gene 
expression  
betaTub60D_ 
beta3-14/vm1 
Tin Sur Akasaka, T., Klinedinst, S., Ocorr, 
K., Bustamante, E.L., Kim, S.K., 
and Bodmer, R. (2006). Proc Natl 
Acad Sci U S A 103, 11999-12004. 
&  Hendren, J.D., Shah, A.P., 
Arguelles, A.M., and Cripps, R.M. 
(2007). Mech. Dev. 124, 416-426. 
In this gene a tin-responsive enhancer was 
discovered using bioinformatics approaches 
looking for tin binding sites based on the 
consensus sequence. 
En3 
Tin svp Ryan, K.M., Hendren, J.D., 
Helander, L.A., and Cripps, R.M. 
(2007). Dev biol 302, 694-702. 
In this gene a tin-responsive enhancer was 
discovered using bioinformatics approaches 
looking for tin binding sites based on the 
consensus sequence where the identified sites 
were conserved over multiple genomes. 
SCE 
Tin eve Knirr, S., and Frasch, M. (2001). 
Dev biol 238, 13-26. 
Mutation of 2 tin sites identified based on its 
consensus recognition element inactivates 
enhancer 
EME b3' 
Bcd 
& 
Cad 
kni Rivera-Pomar, R., Lu, X., Perrimon, 
N., Taubert, H., and Jackle, H. 
(1995). Nature 376, 253-256. 
Demonstrates that sets of binding sites for cad 
and bcd are sufficient for anterior patterned 
expression in absence of other factor binding 
sites.  Composition of sites not critical, just 
number and quality. 
kni_64 
Ap Ser Yan, S.J., Gu, Y., Li, W.X., and 
Fleming, R.J. (2004). Development 
131, 285-298. 
14 Ap sites identified by DNaseI footprinting 
when mutated abrogate activitiy. 
Ser_minimal_ 
wing_enhancer 
Bcd eve Arnosti, D.N., Barolo, S., Levine, 
M., and Small, S. (1996). 
Development 122, 205-214. 
Mutating individual bcd sites reduces activity.  
Adding novel sites to new positions restores 
activity demonstrating that the bcd site position 
is not critical.  
eve_stripe2 
Ubx sal Galant, R., Walsh, C.M., and 
Carroll, S.B. (2002). Development 
129, 3115-3126. 
Ubx represses sal expression in the haltere. The 
development of the haltere is not dependent on 
Exd or Hth, so the interaction of Ubx with the sal 
328 element is thought to be independent of these 
TFs (although potentially dependent on other 
unknown TFs).  Mutation of individual Ubx sites 
results in a loss of repression of the reporter gene 
in the haltere  
sal 328  
Dfd rpr Lohmann, I., McGinnis, N., 
Bodmer, M., and McGinnis, W. 
(2002). Cell 110, 457-466. 
Dfd regulates rpr in maxillary segment 
boundary.  Loss of 4 Dfd sites severely decreases 
reporter expression.  Gel shift analysis suggests 
that Exd does not bind cooperatively with Dfd on 
this element.  
rpr_4S3 
HD= homeodomain; *Enhancer names were taken directly from the literature or extracted from REDfly 
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monomer binding sites are enriched at sites that are occupied in vivo (Li et al., 2008) and 
that the combination of ChIP data and analysis of conserved transcription factor binding 
sites generally provides significant improvement in the prediction of functional targets 
over either method alone (Kheradpour et al., 2007). The complete analysis of D. 
melanogaster specificities also highlights the importance of identifying factors with 
overlapping specificities to properly interpret conservation and ChIP data.   Conserved 
binding sites might reflect recognition sequences for a number of potential factors with 
overlapping specificities and factors with overlapping specificities and expression 
patterns will sometimes compete to occupy binding sites identified in ChIP experiments.   
 
Many homeodomains are known to recognize DNA not only as monomers, but also 
as homodimers, heterodimers or higher order complexes; in several examples, the 
preferred recognition sequence of monomers in these complexes may even be modified 
(Pearson et al., 2005; Ryoo and Mann, 1999; Wilson and Desplan, 1999). Both structural 
data and our analysis suggest that a likely site for modified specificities is in the flexible 
N-terminal arm (Figures 4.1, 4.8 and 4.12). The recently described structures of Scr-Exd 
heterodimers bound to DNA reveal how complex formation with Exd can alter the 
interaction with DNA of residues within and beyond the N-terminal arm in Scr (Joshi et 
al., 2007). Thus, while the primary sequence determinants within the N-terminal arm, 
such as Arg3 and Arg5, are important in defining sequence preferences, the influence of 
secondary effects, whether intramolecular (e.g. Ala8 in Caup; Figure 4.12) or 
intermolecular (complex formation with other DNA-binding domains; Scr-Exd), can also 
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influence recognition.  It is currently unclear how frequently monomeric specificities are 
modified by protein-protein interactions, but our systematic characterization of 
monomeric specificities provides a foundation to begin to fully explore this question.  
 
The analysis of homeodomain specificities in D. melanogaster also provides the basis to 
predict most homeodomains specificities in other organisms. Using a comparative 
approach that is based both on the overall sequence similarity and on the identity of the 
key recognition residues, we predicted the DNA-binding specificities of 79% of the 
independent homeodomains in the human genome with moderate to high confidence 
(Figure 4.21).  The quality of these predictions was validated by characterizing a small 
number of human homeodomains in the B1H system and, where available, by 
comparison to previously published data. Our robust prediction scheme can be applied to 
homeodomains from any species, thereby providing an important community resource to 
help identify functional binding sites in regulatory regions of target genes. We have 
developed a web-based tool that will evaluate the specificity of any input homeodomain 
sequence based on its amino acid sequence using our database and evaluation criteria.  
Because our understanding of homeodomain recognition is still imperfect, future 
improvements to our algorithm should lead to more comprehensive specificity 
predictions based on the composition of residues at the recognition interface, such as the 
incorporation of a probabilistic recognition code to approximate the specificities of 
factors that do not have good homologs in our database (Benos et al., 2002; Liu and 
Stormo, 2005).  
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Continued B1H analysis of homeodomain specificity should lead to more detailed 
understanding of recognition by this family. Our current experiments have led to a 
catalogue of specificity determinants that can be used to rationally engineer the DNA-
binding specificity of homeodomains with reasonable success; this is most clearly 
demonstrated by the conversion of Engrailed into a TGIF-like factor. Intermediate 
specificity alterations were also obtained in these experiments (Figure 4.17B and Figure 
4.24) including homeodomains with the novel specificities TAACA and TGATTA, 
which are not observed for any of the natural homeodomains characterized in this study. 
The throughput of the B1H system will facilitate the synthesis of a more comprehensive 
recognition model as homeodomains from other species with different combinations of 
recognition residues are characterized and as additional mutagenesis experiments are 
performed to more thoroughly interrogate specificity. Using the B1H system, it should 
also be possible to perform selections on pools of mutagenized homeodomains to select 
proteins with a desired DNA-binding specificity, providing a relatively unbiased 
assessment of the range of residues that are compatible with recognition of a given motif. 
Obviously, this type of family-wide specificity analysis can also be applied to other 
classes of DNA-binding domains to characterize their specificities and decipher their 
specificity determinants with the ultimate goal of producing a complete map of the 
specificities of all of the transcription factors in a genome. 
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Figure 4.24 
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Figure 4.24.  Conversion of Engrailed into a factor with an NK-2 type specificity.  A 
single mutation was introduced into Engrailed at position 54 (A54Y) to attempt to 
convert this homeodomain into a specificity that is similar to the NK-2 class.  This 
mutation has been introduced previously into Antp and Gsc with a resulting conversion 
of sequence preference at position 4 of the binding site from Thy to Gua (Damante et al., 
1996; Pellizzari et al., 1997).  We observe a similar phenomenon, where this single 
mutation is sufficient to convert the specificity of Engrailed at position 4 from Thy to 
Gua.  For reference the specificity of Bap, a NK-2 family member, is shown below the 
specificity of the A54Y mutant. 
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This selection system also provides a promising platform for the creation of artificial 
DNA-binding proteins with unique specificities.  Previous studies have focused on the 
utility of zinc fingers as a flexible system to create artificial DNA-binding domains for  
genetic engineering of cell lines or animals (Beumer et al., 2006; Urnov et al., 2005). Our 
zinc finger-homeodomain (ZFHD) selection framework, which is derived from ZFHD1 
(Pomerantz et al., 1995), provides a system in which the specificity of both components 
can now be engineered to create hybrid transcription factors that can be used for targeted 
gene regulation or modification. Our analysis of D. melanogaster homeodomains creates 
a catalog of naturally-occurring components that can be incorporated into chimeric 
transcription factors and provides a blueprint for engineering homeodomains with novel 
specificities, expanding the list of modular DNA-binding components that can be used to 
manipulate natural systems. 
 
Experimental Procedures 
 
Homeodomain binding site selections:  A detailed description of the general B1H 
selection protocol is described in Chapter 1, modifications are detailed below. The 
sequences of the homeodomains used in the B1H selection and the raw selected binding 
sites are found in Appendix Table A.2. 
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Identification and boundary definition of the independent homeodomains 
     These 84 homeodomains represent all of the fly homeodomains in the SMART 
database that are not associated with another major type of DNA-binding domain: 18 
unique homeodomains are associated with PAX, POU or ZnF-C2H2 domains or an 
additional homeodomain based on the SMART annotation (Letunic et al., 2006; Schultz 
et al., 1998). There are homeodomains in our set that are associated with another DNA-
binding domain, such as those in the Cut family, which were retained because of 
interesting sequence composition. The sequences of the homeodomains used in the B1H 
selection and the raw selected binding sites are found in the Appendix, Table A.2. The 
region of the homeodomain that was fused to omega was defined by the length of the 
core homeodomain identified by SMART: 60 to 63 amino acids depending on the 
presence of a TALE insertion. 10 additional amino acids in the protein sequence were 
included beyond the C-terminus of the homeodomain (if present). The amino acids were 
removed from the terminus if a hydrophobic residue occurred (YFIVLWPM), since 
terminal hydrophobic residues can induce protein degredation in E coli (Parsell et al., 
1990). 
 
Omega-Zif12 fusions for the selection of homeodomain specificity 
     Homeodomains were expressed as omega fusions in combination with fingers one and 
two of Zif268 (Zif12) under control of the lacUV5mut promoter plasmid (pB1H2ω2-
12HD; Figure 4.2). Each homeodomain (with two additional N-terminal residues) was 
cloned between the KpnI site and the Xba1 site downstream with a stop codon introduced 
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just prior to the Xba1 site. Two additional amino acids were added after the Kpn1 site 
prior to the start of the homeodomain.  The first amino acid was always glycine.  In the 
majority of the homeodomains, the second amino acid was the -1 amino acid of the 
specific homeodomain being assayed, however for a subset we used the -1 residue of 
Oct1, which is arginine, for purely historical reasons.  The KpnI site and the inserted 
residues created a 5 amino acid linker between the 2nd His of Zif268 finger 2 and the 
beginning of the HD (Zif12-TGTGN-HD; Figure 4.2). All expression constructs were 
sequence verified.  
 
Alternate selection conditions 
     The vast majority of the selections were successful in the initial attempt, however a 
handful did not yield an obvious enrichment in the number of selected clones as defined 
by a low fold increase (or no increase) in the number of surviving clones on selective 
media relative to the background when normalized to the number of cells plated. In most 
cases this was resolved by expressing the omega-Zif12-homeodomain at higher levels 
using a stronger promoter (lacUV5). In the case of one homeodomain, Eve, where our 
initial selections failed, we found that the removal of a small string of hydrophobic 
residues from the C-terminus of the protein just after the end of the homeodomain 
resulted in a significant improvement in activity.  Hydrophobic residues at the C-terminus 
of a protein can lead to lower levels of functional expression in bacteria (Parsell et al., 
1990).  
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Construction of the master alignment of sites: 
     The master alignment contains 1860 binding sites for 83 of the 84 Drosophila 
homeodomain proteins as well as Oct1 (Lag1 was excluded because it lacks Asn51, 
which makes the alignment of its sites to all others within the dataset problematic). 
CONSENSUS selected substrings from 1868 of the 2211 input sequences and took the 
reverse complement of 657 of these substrings, wherein alignments were generated for 
each factor independently(Hertz and Stormo, 1999). In every case, the length of the motif 
was selected by varying the motif length parameter (-L) and selecting the alignment with 
the smallest e-value. These 84 separate alignments formed the basis for the construction 
of the master alignment.  The orientation of the alignments for individual factors 
produced by CONSENSUS was somewhat arbitrary; consequently, we manually reversed 
the orientation of 35 sets of sequences (about 588 sites). As described previously, the 
high information content Ade (recognized by Asn51) was used as an anchor to help align 
the sets of sites (notice that all but 4 sites contain Ade at position 6 in the master 
alignment below).  Information about the probable orientation of each individual site 
gleaned from the observed site biases (described above) led us to manually ‘flip’ the 
orientation of some individual sites (47), overriding some orientation decisions made by 
CONSENSUS.  For the master alignment of all 84 sets of sites we used the entire 
sequence of each aligned site, not just the 1868 substrings returned by CONSENUS (8 
problematic sites were removed; Supplementary Table 3).  At this point, the alignment 
contained 15 columns as the registers of the aligned subsites in each sequence varied, so 
the 5’ and 3’ flanking columns 1, 2, 13, 14, and 15 were removed to generate a master 
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alignment with 10 columns because from 57 to 99 percent of these columns were 
comprised of gaps as the library sequence elements are only 10 bp in length. 
 
Count matrix for the entire master alignment: 
         1      2      3      4      5      6      7      8      
9     10  
A |    297    435    269     78   1511   1856     48    326    
983    260  
C |    310    396    419     66      1      0    219    143    
109    254  
G |    242    446    161     19    213      2     84    328    
512    345  
T |    358    542   1006   1697    135      2   1509   1063     
60    119  
- |    653     41      5      0      0      0      0      0    
196    882 
 
All Sequence logos (Schneider and Stephens, 1990) for these factors were generated 
using WebLogo (Crooks et al., 2004). We note that the number of selected binding sites 
that comprise a particular logo are modest (typically 20 to 40) and consequently, the 
significance of bases that are absent or occur infrequently in a motif cannot be fully 
assessed. 
 
Clustering of binding site motifs 
     The master alignment of sites was used to determine the pairwise global alignments 
between every set of homeodomain binding sites.  The aligned sites for each 
homeodomain protein were converted to count matrices.  Pairwise distances between all 
matrices were calculated based on average log likelihood ratio (ALLR) similarity scores 
(Wang and Stormo, 2003).  When calculating the ALLR scores, gaps were treated as 
missing data and ignored.  The formula for the ALLR score was modified slightly: 
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instead of using the natural logarithm function (log base e), log base 2 was used. The 
Neighbor program from the Phylip phylogenetic analysis package (Felsenstein, 2005) 
was used to cluster the motifs using the neighbor joining method.  The input to Neighbor 
was a pairwise distance table based on the master alignment of sites. The radial 
logarithmic neighbor joining tree of the motifs in Figure 2 was produced using the 
TreeIllustrator program (Trooskens et al., 2005).  The branch lengths displayed in this 
image are logarithmically proportional to the actual branch lengths calculated by the 
Neighbor program.  The phylogram of the homeodomain amino acid sequences in Figure 
2 was produced using TreeIllustrator with the pairwise distances determined by ClustalW 
(Thompson et al., 1994). 
 
MI analysis 
     MI analysis was performed on the dataset using the Master alignment of binding sites 
as previously described (Gutell et al., 1992). The MI plot was transformed into a joint 
rank product matrix by transforming each element in the MI matrix by calculating the 
rank of each element's MI value in that column (the column-wise rank) and the rank of 
each element's MI value in that row (the row-wise rank). The column-wise rank and row-
wise rank for each element were multiplied to yield the joint rank product matrix.  The 
product matrix was transformed to generate a heat plot using the following formula: 
))(max(
)())(max(
XLn
XLnXLn ij!  
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where ijX  is the joint rank product matrix element ij and max(X) is the maximum value 
in X (600). 
 
G-test significance analysis 
     The significance of an apparent difference between motifs for two groups of 
homeodomains was estimated using a G-test (Sokal and Rohlf, 1995). Aligned binding 
sites for each group of factors were pooled and one position (column) in the DNA 
binding motif was analyzed by generating a 2 by 4 contingency table, where rows 
contained the 2 classes and columns 4 DNA bases.  Small pseudo counts (0.01) were 
added to each value and the G-test statistic was calculated allowing 3 degrees of freedom 
for each base, unless a base was not observed in both of the two classes, in which case 1 
degree of freedom was subtracted. 
 
Specificity Predictions for the human homeodomain set 
     193 homeodomains containing proteins were annotated in the SMART human genome 
database and 175 of these were independent homeodomains containing Asn51.  To 
predict the DNA-binding specificity of this set we used the DNA-binding specificity of 
up to 3 of the fly homeodomains with the highest BLOSUM45 similarity scores 
(calculated from a sequence-to-profile multiple sequence alignment (Edgar, 2004) 
between the query sequence and the 84 fly homeodomain profiles) provided that: 1) they 
contained Asn51; 2) they contained identical residues at the other 5 key recognition 
positions (5, 47, 50, 54 and 55); and 3) they passed a BLOSUM45 similarity score 
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threshold. The similarity score threshold was set to 200, based on a cross validation 
analysis of the fly homeodomain set (data not shown).  Additionally, once a reference 
protein passed all of our filters, additional reference proteins were only added to the 
predictive set if their similarity score was within 40 similarity score units of the most 
similar reference protein. If no reference homeodomain passed these three criteria, we 
considered up to 3 homeodomains within the set that contained identical residues at 4 of 
the 5 key recognition positions, as long as they also passed the similarity score threshold.  
Specificity predictions comprise all of the selected binding sites for all of the reference 
homeodomains that passed the filters.  In some cases no fly homeodomains met these 
criteria and consequently no prediction was made.  
 
Cross-validation analysis and prediction of the Transfac homeodomains 
     To assess the accuracy of the specificity predictions we performed a cross-validation 
analysis where the binding specificity of each fly homeodomain was predicted based on 
the information of all of the other homeodomain proteins. All TRANSFAC 10.2 datasets 
associated with proteins classified as homeodomains (TRANSFAC classes C0006, 
C0027, C0047, C0053) and that contain at least 20 binding sites were extracted from the 
database (Matys et al., 2006). The 47 groups of binding sites that met these requirements 
were reanalyzed with CONSENSUS to generate new motifs. 27 of these 47 transcription 
factors were sufficiently similar to a D. melanogaster homeodomain to make a prediction 
based on our criteria (described in the text).  In some cases (8), multiple homeodomains 
were associated with one dataset in TRANSFAC and vice versa (5).  In these cases, we 
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compared the predicted matrix for a factor to each of the CONSENSUS matrices 
associated with it.  We used the ALLR score to determine the best local alignment 
(Matalign-v2a, Wang, T & Stormo, G. D. unpublished) between the predicted and 
CONSENSUS matrices.  Based on these alignments, we assessed the degree of similarity 
using the ALLR similarity score, the ALLR based distance and the e-value computed by 
Matalign. 
 
Competition Gel Shift Assay 
 
Oligonucleotides.   
     The Oligonucleotides used for this assay were designed to have a single, central 
homeodomain binding site that represents the consensus recognition sequence of one of 7 
core specificity groups (Engrailed, Bar, Abd-B, Bicoid, NK-2, Six, and TGIF) as well as 
one outlier (CG11617).  Once annealed, the resulting duplex oligonucleotides contain a 
5’ GG overhang at each end that can be used to radiolabel the DNA.  These sequences of 
the oligonucleotides are listed below with the recognition sequence in bold. Where 
multiple binding sites were examined for a single specificity group, the differences within 
these sequences are underlined: 
Engrailed Top 
GGGCAGGCAGTAATTAGGACGTCG 
Engrailed Bottom 
GGCGACGTCCTAATTACTGCCTGC 
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Bar Top 
GGGCAGGCAGTAATTGGGACGTCG  
Bar Bottom 
GGCGACGTCCCAATTACTGCCTGC 
Abd-B-A Top 
GGGCAGGCAGTTATTAGGACGTCG 
Abd-B-A Bottom 
GGCGACGTCCTAATAACTGCCTGC 
Abd-B-G Top 
GGGCAGGCAGTTATTGGGACGTCG 
Abd-B-G Bottom 
GGCGACGTCCCAATAACTGCCTGC 
Bicoid Top 
GGGCAGGCAGTAATCCGGACGTCG 
Bicoid Bottom 
GGCGACGTCCGGATTACTGCCTGC 
NK-2 Top 
GGGCAGGCAGCAAGTGGGACGTCG 
NK-2 Bottom 
GGCGACGTCCCACTTGCTGCCTGC 
CG11617-A Top 
GGGCAGGCAGTTAACAGGACGTCG 
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CG11617-A Bottom 
GGCGACGTCCTGTTAACTGCCTGC 
CG11617-C Top 
GGGCAGGCAGTTCACAGGACGTCG 
CG11617-C Bottom 
GGCGACGTCCTGTGAACTGCCTGC 
CG11617-T Top 
GGGCAGGCAGTTTACAGGACGTCG 
CG11617-T Bottom 
GGCGACGTCCTGTAAACTGCCTGC 
Six Top 
GGGCAGGCAGTGATACGGACGTCG 
Six Bottom 
GGCGACGTCCGTATCACTGCCTGC 
TGIF Top 
GGGCAGGCAGTTGACAGGACGTCG 
TGIF Bottom 
GGCGACGTCCTGTCAACTGCCTGC 
 
Expression and Purification of Proteins. 
     Each homeodomain was expressed as a C-terminal fusion to maltose binding protein 
(MBP) from pJH196 (a generous gift from Keith Joung, {Hurt, 2003}) using an in vitro 
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transcription-translation system (ExpresswayTM Cell-Free E. coli Expression System, 
Invitrogen).  The zinc fingers utilized for the binding site selection in the B1H system 
were not incorporated into these constructs.  Each MBP-HD construct was expressed in 
two 100µl reactions from approximately 2µg of plasmid DNA per reaction. These 
reactions were incubated while rotating for 6.5 hours at 37oC.  The reactions for each 
construct were combined together with one of the binding buffers listed below (900 µl 
final volume) and the MBP-HD proteins were captured on 100µl of Amylose Resin (New 
England BioLabs) by incubation at 4°C for 1.5 hours while rotating. The resin-bound 
MBP-HD proteins were washed 4 times with 1ml binding buffer.  Finally, the protein was 
eluted from the resin by incubation with 50ml of binding buffer supplemented with 
40mM maltose at room temperature, while rotating for 30 minutes.  Aliquots of protein 
were stored at -80oC.  
 
     Two different binding buffers were used in these experiments.  The majority of the gel 
shift assays utilized a binding buffer consisting of 10mM Tris-HCl pH 7.5, 0.1mM 
EDTA, 25mM NaCl, 1mM DTT and 5% glycerol.  The more complex binding buffer for 
Ptx and Caudal consisted of 15mM HEPES pH 7.8, 50mM KCl, 50mM KGlutamate , 
50mM KOAc, 5mM MgCl2, 1mM DTT and 5% glycerol.  All binding buffers were 
supplemented with 0.1mg/ml BSA and 0.1% IGEPAL CA-630 for the gel-shift assays. 
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Gel Shift Competitions.  
     To perform the competition gel shift assays, oligonucleotides for the consensus 
binding site corresponding to each homeodomain were annealed and then endlabeled. 30 
ml labeling reactions were done using 200ng of annealed oligonucleotide, 40mCi a-32P 
dCTP, 5 units Klenow (exo-), and a final concentration of 3.33mM dNTPs minus dCTP.  
These reactions were incubated at 37oC for 30 minutes and then chased with 3.33mM 
dNTPs (including dCTP) for an additional 30 minutes at 37oC.  The labeled 
oligonucleotides were recovered from free radionucleotides using a G-25 spin column 
(BioRAD).   
 
     The optimal amount of protein for each homeodomain to be used in the DNA-binding 
reaction for the competition assay was determined by performing shift assays with a 
titration of protein on its labeled consensus site.  Titrations of both protein and DNA were 
performed to ensure that binding reactions were under Kd conditions with [labeled DNA] 
<< Kd and that the amount of HD-DNA complex formation was not saturated (data not 
shown).  The appropriate concentration of cold consensus binding site needed to 
effectively compete the majority of the HD-DNA* complex at the optimal protein 
concentration was determined by titration of competitor.   
 
     The competition assays were then performed by equilibrating the homeodomain with 
80pM of its labeled target site and one of the cold competitor duplexes in a 20µl reaction 
for at least 2 hours at room temperature.  Each protein was challenged in a separate 
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reaction with each of the eight of the specificity group binding site oligonucleotides and 
one control reaction without competitor.  The final concentrations of cold competitor 
DNA used for each homeodomain is as follows: 
CG11617 used 5.625nM 
En, Vis, and Tin used 9nM 
Lbe, Optix, CG34031, Ptx, and Cad used 90nM 
10µl of each reaction was then run on a pre-run (35 minutes at 300V) 7.5% native 
polyacrylamide gel (0.5xTBE) for 35 minutes at 300V.  The gels were dried and then 
exposed phosphoimaging plates for 8-12 hours.  These plates were scanned with a 
FUJIFILM FLA-5000 and the percentage of protein-DNA complex in each reaction was 
determined by quantifying the free DNA and bound DNA bands with FUJIFILM’s 
program, Image Gauge 4.22. 
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The Bacterial One-Hybrid System 
We have developed an omega-based B1H system that allows the high throughput 
determination of TF DNA-binding specificity.  This system has several advantages over 
other techniques for characterizing DNA-binding specificity.   First, the use of E. coli as 
our platform allows the isolation of complementary TF - binding site combination in vivo 
in a single round of selection using relatively simple techniques.  Because E. coli 
demonstrate an extremely high transformation efficiency, randomized binding site 
libraries with complexity greater than 108 members can be utilized. Perhaps the greatest 
advantage realized by this system is the flexibility provided by utilizing omega-TF 
hybrids, as the absence of competition from endogenous omega has resulted in an 
extremely sensitive selection system with a much greater dynamic range than previous 
systems (Durai et al., 2006; Meng et al., 2005). This sensitivity has allowed us to 
successfully characterize TFs that failed to generate motifs in the alpha-based B1H 
system.   
 
Using this system we have determined recognition motifs for ~14% of the predicted D. 
melanogaster TFs. For comparison the FlyREG database contains motifs for 53 TFs 
constructed from 5 or more identified binding sites (Bergman et al., 2005); thus our 
database doubles the number of specificities that are available, and in cases where these 
databases overlap, our data is typically of higher quality. The rate of successful TF 
characterization within this system (101 of 102) makes it amenable to perform 
comprehensive surveys of TF specificity in complex organisms: once cloned, ten or more 
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factors can be analyzed in parallel in the B1H system in a manner of days.  Moreover, the 
success rate and high throughput nature of this system has allowed us to efficiently 
analyze a complete set of DNA-binding domains.  The B1H system offers two additional 
advantages for the analysis of transcription factor specificity. Binding sites are assayed 
for the ability to activate a biological response in the context of competition from a pool 
of potential sites in the E. coli genome. For some factors, this assay may provide more 
relevant measure of specificity than the off-rate measurements obtained in in vitro assays 
using oligonucleotides (Berger et al., 2006).  Perhaps more importantly, the ability to 
determine the orientation of the homeodomain on its binding site allows even partially 
symmetric sites to be properly aligned when constructing recognition motifs.  If it is 
possible to determine the orientation of other domains characterized with the B1H 
system, it may be possible to draw the same types of predictive conclusions about the 
amino acid sequence-DNA-binding specificity correlations.   At the very least, it would 
provide a much greater understanding of the protein-DNA interaction for several DBD 
families. 
 
Our current dataset is focused primarily on monomeric DNA-binding domains, but 
also includes homodimers and heterodimers.  This reductionist approach overlooks the 
potential for sets of factors to cooperatively recognize motifs that are not a simple 
composite sites formed from their individual motifs, such as the Exd-Hox combinations 
that play critical roles in specification during development (Pearson et al., 2005; Ryoo 
and Mann, 1999; Wilson and Desplan, 1999).  In addition, Young’s analysis of the yeast 
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regulatory networks uncovered one primary group of regulators considered ‘condition 
altered’.  In other words, their promoter preference was altered under different growth 
conditions (Harbison et al., 2004).  The difference in promoter preference is likely due to 
interactions with different cofactors or dimerization partners available in one condition 
versus another, which may alter the sequence specificity.  Certainly these alterations are 
lost in a set of monomeric specificities.  However, these types of combinations can 
potentially be characterized using the B1H system, as a set of complementary expression 
plasmids for the characterization of heterodimers have been developed (Meng et al., 
2005; Meng and Wolfe, 2006).  Still, a great number of questions remain unanswered for 
the characterization of a heterodimeric B1H systems such as what promoter strength(s) to 
use, which monomer is the optimal omega fusion partner, and how to decipher the 
possibility of recovering monomeric, homodimeric and heterodimeric binding sites.  In 
addition, some criteria for choosing sets of factors to be evaluated must be applied 
because of the combinatorial issues involved with testing all possible pair-wise 
combinations.  
 
The Genome Surveyor 
The PWMs generated from our B1H data when used in combination with Genome 
Surveyor provide a fast, flexible and accessible platform for user-guided prediction of 
CRMs in the fly genome. This type of PWM-guided CRM discovery has been previously 
accomplished with a set of maternal and gap TFs by several groups (Berman et al., 2002; 
Berman et al., 2004; Rajewsky et al., 2002; Schroeder et al., 2004) using different 
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computational approaches.  Both demonstrated that known CRMs and novel CRMs could 
be successfully identified within the genome based on the presence of clusters of binding 
sites for factors that function in a common regulatory pathway.  These studies 
demonstrated that even relatively crude representations of the DNA-binding specificity of 
a TF, typically constructed from DNaseI footprinting on a limited number of sites 
(Adryan and Teichmann, 2006), could help identify CRMs and that these predictions 
could be improved by using two related fly genomes (Berman et al., 2004; Sinha et al., 
2004).  These computational approaches, as well as an additional method (Sosinsky et al., 
2003), differ in the tactics used for CRM identification, but share a common strategy with 
Genome Surveyor of identifying clusters of overrepresented binding sites.  
 
The key features of Genome Surveyor are that it evaluates the quality of each binding 
site as well as over-representation of binding sites relative to the genome average, but is 
still rapid enough to allow genome-wide searches to be performed on a web-server.  
Thus, Genome Surveyor, which is integrated within the GBrowse software interface, 
provides a particularly powerful platform for gene-specific or genome-wide searches for 
CRMs regulated by a combination of factors.  Users can rapidly perform genome-wide 
searches with any combination of 100 factors over the D. melanogaster and D. 
pseudoobscura genomes and then investigate the locations of peaks of interest within the 
genome using the GBrowse tools.  Peaks that overlap with previously identified CRMs 
can be easily identified by uploading annotations for these elements from the REDfly 
website (redfly.ccr.buffalo.edu)(Gallo et al., 2006). The number and quality of PWMs 
270 
available for these searches will increase with the adoption of new, high-depth 
sequencing and barcoding technologies such 454 (Hoffmann et al., 2007; Margulies et al., 
2005) and SOLEXA-based sequencing (Barski et al., 2007; Johnson et al., 2007) for the 
analysis of the B1H-selected binding sites. 
 
Future Directions for CRM Prediction 
As the number of factors with high quality PWMs increases, it should be feasible to 
annotate most potential CRMs using combinations of factors that function in common 
regulatory networks.  Cooperating TFs could be identified based on common expression 
patterns, phenotypes, or physical interactions. Because Genome Surveyor is built into the 
GBrowse webtool format (Stein et al., 2002), it will also be possible to incorporate other 
corroborating datasets into these tools, such as genome wide ChIP analysis of TF binding 
or chromatin structure. The combination of these experimental and computation 
approaches for the identification of CRMs should provide the most robust method for the 
functional annotation of these elements throughout eukaryotic genomes.  
 
A Catalog of Homeodomains Specificities 
Using the Omega-based B1H system we characterized the specificity of 84 
homeodomains from D. melanogaster and 16 additional specificity mutants. This dataset 
dramatically increases the number of characterized fly homeodomains; for example, only 
18 of the homeodomains in this study have binding site information present in the 
FlyREG database (Bergman et al., 2005) and the specificity of two of these factors is 
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described by only a single binding site. B1H binding site data is now available for all the 
independent homeodomains in D. melanogaster.  Perhaps the greatest advantage of the 
B1H determined homeodomain specificities has been our ability to determine the 
orientation of the homeodomain on its binding site. This orientation data allows even 
partially symmetric sites to be properly aligned when constructing recognition motifs. 
Correct alignment of selected sites is not only critical for a precise ranking of predicted 
binding sites in genomic DNA sequences, but it is also required to construct an accurate 
recognition code. 
 
In principal, technical factors such as the use of an N-terminal fusion partner or the 
number of selected sequences analyzed could have limited the accuracy or precision of 
our dataset. However, several observations argue against these concerns. First, the ability 
to cluster factors based on their observed binding specificities and to identify correlations 
in DNA contact residues demonstrates a striking internal consistency within the dataset.  
The ability to use this data to rationally alter DNA-binding specificity in mutagenesis 
experiments provides an essential confirmation of the significance of these correlations. 
Second, gel shift competition assays of homeodomains expressed independently of the 
zinc finger fusion behave as the B1H data would predict.  Third, comparisons with 
external data sources - the previously determined in vitro and in vivo specificity data for 
fly homeodomains - provides clear evidence of the accuracy of our data. For example, a 
comparison with the detailed characterization of Ubx, Dfd and Abd-B by Beachy and 
colleagues (Ekker et al., 1994; Ekker et al., 1992), confirms the high degree of precision 
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observed within some of the specificity groups. Combined with the advantages discussed 
above, this validation of the homeodomain dataset confirms the utility of the B1H 
system.  
 
This study provides the first global analysis of homeodomain specificities in an 
organism. We find that the homeodomain family displays a greater than expected range 
of specificities.  Within the core 6 bp binding site, a wide variety of bases can be 
preferred at most positions.  The majority of homeodomains (93%) in our dataset can be 
clustered into eleven different specificity groups.  Factors that fall within a particular 
group often share common residues at the DNA recognition positions. Besides the eleven 
specificity clusters, there are 6 individual homeodomains with divergent specificities.  In 
general, these orphan factors display different combinations of amino acids at the key 
DNA-recognition positions than are found in the specificity groups. Thus, while the 43 
homeodomains in the Antp and En groups all have related binding specificities, we find 
evidence for at least 17 different-DNA binding specificities within the entire D. 
melanogaster homeodomain set.  
 
Specificity Determinants 
An important conclusion from our analysis is that overall sequence similarity between 
two homeodomains is a useful, but sometimes misleading indicator of the degree of 
similarity in their DNA-binding specificities. Once factors are clustered into specificity 
groups, it is possible to overlay this information with their degree of sequence homology. 
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A substantial correlation between sequence similarity and preferred recognition motif is 
observed as expected since proteins with greater overall homology are also more likely to 
be similar at the DNA-recognition positions. However, we observed multiple examples 
where pairs of closely related homeodomains cluster into different specificity groups.  In 
both naturally-occurring and mutant homeodomains, single amino acid changes at 
putative DNA recognition positions appear sufficient to significantly alter specificity. 
Conversely, alteration of only 5 recognition positions in En is sufficient to change its 
specificity to that of the TGIF family member Achi, although these homeodomains only 
share 17 common residues.  These observations illustrate the importance of defining 
which amino acid positions contribute to variations in binding site specificity in order to 
make accurate predictions. 
 
Among the specificity groups, there are clear correlations between amino acid 
sequence and specificity.  Using this data we have produced a qualitative recognition 
code for homeodomains based on our computational and mutagenic analysis of 
specificity combined with previous biochemical and structural data. Our recognition code 
clarifies the key specificity determinants that define variation in sequence recognition 
preferences among homeodomains.  The origin of specificity is much clearer for residues 
that are found in the recognition helix than for those in the N-terminal arm.  At the 3’ end 
of the binding site, positions 4, 5 and 6 are specified directly by the combination of 
residues at positions 47, 50 and 54. However, the influence of each of these residues does 
not map to a single position within the binding site; their influences are complex, where 
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multiple residues can simultaneously affect specificity at multiple binding site positions. 
The mutational analysis of Bcd highlights this complexity, as residues at all three of these 
positions impinge upon the nucleotide preference at position 4.  Consequently, our 
recognition code describes how specific residues bias the specificity of a homeodomain 
towards a particular base or bases, but global specificity preferences are dependent on a 
constellation of primary and secondary effects at the protein-DNA interface. In some 
cases, the specificity preferences dictated by one residue are subordinate to a residue at a 
second position. Arg54 is usually associated with a strong preference for Cyt at binding 
site position 4, but not in Bcd where Ile47 supercedes Arg54, resulting in a preference for 
Thy. Even more dramatic is the effect of Ala8 on recognition in the Iroquois group, 
which disrupts the ability of Arg5 and Arg55 to dictate strong specificity preferences at 
binding site positions 1 and 2.  Interestingly, although Ala8 is highly conserved within 
this class, introducing a hydrophobic residue (Ala8Phe) reestablishes the expected 
specificity preferences at binding sites positions 1 and 2. Thus, a binding pocket 
complementary to an aromatic residue at residue 8 is present in Caup despite the presence 
of Ala; this pocket may mediate important protein-protein interactions, such as 
homodimerization observed within this family (Bilioni et al., 2005). 
 
Despite the ability of the B1H homeodomain dataset to identify a large number of 
homeodomain specificity determinants, there are clearly aspects of DNA-recognition that 
remain inadequately described. Precisely how variation in N-terminal arm residues 
contribute to specificity remains mysterious. In addition, the numerous examples of 
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homeodomains with unique specificity strongly suggest that additional combinations of 
recognition residues can occur that will generate specificities not present in the D. 
melanogaster set. Nonetheless, this dataset is likely to contain examples of the most 
widely occurring homeodomain specificities in metazoans and thus will provide a 
powerful tool to predict the specificities of homeodomains in any organism. Because our 
recognition code is qualitative and incomplete, the sequence similarity throughout the 
homeodomain as well as at the key recognition positions are important factors for 
accurate specificity predictions. Taking both of these elements into account, we have 
predicted the DNA-binding specificities of 79% of the independent homeodomains in the 
human genome (http://ural.wustl.edu/flyhd/).  These specificities should provide an 
important resource for predicting functional binding sites in regulatory regions of genes 
that are controlled by these factors.  The same principles that were employed to predict 
the specificity of the human set should be applicable to the prediction of homeodomain 
specificities in other organisms.  
 
CRM Prediction with Homeodomain Specificities 
This dataset should also be useful to help predict target sites for these factors in the D. 
melanogaster genome (Berman et al., 2004; Schroeder et al., 2004; Sinha et al., 2003). 
The reductionist approach of analyzing isolated homeodomains has resulted in robust 
determination of monomeric homeodomain specificities and identification of clear 
correlations between amino acid sequence and binding site preference. However, our 
dataset will not always provide a complete representation of the “functional” DNA-
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binding specificity of each factor, as many are known to recognize DNA not only as 
monomers, but also as heterodimers or higher order complexes within which their 
preferred target sequence may be modified (Pearson et al., 2005; Ryoo and Mann, 1999; 
Wilson and Desplan, 1999). A full description of the protein-protein interactions among 
homeodomains and between homeodomains and other transcription factors will further 
improve the value of this dataset. 
 
Continued B1H experiments should lead to more detailed understanding of 
homeodomain recognition. Our current experiments have led to a recognition code that 
can be used to rationally reengineer the DNA-binding specificity of homeodomains; this 
is most clearly demonstrated by the successful conversion of Engrailed into a TGIF-like 
factor. Intermediate specificity alterations were also obtained in these experiments 
including homeodomains with specificities (TAACA and TGATTA) not observed for any 
of the natural homeodomains characterized in this study. The throughput of the B1H 
system will facilitate the synthesis of a more comprehensive recognition model by 
allowing the characterization of additional homeodomains with differ combinations of 
recognition residues obtained from other species or mutagenesis experiments. With the 
B1H system, it should also be straightforward to perform selections on pools of 
mutagenized homeodomains to select proteins with novel DNA-binding specificity, 
providing a relatively unbiased assessment of the range of residues that are compatible 
with recognition of a given motif.  As more specificity data is determined for unique 
homeodomains from disparate species, homodimeric and heterodimeric specificities, and 
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potentially engineered homeodomain specificities, the recognition code for this domain 
will become more refined.  If so, a refined recognition code may make it possible to 
accurately predict CRMs using predicted homeodomain specificities and therefore 
alleviate the need to characterize homeodomains in every genome. 
 
Artificial Domains 
In addition to the characterization of TF DNA-binding specificity, the omega-based 
bacterial one-hybrid system provides an intriguing platform for the creation of artificial 
DNA binding proteins with unique specificities.  We reasoned that the same sensitivity 
and dynamic range demonstrated by the characterization of TF specificity would likely 
provide a responsive assay for the survey of the protein DNA interface and selection of 
DBD’s with novel specificity.  In fact, we have already used this system to engineer 
Cys2His2 Zinc fingers with novel specificity by simply by swapping the bait and prey 
combination in the selection system (Meng et al., 2008).  In other words, by installing a 
fixed sequence of interest upstream of the reporter, we have selected zinc fingers able to 
bind that fixed sequence from a library of randomized zinc finger proteins.   
 
     Cys2His2 Zinc fingers have been the focus of much research since it was first 
demonstrated that the specificity of this domain could be easily modified (Rebar and 
Pabo, 1994).  The Pabo lab first established the fundamental doctrine of this field: by 
focusing randomization on positions that structures indicate are able to make base 
specifying contacts (typically positions -1, 2, 3 and 6 of the recognition helix) and then 
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selecting functional interactions with the target site, zinc fingers that specify a wide range 
of sequences can be engineered (Rebar and Pabo, 1994; Wolfe et al., 1999; Joung et al., 
2000).  This general approach has produced zinc fingers that have successfully targeted 
attached auxiliary domains such as activators, repressors, methyltransferases, and 
nucleases to specified sequences in multiple genomes (Urnov and Rebar, 2002; Dreier et 
al., 2005; Smith and Ford, 2007; Perez et al., 2008).  Fused to nucleases, zinc fingers 
have now been used to target double strand breaks in species from Drosophila to 
zebrafish to human cell lines, which have in turn resulted in targeted knockouts and 
knock-ins (Beumer et al., 2006; Meng et al, 2008; Lombardo et al., 2007).   
 
     Though zinc finger nucleases (ZFNs) have been successfully used to cleave their 
genomic targets, the common designs of ZFNs have limitations that stand in the way their 
use as a therapeutic.  First and perhaps most importantly, the platforms currently in use to 
engineer zinc fingers result in imperfect specificities that lead to off target lesions.  
Second, zinc fingers appear to have difficulty specifying A-T rich sequences; limiting the 
number of potential targets.  Third, potential targets are limited to the current architecture 
of a ZFN, two monomers each consisting of 3 or 4 N-terminal zinc fingers fused to a C-
terminal nuclease.  These monomers are targeted to binding sites spaced by 5 or 6 base 
pairs (Cathomen and Joung, 2008).  Any potential targets that would require a different 
architecture of domains, such as an N-terminal nuclease, or different spacings are not 
currently possible.  Finally, the improved efficiency of homologous recombination due to 
a double strand break decreases dramatically with the distance between the cut site and 
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desired genetic conversion.  In fact, a distance of only 45 bases will reduce the efficiency 
of repair by over 60% (Elliot et al, 1998).  Therefore, the ability to target an exact 
sequence, despite the failings of current designs and selection procedures, may be 
absolutely critical to the development of these therapeutic agents. 
 
Previous studies have focused on the utility of zinc fingers as a modular, flexible 
system to create artificial DNA binding domains for genetic engineering of cell lines or 
animals (Beumer et al., 2006; Urnov et al., 2005).  To account for the GC bias of zinc 
fingers, target sequences are typically chosen by their GC content to accommodate this 
bias. However, our zinc finger-homeodomain (ZFHD) selection framework, which is 
derived from ZFHD1(Pomerantz et al., 1995), provides a system in which the specificity 
of both components can, in principle, be engineered to create hybrid transcription factors 
that can be used for targeted gene regulation or modification.  Incorporation of the 
homeodomain into the artificial DBD arsenal has the potential to provide a set of modules 
able to strongly specify A-T rich sequences.  Together, zinc fingers and homeodomains 
would provide a more complete index of sites that are able to be specified efficiently by 
artificial DBDs.  Our analysis of the full complement of D. melanogaster homeodomains 
has begun to catalog the versatility of this tool utilized by nature to recognize a variety of 
specific sequence elements and provides a blueprint for their future utilization by 
scientists to manipulate natural systems. 
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Appendix  
 
Table A.1 
Amino acid sequence, selection promoter strength/stringency and the binding 
sites recovered for each AP factor assayed. 
 
Abd-A 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
RRRGRQTYTRFQTLELEKEFHFNHYLTRRRRIEIAHALCLTERQIKIWFQN
RRMKLKKELRAVKEINEQAR 
 
Selected sequences 
>AbdAG04 >AbdAG09 >AbdAH02 >AbdAH07 >AbdAH12 
TTTTTAATTA TACCAAACCC TACGTAACTT CGTTCTTTAA ATCTTAATTAC 
>AbdAG05 >AbdAG10 >AbdAH03 >AbdAH08 >AbdAG02 
CTACCATTTT CACTAATTA GGTCATTAAA GATTTAATTA GGTAATTAAA 
>AbdAG06 >AbdAG11 >AbdAH04 >AbdAH09 >AbdAG03 
TTAATTAC CATAATTA TTTTTTATGA GCGCTAATGA TCGTTAATGA 
>AbdAG07 >AbdAG12 >AbdAH05 >AbdAH10  
TTCTTTATTA GTTTTAATTA CTACTAATTC TGTTTAATGA  
>AbdAG08 >AbdAH01 >AbdAH06 >AbdAH11  
GGACCCACAT GGTTGCGGCC TGCAATTAAA GGCAATTAAG  
 
Abd-B 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
VRKKRKPYSKFQTLELEKEFLFNAYVSKQKRWELARNLQLTERQVKIWF
QNRRMKNKKNSQRQANQQNNNN 
 
Selected sequences 
>abdb2 >abdb7 >abdb13 >abdb19 >abdb24 
GGGTTTATAG GGTTTACAAC TTTTTATAAC GCTTTTATTA TGTTTTATGA 
>abdb3 >abdb8 >abdb14 >abdb20  
GTTTTATTGT CGTTTAATGT TTATTAATTA ACTTTTACGA  
>abdb4 >abdb10 >abdb15 >abdb21  
TTTTTTATGG TGATTTATGT GTTTTATGA TGATTTATTA  
>abdb5 >abdb11 >abdb17 >abdb22  
TGATTAATGG CATATTATGA AGTTTTATGG TGATTTATTA  
>abdb6 >abdb12 >abdb18 >abdb23  
CGCTTTATGT GCATTTATTA TCTTTAACGA TCTTTAATTA  
 
Antp 
Promoter-Stringency UV5m-10mM 
301 
Amino Acid 
Sequence 
RKRGRQTYTRYQTLELEKEFHFNRYLTRRRRIEIAHALCLTERQIKIWFQ
NRRMKWKKENKTKGEPGSGGEGD 
 
Selected sequences 
>AntpA02 >AntpA07 >AntpB01 >AntpB08  
GCCTTAATTA GGTTTAATGA TTCATAATTA GGCAATTAAG  
>AntpA03 >AntpA08 >AntpB02 >AntpB09  
AATTTAATTA GGC TTAATGA GTGTTAATTA CGTTTAATTA  
>AntpA04 >AntpA10 >AntpB04 >AntpB11  
AGCTTAATGA CTACTAATTA GATTTAATTA TTTTTAATGA  
>AntpA05 >AntpA11 >AntpB06 >AntpB12  
TTGTTAATGA CCCTTAATGG TGTTTAATGA CCTTTAATGA  
>AntpA06 >AntpA12 >AntpB07   
GGTAATTAAA TAGCACTTTT TTTTTAATGA   
 
Bcd 
Promoter-Stringency UV5m-5mM 
Amino Acid 
Sequence 
PRRTRTTFTSSQIAELEQHFLQGRYLTAPRLADLSAKLALGTAQVKIWFK
NRRRRHKIQSDQHKDQSYEG 
 
Selected sequences 
>Bcd21G1 >Bcd21G6 >Bcd21G12 >Bcd21H5 >Bcd21H10 
CTGAAAATCT CTGGTTTAAC AGGACTAAGC CCTTAAATCT CTATTAAGCT 
>Bcd21G2 >Bcd21G7 >Bcd21H1 >Bcd21H6 >Bcd21H11 
CCTTAAGTCG CTTCTAATCC TGGGTAATCT ATTCTAATCT ATCCAAATCC 
>Bcd21G3 >Bcd21G9 >Bcd21H2 >Bcd21H7  
AGATAAGTCA CAATCAATCC GGGAATTAGA TCTTCAATCC  
>Bcd21G4 >Bcd21G10 >Bcd21H3 >Bcd21H8  
TTGTAAGCTG AACAAATCCT ACCGCTAAGC GTTTAAGCCC  
>Bcd21G5 >Bcd21G11 >Bcd21H4 >Bcd21H9  
TTCCATAATCT TAGATTAATG CGACCTAATC CCTTAAGCTA  
 
Bcd 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
PRRTRTTFTSSQIAELEQHFLQGRYLTAPRLADLSAKLALGTAQVKIWFK
NRRRRHKIQSDQHKDQSYEG 
 
Selected sequences 
>bcd1 >bcd6 >bcd11 >bcd17 >bcd23 
TGTTAATCCG TCTTAATCCC CGGGTAATCC GGTTATCCG GGTTAATCCG 
>bcd2 >bcd7 >bcd13 >bcd18 >bcd24 
ATGGATTAGA GCTTAATCCG TGTTAATCC TGTTAATCCC ATGGATTAGA 
302 
>bcd3 >bcd8 >bcd14 >bcd20  
CGTTAATCTC GGGTTAATCC TGGGATTATA CGCTTAATCC  
>bcd4 >bcd9 >bcd15 >bcd21  
GGTTTAATCC GAGATAATCC GCGTAATCCA TTACTAATCC  
>bcd5 >bcd10 >bcd16 >bcd22  
TCTATAATCC AGCTTATCC GGCTTAAGCC GTCCTAATCC  
 
Blimp-1 
Promoter-Stringency UV5m-10mM 
Amino Acid Sequence GKMHYECNVCCKTFGQLSNLKVHLRTHSGERPFKCNVCTKSFTQLAH
LQKHHLVHTGEKPHQCDICKKRFSSTSNLKTHLRLHSGQKPYACDLCP
QKFTQFVHLKLHKRLHTNDRPYVCQGCDKKYISASGLRTHWKTTSCK
PNNLEEE 
 
Selected Sequences 
>CG5249C3  
CCATGGCCCGTAAGAGAAAGTGAGAGTG  
>CG5249C4  
GCATGAGAGTGAAAGTTAGCTCAACTAG  
>CG5249C6  
GCAAAATCAGTGAAAGTGGCGGGCGCAT  
>CG5249C7  
GCGCCGACGAGACTAAAAGTGAAAGTTC  
>CG5249C9  
GGCCACTGAAAGTGAAAGCTGGCCACCA  
>CG5249C11  
CCTACACTGGCTGAACGAAAGCGAAAGT  
>CG5249D1  
GCCGTGTAATCTGAAGAAAGTGAAAACA  
>CG5249D2  
TACGGGACGAACGAAAGTGAAAGCAAGT  
>CG5249D3  
CTAAAAAGTGAAAGTCCTGCTCTGGATG  
>CG5249D4  
CAGCTTCAAGTCCCGAAAGGGAAAGTT  
>CG5249D5  
GCTGCAAAAGTGAAAGTAGCCAAAAACG  
>CG5249D6  
GAAAATGAAAACGAAAGTGCGCGCATCC  
 
 
Btd 
Promoter-Stringency UV5m-10mM 
Amino Acid Sequence QHICHIPGCERLYGKASHLKTHLRWHTGERPFLCLTCGKRFSRSDELQ
RHGRTHTNYRPYACPICSKKFSRSDHLSKHKKTHFKDKK 
 
Selected Sequences 
>5BtdE2 >5BtdF7 
GCCCCCCCTCCTAGATACGCCCCCCTAA AGGCCATCGAAAGTCAGGAGGGCGGACA 
303 
>5BtdE3 >5BtdF8 
ACTAGGTGCACTGGGAAGTAGGCGGACA ACGACGCGGAGGGGGCGTGACTATTACA 
>5BtdE4 >5BtdF9 
GAGAATACGCCCACATGCACGAACTCTC CGAAACTCGCAGATAAGAGGGGCGGATT 
>5BtdE5 >5BtdF10 
CCTAACCTCTATGGACCGTGGGCGGTAG CGAAGATAACCCCCCGAAGGGGCGGCAC 
>5BtdE6 >5BtdF11 
TTGAAAGCCGACAACGAGAAGGCGTATG AAGGTAGACGTAAACTTTGGGGGCGGAGT 
>5BtdE7 >5Btd2G1 
CCAACCCAAGACGAAAAGGGGCGGAACG GAACAGTGGGCGGGTACGAAGTCACTAA 
>5BtdE8 >5Btd2G2 
GAAGCATAAGAAAAAAAAGGGGAGGATG ACCCCCGCAAGTATTGACAGTTGCCATG 
>5BtdE9 >5Btd2G3 
GCATGCAGTTACACAGAAGGGGGCGGGT ACCCCCGCAAGTATTGACAGTTGCCATG 
>5BtdE10 >5Btd2G4 
GATAAGTGAAATATGGAGAGGGCGGGTG GAAGCATAAGAAAAAAAAGGGGAGGATG 
>5BtdE11 >5Btd2G5 
AAGTATCGCCCACAACCCCGCCCCTCAAA ACGCCCGTACGCTTACGCCCCCTTACAG 
>5BtdE12 >5Btd2G6 
AACCCAGACAGCAAAAACGCCCCCCAAT TAACCGGCGACGGCTGAAAAGGGGCGGG 
>5BtdF1 >5Btd2G7 
ACACCCTTGCTACCATACGCCCACGAAA GGCGTAAGCATCATTGTAGGGGCGGTAC 
>5BtdF2 >5Btd2G9 
GCCCACGTCCTTCAACACAGGGGCGGACA ATGTACCCCTCGCCATCCGCCCCCCACA 
>5BtdF3 >5Btd2G10 
GCGACAGAGTGGGCGGATGTGAAAGACA GACCTATCCGAGGGGCGGGGAAATACGA 
>5BtdF4 >5Btd2G11 
CGATGACCTTGGGGGCGGGGCCAAAACACC AGAAGTTGTCAACTCACGCCCACACCAA 
>5BtdF5 >5Btd2G12 
AATTTAGAGGGCGTTTCATATTAATGCG AGAAGTTGTCAACTCACGCCCACACCAA 
 
Cad 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KDKYRVVYTDFQRLELEKEYCTSRYITIRRKSELAQTLSLSERQVKIWFQ
NRRAKERKQNKKGSDPNVMGVG 
 
Selected sequences 
>CadE1 >CadE11 >CadF8 >Cad2E7 >Cad2F4 
CCACAAATTA AGCAATTAAG CTCAATAAAA ACTCTAATTG ACCATAATTA 
>CadE2 >CadE12 >CadF9 >Cad2E8 >Cad2F5 
CTAATCAACA CTAATAAAA ATCATAAAAC CCAATAAACT GCAATAAAAA 
>CadE3 >CadF1 >CadF10 >Cad2E9 >Cad2F6 
GTAATAACTT ACCGTAATTA ATTCCGCTCT GCAATCATTA CTTTTTATTG 
>CadE4 >CadF2 >CadF11 >Cad2E10 >Cad2F7 
GAATTAATAG CCAATAAATG GTAATAAAGT CCTTAAATTA CCCATAAATT 
>CadE5 >CadF3 >Cad2E1 >Cad2E11 >Cad2F9 
GCTTAAATGA GCCATTAAAG CCAATAAAGG AAAAGGATTC GTTTTTATGA 
304 
>CadE6 >CadF4 >Cad2E2 >Cad2E12 >Cad2F10 
ATGATTTATTT AGTTTAATAA GACATTATTA AGGCACTACG CCCATATAAT 
>CadE8 >CadF5 >Cad2E3 >Cad2F1 >Cad2F11 
CTTATAAAAT CTATTTATTA GCTAATAAAT GTTCTAATTA GCAATAAAAA 
>CadE9 >CadF6 >Cad2E4 >Cad2F2  
ACAGTAATTA TATTTTATTA TTATTTATTA CTCATAAACA  
>CadE10 >CadF7 >Cad2E5 >Cad2F3  
GAACACTACT GCAATAAACA TCGAGCATGT GGATTTATAA  
 
D 
Promoter-Stringency UV5m-5mM 
Amino Acid Sequence MHSLATSPGQEGHIKRPMNAFMVWSRLQRRQIAKDNPKMHNSEISKR
LGAEWKLLAESEKRPFIDEAKRLRALHMKEHPDYKYRPRRKPKNPLT
AGPQGGLQMQ 
 
Selected Sequences 
>DykD1 >DykE6 
AATCCCATTGTTATACATGCTGCAATAT GAAAAATAAACACAAAAGGATACTATAA 
>DykD2 >DykE7 
CGTCCCACGCAACACAATGGACAACATA CTACGCGTCAAACAAAAGGCGCGAAGAA 
>DykD3 >DykE8 
TCGAGCCACGTGTACCATTGTTGTAGGA TAGACAACCATGACTGGACATTCAAGAG 
>DykD4 >DykE9 
TAGACAACCATGACTGGACATTCAAGAG GCGGCATAAGAACAAAGGATTTCTAGCT 
>DykD5 >DykE10 
TTCCACATTGACCATAGCCAGCCACTCC ACCCCCGCAGTATTGACAGTTGCCATG 
>DykD6 >DykE11 
CAATGGGCCTTGATCCATTGTTCACGAC CGCATACTAGAACAATAGGCCACTACGAA 
>DykD7 >DykF1 
CTGTCACAAATAACAATAGGAGGCGAAC GAACCCATCGTGTCCATTGTTCACCATT 
>DykD8 >DykF2 
CAATGGGCCTTGATCCATTGTTCACGAC AACGCCCCGAGAACAATAGGGAACCATA 
>DykD9 >DykF3 
AGCAAAGTACAACAATGGAAGGCTCAAT GCCCAGACAATAAAAGCCCTTTAGAGTC 
>DykD10 >DykF4 
ACCCCCGCAAGTATTGACAGTTGCCATG AAAAAGACATAACAATAGAGCTCGGTTG 
>DykD11 >DykF5 
AACGCCCCGAGAACAATAGGGAACCATA AGTACAATGAAAACAAAGAAACCCCCAA 
>DykD12 >DykF6 
ACGACAAAACATAAAAGCGTCACACATG ACCCCCGCAAGTATTGACAGTTGCCATG 
>DykE1 >DykF7 
ACCCCCGCAAGTATTGACAGTTGCCATG ACTCCCTTAAGGGCCCATTGTTCTCCCC 
>DykE2 >DykF8 
CAGACGCTTACACAAAGAAACGGTGAAG TAACCCAAAAGAACAAAGGATACAATGG 
>DykE3 >DykF10 
CAACATCGCTAAACAATAGCCTAAAGTA GTTCACACAGAACAATGGCCCCGACAAC 
>DykE4 >DykF11 
ATCCCCTCGAAACAATAGAAGCGACATC CCGCACTGCAATACAAAGGAATACAGAT 
305 
>DykE5 >DykF12 
ACAACATCAACGACAATGGAAGAACCAA CAATGGGCCTTGATCCATTGTTCACGAC 
 
Dfd 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
PKRQRTAYTRHQILELEKEFHYNRYLTRRRRIEIAHTLVLSERQIKIWFQN
RRMKWKKDNKLPNTKNVRKKT 
 
Selected sequences 
>dfd1 >dfd6 >dfd11 >dfd16 >dfd21 
CTTCATTAAG CCTAATTAAG AGCTATTAAA CTCATTACT CGACTAATGA 
>dfd2 >dfd7 >dfd12 >dfd17 >dfd22 
GGTCATTAAT GATAATTAAT GCACTAATGA CTTCATTAAG TATCATTAAC 
>dfd3 >dfd8 >dfd13 >dfd18 >dfd23 
TATCATTAAA CCTAATTAAG TCGTAATGA AGTCATTAGG CCGTTAATGA 
>dfd4 >dfd9 >dfd14 >dfd19 >dfd24 
GGTCATTAAT CCCCATTAAT TGCTTAATGG TACCTAATGA CAATTAATGA 
>dfd5 >dfd10 >dfd15 >dfd20  
GTCATTAACA TTTTTAATGA ATCGTAATTA TGGATAATGA  
 
ems 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
PKRIRTAFSPSQLLKLEHAFESNQYVVGAERKALAQNLNLSETQVKVWF
QNRRTKHKRMQQEDEKGGEGGSQR 
 
Selected sequences 
>emsA1 >emsA6 >emsA11 >emsB5 >emsB10 
TTAATTATA GGTCATTACT CCAATTATTG TTTCTAATGA CTAATTAGAG 
>emsA2 >emsA7 >emsA12 >emsB6 >emsB11 
CCATTTATGT GTCCATTAAT CCATAAATTA TGCCTAATGA CTAATTAGCG 
>emsA3 >emsA8 >emsB1 >emsB7  
CATTTTATGA TGTGATTAAC TCTGGAGAGG TCACTAATTA  
>emsA4 >emsA9 >emsB2 >emsB8  
GCCATGGACC ACATAAATGA GCCAATTATA GGTCTAATGA  
>emsA5 >emsA10 >emsB3 >emsB9  
TTCACTAATA ACTAATTAAA CTCCATTAAA CCAATTAGAG  
 
en 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
EKRPRTAFSSEQLARLKREFNENRYLTERRRQQLSSELGLNEAQIKIWFQ
NKRAKIKKSTGSKNPLALQLMAQ 
 
Selected sequences 
306 
>eng1 >eng7 >eng12 >eng17 >eng22 
CTAATTAGCG GTGCTAATTA CAATTAAAA CGACTAATTA CCAATTAAAC 
>eng2 >eng8 >eng13 >eng18 >eng23 
TATTTAATTA TCAATTAACC CCAATTAAAA CCAATTAAAA TCAATTAAG 
>eng3 >eng9 >eng14 >eng19 >eng24 
CTCATTAGTG ACGTTAATTA TAACTAATTA CTCAATTAAG CGGCTAATTA 
>eng4 >eng10 >eng15 >eng20  
AGGGTAATTA TAGGTAATTA CTCTTAATTG GCGTTAATGA  
>eng5 >eng11 >eng16 >eng21  
GCAATTATCA CGGCTAATTA CCGATAATTG GCTAATTAAG  
 
eve 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
VRRYRTAFTRDQLGRLEKEFYKENYVSRPRRCELAAQLNLPESTIKVWF
QNRRMKDKRQRIAVAWPYAAVYSD 
 
Selected sequences 
>Eve-G1 >Eve-G6 >Eve-G11 >Eve-H4 >Eve-H9 
TCCGACATAA CTTCTAACGA ACACATTAAC TGTTTAATGA TTGCTAATGA 
>Eve-G2 >Eve-G7 >Eve-G12 >Eve-H5 >Eve-H10 
TTACTTAATT CATCATTATA CCTCATTATG CGGCTAATTA CCTCATTAAT 
>Eve-G3 >Eve-G8 >Eve-H1 >Eve-H6 >Eve-H11 
TCGATTATTA GTCGTTAGTA GTTAATTAAA TTGCTAATTA GGTCATTAAC 
>Eve-G4 >Eve-G9 >Eve-H2 >Eve-H7  
CTTCTAATCA TGGCTAATTG TCCCATTAAC ACACTAATTA  
>Eve-G5 >Eve-G10 >Eve-H3 >Eve-H8  
TAGTAAATTA TCAATTAGAC AGTCATTAAA GTAATTAGTA  
 
fkh 
Promoter-Stringency UV5m-10mM 
Amino Acid Sequence GRSRVDKPTTYRRSYTHAKPPYSYISLITMAIQNNPTRMLTLSEIYQFIM
DLFPFYRQNQQRWQNSIRHSLSFNDCFVKIPRTPDKPGKGSFWTLHPD
SGNMFENGCYLRRQKRFKDEKKEAIRQLHKSPSHSSLEATSPGKKD 
 
Selected Sequences 
>FkhA1 >Fkh2A3 
CCAAGTTTGCTTTGTGCAAGAAGTTAAG TGGTCGTTTACTAACAATAAATTATTTG 
>FkhA3 >Fkh2A4 
CGGCACAGTACACTTTATTTACTCAACG ATTGTTTGTACAAAGCAACCCTGACGA 
>FkhA4 >Fkh2A6 
CCTATGCCGCCAAAAATGAAAACAGATT AACTGAGGCCAGGTGTTTATCTATCAAC 
>FkhA5 >Fkh2A7 
CCACTTTAAAATGCAAATAGACTAAACA AATGTTGACCTAAAGAAAACGATCAACA 
>FkhA6 >Fkh2A8 
307 
CTTATGAGAAAACGAGATTAAATAAACA AAAACCCACCCACAATATTTACGCAAGAC 
>FkhA7 >Fkh2A9 
GCAGGGCAAAACCTGTTTGTTGAAGAGC GCAGGGCAAAACCTGTTTGTTGAAGAGC 
>FkhA8 >Fkh2A10 
ACAGATACAAGTCTAAATGGACTGTTTGC TCAAGGACCCCATTGTTTACCTTAGATG 
>FkhA9 >Fkh2A11 
ACTTTTAGAAATGTAAATAAACAACACCG AAATTGTTATATCCAAACATAAACAAA 
>FkhA10 >Fkh2A12 
GATTCTGGCAGAGATAACCCCCAGACGTG GAGGCCCCCGCCAATATTTGACCAAAGG 
>FkhA12 >Fkh2B1 
CCGCAAACCCCCTTTGTTTACCTACTCT CACATCTTTGAGATAAGTTTACACAGAGA 
>FkhB2 >Fkh2B2 
CTTTCGAACCCAAAGGCACGCGATCAAA GGAATCCATAAATAAACAACAAGGATGA 
>FkhB3 >Fkh2B5 
GGCGCGGGGAATAATGAAGGACCTCCAA GCAGAAGAATGACTATTTGCTCATCTAC 
>FkhB6 >Fkh2B6 
TGCAAAGAGACGTGTGTTTACCCAAAGC AAGCGGCGTGCGGTGGAATCGGCCCAAA 
>FkhB7 >Fkh2B7 
GCAGGGATGCGTGTAAACACAAGCAAAA TCGTCCCAACCTCGTGTTTGAATAATGA 
>FkhB8 >Fkh2B8 
CCGGAAATAATAGAGCCGCCCGTGTTTG ACGGGGAACAAGGAAGTTTGTTTAAGTT 
>FkhB9 >Fkh2B9 
TGGACCCGCTCGGATGTTTGCCTAAGCT CGGTGCCCTACGCAAACAATGAAGCTAC 
>FkhB10 >Fkh2B10 
CCCCCCGGCGGATTGTTTGAGTAAGGTG AAGAGCTGCTGATCAAATAGTTCACTGA 
>FkhB11 >Fkh2B11 
GCATCCCTGGTGTTACCACAGTCACAAA CAGCTACCGCGAACTGTTTGCACACAAC 
 
ftz 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
SKRTRQTYTRYQTLELEKEFHFNRYITRRRRIDIANALSLSERQIKIWFQN
RRMKSKKDRTLDSSPEHCGAG 
 
Selected sequences 
>FtzG1 >FtzG6 >FtzG11 >FtzH5 >FtzH10 
ATCATAATTG TTACTAATGA CATCATTAAC GAGTTAATGA ATATTAATTA 
>FtzG2 >FtzG7 >FtzG12 >FtzH6 >FtzH11 
CAGCCGCCC TTATAAATGA TGCTTAATTA GCCCTAAGAT TTGTTAATGA 
>FtzG3 >FtzG8 >FtzH1 >FtzH7  
TCCCATTAAC TTTTTAATTG GGCTTAATGG CTGTTAATTA  
>FtzG4 >FtzG9 >FtzH2 >FtzH8  
CTCTTAATTA CGCCTAATGA GAACCTACTT GGGTTAATTA  
>FtzG5 >FtzG10 >FtzH3 >FtzH9  
ATGCTCCCGC TAGTTAATTA CCGTTAATTA TTTTTAATGA  
 
Gsc 
Promoter-Stringency UV5m-10mM 
308 
Amino Acid 
Sequence 
KRRHRTIFTEEQLEQLEATFDKTHYPDVVLREQLALKVDLKEERVEVWF
KNRRAKWRKQKREEQERLRKLQEE 
 
Selected sequences 
>GscA1 >GscA6 >GscA11 >GscB5 >GscB10 
CCGATTACGA TCAGATTATC TAGGATTATG TCGGATTAAG ATGGATTAGT 
>GscA2 >GscA7 >GscA12 >GscB6 >GscB11 
CAAGTAATCC TAGGATTACT ACAATAATCC ACGGATTAAA GGATTAATG 
>GscA3 >GscA8 >GscB1 >GscB7  
AAGATTAGTC TGCGATTAAG TCGTTAATCT CCCCTAATCC  
>GscA4 >GscA9 >GscB3 >GscB8  
TAGGATTATT ATCGTAATCC GGGATTAACA GGGATTAACA  
>GscA5 >GscA10 >GscB4 >GscB9  
AAGATTAGTA TCGTTAATCT CGAGATTAAG TGGATTAGGA  
 
gt 
Promoter-Stringency lppC-5mM 
Amino Acid Sequence KRVLEQIRSSNGGSRTVTNPKMRRTNSRSGSVNEGSSSNNNSESEDRA
AAEESSDCDSQAGNFESKSATSSSSNLANATAANSGISSGSQVKDAAY
YERRRKNNAAAKKSRDRRRIKEDEIAIRAAYLERQNIELLCQIDALKV
QLAAFTSAKVTTA 
 
Selected Sequences 
>LGiantH1 >LGiantA7 
GCATCACATAAATACGCCAAAACAGAAA TCCCTTACGTAACAAAGTAACGAGGAAG 
>LGiantH2 >LGiantA8 
ATATTGCGTAACAGGGTAGTGCCACC GGCGGACGGTCATTACGTCATCACGATG 
>LGiantH3 >LGiantA9 
TAAACAAAGATAGAAGCGTTATATTAAA TATAACTATGACGTAACCGCAGATAGCT 
>LGiantH4 >LGiantA10 
CGAAGCATTATGTAACACGCGTAACAAC TCATTGCACACGGTTATGTAATACCACT 
>LGiantH5 >LGiantA11 
GCCAATACGCCGGAGCTTTACAGTGGTT AAAAAATTACGCAACACCGTTTTGGTAA 
>LGiantH6 >LGiantA12 
ATTACGTAACTTAAGGGCAAGTTACTCT ATTACGTAACTTAAGGGCAAGTTACTCT 
>LGiantH7 >LGiantB1 
AAGGGATATTGCGTAACCGTAATCCTTC CCAACGTCCGTGTTGCGTAACTTCGAAC 
>LGiantH8 >LGiantB2 
CAAAGCGCCATTACGCAATCACGCGAAC TGGCGATTACGTAAGTCAAGACGAGGTT 
>LGiantH9 >LGiantB3 
GCTCACAACAGCGTTACGTAACATACAG ATACCCGCCATTACGTAATCGCCACTCC 
>LGiantH10 >LGiantB4 
ATGTAGATTACGTAACAGGGGACCATGA TCTTCATGTTACGTAAGATAACCCAGGT 
>LGiantH11 >LGiantB5 
CATCAAGTGTTACGCAATCGGGACCAAC GTGCGGTATTACATAACTTCACCATTTG 
>LGiantH12 >LGiantB6 
TCATCGAAACCTCATTACGTAATAGCAT GGCTCTTGCATATTACGTAAGCACTATA 
309 
>LGiantA1 >LGiantB7 
TTCCCTCCGTACCTTACGTAACGCAACA TAGGCACCAAACATTACGTAATACAAGG 
>LGiantA2 >LGiantB8 
TAGGCTACAACTAATGAAAATAAAAAAA TATAAGTGTGACGTAATACACGAGATAC 
>LGiantA3 >LGiantB9 
TAGGCTACAACTAATGAAAATAAAAAAA GGAATTACGTAACAACATAGTGATCTCT 
>LGiantA4 >LGiantB10 
TAGGTTATTACATAACAGGATCATAGCT GTGCGGTATTACATAACTTCACCATTTG 
>LGiantA5 >LGiantB11 
GACAATAGGGTTCAGTCCATACTCGCAAA CCAATTACGTAACAAGTACTACAGGTAG 
>LGiantA6  
GGACGGAAGCATAATGTGTTACGTAACT  
 
h 
Promoter-Stringency lppC-5mM 
Amino Acid Sequence VTGVTAANMTNVLGTAVVPAQLKETPLKSDRRSNKPIMEKRRRARIN
NCLNELKTLILDATKKDPARHSKLEKADILEKTVKHLQELQRQQAAM
QQAADPKIVNKFKAGFAD 
 
Selected Sequences 
>LHairyA1 >LHairyB11 
ACGCGCCACATCAAACTCTCCAATTGAA CCCCACAGTCTTTGGCACGTGCCAGATC 
>LHairyA2 >LHairy2E1 
GACAATAGGGTTCAGTCCATACTCGCAAA GAAGCGCGCCAGCGAAAAAAGATCACCAC 
>LHairyA3 >LHairy2E2 
CCCCGTCCTGACACGCGCCGGACCCAAG ACGCGCCACACGCAGGGACTTTAGAGGG 
>LHairyA4 >LHairy2E3 
TGATCAGCCACGTGGCCAAAACCCCACG GAGTCATAAAGCTGCCCGCGAGCCCTGT 
>LHairyA5 >LHairy2E4 
ACGTGTGAACTTGAAAATTAATTCATTG ACCTTGCCCCCACGCGCAGACTACAAAA 
>LHairyA6 >LHairy2E5 
ACGTGCCAGGAGGGCCCCTTGAACCAAT GACCCAACGCGAAGCAATTGGCACGTGCC 
>LHairyA7 >LHairy2E6 
GAAAAAGCAGAATCGTAATTACGCAAGT ACGTGTCACTGGGATGATAATCTCCACA 
>LHairyA8 >LHairy2E7 
ACGCGCCACATCAAACTCTCCAATTGAA ACGCGCCATACATTCGCAAAATAAAACG 
>LHairyA9 >LHairy2E8 
ACGCGACCCCCCAACTACCATGCTACGGC GGAACTAAATAAATGGCACGTGCCCATT 
>LHairyA10 >LHairy2E9 
CGGCTTGCCACGCGCCAACGCCCGATGC GGCACCGGCACGCGACGTTTTACCCAGC 
>LHairyA11 >LHairy2E11 
ACGCGACCCGTACAACAAATTTCACCAG TCTAGCAGCGGTCTAGCCACGCGACCAC 
>LHairyA12 >LHairy2F1 
GGGACACCCGGGCAACCGCAAATGATAA GGGAAGACACGCGACACCAAAACGAATC 
>LHairyB1 >LHairy2F2 
GAATATCGGCACGTGGCCCTAGAGACCA ACGCGCCACATCAAACTCTCCAATTGAA 
>LHairyB2 >LHairy2F3 
ACGCGCCACATCAAACTCTCCAATTGAA CTGACCGGCACGCGACATTCGCCACACT 
>LHairyB3 >LHairy2F4 
TGTCTACACGCCCTGTTCTAGCTACGCC CACGTGCCAGATATTACCGCCCACCAGA 
>LHairyB4 >LHairy2F5 
310 
AGAAATGGCACACGCCATGAGTGCACTA ATATTCGCCACGCGACCACCGACCCCAC 
>LHairyB5 >LHairy2F6 
CACGTGGCATACCGGTAGAAAAGCCGAC TGAATGAGGACACGTGCCGTGAAAACGC 
>LHairyB6 >LHairy2F7 
AATAGCCACGCGCCAGACGTATATTCAC GATCGAAAAACTACAAAATTAATTAACA 
>LHairyB8 >LHairy2F9 
AGCGTGAAGGCACGTGCCACCGACAGCC CTATGGCACGTGCGCCCCCTCAGCCGAA 
>LHairyB9 >LHairy2F10 
CAAGGACACGCGCAACGGTGCCCGGACA CTGACCGGCACGCGACATTCGCCACACT 
>LHairyB10 >LHairy2F11 
CACGTCAGGCACGCGACCCCTTCTCGCA GGAGCACGCAGTGTGGCATGGCACGTGCC 
 
hb 
Promoter-Stringency UV5-5mM 
Amino Acid Sequence KMKNYKCKTCGVVAITKVDFWAHTRTHMKPDKILQCPKCPFVTEFKH
HLEYHIRKHKNQKPFQCDKCSYTCVNKSMLNSHRKSHSSVYQYRCAD
CDYATKYCHSFKLHLRKYGHKPGMVLD 
 
Selected Sequences 
>5HbG1 >5HbH7 
AACAATACAAGTAATAAAAAAATAAGGA TTCAATCTCCGTGAAAAACGTTCATGTG 
>5HbG2 >5HbH8 
CCAGCTCAAACCTTTTTCCCTTTGCCAC GTTGCCAAAAAAAAAACGTCATCACAAA 
>5HbG3 >5HbH9 
ATGGATAGCGCAAACGAAAAAAAAAGTG GAAGTATCTCCGAACCCAAAAAAACACG 
>5HbG4 >5HbH10 
TGAAGAAGAACACTGAAGAAAAAAATCG TAAAAGATAAATCCCACAAAAAACCAGA 
>5HbG6 >5HbH11 
CGTGACGTCAGTGTGAAAAAAAAGGTCA GCTGACCCAATTCACACAAAAAACGAAC 
>5HbG7 >5HbC1 
CCGTCCCACAGATGATAAAAAAAACTTC AGGAGCCCACAACCCAACATTAACTCAC 
>5HbG8 >5HbC2 
CGATAGTGTCCCTATCAAAAAAACATTT ACCGGATAAATACCCGTACCAACCATGC 
>5HbG9 >5HbC3 
ACATGAAAAGCAAAAAAACGAGT CACACGACGAAAGTGCACAAAAAAATTC 
>5HbG10 >5HbC4 
CCGTTATGACCGCGATCAAAAAAACCAT GCATATCCCCGTGGCTATGAAGCAAACT 
>5HbG11 >5HbC5 
TACCGGAGCGATACACAAAAAAACATGC ACTAACACATCGCAACGCAAAAAACGCA 
>5HbG12 >5HbC6 
TGAATTTGGAGTGGAGTAAAAAAACGCT AATGCCAAAAAGAGCAAAAAAACACCAA 
>5HbH1 >5HbC7 
ACATCAAGCGAGATCCACAAAAAACTAG AATATGAAAGAACAAGCAAAAAAATAGC 
>5HbH2 >5HbC8 
CCCACGATCGTCTACAACAAAAAACACA ATATAAAAAATTAAACATAAAAAAATAC 
>5HbH3 >5HbC9 
CACCCTGTCGCAACCCCAAAAAAACATC CACAGCTACTCACCCAAAAAAAACACAT 
>5HbH4 >5HbC10 
GAGGGCTCACCGCTGCAAAAAAACACCC ACTAGTCCAGAGAGAACAGCATTCTGGC 
>5HbH5 >5HbC11 
GCAATGAACATTGCGTCCCCAATAAATC CAACCCGCCAGCATCAAAAAAAACAGGC 
311 
>5HbH6 >5HbC12 
ACATCAAGGCTGAAGGCCCCTGGACGTC GCACGCGCCATAGTCAAAAAAACCACAA 
 
hkb 
Promoter-Stringency UV5m-10mM 
Amino Acid Sequence KFKCPNCDVAFSNNGQLKGHIRIHTGERPFKCDVNTCGKTFTRNEELT
RHKRIHTGLRPYPCSACGKKFGRRDHLKKHMKTHMPQE 
** alternative linker:  AAADYKDDDDKFRTGSTSLYKKAGS 
Selected Sequences 
>Hkb2B1 >HKB5G1 
TTGATCAACTGCAGTGCGAACCGGATCCC CCACCAGCTTCCAAGTAGGCAACCCAGAC 
>Hkb2B2 >HKB5G2 
ATGACATTTGACTCAGCATCTACCCCCC CAAGAACCGATTACTGACAACATCGAAA 
>Hkb2B3 >HKB5G3 
ACAGACAACACAGCAGGCTTGGGCGTGAC ACATACCAGCCTGTAATCACGCCTATGT 
>Hkb2B4 >HKB5G4 
CAGCCGCCGCCCATAGACTGCCGGCAA AGGAGCCCACAACCCAACATTAACTCAC 
>Hkb2B6 >HKB5G5 
AGACCCCTCCAACAGGAAGAAGGCGTGA GACTCGGGCCGTAGACACGCCCACCACG 
>Hkb2B7 >HKB5G6 
ACCTCCGTCGGTGAGCATCACGCCTACC CACACTTAATCACTACTCACGCCCCTCG 
>Hkb2B8 >HKB5G7 
ACAGGGGGCGTGAGTACGACTACCCACC TCAACACACTGATGCGTATCACGCCTCT 
>Hkb2B9 >HKB5G8 
CTATAACTTACCCCCCCCTCACGCCCCC AGTTTCGTACATATTCCCGCCCCTCAAT 
>Hkb2B10 >HKB5G9 
TGATGGTGGGTGCTACACTCACGCCCCC TACGAATGATGTTAGTAGGGGCGTGATG 
>Hkb2B11 >HKB5G10 
GATCTAAGCCATAAAAAGGGGCGTGAAC GCGACCGCGAAGCAAGGGGGCGTGACGCG 
>HKBB2 >HKB5G12 
TCACATCACGCCCCCTCCCGACCCACCC CCCAGCAAATCCCTGATGTCACGCCCCCCG 
>HKBB3 >HKB10H2 
AAGGATCGGGTGAACGCCCCTTTACCGG TACAAAATAGAGCAACCCGCCCCCCATC 
>HKBB4 >HKB10H3 
GACTGCCACAGTGCTCCGATAGGCGTGA ACGACAGGGAGGAGCGTGGGCGTGCACT 
>HKBB5 >HKB10H4 
CCCACAGATAACCTCGCTCCTCACGCCTA CACCCCGGTCAAACAGCACGCCCCCCAC 
>HKBB6 >HKB10H5 
GTGAATTACAGCAAATACACCTAGCATT CTAACGCGTCGACACACACGCCCCCTTC 
>HKBB7 >HKB10H6 
TGCGTTAACAACGGCAAATCACGCCTTC ACTTGGGAACCAAAATATCACGCCCAGT 
>HKBB8 >HKB10H7 
GCGCTTGCATCCCCCCACGCCCACATAA TTCTTTCCTGATTCCGTGAAAGGCGTGA 
>HKBB10 >HKB10H8 
ACGGGAACAACCCTAGAGGGGCGTGAGG GGCCTGGAGTGGGCGGGGAGAACACAAC 
>HKBB11 >HKB10H12 
GCAAGTGATCTGCTAGCCCTCACGCCCCC AGGAGTAGCCATGACGTGGGCGTGAACC 
>HKBB12  
CTGCGCGAACCCCCCCCTCACGCCCCCT  
 
Inv 
312 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
EDKRPRTAFSGTQLARLKHEFNENRYLTEKRRQQLSGELGLNEAQIKIWF
QNKRAKLKKSSGTKNPLALQLMAQ 
 
Selected sequences 
>InvC1 >InvC7 >InvC12 >InvD5 >InvD10 
ATAATTAACC GGTAATTATA CCTAATTAAA GTAATTAGTA TCACGCCGAG 
>InvC2 >InvC8 >InvD1 >InvD6 >InvD11 
ACTAATTAAT TCTAATTAAA CCAATTAAAT GATGCTAAAC GGTAATTAAC 
>InvC3 >InvC9 >InvD2 >InvD7  
ATAATTAGCA AGCCCTCGCA TCAATTAGAG CCAATTAGTT  
>InvC5 >InvC10 >InvD3 >InvD8  
CCACTAATTA AGTCAGCATG TCAATTAAAA TCAATTAAAA  
>InvC6 >InvC11 >InvD4 >InvD9  
CTTCACTGAA TAATTAGAG CTAATTAGAA ATTCCGCTCT  
 
kni 
Promoter-Stringency UV5-10mM 
Amino Acid Sequence NQTCKVCGEPAAGFHFGAFTCEGCKSFFGRSYNNISTISECKNEGKCII
DKKNRTTCKACRLRKCYNVGMSKGGSRYGRRSNWFKIHCLLQEHEQ
AAAAAG 
 
Selected Sequences 
>KnirpsE1 >Knirps7 
AGAGTAAAACCCTTGCACCCGGAGATC GCCAAAGGAGAAATTAGAGCAGACTAAG 
>KnirpsE2 >Knirps2F1 
AACATCGGCGGAATGAGAGCAACGAATA GTCTCACCGGAATTAGAGCACGCAGAAC 
>KnirpsE3 >Knirps2F2 
TAGAAGAGCTACATGTAGGTCACCACACG TTCAACCTACCAAATATAGGCCACCTAA 
>KnirpsE4 >Knirps2F3 
AAACCGCCATTGCACCAGTTTCTAGCAG AAACTGGAGCAGATACGACTATGACGCG 
>KnirpsE6 >Knirps2F4 
CCTAACGTGTCAAAAGTAGAACACAAGC AGATCGTCCAAATCAGGGCACCCGCCCA 
>KnirpsE7 >Knirps2F5 
CCACGGGGAAACATGCTCCAGATAAATC GACGGCTGCCGACTAGACACGACTAGCA 
>KnirpsE8 >Knirps2F6 
AACACGGAGAAAATTTAGAGCGGCGACG GGCGCGTTTGAACAGGACTATAGACCAC 
>KnirpsE10 >Knirps2F7 
GCATGGCGGTTAAACCAGGTCAATAAAA GTGCCTAGCAATGTGCCCTAGATACTAC 
>KnirpsF1 >Knirps2F8 
GTATGCCCGAAAAATAGAGCACTAGGGGA AGCCAGTGCCATTAAACCAGGTCACGCAC 
>KnirpsF3 >Knirps2F9 
AATTGCAACCGAAAGTAGAGCAGGAATA TAGAAAGCAGACAAAGTAGAGCACGATT 
>KnirpsF4 >Knirps2F10 
GCCCAGCCAGAAAAATAGAGCAGTACAC TAAATTAAGCAATCCAGGGCAAGGTGAA 
>Knirps1 >Knirps2F11 
TCCTTTCTACTTGCTCCATATAAAATCA GGCACGCTCAGTAAGTAGAGCAGACTAT 
313 
>Knirps3 >Knirps2F12 
CAGCCATTTCGATGGTCTAGTTTTAAGA ACTACTTAAAATCTAGAGCAGTTTGAAC 
>Knirps5 >Knirps2F12 
AGCCCGTCCGAATGTGGAGCACAAAACT ACTACTTAAAATCTAGAGCAGTTTGAAC 
>Knirps6  
CTGCGACGGTAAATTAGGTCACGTAATC  
 
Kr 
Promoter-Stringency UV5m-10mM 
Amino Acid Sequence KSFTCKICSRSFGYKHVLQNHERTHTGEKPFECPECHKRFTRDHHLKT
HMRLHTGEKPYHCSHCDRQFVQVANLRRHLRVHTGERPYTCEICDGK
FSDSNQLKSHMLVHNGEK 
** alternative linker:  AAADYKDDDDKFRTGSTSLYKKAGS 
Selected Sequences 
>KrE1 >KrF7 
GACAATAGGGTTCAGTCCATACTCGCAAA ATAAAAACTAGGCCGCTAACGAGTTAAC 
>KrE2 >KrF8 
CAGAACGCAACAAGTCGAAAGAACAGCC AAATCGACGGCTATCCAAAAGGGGTAGA 
>KrE3 >KrF9 
GCAAGCTACATACTACGAGAAGAGACAG CCATTCGAAAGGGTGAAGACAGAACAGA 
>KrE4 >KrF10 
AAGAACACAGAAGAGGATCAAAGGGTGT GCTCAGAGCAAATGCACCAAAGGGGTTT 
>KrE5 >KrF11 
CGCTCTATCAAAAGGATTAGTTTAAATC CAACTCTAGCAAGGGGTAAAGATACAAC 
>KrE6 >KrD1 
GCTCGCACGCCACAAGAAAGGATTCACG CAACTTAACGGGTGAACCACTAGCAAGA 
>KrE7 >KrD2 
GCAACTTACGAAAGGGTAAGCAACCTCT GTACCCCCCTCCGTGAGGTTAAAGGGTA 
>KrE8 >KrD3 
CGTACGAACGGGTTCAGCCCGTGAGCGG GACATTCAAAAGGGTAATGTGGTCATTGC 
>KrE9 >KrD4 
CAACGTCTGAAGGGGTAAACGGAGCTAG GGACCCAACCCGCCCACAGGAAGGGGTA 
>KrE10 >KrD5 
TCTACTGGCTCAAGAACGAACGAGTTAT GGCACGAACAGAAATAAAGGGGGTAAGC 
>KrE12 >KrD6 
AAACCTAACCCTTCAACCCACTCTCCAA GGAAAAGGGTGAAAAAGCTCATTCAATC 
>KrF1 >KrD7 
TGATAACACCGACATAACGAACGGGTTT CAACCCTTCCGTCCCTAACCCTACCAGA 
>KrF2 >KrD8 
GCCTTTCGCATAGTACCAAAAGGGCTAG TGCCCACCAAGACATGTAACCCCTTACCC 
>KrF3 >KrD9 
GTGGCCGCCAGGTGGCCAACGGGGTAAC GCCTCCCTCACCTTTCCGAAAAGGGGTA 
>KrF4 >KrD10 
CACGGCGCCAATACCTCATCCAGTTAAT TCAGATGCCGGTGCCGCAAAGGGTAACA 
>KrF5 >KrD11 
CAGCACCACGTACCCAATAAAGGGGTTC TACGCAAAGGGGTTGGAGAAACACTAAT 
>KrF6 >KrD12 
ACAATCATAGACCACACAACCCTTCCAG AAGTCATGAAGGGTTAAAGAACAATGAC 
 
lab 
Promoter-Stringency UV5m-10mM 
314 
Amino Acid 
Sequence 
NNSGRTNFTNKQLTELEKEFHFNRYLTRARRIEIANTLQLNETQVKIWFQ
NRRMKQKKRVKEGLIPADILTQH 
 
Selected sequences 
>LabE1 >LabE8 >LabF4 >LabF11  
TCATTAACGA TAGTTAATTA CTTCACTGAA AGTCTAATGA >LabH10 
>LabE2 >LabE9 >LabF5 >LabH3 TATCGCCCAC 
GCCTTAATTA ATACTAATTA CTGTTAATTA GCTGTTATTT >LabH11 
>LabE3 >LabE10 >LabF6 >LabH5 AATGATCGTC 
TGGCTAATTA CGTTCTTTAA AATGATCGTC GTGCGCGCAG >LabH12 
>LabE4 >LabE11 >LabF7 >LabH6 TACATAATGA 
GATAATTAAT GCTTGATGCG GTCCAGATTG GTGTTAATTA  
>LabE5 >LabF1 >LabF8 >LabH7  
CATACCCAGA AGTCATTAAG CGTTAATT GTCTTAATTA  
>LabE6 >LabF2 >LabF9 >LabH8  
AATTTAATTA CTACCAGATT GGTCATTAAT TCACGCCGAG  
>LabE7 >LabF3 >LabF10 >LabH9  
GCTAATTAAT GTAGCCAATG CAGGCACCCA CTACTAAATT  
 
nub 
Promoter-Stringency UV5m-10mM 
Amino Acid Sequence RAAGEPSPEETTDLEELEQFAKTFKQRRIKLGFTQGDVGLAMGKLYGN
DFSQTTISRFEALNLSFKNMCKLKPLLQKWLDDADRTIQATGGVFDPA
ALQATVSTPEIIGRRRKKRTSIETTIRGALEKAFLANQKPTSEEITQLAD
RLSMEKEVVRVWFCNRRQKEKRINPSLDS 
 
Selected Sequences 
>2NubG1 >2NubC4 
TGCATGGGTCAAAATCTGCATAAACAAT AATATGCAAAACAGAGCTAAACGCGGGG 
>2NubG2 >2NubC5 
ACAGGATGCAAATTAGTCGACAGCCCTA ATATTCAAATTAGAACGGACATACCCCC 
>2NubG3 >2NubC6 
ACCCTTGACGCACCCATGCAAATGAGGG GACCAACCCTCATTACCATATCCCATCC 
>2NubG4 >2NubC7 
GATTGGATCACAATTAACATATAACCCT GAGCTCCGAGTATTATGTAAATACGTCT 
>2NubG5 >2NubC8 
GTAGCTTAATTATGCAATACATAGTGC GCTTATGCAAATACAAACCCCTCTCAAG 
>2NubG6 >2NubC9 
TTACTGGTAACCAAATTCAAATCAAAAA AAAGATGCATATGCTAATTAGCACTACG 
>2NubG7 >2NubC10 
GTGAATTACAGCAAATACACCTAGCATT TCATATTTAAATGAGTTTAGGCCACAAA 
>2NubG8 >2NubC11 
GCAATGTAATGATATGCAAGGTGACCGC ATTATGCAAATACGGTTAACCGTTCTGA 
>2NubG9 >2NubC12 
TTAATGTTCAAATTTACATAATGCCTTA ATACTGACACGAATGCAAATCAGGATAC 
>2NubG10 >2NubD1 
315 
ACTCGCCACCGCATATGTAAAACAGATAC CACACCCCCAGTATGCTAATGTGAGATA 
>2NubG11 >2NubD4 
ACGATATGCAAATGAGGCTCCCCACATA ATTAGTTCATTAATATTCATCCAAATCC 
>2NubG12 >2NubD5 
GGGTGCTCATTACGTATGTAAACACTCC ACAAGCACAAATATGCAAATGATGGCTT 
>2NubH1 >2NubD6 
CCGGTTATACGTATGCAAATGCCGTAGA TGCGCGTTCAAAATATGTTAATGACTAA 
>2NubH5 >2NubD9 
AAGACATCCATTATGCAAATAATGGTTA TACATTTAATTTACATATAGTAGCATCA 
>2NubC1 >2NubD10 
TTATTTAAATATTAGAGTTTCCTAAATA GAATCTCTCAATATGCAAATTAACTTC 
>2NubC2 >2NubD11 
CGATATGCAAAATACCCGGAACCCACTA TCGAAACCCCGTATGCAAATTAGCTTTA 
 
oc 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
QRRERTTFTRAQLDVLEALFGKTRYPDIFMREEVALKINLPESRVQVWF
KNRRAKCRQQLQQQQQSNSLSSSK 
 
Selected sequences 
>OcA1 >OcA6 >OcA11 >OcB5 >OcB10 
CCACTAATC TATATAATCC GCAGATTAAC CTGGATTAAG TCGGATTAAG 
>OcA2 >OcA7 >OcB1 >OcB6 >OcB11 
AGCTTAAGCC TTTGCTAATC GTGGATTAAT AGGGATTATA CCGGATTAAC 
>OcA3 >OcA8 >OcB2 >OcB7  
CGATAATCCC CATTAATAAC TTCATAATCC GAGTTAATCC  
>OcA4 >OcA9 >OcB3 >OcB8  
GGGGCTTAAA CGCGGATTAG GAGGATTACG CTGGATTAGT  
>OcA5 >OcA10 >OcB4 >OcB9  
GAGGATTATT AGGATTAAGG AGCGATTAAG AGGATTAAT  
 
odd 
Promoter-Stringency UV5m-10mM 
Amino Acid Sequence SSRPKKQFICKYCNRQFTKSYNLLIHERTHTDERPYSCDICGKAFRRQD
HLRDHRYIHSKDKPFKCSDCGKGFCQSRTLAVHKVTHLEEGPHKCPIC
QRSFNQRANLKSHLQSHSEQS 
** alternative linker:  AAADYKDDDDKFRTGSTSLYKKAGS 
Selected Sequences 
>Odd1 >OddB1 
TCACCGTACGCACCTGGTCATCGAAGAC ACGCCTTCTACAGTAGCAAGATGTCGCA 
>Odd3 >OddB3 
ATCAAATTACAGTAGCACTAGACACGCG CACTGCAATACAGTAGCAAACCAGTTTC 
>Odd4 >OddB5 
CGCGCTCTACCGGTAGCACTAGTAATAT GCGCTGCAACCAGTAGCCGTAATGCGAC 
>OddA2 >OddB6 
GGCGCGTACTGGAAGCAACACTTGACCC CCTATTCACACAGTAGCACGAATCCTCA 
>OddA4 >OddB7 
316 
ATTTCGTAAACGGTAGCAGTTTTGCGCG GCCCCCCGCACAGTAGCAACGTTGGACA 
>OddA5 >OddB8 
AAGACTTCCCGGTAGCAGTTGCTGCGAT TGATGCCACACAGTAGCGGAAGAGATTA 
>OddA6 >OddB9 
TACAAAAAACAGTAGCAGCAACAGGAGC GCTGCACGAGTAGCCAAAGTCAGACACA 
>OddA8 >OddB10 
CATAAAAACCAGTAGCAGGTCCAAATAA GAATTTCCGCGCGCTAGACAGTCTCACG 
>OddA11 >OddB11 
CCTCATGCACAGTAGCACGCAAGGCGAG GATTTCCACCCCCATTGCAAAGACTCGA 
>OddA12 >OddB12 
TGTTAATTGAGTAGTGGCATCTTGCACC AGACGGGAACAGTAGCCACGAGAACGCA 
 
opa 
Promoter-Stringency UV5m-10mM 
Amino Acid Sequence QCLWIDPDQPGLVPPGGRKTCNKVFHSMHEIVTHLTVEHVGGPECTTH
ACFWVGCSRNGRPFKAKYKLVNHIRVHTGEKPFACPHPGCGKVFARS
ENLKIHKRTHTGEKPFKCEHEGCDRRFANSSDRKKHSHVHTSDKPYNC
RINGCDKSYTHPSSLRKHMKVHGNVDEKSPSH 
 
Selected Sequences 
>Opa2G9 >Opa2H11 
CCCCCGCCGTGAATTTCAGATAGTAGGCT GATCCAGACTCGGTCCGACCCCCCGCTG 
>Opa2G10 >OPAC2 
CCATTCACCTCCCGCAGAAGCAGCACACC CAAAAGACTGCTGTAGGCCCCCCCATGG 
>Opa2G11 >OPAC3 
AGAATCTTACCGCCCCGACCCCCCGCCA TATTGTGCGAGTCCCAGCTCCCCTACAG 
>Opa2G12 >OPAC4 
AACCTGGACCCGCTATGCCCCCCCACGA TACAACCTCACCACAGCAGGGAGCCCTC 
>Opa2H1 >OPAC5 
GCTTCCCCCCCGCTGCGCAGGAACCATT CTCTCCTCCCGATTCGCCGCCCTGCTG 
>Opa2H2 >OPAC6 
GCAACTATAAGCCAAGCCCCCCCGCTGG AGCACAACGACTAAGTTGGCACCCGCTG 
>Opa2H3 >OPAC7 
TAAACTATACCCCCTGCTGGCACCCTCA GAAGCACCCGCCCAGAGAACCCCCGGTG 
>Opa2H4 >OPAC8 
GCACCGGCCCAGTACGGACCGCCCGTTG GTGGACCAGGCTAAGACACCCCGCGGAG 
>Opa2H5 >OPAC9 
GCCTCCAGTAGCCCCTGCCCCCCCGCTG GAAGGGAAACTAGTCCACAGGTACACAA 
>Opa2H6 >OPAC12 
GCGTATACGGCGCAGAAGACCCCCCTGGGG CCCGCTACGAACCGAAGACCCCCCGCTG 
>Opa2H10  
GCCACAGAGGGGAGGGGACCCCCCACAG  
 
Optix 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
GEQKTHCFKERTRSLLREWYLQDPYPNPTKKRELAKATGLNPTQVGNW
FKNRRQRDRAAAAKNRIQHSQNSSG 
 
Selected sequences 
>11617C2 >11617D1 >OptixE2 >Optix2A2 >Optix2B2 
317 
GAACCTACTT GTAGTGCTAG GTAGCCAATG GCCCATGATA TTTCTGCGTG 
>11617C3 >11617D2 >OptixE3 >Optix2A3 >Optix2B3 
GCGCATGAGA CCGTCTAAAC CGTTCTTTAA ACATGTGATA CATTGCGATA 
>11617C4 >11617D3 >OptixE4 >Optix2A4 >Optix2B4 
TGAAGTGATA TAATGCACAC CCCTAACATG GGAGCTGATA GTGATTGATA 
>11617C5 >11617D5 >OptixE5 >Optix2A5 >Optix2B5 
CAACGTATT CTTTTCATCT GAACCTACTT CAATCTGATA CCAAGTGATA 
>11617C6 >11617D7 >OptixE6 >Optix2A6 >Optix2B6 
CAATGTGATA AGAAACTATG ATCTTAATTAC GTAGCTGATA ATAAGTGATA 
>11617C7 >11617D8 >OptixE7 >Optix2A7 >Optix2B7 
ACCAGTGATA ATAAATGATA GTGCGTACTG TACCCACGCC CGTTATGATA 
>11617C8 >11617D9 >OptixE8 >Optix2A9 >Optix2B8 
GATTGCGATA GTTAGTGATA GGAAGTGATA GAAGTGATAG CTTTCTGATA 
>11617C9 >11617D10 >OptixE9 >Optix2A10 >Optix2B9 
CATCGCTATG ATAAGTGATA ATCTTATTAC AACCGCGATA ATTCAAACA 
>11617C10 >11617D11 >OptixE10 >Optix2A11  
ACGTATTGGT CGTAGTGATA CTACTAAATT GTGATTGATA  
>11617C11 >11617D12 >OptixE11 >Optix2A12  
CGTAGTGATA AGAGATGATA ATCAGTCCTT TCCCTTGATA  
>11617C12 >OptixE1 >OptixE12 >Optix2B1  
ATCTTATTAC TCTTCCATTA CTACCAGATC ATTCGCGATA  
 
pb 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
PRRLRTAYTNTQLLELEKEFHFNKYLCRPRRIEIAASLDLTERQVKVWFQ
NRRMKHKRQTLSKTDDEDNKDS 
 
Selected sequences 
>Pb1 >pBG3 >pBG8 >pBH3 >pBH8 
GGTCATTAGA CTCATTAAA TGACTAATGA GGTAATTATA AGGTTAATGA 
>Pb2 >pBG4 >pBG9 >pBH4 >pBH9 
GGTAATTAAC GGTAATTATA GCGTTAATGA GATAATTATC TCATTAATGA 
>Pb3 >pBG5 >pBG11 >pBH5 >pBH10 
TGTAATTAAA CTGTTAATTA GCTCATTAAG CCAGCAAGAT CCTCATTAGA 
>Pb4 >pBG6 >pBG12 >pBH6 >pBH11 
GGTCATTAAC CGTAATTAAT GCTAATTAAT TTGCTAATGA GGTAATTAGA 
>pBG2 >pBG7 >pBH1 >pBH7 >pBH12 
ATCCTAATTA TACATAATGA TGTAATTAAA GCTAATTAAG TTGCTAATTA 
 
prd 
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Promoter-Stringency UV5m-10mM 
Amino Acid Sequence NSGQGRVNQLGGVFINGRPLPNNIRLKIVEMAADGIRPCVISRQLRVSH
GCVSKILNRYQETGSIRPGVIGGSKPRIATPEIENRIEEYKRSSPGMFSW
EIREKLIREGVCDRSTAPSVSAISRLVRGRDAPLDNDMSSASGSPAGDG
TKASSSCGSDVSGGHHNNGKPSDEDISDCESEPGIALKRKQRRCRTTFS
ASQLDELERAFERTQYPDIYTREELAQRTNLTEARIQVWFSNRRARLR
KQHTSVSGGAPGGAAASVSH 
 
Selected Sequences 
>1prd2A12 >21PrdD6 
GACTCGAATAACAATTGGTCACGCTTCG AGAGTAAAACCCTTGCACCCGGAGATC 
>2PrdD5 >22PrdD7 
ACTACGTAAACAATACAGTCACGCCTGT TTTCACAACTAATTAACCACGCCACCAA 
>3prd2A8 >23PrdD8 
TACAAGGACTAAGCCGACACGGTAGGGA CGAAACCTATTAGCGTCACGCCCCCCAC 
>5PrdD2 >24PrdD9 
GCGCCCACGAGGCAGTCCGACACGCTCA AAACCGAGTTCCGATCCGTCACGGCTTT 
>6prd8 >25prd2A2 
CACGACGTCACGGTAGGAAATCCCGTCC TCACCGCGGAGGTCTCGTTCCGGTCTGT 
>7prd2A3 >26prd2A5 
GATTTCGTCACGCTCCGTAACGATCCTG ATTAGGGATTAATTCCGTTACGGCCACC 
>8prd2A7 >27prd2A10 
TCTGCTCTGAACCACACGGTCACGGTGA ATTAGTCACGCTCTCAATTAACTCATGC 
>9prd13 >29prd6 
GTTAATTACCGTGACGCGCTTGAGAGAT CTAAAAAGCAATCCTCCGACACGCCCCA 
>10PrdD4 >30prd7 
CCCGGACCCGCTAAACGTTTCACGGTTC CAATTAGGCACGGGAGGCTGAGACATAA 
>11prd17 >31prd9 
CACCTGACAGCGTCCCGTCACGCTGCCCC ATAATTAGAAAACCAGATGAAACCGTGA 
>12prd2 >32prd10 
CTGATCCTCAACCCCTCACGGTGAGCA TGCGAGCACATAATACTTTCACGCATGA 
>13prd15 >33prd11 
GGTCTGGAATATCGGCATTCACGCTTGA CAAAGTGTCTTCATTGCCGGTAAGCATA 
>14prd12 >34prd14 
ACCCCCGCAAGTATTGACAGTTGCCATG GGCGCGTTTGAACAGGACTATAGACCAC 
>15prd16 >35prd19 
GTACCTGACCCGCATTTCACGGTGGGCC GCAGCCCAACCCCCTCCGTCACGCCACC 
>16PrdD3 >36prd20 
ACACATCACAACCAACGTTACGCTCCCC GAGTCTCACATACATCCGTCACGCCACC 
>17prd2A4 >37prd21 
CACGTAAAAAGCCAGACACCGTGACGCA CACACTAACACGGATTAGTCACACAGTC 
>18prd24 >38prd22 
CTAAAAACCCAATTAGACTCGGTACCAG AATTAGTCACACCGGTCCAAAAGTAATG 
>19PrdD11 >39prd23 
TCACGTTAATTAATGCGGTCACGCATGG ACCGCGCGCGTGACATTAGTCACGCAACA 
>20PrdD12  
TTACAGGTAACCCATTAGTCACGCATCA  
 
Scr 
Promoter-Stringency UV5m-10mM 
Amino Acid TKRQRTSYTRYQTLELEKEFHFNRYLTRRRRIEIAHALCLTERQIKIWFQN
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Sequence RRMKWKKEHKMASMNIVPYHMG 
 
Selected sequences 
>ScrE04 >ScrF01 >ScrF11 >ScrG7 >ScrH3 
CCTTAATGA GGAAAGTGGA TCATTAATGA CTGTTAATTA ACGTTAATGA 
>ScrE05 >ScrF02 >ScrF12 >ScrG8 >ScrH4 
TACATAATGA CGATAATGA TCGTTAATGA CACTAATTA CTATTAATGA 
>ScrE06 >ScrF04 >ScrG1 >ScrG9 >ScrH7 
TTGGGTACAA GACTTAATGA GCAATTAAAG CCGTTAATTA TTGGGTACAA 
>ScrE08 >ScrF06 >ScrG2 >ScrG10 >ScrH9 
CTACTAATTA ACGCTAATGA GAATTAATGA GTCCAGATTG GTACTAATGA 
>ScrE09 >ScrF07 >ScrG3 >ScrG12 >ScrH10 
ATAGGTCCGT TACACACAGC GGTTTAATGA GCGCTAATGA TATTTAATGA 
>ScrE11 >ScrF09 >ScrG5 >ScrH1 >ScrH11 
AGTGCTTCAC GGAAATACGC CCACTAATTA TGTTAATGA TCACTAATGA 
>ScrE12 >ScrF10 >ScrG6 >ScrH2  
TCCTTAATGA CTACTAACTT GCAATTAACG GACATAATGA  
 
Slp1 
Promoter-Stringency UV5-10mM 
Amino Acid Sequence DKLDVEFDDELEDQLDEDQESEDGNPSKKQKMTAGSDTKKPPYSYNA
LIMMAIQDSPEQRLTLNGIYQYLINRFPYFKANKRGWQNSIRHNLSLN
KCFTKIPRSYDDPGKGNYWILDPSAEEVFIGETTGKLRRKNPGASRTRL
AAYRQAIFSPMMAASPYGAPASSYGYPA 
 
Selected Sequences 
>5SlpE1 >5SlpG1 
GCTCACTACAATTTGTGTTTGACCAAGA GAACGCCTCAACGTAAATACATGACAGC 
>5SlpE2 >5SlpG2CG 
CATAAAAGTACCACAACAAAGCGCATT GGTGCATGCATATCCCCGGGTATAAACAC
G 
>5SlpE3 >5SlpG3 
GGGAATCTACCAAAACATGAACCCAAAC CAGGAAAAGACAACAACAACACTACCAT 
>5SlpE4 >5SlpG4 
AATTAAAAAACAAAAACAATCAAAAAAC CCATTGCGCCATTTATTTACAAAATCC 
>5SlpE5 >5SlpG5 
GCCGTCAGAGCATAAACATGGCCACTGT ATAAAGCCCGCAATGAAAACAATACGAA 
>5SlpE6 >5SlpG6 
CTCCCATATCAGATGTTGGAACACAAAA CCCCCCAAGAGTAAACAGACTTGGGAGG 
>5SlpE7 >5SlpG7 
CCCTCATCTAACGGCTGATACGGTGAAA GCGTAGAGCACCAAAACATACCCGCGTT 
>5SlpE8 >5SlpG8 
CGCACTGTTTATCTACCGCAGACTAACC ATGGCGTGGAGTCCAAACACTGATCTGA 
>5SlpE10 >5SlpG9 
AGCCACCCGATGGTAAACAATGAAAATT AATAAGACCTGTGTAAATACAATGAAGA 
>5SlpE11 >5SlpG10 
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ACAGAATAATGTAAACACTCGGCAAACC CCAACGCGAATGTAAACACCTGATTAAC 
>5SlpE12CG >5SlpG11 
AAACAATCCGCATAGTTTGTGTAAACACG GATCTCCCCGCCGTAAACATTACTCAAG 
>5SlpF1 >5SlpG12 
TTACCCATTAACAAAAACAAAGGACAAG ACACCAGACAGGTAAACAAGAGACAGAT 
>5SlpF2 >5SlpH2 
TGAGGCGCCTGTGTAAACAGACACCATT AGCCTGGACCCGCAAACAAAAGGACTAA 
>5SlpF3 >5SlpH3 
GCAGCCAAACTGTAAACATACGTCAATA GACACTTGAACATAAACACCCCCATATA 
>5SlpF4 >5SlpH4 
GATGTTTACATAACCCAAACAAGACGGT ATACGCCCTAACCTAAACACAGGGCTAG 
>5SlpF5 >5SlpH5 
GCCACCTAGATATAAACAAATAACCCAA GCCTGACAATGTAAACAATACATAAGTG 
>5SlpF6 >5SlpH6 
ACCAGTAGGACTGGATGTTTACACATCG TACACTGAGGCGGTGTTTACGCAAGGCG 
>5SlpF7 >5SlpH7 
AAATAACTCCTTGTAAACAATCCGAGCA AACTAGTCCCGCTTGTTTATCCACCTTA 
>5SlpF9 >5SlpH8 
CGTACAGAGTGTGTTTGTGTAACGAAAC TTGCCGTACTATGTAAACAAGCAAACTC 
>5SlpF10 >5SlpH9 
GCGTGTGCCGGAAATGTTTTGCCTGAGTG CGTGCACCCAACCAAAACAATCCTAACA 
>5SlpF11 >5SlpH11 
TCAAGGACCCCATTGTTTACCTTAGATG GCACAGCGCAGTATAAACACAATTACCT 
 
tll 
Promoter-Stringency UV5-10mM 
Amino Acid Sequence SSRILYHVPCKVCRDHSSGKHYGIYACDGCAGFFKRSIRRSRQYVCKS
QKQGLCVVDKTHRNQCRACRLRKCFEVGMNKDAVQHERGPRNSTLR
RHMAMYKDAMMGAGEMPQIPAEILMNTAALTGFPGVPMPMPGLPQR
AGHHPAHMAAFQPPPSAAAVLDLSVPRVPHHPVHQGHHGFFSPTAAY
MNALATRALPPTPPLMAAEHIKETAAEHLFKN 
 
Selected Sequences 
>5TllA1 >5TllB11 
ACACACAACGCCAAACACACTCCCACCC GCTAGGACATTTCTAAAGTCAACCCTAA 
>5TllA2 >5TllE1 
ACGGCGACCTGATCTACCATCAAACACT CTTACGCTCCCAGAAAAGTCAAAACCAC 
>5TllA3 >5TllE2 
CAAACCAGCACGCCTTAAAGTCAACGAT GTCATCCAAACCCCAAAGTCAAAATGTA 
>5TllA4 >5TllE3 
GCGCCAGGCTCCGCTAAAGTCAGGTTAT GCGGACGAAGGTTTGCAAAGTCAATTAA 
>5TllA6 >5TllE4 
ACATCCACCGGGATGAAAGTCAAAACACT AGGAGCACTCTCATGAAGTCAAATAAAC 
>5TllA8 >5TllE5 
TATCCCAGCCGAGAGAAAGTCAAAATCA CTACCCCGAAGCTAAAAGTCAAAGCAAC 
>5TllA9 >5TllE6 
CCCCAGCCAAGGTGTAAAGTCAACTTGA GAAGCAACCAGCCAAAAGTCAAACCTTC 
>5TllA10 >5TllE8 
AACAGCGCCCGATTAAAAGTCAACCGTT CAACGCTACAAGCAGAAAGTCAACCTAG 
>5TllA11 >5TllE9 
CGGAGTTTGAGGACGGAAGGCCAAATAA TCGGGGCACAAGTAAAAGTCAAACCACG 
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>5TllA12 >5TllF1 
ACACTGACCGGGCACGAAGTCAACCTAA TCCATTCACATAAATAAAAGTCAACTAG 
>5TllB2 >5TllF2 
ATGAGTGCATGGCAAAAGTCAAACAAGG TCGATCACACAACTAAAAGTCAATAACC 
>5TllB5 >5TllF5 
GAGCACCAGTGACAAGAAGTCAACCAAA ACTCTTGGGACCGTAAAAGTCAACATTA 
>5TllB6 >5TllF7 
AAACACTGGTAAAGAAAAGTCAACAAAC AGACCTACCCAAATAGAAGTCAAATTAG 
>5TllB7 >5TllF8 
GGAAAGTGGCCGCTAAAAGTCAAACCGC CTGCCCTTATGGGTAAAAGTCAAAGTCA 
>5TllB8 >5TllF9 
CGACGCCCGAGCAAAAAGTCAATCCAAG ATTAGATACCAGGAAAAGTCATATCTAA 
>5TllB9 >5TllF10 
CTCTCGACCTGGCAAAAGTCAAACCCAG CTCCACAGGGCCGAAAAGTCAATAACTA 
>5TllB10 >5TllF11 
AATGCTCAGCACTAAAAGTCAAGTCTCA ATCCCCAACTTACTAAAAGTCAAAACAC 
 
ttk 
Promoter-Stringency UV5-10mM 
Amino Acid Sequence DYCTKEGEHTYRCKVCSRVYTHISNFCRHYVTSHKRNVKVYPCPFCF
KEFTRKDNMTAHVKIIHKIE 
 
Selected Sequences 
>5TtkG1 >5TtkH1 
ACGCACTGTAAACAGGATAAGCAAAAAC ACATACAAGGCAAGGATAACTATTCCAC 
>5TtkG2 >5TtkH2 
AGAAGGAAAGACCAAGGATAAGCCTCTC CAGGATAATGGGAAACTAGACATTAATT 
>5TtkG3 >5TtkH3 
CAAAGGATAATAAACTCTGCCCCAAGTC GTATCAGGTCTAGGATAATCAGAGCAGT 
>5TtkG4 >5TtkH4 
CAGTGAGCCTTCGAGGACAATCCTATCC ATCCCAACAACAGGACAATGGAAACTCG 
>5TtkG5 >5TtkH5 
GTGCCTCGGGCAGGATAAGCGCACGTGA CCTCGCTACACAGGATAATTTGTAAATT 
>5TtkG7 >5TtkH6 
CGACCGAGCCGAGGATAATCTTTCATCT TTACTCTACTAAGAGGATAATCAACGGC 
>5TtkG8 >5TtkH7 
CAGAACGCACCGCAAGGATTACAGAACT TAGTGTGGCAACCAGGACAATATACGCA 
>5TtkG9 >5TtkH8 
ATGACTATAAGAAAGGACAAACTAGTTT GGGGCACGACGCCAGGATAATGAGATCT 
>5TtkG10 >5TtkH9 
AAGGATAACACATATAATTAAGACGGGC CAAATCAAACGAAGGATAATCCAAAAGA 
>5TtkG11 >5TtkH10 
GTATCAGCCACCTAAAGGATAACCCATCC GGTATATCCACCAGGATAATGCAAAGTT 
>5TtkG12 >5TtkH11 
AGCGGAGCCACAAAAGGACAACTGCAATG GACACATCCGCCCAAGGATAATCAGACC 
 
 
Ubx 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
RRRGRQTYTRYQTLELEKEFHTNHYLTRRRRIEMAHALCLTERQIKIWF
QNRRMKLKKEIQAIKELNEQEKQA 
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Selected sequences 
>UbxC02 >UbxC07 >UbxD02 >UbxD08  
TAATTAATTA TGCAATAAAA GCGTTAATTA TCCTTAATGA  
>UbxC03 >UbxC08 >UbxD04 >UbxD09  
AATTTTATTA GGCAATTAAG GCCTTAATTA GCCTTAATTA  
>UbxC04 >UbxC11 >UbxD05 >UbxD10  
GCTTTAATTA GTATTAATGA GACAATTAAA CTTTTTATGA  
>UbxC05 >UbxC12 >UbxD06 >UbxD11  
GCTTTAATTA AATTTAATGG CCGTTAATTA GGTAATTAAC  
>UbxC06 >UbxD01 >UbxD07 >UbxD12  
CTATTAATTA TCTTAATGA GCCCATTAAA TGCAATTAAA  
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Table A.2 
Amino acid sequence, selection promoter strength/stringency and the binding 
sites recovered for each homeodomain assayed. 
 
 
Abd-A 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
RRRGRQTYTRFQTLELEKEFHFNHYLTRRRRIEIAHALCLTERQIKIWFQN
RRMKLKKELRAVKEINEQAR 
 
Selected sequences 
>AbdAG04 >AbdAG09 >AbdAH02 >AbdAH07 >AbdAH12 
TTTTTAATTA TACCAAACCC TACGTAACTT CGTTCTTTAA ATCTTAATTAC 
>AbdAG05 >AbdAG10 >AbdAH03 >AbdAH08 >AbdAG02 
CTACCATTTT CACTAATTA GGTCATTAAA GATTTAATTA GGTAATTAAA 
>AbdAG06 >AbdAG11 >AbdAH04 >AbdAH09 >AbdAG03 
TTAATTAC CATAATTA TTTTTTATGA GCGCTAATGA TCGTTAATGA 
>AbdAG07 >AbdAG12 >AbdAH05 >AbdAH10  
TTCTTTATTA GTTTTAATTA CTACTAATTC TGTTTAATGA  
>AbdAG08 >AbdAH01 >AbdAH06 >AbdAH11  
GGACCCACAT GGTTGCGGCC TGCAATTAAA GGCAATTAAG  
 
Abd-B 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
VRKKRKPYSKFQTLELEKEFLFNAYVSKQKRWELARNLQLTERQVKIWF
QNRRMKNKKNSQRQANQQNNNN 
 
Selected sequences 
>abdb2 >abdb7 >abdb13 >abdb19 >abdb24 
GGGTTTATAG GGTTTACAAC TTTTTATAAC GCTTTTATTA TGTTTTATGA 
>abdb3 >abdb8 >abdb14 >abdb20  
GTTTTATTGT CGTTTAATGT TTATTAATTA ACTTTTACGA  
>abdb4 >abdb10 >abdb15 >abdb21  
TTTTTTATGG TGATTTATGT GTTTTATGA TGATTTATTA  
>abdb5 >abdb11 >abdb17 >abdb22  
TGATTAATGG CATATTATGA AGTTTTATGG TGATTTATTA  
>abdb6 >abdb12 >abdb18 >abdb23  
CGCTTTATGT GCATTTATTA TCTTTAACGA TCTTTAATTA  
 
Achi 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
LRKRRGNLPKTSVKILKRWLYEHRYNAYPSDAEKFTLSQEANLTVLQVC
NWFINARRRILPEMIRREGNDPLHFT 
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Selected sequences 
>AchiG1 >AchiG8 >AchiH5 >achi2F3 >achi2F11 
TGTCAAG GCCTGTCATA AATGGATATT CTGTCAATC TGCTGTCAAA 
>AchiG2 >AchiG9 >AchiH6 >achi2F4 >achi2F12 
AATGTGACA GTTGTCAAAA GCTGTCAAAA AGCTGTCAAA CCTGTCAAAC 
>AchiG3 >AchiG10 >AchiH8 >achi2F5  
AGCTGTCATG AGATCTGACA CTCTTTAGCC AAACTAAGAT  
>AchiG4 >AchiH1 >AchiH10 >achi2F6  
TTATCTGACA ATATCAAATG ATTCCGCTCT TAAGATGACA  
>AchiG5 >AchiH2 >AchiH11 >achi2F8  
AGCATGACAG AGCTGTCAGA GCTGTCAAAG CCTGTCAAA  
>AchiG6 >AchiH3 >achi2F1 >achi2F9  
TGTTTGACAT GAAATGACA CGAATGACAA GTCCAGATTG  
>AchiG7 >AchiH4 >achi2F2 >achi2F10  
AAGGCAGAGA ATCTGTCAGT TGTTGTCAAA GTCCAGATTG  
 
Al 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
QRRYRTTFTSFQLEELEKAFSRTHYPDVFTREELAMKIGLTEARIQVWFQ
NRRAKWRKQEKVGPQSHPYN 
 
Selected sequences 
>AlE2 >AlE9 >AlF2 >AlF7 >AlF12 
GCTAATTAAT GATTAATTAA GACTAATTAA TAATTAATT GTTAATTAAA 
>AlE5 >AlE10 >AlF3 >AlF8  
TTTTAATTAA TTCTAATTAA CGCTAATTGA CACTAATTAC  
>AlE6 >AlE11 >AlF4 >AlF9  
TGCTAATTAA TATAATTAA TCATAATTAA GTCTAATTAA  
>AlE7 >AlE12 >AlF5 >AlF10  
GCATAATTAA TGCTAATTAA CGCTAATTGG GGCTAATTAA  
>AlE8 >AlF1 >AlF6 >AlF11  
GACTAATTAA ACACGCTAAT ACCTAATTAA CCCTAATTGA  
 
Antp 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
RKRGRQTYTRYQTLELEKEFHFNRYLTRRRRIEIAHALCLTERQIKIWFQ
NRRMKWKKENKTKGEPGSGGEGD 
 
Selected sequences 
>AntpA02 >AntpA07 >AntpB01 >AntpB08  
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GCCTTAATTA GGTTTAATGA TTCATAATTA GGCAATTAAG  
>AntpA03 >AntpA08 >AntpB02 >AntpB09  
AATTTAATTA GGC TTAATGA GTGTTAATTA CGTTTAATTA  
>AntpA04 >AntpA10 >AntpB04 >AntpB11  
AGCTTAATGA CTACTAATTA GATTTAATTA TTTTTAATGA  
>AntpA05 >AntpA11 >AntpB06 >AntpB12  
TTGTTAATGA CCCTTAATGG TGTTTAATGA CCTTTAATGA  
>AntpA06 >AntpA12 >AntpB07   
GGTAATTAAA TAGCACTTTT TTTTTAATGA   
 
Ap 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
TKRMRTSFKHHQLRTMKSYFAINHNPDAKDLKQLSQKTGLPKRVLQVW
FQNARAKWRRMMMKQDGSGLLEKGE 
 
Selected sequences 
>ApA2 >ApA7 >ApB2 >ApB7  
ATCATTAACC GTGCTAATTG TGCCAATATA TCGTTAATGA  
>ApA3 >ApA8 >ApB3 >ApB8  
AGACTAATTG GCTAATTAAT TCCTTAATGA TCGCTAATTA  
>ApA4 >ApA9 >ApB4 >ApB9  
AGGTTAATTA CCAATTATGA CTAATTAAGT CGACTAATTA  
>ApA5 >ApA10 >ApB5 >ApB10  
TAAATAATGA CTAATTAAGG TCTCATTAAA CGCTAATGA  
>ApA6 >ApA11 >ApB6 >ApB11  
CTAATTAGCG ACAAATTAAG ACTAATTAAT CTAATTAGCA  
 
Ara 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
LAARRKNATRESTATLKAWLNEHKKNPYPTKGEKIMLAIITKMTLTQVS
TWFANARRRLKKENKMTWEPKNRTDDD 
 
Selected sequences 
>AraG1 >AraG11 >AraH10 >Ara2G7 >Ara2H4 
GGGTATTACA GTGATATACA TGCAAAAACA GGTAATAACA TCAAATTACA 
>AraG2 >AraG12 >AraH11 >Ara2G8 >Ara2H6 
TGTACTTACA GTTTAGAACA AGCTTTTACA GTGTAGAACA TGGAAAAACA 
>AraG4 >AraH3 >Ara2G1 >Ara2G10 >Ara2H8 
GCAGTTTACA TCGAATAACA ACCCCAAACA CCTGAAAACA TAACATTACA 
>AraG5 >AraH5 >Ara2G2 >Ara2G11 >Ara2H9 
CGTAATTACA AAACATAACA GCAATTAACA GAAAGAACA CTACAAAACA 
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>AraG6 >AraH6 >Ara2G3 >Ara2G12 >Ara2H10 
TCTGTTGAGT CATGTAAACA GCAAGTTACA AGAATTAACA AGAGAAAACA 
>AraG7 >AraH7 >Ara2G4 >Ara2H1 >Ara2H11 
CAGGAAAACA TGTTCAGCTA TAAGAGAACA GGAAAAAACA ATGAATTACA 
>AraG8 >AraH8 >Ara2G5 >Ara2H2  
TTGTATTACA TTCAAAAACA CATATAAACA TCCCAAAACA  
>AraG9 >AraH9 >Ara2G6 >Ara2H3  
GTCCAGATTG AAACATAACA GGGAAAAACA TGAAGCCTTG  
 
Awh 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KTKRVRTTFTEEQLQVLQANFQIDSNPDGQDLERIASVTGLSKRVTQVW
FQNSRARQKKHIHAGKNKIREPEGS 
 
Selected sequences 
>AwhC1 >AwhC10 >AwhD8 >Awh2A9 >Awh2B6 
GTAATCAAAT TTCATTAATA CAATTAGCG TCTAATTAAA ATCCTAATTA 
>AwhC2 >AwhC11 >AwhD9 >Awh2A10 >Awh2B7 
CCAATCAGCC TCCTGACAGT TAGTTAATTA CCAATTAGCA TCTAATTAAA 
>AwhC3 >AwhC12 >AwhD10 >Awh2A11 >Awh2B8 
GTTCATTAAA CACTTGATTA GTACTAATGA CATAATTA CTATTAATTA 
>AwhC4 >AwhD1 >AwhD11 >Awh2A12 >Awh2B9 
CTGATTACGC CTCATTAGCG TACCTAATGA TTAATTAGGC ACCCTAATGA 
>AwhC5 >AwhD2 >Awh2A1 >Awh2B1 >Awh2B10 
GATTTGATTA TGTCTAATTA GCCTTAATTT TAGTTAATTA TAGTTAATGA 
>AwhC6 >AwhD3 >Awh2A2 >Awh2B2 >Awh2B11 
TCAGCTAATT GTAATTAGGT CTAATCAAAT AAGATAATTA CCTCTAATTG 
>AwhC7 >AwhD5 >Awh2A3 >Awh2B3  
CTACTTAATT TCACTAATTA TTAATTATC ATAATTAAG  
>AwhC8 >AwhD6 >Awh2A4 >Awh2B4  
CTAATTACTC GTAATTAAAG CTTTTGATTA TAACTAATTA  
>AwhC9 >AwhD7 >Awh2A8 >Awh2B5  
ATAATTATGG TTTTTAATTA ACCTAAATGA CCACTAATTT  
 
Bap 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KKRSRAAFSHAQVFELERRFAQQRYLSGPERSEMAKSLRLTETQVKIWF
QNRRYKTKRKQIQQHEAALLGASK 
 
Selected sequences 
>BapA2 >BapA11 >BapB8 >Bap2C5 >Bap2D3 
327 
GCTTAAGTGG ATCTTATTAC GGACCCACAT GACTTAAGTG GGTTAAGTGG 
>BapA3 >BapA12 >BapB9 >Bap2C6 >Bap2D4 
TCTTAAGTGG AGTTAAGTGG TGTTAAGTGG GCTTAAGTGC CTTTATAACT 
>BapA4 >BapB1 >BapB10 >Bap2C7 >Bap2D5 
TAACGCTGCA GTTTAAGTGG TCTTCCATTA ACTTAAGAAC CTTTATAACT 
>BapA5 >BapB3 >BapB11 >Bap2C8 >Bap2D6 
ATCAGTCCTT ACTTATCTGA CGTTAAGTGG TCTTAAGTAC ACTTAACGT 
>BapA6 >BapB4 >Bap2C1 >Bap2C9 >Bap2D9 
AGTTCTTAAG TCACGCCGAG ACACTTAAAG ATTTAAGTGA TTAAGTACC 
>BapA7 >BapB5 >Bap2C2 >Bap2C10 >Bap2D10 
ATCTTATTAC TGTTAAGTGG ACTTAAGTAC TATTAAGTAC ATTTAAGTGA 
>BapA9 >BapB6 >Bap2C3 >Bap2C12 >Bap2D11 
ACTTATCTGA TCTTAAGTGG TTTTAAGTGT TTTTAAGTGA ACTTAAGTAC 
>BapA10 >BapB7 >Bap2C4 >Bap2D2  
CATTAATAAC ACTTAAGTAC CTGTAAGTGT CTTTAAGTAC  
 
Bcd 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
PRRTRTTFTSSQIAELEQHFLQGRYLTAPRLADLSAKLALGTAQVKIWFK
NRRRRHKIQSDQHKDQSYEG 
 
Selected sequences 
>bcd1 >bcd6 >bcd11 >bcd17 >bcd23 
TGTTAATCCG TCTTAATCCC CGGGTAATCC GGTTATCCG GGTTAATCCG 
>bcd2 >bcd7 >bcd13 >bcd18 >bcd24 
ATGGATTAGA GCTTAATCCG TGTTAATCC TGTTAATCCC ATGGATTAGA 
>bcd3 >bcd8 >bcd14 >bcd20  
CGTTAATCTC GGGTTAATCC TGGGATTATA CGCTTAATCC  
>bcd4 >bcd9 >bcd15 >bcd21  
GGTTTAATCC GAGATAATCC GCGTAATCCA TTACTAATCC  
>bcd5 >bcd10 >bcd16 >bcd22  
TCTATAATCC AGCTTATCC GGCTTAAGCC GTCCTAATCC  
 
BH1 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
QRKARTAFTDHQLQTLEKSFERQKYLSVQERQELAHKLDLSDCQVKTW
YQNRRTKWKRQTAVGLELLAEAGN 
 
Selected sequences 
>B1HG1 >B1HG10 >B1HH8 >BH12E8 >BH12F5 
GCAAACCCCT TGTTAAACGG GCTGTTATTT AGCAATTATG ATTGGCCACC 
328 
>B1HG2 >B1HG11 >B1HH9 >BH12E9 >BH12F6 
TCGTTTCCCT TCACGCCGAG GGCAATTAAG TGTTAAACGG AACATTTAAT 
>B1HG3 >B1HH1 >B1HH10 >BH12E10 >BH12F8 
TCACGCCGAG CCCTAACATG CCCGTTCGTG TCTTAAACGG TTGGGTACAA 
>B1HG4 >B1HH2 >BH12E2 >BH12E11 >BH12F9 
GCCTAAGAGA CATTGTACTA TTCTAAACGG TCTTAAACGG GTCGGTACCC 
>B1HG5 >B1HH3 >BH12E3 >BH12E12 >BH12F10 
GGTAAAGCAT GGTAAAGCAT GCCAATTAAC AGATAATTGC CTACCAGATT 
>B1HG6 >B1HH4 >BH12E4 >BH12F1 >BH12F11 
CGCTAAAGTG TCTGTTGAGT GGCTAATTGA GGATAATTGA TTCTAATTGA 
>B1HG7 >B1HH5 >BH12E5 >BH12F2  
ATCTTATTAC CGTTAATT AGTTAATAGG ACTTAAACGT  
>B1HG8 >B1HH6 >BH12E6 >BH12F3  
GCTAATTGA AGTTGACCAC AACAATTAAC GATAATTAA  
>B1HG9 >B1HH7 >BH12E7 >BH12F4  
GTTAATTGA TCACGCCGAG ATCAATTAAC CTTTAAACGG  
 
BH2 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KQRKARTAFTDHQLQTLEKSFERQKYLSVQDRMELANKLELSDCQVKT
WYQNRRTKWKRQTAVGLELLAEAGN 
 
Selected sequences 
>BH2E1 >BH2E7 >BH2E12 >BH2F5 >BH2F10 
GCCGTTTATC AGCCATTAAG GCCCATTAGA ACCAATTATC ATCAATTAAG 
>BH2E2 >BH2E8 >BH2F1 >BH2F6 >BH2F11 
TGCAATTAAA GCTAATTGA ACCAATTATC AGCAATTATA ACCAATTAAG 
>BH2E4 >BH2E9 >BH2F2 >BH2F7  
GACTATTAAG ACCTTTTAAG GTCATTTAAG ATCAATTAAC  
>BH2E5 >BH2E10 >BH2F3 >BH2F8  
GCCATTTAGT ACCAATTAAT ACCAATTACA AGCAATTAAC  
>BH2E6 >BH2E11 >BH2F4 >BH2F9  
ACCTATTAAA ATCATTTATC TCCAATTATG ATCAATTAAC  
 
Bsh 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
RRRKARTVFSDPQLSGLEKRFEGQRYLSTPERVELATALGLSETQVKTW
FQNRRMKHKKQLRRRDNANEP 
 
Selected sequences 
>BshE1 >BshE7 >BshE12 >BshF7  
329 
ACCCATTAGG CTCTTAACGA GTCGATTAAG GCTAATTAAT  
>BshE2 >BshE8 >BshF1 >BshF8  
GTCGATTAAA GATCATTAAG GCTCATTAGA GCTAATTAAT  
>BshE3 >BshE9 >BshF3 >BshF9  
CGTCATTAAG TTTTTAATTA CTACTAATAT GCTCGTTAAG  
>BshE4 >BshE10 >BshF4 >BshF10  
ACCAATTACA AAGATAATGA GCTCATTAGA GCCAATTATA  
>BshE6 >BshE11 >BshF6 >BshF11  
TGCAATTAAT GTCGATTAAA GGCAATTAAC ACCAATTACA  
 
Btn 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
NRKERTAFSKTQLKQLEAEFCYSNYLTRLRRYEIAVALELTERQVKVWF
QNRRMKCKRIKLEEQQGSSAKT 
 
Selected sequences 
>BtnE1 >BtnE6 >BtnE11 >BtnF4 >BtnF9 
TGCCATTAAA GCTGTAATTA GATAATTAA AATATAATGA TCCTTAATGA 
>BtnE2 >BtnE7 >BtnE12 >BtnF5 >BtnF10 
TCAGTAATGA GGTCATTACC CTCGTAATGA GCTAATTATC ACGTTAATGA 
>BtnE3 >BtnE8 >BtnF1 >BtnF6 >BtnF11 
CACTTGATTA GGTCGTTAAG TATCATTATA CGTAATTAAT GAGTTAATGA 
>BtnE4 >BtnE9 >BtnF2 >BtnF7  
GTACATTAAT AGCCTAATTA CTTAATTAAC AGTCATTAAG  
>BtnE5 >BtnE10 >BtnF3 >BtnF8  
CCCCATTAAG AGCAATTATA GGTCATTAAT GACTTAATGA  
 
C15 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KRKKPRTSFTRIQVAELEKRFHKQKYLASAERAALARGLKMTDAQVKT
WFQNRRTKWRRQTAEEREAERQ 
 
Selected sequences 
>C15A1 >C15A6 >C15A11 >C15B6 >C15B11 
AATTTAAAGA GTTTAACA ATCATTTAAG ATCTTATTAC GGCAATTAAC 
>C15A2 >C15A7 >C15A12 >C15B7  
GCCAATTAAC TGTTTAACGA AATTTAATTG TCACGCCGAG  
>C15A3 >C15A8 >C15B1 >C15B8  
CCCCATTAAC ACGTTAACGA GCCAATTAAC GCTAATTAAT  
>C15A4 >C15A9 >C15B2 >C15B9  
GTCGTTTAAG ATCTTAATTG ACCCATTATT CCTATTTAAA  
330 
>C15A5 >C15A10 >C15B4 >C15B10  
GCTCGTTAAG TCGTTAATGA GCTAATTAAA TCACAATCAC  
 
Cad 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KDKYRVVYTDFQRLELEKEYCTSRYITIRRKSELAQTLSLSERQVKIWFQ
NRRAKERKQNKKGSDPNVMGVG 
 
Selected sequences 
>CadE1 >CadE11 >CadF8 >Cad2E7 >Cad2F4 
CCACAAATTA AGCAATTAAG CTCAATAAAA ACTCTAATTG ACCATAATTA 
>CadE2 >CadE12 >CadF9 >Cad2E8 >Cad2F5 
CTAATCAACA CTAATAAAA ATCATAAAAC CCAATAAACT GCAATAAAAA 
>CadE3 >CadF1 >CadF10 >Cad2E9 >Cad2F6 
GTAATAACTT ACCGTAATTA ATTCCGCTCT GCAATCATTA CTTTTTATTG 
>CadE4 >CadF2 >CadF11 >Cad2E10 >Cad2F7 
GAATTAATAG CCAATAAATG GTAATAAAGT CCTTAAATTA CCCATAAATT 
>CadE5 >CadF3 >Cad2E1 >Cad2E11 >Cad2F9 
GCTTAAATGA GCCATTAAAG CCAATAAAGG AAAAGGATTC GTTTTTATGA 
>CadE6 >CadF4 >Cad2E2 >Cad2E12 >Cad2F10 
ATGATTTATTT AGTTTAATAA GACATTATTA AGGCACTACG CCCATATAAT 
>CadE8 >CadF5 >Cad2E3 >Cad2F1 >Cad2F11 
CTTATAAAAT CTATTTATTA GCTAATAAAT GTTCTAATTA GCAATAAAAA 
>CadE9 >CadF6 >Cad2E4 >Cad2F2  
ACAGTAATTA TATTTTATTA TTATTTATTA CTCATAAACA  
>CadE10 >CadF7 >Cad2E5 >Cad2F3  
GAACACTACT GCAATAAACA TCGAGCATGT GGATTTATAA  
 
Caup 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
LAARRKNATRESTATLKAWLSEHKKNPYPTKGEKIMLAIITKMTLTQVS
TWFANARRRLKKENKMTWEPKNKTEDD 
 
Selected sequences 
>CaupA2 >CaupA7 >CaupA12 >CaupB5 >CaupB11 
ATTATTAACA TTCATTAACA GGCTAAAACA GATAATAACA ATAAAAAACA 
>CaupA3 >CaupA8 >CaupB1 >CaupB6  
GTCTTTTACA GCAGTTAACA GCTAATAACA CTAAAAACA  
>CaupA4 >CaupA9 >CaupB2 >CaupB7  
AGCAAAAACA GGAAAGAACA ATTTGTGACA TGAAAAACA  
>CaupA5 >CaupA10 >CaupB3 >CaupB9  
331 
TGGTTGTACA TTCTTTAACA ACCGGAAACA CGCAGCAACA  
>CaupA6 >CaupA11 >CaupB4 >CaupB10  
AACTATTACA AAAAATGACA TCGGTTAACA AACTGTAACA  
 
Ct 
Promoter-Stringency UV5-5mM 
Amino Acid 
Sequence 
SKKQRVLFSEEQKEALRLAFALDPYPNVGTIEFLANELGLATRTITNWFH
NHRMRLKQQVPHGPAGQDNPIPS 
 
Selected sequences 
>5CtE1 >5CtE6 >5CtE11 >5CtF4 >5CtF9 
CTTGCTAAAC TAGATTAAAC TAGTTCAAAG AGATTGACTA TGGCTAAAAC 
>5CtE2 >5CtE7 >5CtE12 >5CtF5 >5CtF10 
TCGTCTGAAC GCTCTTGAAC ACGCTCGAGC CATTCTGAAC TGTCTTGAAC 
>5CtE3 >5CtE8 >5CtF1 >5CtF6 >5CtF11 
AAGGTTAAAC GGCAAAGAGA AGTCCTGAAC AGCCTTGAAC CGTCCTGAAC 
>5CtE4 >5CtE9 >5CtF2 >5CtF7  
TACGTTAATC GAAGTTAAAC GGGATAAAC GTACTTAAAC  
>5CtE5 >5CtE10 >5CtF3 >5CtF8  
CACATTGAAC TATGCTAATC CTAATTGAAC GTGGTTGAAC  
 
Dfd 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
PKRQRTAYTRHQILELEKEFHYNRYLTRRRRIEIAHTLVLSERQIKIWFQN
RRMKWKKDNKLPNTKNVRKKT 
 
Selected sequences 
>dfd1 >dfd6 >dfd11 >dfd16 >dfd21 
CTTCATTAAG CCTAATTAAG AGCTATTAAA CTCATTACT CGACTAATGA 
>dfd2 >dfd7 >dfd12 >dfd17 >dfd22 
GGTCATTAAT GATAATTAAT GCACTAATGA CTTCATTAAG TATCATTAAC 
>dfd3 >dfd8 >dfd13 >dfd18 >dfd23 
TATCATTAAA CCTAATTAAG TCGTAATGA AGTCATTAGG CCGTTAATGA 
>dfd4 >dfd9 >dfd14 >dfd19 >dfd24 
GGTCATTAAT CCCCATTAAT TGCTTAATGG TACCTAATGA CAATTAATGA 
>dfd5 >dfd10 >dfd15 >dfd20  
GTCATTAACA TTTTTAATGA ATCGTAATTA TGGATAATGA  
 
Dll 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KMRKPRTIYSSLQLQQLNRRFQRTQYLALPERAELAASLGLTQTQVKIW
FQNRRSKYKKMMKAAQGPGTNSG 
332 
 
Selected sequences 
>DllC1 >DllC6 >DllC11 >DllD4 >DllD9 
AGACAATTAA ACAAATTAGG AGAGTAATTA GGTTAATTAC AGTAATTACA 
>DllC2 >DllC7 >DllC12 >DllD5 >DllD10 
GTCCATTATCA TGCCATTAAA GATCATTAGA CGCAATTAGA CTAATTACA 
>DllC3 >DllC8 >DllD1 >DllD6 >DllD11 
CGCTATTACA CACAATTTGT CGTTATTAAG CGCAATTATA CTACTAATTA 
>DllC4 >DllC9 >DllD2 >DllD7  
AGAAATTAAC ACGTAATTAT CATAATTTTC TCCAATTACG  
>DllC5 >DllC10 >DllD3 >DllD8  
TATAATTTTA TAAGTAATTA CTGATAGGCG TGGATAATTA  
 
Dr 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
NRKPRTPFTTQQLLSLEKKFREKQYLSIAERAEFSSSLRLTETQVKIWFQN
RRAKAKRLQEAEIEKIKMAALG 
 
Selected sequences 
>DrA2 >DrA7 >DrB2 >DrB7 >DrB12 
ACCTCAATTA TCACCAATTA CCTCCAATTA GGACCAATTA AGTCCAATTA 
>DrA3 >DrA8 >DrB3 >DrB8  
AAAGCAATTA AGAGCAATTA CGGCCAATTA TCTCCAATTA  
>DrA4 >DrA9 >DrB4 >DrB9  
TGGCCAATTA AGGGTAATTA AAAACAATTA TGAGTAATTA  
>DrA5 >DrA10 >DrB5 >DrB10  
TAACTAATTA TGACTAATTA GAACCAATTA TCAGCAATTA  
>DrA6 >DrA11 >DrB6 >DrB11  
TCTCCAATTA TCGCTAATTA CGAGCAATTA GCCCCAATTA  
 
E5 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
PKRVRTAFSPTQLLKLEHAFEGNHYVVGAERKQLAQGLSLTETQVKVW
FQNRRTKHKRMQQEGGDGSDTKSNK 
 
Selected sequences 
>E5C1 >E5C11 >E5D9 >E52C8 >E52D6 
TTCAATTAGG TTTATAATTA AATCTAATTA TCAATAATGA TCAATTAAGA 
>E5C2 >E5C12 >E5D10 >E52C9 >E52D7 
TTAATTAAAT TTAATTAGAA GCACTAATGA GAACCCACA ACATTAATGA 
>E5C3 >E5D1 >E5D11 >E52C10 >E52D8 
333 
CTAATTTACA CCGGGAAGGT TGACTAATGA ATTCATTAGT ACAATAATTA 
>E5C4 >E5D2 >E52C1 >E52C11 >E52D9 
CCATTAAGC GGTATAATGA TGACTAATAG CGGGTAATTA CATCTAATGA 
>E5C5 >E5D3 >E52C2 >E52C12 >E52D10 
ATAAATTAAC TCAATAGTGC CCCATTAACC GGTTTAATGA ACGGTAATTA 
>E5C6 >E5D4 >E52C3 >E52D1 >E52D11 
TTGTTAATAA GTGTTAATTG GGGCTAAATA GATGTAATGA AGTAATTAGC 
>E5C7 >E5D5 >E52C4 >E52D2  
ACCGTAATTA TAGCTAATGA TTCATTACGT TTTTTAATTA  
>E5C8 >E5D6 >E52C5 >E52D3  
GCTTAAGTA AGTTGACGC CACTATTAAG CGCATAATTA  
>E5C9 >E5D7 >E52C6 >E52D4  
ATCAATTAGC TGGCTAATTA CATTAAATGA CCGTTAATAG  
>E5C10 >E5D8 >E52C7 >E52D5  
CCTGTAATGA ATATTAATTA GACTTAATAA AAACTAATTA  
 
Ems 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
PKRIRTAFSPSQLLKLEHAFESNQYVVGAERKALAQNLNLSETQVKVWF
QNRRTKHKRMQQEDEKGGEGGSQR 
 
Selected sequences 
>emsA1 >emsA6 >emsA11 >emsB5 >emsB10 
TTAATTATA GGTCATTACT CCAATTATTG TTTCTAATGA CTAATTAGAG 
>emsA2 >emsA7 >emsA12 >emsB6 >emsB11 
CCATTTATGT GTCCATTAAT CCATAAATTA TGCCTAATGA CTAATTAGCG 
>emsA3 >emsA8 >emsB1 >emsB7  
CATTTTATGA TGTGATTAAC TCTGGAGAGG TCACTAATTA  
>emsA4 >emsA9 >emsB2 >emsB8  
GCCATGGACC ACATAAATGA GCCAATTATA GGTCTAATGA  
>emsA5 >emsA10 >emsB3 >emsB9  
TTCACTAATA ACTAATTAAA CTCCATTAAA CCAATTAGAG  
 
En 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
EKRPRTAFSSEQLARLKREFNENRYLTERRRQQLSSELGLNEAQIKIWFQ
NKRAKIKKSTGSKNPLALQLMAQ 
 
Selected sequences 
>eng1 >eng7 >eng12 >eng17 >eng22 
CTAATTAGCG GTGCTAATTA CAATTAAAA CGACTAATTA CCAATTAAAC 
334 
>eng2 >eng8 >eng13 >eng18 >eng23 
TATTTAATTA TCAATTAACC CCAATTAAAA CCAATTAAAA TCAATTAAG 
>eng3 >eng9 >eng14 >eng19 >eng24 
CTCATTAGTG ACGTTAATTA TAACTAATTA CTCAATTAAG CGGCTAATTA 
>eng4 >eng10 >eng15 >eng20  
AGGGTAATTA TAGGTAATTA CTCTTAATTG GCGTTAATGA  
>eng5 >eng11 >eng16 >eng21  
GCAATTATCA CGGCTAATTA CCGATAATTG GCTAATTAAG  
 
Eve 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
VRRYRTAFTRDQLGRLEKEFYKENYVSRPRRCELAAQLNLPESTIKVWF
QNRRMKDKRQRIAVAWPYAAVYSD 
 
Selected sequences 
>Eve-G1 >Eve-G6 >Eve-G11 >Eve-H4 >Eve-H9 
TCCGACATAA CTTCTAACGA ACACATTAAC TGTTTAATGA TTGCTAATGA 
>Eve-G2 >Eve-G7 >Eve-G12 >Eve-H5 >Eve-H10 
TTACTTAATT CATCATTATA CCTCATTATG CGGCTAATTA CCTCATTAAT 
>Eve-G3 >Eve-G8 >Eve-H1 >Eve-H6 >Eve-H11 
TCGATTATTA GTCGTTAGTA GTTAATTAAA TTGCTAATTA GGTCATTAAC 
>Eve-G4 >Eve-G9 >Eve-H2 >Eve-H7  
CTTCTAATCA TGGCTAATTG TCCCATTAAC ACACTAATTA  
>Eve-G5 >Eve-G10 >Eve-H3 >Eve-H8  
TAGTAAATTA TCAATTAGAC AGTCATTAAA GTAATTAGTA  
 
Exd 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
ARRKRRNFSKQASEILNEYFYSHLSNPYPSEEAKEELARKCGITVSQVSN
WFGNKRIRYKKNIGKAQEEANLYAAKKAAGAS 
 
Selected sequences 
>ExdE1 >ExdE6 >ExdE11 >ExdF4 >ExdF10 
TGTTTGACAT CCATTTGACA GCGCATGAGA GCATTTGACA AGTCTGTGGT 
>ExdE2 >ExdE7 >ExdE12 >ExdF5  
CATGATGATT ACTTTGATGA GCTTTTGACA CGGTTTGACA  
>ExdE3 >ExdE8 >ExdF1 >ExdF6  
TCTTTGACAT CGATTGATGA GAGTTGACAT TGTTTGATGA  
>ExdE4 >ExdE9 >ExdF2 >ExdF7  
CTTCATAC CAAGTTGACA ATTTTGATGG AATTTTGACA  
>ExdE5 >ExdE10 >ExdF3 >ExdF9  
335 
CCTTTTGACA ATTTTGACGA ACTTTGATGA GTCTTTGACA  
 
Exex 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
TRRPRTAFTSQQLLELEKQFKQNKYLSRPKRFEVASGLMLSETQVKIWF
QNRRMKWKRSKKAQQEAKERAKAN 
 
Selected sequences 
>ExexE1 >ExexE6 >ExexE11 >ExexF4 >ExexF9 
CTTAATTAGA ACAGTAATTA TGGCTAATTA TGTAATTAAT AGCAATTAAA 
>ExexE2 >ExexE7 >ExexE12 >ExexF5 >ExexF10 
ACCAATTAAG ACGTTAATTA AGAGTAATTA ACTTAATCAC CATGTAATTA 
>ExexE3 >ExexE8 >ExexF1 >ExexF6 >ExexF11 
GGGTAATTAA ATCTTATTAC GGTAATTAGA TCTAATTAA CGCTAATTAA 
>ExexE4 >ExexE9 >ExexF2 >ExexF7  
AGAGTAATTA GCTAATTACT TTCTAATTGA ACTAATTAG  
>ExexE5 >ExexE10 >ExexF3 >ExexF8  
CTTAATTATC TGTGTAATTA AGTTAATTAC TGGCTAATTA  
 
ftz 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
SKRTRQTYTRYQTLELEKEFHFNRYITRRRRIDIANALSLSERQIKIWFQN
RRMKSKKDRTLDSSPEHCGAG 
 
Selected sequences 
>FtzG1 >FtzG6 >FtzG11 >FtzH5 >FtzH10 
ATCATAATTG TTACTAATGA CATCATTAAC GAGTTAATGA ATATTAATTA 
>FtzG2 >FtzG7 >FtzG12 >FtzH6 >FtzH11 
CAGCCGCCC TTATAAATGA TGCTTAATTA GCCCTAAGAT TTGTTAATGA 
>FtzG3 >FtzG8 >FtzH1 >FtzH7  
TCCCATTAAC TTTTTAATTG GGCTTAATGG CTGTTAATTA  
>FtzG4 >FtzG9 >FtzH2 >FtzH8  
CTCTTAATTA CGCCTAATGA GAACCTACTT GGGTTAATTA  
>FtzG5 >FtzG10 >FtzH3 >FtzH9  
ATGCTCCCGC TAGTTAATTA CCGTTAATTA TTTTTAATGA  
 
Gsc 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KRRHRTIFTEEQLEQLEATFDKTHYPDVVLREQLALKVDLKEERVEVWF
KNRRAKWRKQKREEQERLRKLQEE 
 
Selected sequences 
>GscA1 >GscA6 >GscA11 >GscB5 >GscB10 
336 
CCGATTACGA TCAGATTATC TAGGATTATG TCGGATTAAG ATGGATTAGT 
>GscA2 >GscA7 >GscA12 >GscB6 >GscB11 
CAAGTAATCC TAGGATTACT ACAATAATCC ACGGATTAAA GGATTAATG 
>GscA3 >GscA8 >GscB1 >GscB7  
AAGATTAGTC TGCGATTAAG TCGTTAATCT CCCCTAATCC  
>GscA4 >GscA9 >GscB3 >GscB8  
TAGGATTATT ATCGTAATCC GGGATTAACA GGGATTAACA  
>GscA5 >GscA10 >GscB4 >GscB9  
AAGATTAGTA TCGTTAATCT CGAGATTAAG TGGATTAGGA  
 
H2.0 
Promoter-Stringency UV5-10mM 
Amino Acid 
Sequence 
RSWSRAVFSNLQRKGLEIQFQQQKYITKPDRRKLAARLNLTDAQVKVW
FQNRRMKWRHTRENLKSGQEKQPSA 
 
Selected sequences 
>H20C1 >H20C7 >H20C12 >H20D5 >H20D10 
TTTTTATATA CCTTTATGGG GGGTAATTAG CTGTAATAAA CGTTTATTAA 
>H20C2 >H20C8 >H20D1 >H20D6 >H20D11 
CTCTTAATGA CGTTGATTAA CTATTATTAA ACCTCATAAT ATTTTATGAG 
>H20C3 >H20C9 >H20D2 >H20D7  
ACATTATTGA AGTCAATAAA TGAATATTGA AATTTATTAA  
>H20C4 >H20C10 >H20D3 >H20D8  
GGTTAATGAT GATTAATTAT GCTTAATTGA ATCTAATTAA  
>H20C5 >H20C11 >H20D4 >H20D9  
TAGATATTAC GGATAATTAA AGATAATAAT TGCTAATAAA  
 
Hbn 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KVRRSRTTFTTFQLHQLERAFEKTQYPDVFTREDLAMRLDLSEARVQVW
FQNRRAKWRKREKFMNQDKAG 
 
Selected sequences 
>HbnA1 >HbnA8 >HbnB4 >HbnB10  
TTAATTATT CTCTAATTGA TACAATTAAT GCTAATTAAC  
>HbnA4 >HbnA9 >HbnB5 >HbnB11  
AGTAATTACC CCTTAATTAA CTTAATTAAA CCAATTAAT  
>HbnA5 >HbnA10 >HbnB6   
TTCAATTACA ACAAATTAAG CTTAATTATC   
>HbnA6 >HbnB2 >HbnB7   
GTCAATTATG AGACTAATTA ACCAATTAAA   
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>HbnA7 >HbnB3 >HbnB9   
GATTAATTAA GACAATTAAA ATTAATTAAA   
 
Hgtx 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KKHTRPTFSGQQIFALEKTFEQTKYLAGPERAKLAYALGMSESQVKVWF
QNRRTKWRKRHAAEMATAKRKQDD 
 
Selected sequences 
>HgtxC1 >HgtxC6 >HgtxD1 >HgtxD6 >HgtxD11 
CCCTATTAAT TCATTAAAAT AGCAATTATC GCTTTAATTA AGTTTAATTA 
>HgtxC2 >HgtxC7 >HgtxD2 >HgtxD7  
AGTAATTGAA CATGTAATTA CGTAATTAGA CTCATTAAA  
>HgtxC3 >HgtxC8 >HgtxD3 >HgtxD8  
AGCTAATTA ATCAATTAAC CTTCATTATT ACTTTAATTA  
>HgtxC4 >HgtxC9 >HgtxD4 >HgtxD9  
GCCAATTATC CCTCATTATG TTAATTAATT GTTTTAATGA  
>HgtxC5 >HgtxC10 >HgtxD5 >HgtxD10  
TTTGTAATTA CTTCATAC TTTTTAATTA TAGTTAATGA  
 
Hmx 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KKKTRTVFSRAQVFQLESTFDLKRYLSSSERAGLAASLRLTETQVKIWFQ
NRRNKWKRQLAAELEAANMANMA 
 
Selected sequences 
>HMXA2 >HMXA10 >HMXE5 >HMXE12 >HMXF9 
ATGTTAATTG TCCTGACAGT TTATTAATCG AGTTCTTAAG GGGAATGAG 
>HMXA3 >HMXA11 >HMXE6 >HMXF1 >HMXF10 
AAGATAATTG AGGAAATGAG CACTTAATTA TTGTCTTCGA CGGAGAATTT 
>HMXA4 >HMXA12 >HMXE7 >HMXF2 >HMXF11 
ACGCTAATTG TTAATTG TAGTTAATTA TCACGCCGAG TCGTCATGCG 
>HMXA5 >HMXE1 >HMXE8 >HMXF4  
AGCCATTTAA ACGTTAATTA CCACTAATTA TGCAATTAAG  
>HMXA6 >HMXE2 >HMXE9 >HMXF6  
ATATTAATTG GACTTAATCG TGTTTAATTG ATCAGTCCTT  
>HMXA7 >HMXE3 >HMXE10 >HMXF7  
CCCTTAATTG CCTCTAATTG TATTTAATTG ATGAACTTGA  
>HMXA8 >HMXE4 >HMXE11 >HMXF8  
GTGTTAATTG CACTTAATCG ATCACTTGCA GGCAATTAAG  
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Hth 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
NQKKRGIFPKVATNILRAWLFQHLTHPYPSEDQKKQLAQDTGLTILQVN
NWFINARRRIVQPMIDQ 
 
Selected sequences 
>hthC2 >hthC8 >hthD1 >hthD6 >hthD11 
CTTGTGACAG TGTCATC CCTGTCACTG AGCTGTCATT TTTCGTGACA 
>hthC3 >hthC9 >hthD2 >hthD7  
ATATGTCAAA GACTGTCAGC AGCTGTCAAA TCACGCCGAG  
>hthC4 >hthC10 >hthD3 >hthD8  
ACGTCAAGG AGACCTGACG TATTTGACAT ATACCCGTGC  
>hthC5 >hthC11 >hthD4 >hthD9  
CCTGTCACAG GCGATGACAG GAGGTGACAG TGTCATTGTA  
>hthC6 >hthC12 >hthD5 >hthD10  
CTGTGACGT TGTCAAACTC GAAGAAACGT ACGCTCGAGC  
 
Ind 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
SKRIRTAFTSTQLLELEREFSHNAYLSRLRRIEIANRLRLSEKQVKIWFQN
RRVKQKKGGSESPTFNLSTNSN 
 
Selected sequences 
>IndC1 >IndC6 >IndC11 >IndD5 >IndD10 
GGATTAATTA GGTAATTAGA GTAATTAATA TTGCTAATTA TCCCTAATTA 
>IndC2 >IndC7 >IndC12 >IndD6 >IndD11 
CGCTAATGA ACGTTAATGA CTCATTAACA GTCCTAATTA CTAATTAGCA 
>IndC3 >IndC8 >IndD1 >IndD7  
TACCTAATGA TGATTAATGA CTAATTAAGG TCACTAATGA  
>IndC4 >IndC9 >IndD3 >IndD8  
CACTTAATAG GCGTTAATGA GTAATTAGAA GCAATTAATA  
>IndC5 >IndC10 >IndD4 >IndD9  
TAATTAGAG GTAATTAGTA ACACTAATGA CCACTAATTA  
 
Inv 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
EDKRPRTAFSGTQLARLKHEFNENRYLTEKRRQQLSGELGLNEAQIKIWF
QNKRAKLKKSSGTKNPLALQLMAQ 
 
Selected sequences 
>InvC1 >InvC7 >InvC12 >InvD5 >InvD10 
ATAATTAACC GGTAATTATA CCTAATTAAA GTAATTAGTA TCACGCCGAG 
339 
>InvC2 >InvC8 >InvD1 >InvD6 >InvD11 
ACTAATTAAT TCTAATTAAA CCAATTAAAT GATGCTAAAC GGTAATTAAC 
>InvC3 >InvC9 >InvD2 >InvD7  
ATAATTAGCA AGCCCTCGCA TCAATTAGAG CCAATTAGTT  
>InvC5 >InvC10 >InvD3 >InvD8  
CCACTAATTA AGTCAGCATG TCAATTAAAA TCAATTAAAA  
>InvC6 >InvC11 >InvD4 >InvD9  
CTTCACTGAA TAATTAGAG CTAATTAGAA ATTCCGCTCT  
 
Lab 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
NNSGRTNFTNKQLTELEKEFHFNRYLTRARRIEIANTLQLNETQVKIWFQ
NRRMKQKKRVKEGLIPADILTQH 
 
Selected sequences 
>LabE1 >LabE8 >LabF4 >LabF11  
TCATTAACGA TAGTTAATTA CTTCACTGAA AGTCTAATGA >LabH10 
>LabE2 >LabE9 >LabF5 >LabH3 TATCGCCCAC 
GCCTTAATTA ATACTAATTA CTGTTAATTA GCTGTTATTT >LabH11 
>LabE3 >LabE10 >LabF6 >LabH5 AATGATCGTC 
TGGCTAATTA CGTTCTTTAA AATGATCGTC GTGCGCGCAG >LabH12 
>LabE4 >LabE11 >LabF7 >LabH6 TACATAATGA 
GATAATTAAT GCTTGATGCG GTCCAGATTG GTGTTAATTA  
>LabE5 >LabF1 >LabF8 >LabH7  
CATACCCAGA AGTCATTAAG CGTTAATT GTCTTAATTA  
>LabE6 >LabF2 >LabF9 >LabH8  
AATTTAATTA CTACCAGATT GGTCATTAAT TCACGCCGAG  
>LabE7 >LabF3 >LabF10 >LabH9  
GCTAATTAAT GTAGCCAATG CAGGCACCCA CTACTAAATT  
 
Lag1 
Promoter-Stringency UV5-5mM 
Amino Acid 
Sequence 
IRSSRPKKAANVPILEKTYAKSTRLDKKKLVPLSKQTDMSEREIERWWRL
RRAQDKPSTLVKFCENTWRC 
 
Selected sequences 
>5Lag1G1 >5Lag1G11 >5Lag1H7 >5Lag12C8 >5Lag12D4 
GGACCTGAAG AAGTTATTAG CTACCAAGAT GAGACGAGAT CCACTAGATT 
>5Lag1G4 >5Lag1G12 >5Lag12C1 >5Lag12C9 >5Lag12D5 
GTAGAAGAGG TCTCTCGCCT GTGGTATGCT CCACCATAAT GCGCATGAGA 
>5Lag1G5 >5Lag1H1 >5Lag12C2 >5Lag12C10 >5Lag12D7 
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TCCCCCATCC TGACTATCAG TCCCTCACTG TAGTAATATT CTACTAAAAC 
>5Lag1G6 >5Lag1H2 >5Lag12C3 >5Lag12C11 >5Lag12D8 
CCACCAACTT CATCGCTATG TCGTACGAAT CTACCATGTT CTACTAGTAT 
>5Lag1G7 >5Lag1H3 >5Lag12C4 >5Lag12C12 >5Lag12D9 
CTACCAAGAA CCCCTAAATT ACTACAAAGG ACTCTGCTTA CCACCAAAAT 
>5Lag1G8 >5Lag1H4 >5Lag12C5 >5Lag12D1 >5Lag12D10 
AGGTCAGATA CTACCATAAA CTACCAGAAG CCCCTGGAAT CTACCAACCT 
>5Lag1G9 >5Lag1H5 >5Lag12C6 >5Lag12D2 >5Lag12D11 
CCACTAATTC CCACCAAATT GGTATACGAC TGTGATATAG CCTCCCGCAC 
>5Lag1G10 >5Lag1H6 >5Lag12C7 >5Lag12D3  
TGTACAACAG CTACCAAGAT CCACCAAATA TACAAATAT  
 
Lbe 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KRKSRTAFTNHQIFELEKRFLYQKYLSPADRDEIAASLGLSNAQVITWFQ
NRRAKQKRDIEELKKDFDSVK 
 
Selected sequences 
>IbeG2 >IbeG7 >IbeG12 >IbeH5 >IbeH10 
GATGATTATG GGTAATTACC TCGATTAACTA GCTAATTAAT CCTCGTTAAA 
>IbeG3 >IbeG8 >IbeH1 >IbeH6 >IbeH11 
CATCTAAGTA GCTATAAGTA GCACTAACAA ACCAATTAAC CCTCGTTAAG 
>IbeG4 >IbeG9 >IbeH2 >IbeH7  
AGGTTAACCA TCTTGTTACA CCTCGTTAGT GCTAATTAAC  
>IbeG5 >IbeG10 >IbeH3 >IbeH8  
TCCTAATCAC GCTGGTTAAC CACATAATCA TTGTTATC  
>IbeG6 >IbeG11 >IbeH4 >IbeH9  
CGTTAAATGA CGCCTAATTA GCTTTAACAA ACCAATTAAC  
 
Lbl 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KRKSRTAFTNQQIFELEKRFLYQKYLSPADRDEIAGGLGLSNAQVITWFQ
NRRAKLKRDMEELKKDVQCEKMS 
 
Selected sequences 
>LblC1 >LblC6 >LblC11 >LblD4 >LblD9 
GATAATTATC GTGCTAATTG CTTGTTAAC ACCAATTATC CGACTAATGA 
>LblC2 >LblC7 >LblC12 >LblD5 >LblD10 
GGTAATTATA GTTAATTAAA CCTCGTTAAG CGACTAATGA CCTCGTTAAG 
>LblC3 >LblC8 >LblD1 >LblD6 >LblD11 
AGGATAATTG AAACTAACGA ACCAATTAAA CTGCTAATCA CGACTAATGA 
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>LblC4 >LblC9 >LblD2 >LblD7  
CCACTAATCA CCTGATTAAG GCTCGTTAAG GCTAATTAAT  
>LblC5 >LblC10 >LblD3 >LblD8  
GCTAATTATT CCAATTATC ACCAATTAAG GCTAATTAAT  
 
Lim1 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
RRGPRTTIKAKQLEVLKTAFNQTPKPTRHIREQLAKETGLPMRVIQVWFQ
NKRSKERRMKQITSMGRPPFFGG 
 
Selected sequences 
>LimC1 >LimC10 >LimD7 >Lim1C4a >Lim1D4a 
TAGATTACGT GTTAATTAGC GAACCAAAGG TCGTTTTGAA AATTAATTAT 
>LimC2 >LimC11 >LimD8 >Lim1C5a >Lim1D6a 
CAACAGTGGG GTTAATTGA CTACTAATAT TGTCCAAAT TTTTAATTAA 
>LimC3 >LimC12 >LimD9 >Lim1C6a >Lim1D9a 
AAGCAAGCCG TTAATTAGT AGTTCACGGG CGGGGAACGT ACTAATTAAA 
>LimC4 >LimD1 >LimD10 >Lim1C9a >Lim1D10a 
AGCAGAATCG TACTAATTA GCTAATTAAT GCCTAATTAA TGCTAATTAA 
>LimC5 >LimD2 >LimD11 >Lim1C10a >Lim1D11a 
TTTTGTGATA ATTAATTAGA AGTTAATTAA GTTAATTACC TTTAATTACA 
>LimC7 >LimD3 >Lim1C1a >Lim1C11a  
CCACCAGATT TGGTAATTAA CCCCCAATTT CCGTGTTAGT  
>LimC8 >LimD4 >Lim1C2a >Lim1C12a  
CCCAGTAAGG TTATAATTAA CTATAATTAG ATTATACTGT  
>LimC9 >LimD6 >Lim1C3a >Lim1D2a  
CAATCGTCTA GTCCAGATTG AAAAGGATTC TACTAATTAA  
 
Lim3 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
PNKRPRTTITAKQLETLKTAYNNSPKPARHVREQLSQDTGLDMRVVQV
WFQNRRAKEKRLKKDAGRTRWSQY 
 
Selected sequences 
>Lim3C1 >Lim3C7 >Lim3D1 >Lim3D6 >Lim3D11 
CCCCTGATTA AAACAAATTA TTTCATTAAA GTCAATTACA CTAATTAGAT 
>Lim3C2 >Lim3C8 >Lim3D2 >Lim3D7  
ATTTATTAAG TTTCATCAGA ATTAACA TCAATTAAGA  
>Lim3C3 >Lim3C10 >Lim3D3 >Lim3D8  
CGCTTAATCA TTAATTTTTA CTCATTAGAT ACTAATTAAC  
>Lim3C4 >Lim3C11 >Lim3D4 >Lim3D9  
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ATAATTATTC TTTCATTTAG CAATTACC ATTAATCAAC  
>Lim3C5 >Lim3C12 >Lim3D5 >Lim3D10  
ATAATCATTA TCTAATTTAT CTCAATTAAG TAATTAGCC  
 
Mirr 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
NGARRKNATRETTSTLKAWLNEHKKNPYPTKGEKIMLAIITKMTLTQVS
TWFANARRRLKKENKMTWEPRNRVDDD 
 
Selected sequences 
>MirrE1 >MirrE10 >MirrF7 >Mirr2C7 >Mirr2D4 
ACTTGTAACA CCAAAAAACA CGAATTTACA AGATTTAACA GTGTTAAACA 
>MirrE2 >MirrE11 >MirrF8 >Mirr2C8 >Mirr2D5 
TTCAGTAACA TAAGAAAACA GCTCAAAACA GCTTGTAACA CGCATAAACA 
>MirrE3 >MirrE12 >MirrF9 >Mirr2C9 >Mirr2D6 
AGTAAATACA GCAAAAAACA CTAGAAAACA AGAGAAAACA TAAGTTACA 
>MirrE4 >MirrF1 >MirrF10 >Mirr2C10 >Mirr2D7 
ACAGCAAACA TCACGCCGAG GCACAAAACA ACATTTACA CCTGAAAACA 
>MirrE5 >MirrF2 >MirrF11 >Mirr2C11 >Mirr2D8 
TGCTATAACA GATACTTACA CAAAATAACA CCTGAAAACA CTAGTTTACA 
>MirrE6 >MirrF3 >Mirr2C2 >Mirr2C12 >Mirr2D9 
GGTAATAACA CAAGAAAACA TGCAGAAACA GTGATATACA TTAGAAAACA 
>MirrE7 >MirrF4 >Mirr2C3 >Mirr2D1 >Mirr2D10 
ACTCGTGACA CTGAAAAACA CTAACAAACA ATCTCTTACA CTCAATAACA 
>MirrE8 >MirrF5 >Mirr2C4 >Mirr2D2 >Mirr2D11 
GGAAGTTACA TTTGAAAACA CTGTACTACA GGAAATTACA TTGAATAACA 
>MirrE9 >MirrF6 >Mirr2C5 >Mirr2D3  
AGAACTTACA ACGCCTGACA ACTTCGAACA GGATATAACA  
 
NK7.1 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
RKKKARTTFTGRQIFELEKMFENKKYLSASERTEMAKLLMVTETQVKIW
FQNRRTKWKKQDNVTNNEAAEHK 
 
Selected sequences 
>NK7E1 >NK7F1 >NK7F10 >NK72A9 >NK72B7 
CATATAATGA TAGCTAATTG CGCTTAATTA GACATAATAG GTATTAATGA 
>NK7E2 >NK7F2 >NK7F11 >NK72A10 >NK72B8 
GAATTAAGTG GCCTAGGGAG TGACTAATTA GAGATAATGA CGTAATTAAG 
>NK7E3 >NK7F3 >NK72A2 >NK72A11 >NK72B9 
GAATTAAGTG GAAGCCGCAA ATCATTAAAC GCTATCAATA CCACTAATTA 
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>NK7E4 >NK7F4 >NK72A3 >NK72A12 >NK72B10 
GGTATTTAAA GCGCTAATGA TACTTAAGTG ACATTAAATG GCCTATTAAA 
>NK7E6 >NK7F5 >NK72A4 >NK72B2 >NK72B11 
AAAATAATTA CTTAGATTTT CGCCGTTCAG TGGTTAAATA CCAATTAAGG 
>NK7E7 >NK7F6 >NK72A5 >NK72B3  
GAGTAAATGA CAATTAAAA GTCCATTAAA GCCGATGACT  
>NK7E8 >NK7F7 >NK72A6 >NK72B4  
AAACTAATTG TCCTTAATAG TGCTATTAAG GAATTAAGTG  
>NK7E10 >NK7F8 >NK72A7 >NK72B5  
GCCACTTAAC GGCAATTAAG GACAATTATA ACTATTAATA  
>NK7E12 >NK7F9 >NK72A8 >NK72B6  
TGTCCAAAT ACCAATTAAG TTAATTAAAA AACCATCAAT  
 
oc 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
QRRERTTFTRAQLDVLEALFGKTRYPDIFMREEVALKINLPESRVQVWF
KNRRAKCRQQLQQQQQSNSLSSSK 
 
Selected sequences 
>OcA1 >OcA6 >OcA11 >OcB5 >OcB10 
CCACTAATC TATATAATCC GCAGATTAAC CTGGATTAAG TCGGATTAAG 
>OcA2 >OcA7 >OcB1 >OcB6 >OcB11 
AGCTTAAGCC TTTGCTAATC GTGGATTAAT AGGGATTATA CCGGATTAAC 
>OcA3 >OcA8 >OcB2 >OcB7  
CGATAATCCC CATTAATAAC TTCATAATCC GAGTTAATCC  
>OcA4 >OcA9 >OcB3 >OcB8  
GGGGCTTAAA CGCGGATTAG GAGGATTACG CTGGATTAGT  
>OcA5 >OcA10 >OcB4 >OcB9  
GAGGATTATT AGGATTAAGG AGCGATTAAG AGGATTAAT  
 
Oct 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
RRKKRTSIETNIRVALEKSFLENQKPTSEEITMIADQLNMEKEVIRVWFCN
RRQKEKRINPPS 
 
Selected sequences 
>oct1 >oct6 >oct13 >oct18 >oct23 
GCGATAATGA GAGATAATTT CAGCTAATTA GCTCATTAAC GCTTTAATTT 
>oct2 >oct7 >oct14 >oct19 >oct24 
GGTTTAATGA GATATAATAA GCATTAATTT CTCATAATCA CTGATAATTA 
>oct3 >oct8 >oct15 >oct20  
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GTTTTAATAA ACATTAATCA TGGTAAATGA AGTTTAATTG  
>oct4 >oct10 >oct16 >oct21  
CACATAATTT TGTGATTAAA TCTCATTAAA GAGATAATTC  
>oct5 >oct11 >oct17 >oct22  
CTATAATTAG TCTCATTAGG GCCCTAATTA GGTTTAATTT  
 
Odsh 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KKRRGRTNFNSWQLRELERVFQGSHYPDIFMREALATKLDLMEGRIAV
WFQNRRAKWRKQEHTKKGPGRPAHNA 
 
Selected sequences 
>OdshC1 >OdshC7 >OdshC12 >OdshD5 >OdshD10 
GTTGTAATTA AGCTAATTA GACAATTAGG CCTAATTAAA CTTAATTAAC 
>OdshC2 >OdshC8 >OdshD1 >OdshD6 >OdshD11 
GAAATTAAA CCTAATTACA TACAATTAAT TCTAATTAAG CTCAATTACC 
>OdshC3 >OdshC9 >OdshD2 >OdshD7  
ATAATTAGCA GCAATTAAGG CCAATTAAAT CCGCTAATTA  
>OdshC4 >OdshC10 >OdshD3 >OdshD8  
TACTAATTAA AGTAATTACC TGCTAATTAA GTCAATTAGT  
>OdshC5 >OdshC11 >OdshD4 >OdshD9  
TAACTAATTG GATTTAATTA GACTTAATTA TTCAATTACA  
 
onecut 
Promoter-Stringency UV5-5mM 
Amino Acid 
Sequence 
PKKPRLVFTDLQRRTLQAIFKETKRPSKEMQVTIARQLGLEPTTVGNFFM
NARRRSMDKWRDDDSKSTMHVAH 
 
Selected sequences 
>5onectG1 >5onectG6 >5onectG12 >5onectH5 >5onectH10 
GAGCTGATTA GGCCAAGTCA GTCAATCAGA AGTCTTGATTT CCCAATCAAA 
>5onectG2 >5onectG7 >5onectH1 >5onectH6 >5onectH11 
CGAAATCAAG CGGTTTGCAA AAGTTGATTG GGAGAGCCTT CTAATCAACG 
>5onectG3 >5onectG8 >5onectH2 >5onectH7  
GCAATCAAGG GCTATGATTA ACAAATCAAT GCAAATCAAC  
>5onectG4 >5onectG10 >5onectH3 >5onectH8  
TTAATCAATA TTAATCAATA CTGGGCTATA GTTATGCGTC  
>5onectG5 >5onectG11 >5onectH4 >5onectH9  
TACCAACAA CCAAATCAAT CCAAATCAAG CCACCATTTT  
 
Optix 
Promoter-Stringency UV5m-10mM 
345 
Amino Acid 
Sequence 
GEQKTHCFKERTRSLLREWYLQDPYPNPTKKRELAKATGLNPTQVGNW
FKNRRQRDRAAAAKNRIQHSQNSSG 
 
Selected sequences 
>11617C2 >11617D1 >OptixE2 >Optix2A2 >Optix2B2 
GAACCTACTT GTAGTGCTAG GTAGCCAATG GCCCATGATA TTTCTGCGTG 
>11617C3 >11617D2 >OptixE3 >Optix2A3 >Optix2B3 
GCGCATGAGA CCGTCTAAAC CGTTCTTTAA ACATGTGATA CATTGCGATA 
>11617C4 >11617D3 >OptixE4 >Optix2A4 >Optix2B4 
TGAAGTGATA TAATGCACAC CCCTAACATG GGAGCTGATA GTGATTGATA 
>11617C5 >11617D5 >OptixE5 >Optix2A5 >Optix2B5 
CAACGTATT CTTTTCATCT GAACCTACTT CAATCTGATA CCAAGTGATA 
>11617C6 >11617D7 >OptixE6 >Optix2A6 >Optix2B6 
CAATGTGATA AGAAACTATG ATCTTAATTAC GTAGCTGATA ATAAGTGATA 
>11617C7 >11617D8 >OptixE7 >Optix2A7 >Optix2B7 
ACCAGTGATA ATAAATGATA GTGCGTACTG TACCCACGCC CGTTATGATA 
>11617C8 >11617D9 >OptixE8 >Optix2A9 >Optix2B8 
GATTGCGATA GTTAGTGATA GGAAGTGATA GAAGTGATAG CTTTCTGATA 
>11617C9 >11617D10 >OptixE9 >Optix2A10 >Optix2B9 
CATCGCTATG ATAAGTGATA ATCTTATTAC AACCGCGATA ATTCAAACA 
>11617C10 >11617D11 >OptixE10 >Optix2A11  
ACGTATTGGT CGTAGTGATA CTACTAAATT GTGATTGATA  
>11617C11 >11617D12 >OptixE11 >Optix2A12  
CGTAGTGATA AGAGATGATA ATCAGTCCTT TCCCTTGATA  
>11617C12 >OptixE1 >OptixE12 >Optix2B1  
ATCTTATTAC TCTTCCATTA CTACCAGATC ATTCGCGATA  
 
Otp 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
QKRHRTRFTPAQLNELERCFSKTHYPDIFMREEIAMRIGLTESRVQVWFQ
NRRAKWKKRKKTTNVFRTPGA 
 
Selected sequences 
>OTPG1 >OTPG6 >OTPG12 >OTPH5  
TTCAATTATG ACCATTAATT CCTAATTAGG TCAATTAAGG  
>OTPG2 >OTPG8 >OTPH1 >OTPH6  
CAAATTAGAA TTCGCTAATTT CCTTAATTAA ATTAATTAAA  
>OTPG3 >OTPG9 >OTPH2 >OTPH7  
AGCAATTAAT CTCATTAAAC CTAATTACAG ATTAATTAGA  
>OTPG4 >OTPG10 >OTPH3 >OTPH10  
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GTTTAATCA TCATTAAAG GCATAATTA TAACTAATTA  
>OTPG5 >OTPG11 >OTPH4 >OTPH11  
ATTGTAATTA TTTAATTAAT ATTCATTAAC TTAATTAGAC  
 
pb 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
PRRLRTAYTNTQLLELEKEFHFNKYLCRPRRIEIAASLDLTERQVKVWFQ
NRRMKHKRQTLSKTDDEDNKDS 
 
Selected sequences 
>Pb1 >pBG3 >pBG8 >pBH3 >pBH8 
GGTCATTAGA CTCATTAAA TGACTAATGA GGTAATTATA AGGTTAATGA 
>Pb2 >pBG4 >pBG9 >pBH4 >pBH9 
GGTAATTAAC GGTAATTATA GCGTTAATGA GATAATTATC TCATTAATGA 
>Pb3 >pBG5 >pBG11 >pBH5 >pBH10 
TGTAATTAAA CTGTTAATTA GCTCATTAAG CCAGCAAGAT CCTCATTAGA 
>Pb4 >pBG6 >pBG12 >pBH6 >pBH11 
GGTCATTAAC CGTAATTAAT GCTAATTAAT TTGCTAATGA GGTAATTAGA 
>pBG2 >pBG7 >pBH1 >pBH7 >pBH12 
ATCCTAATTA TACATAATGA TGTAATTAAA GCTAATTAAG TTGCTAATTA 
 
PhdP 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KQRRIRTTFTSNQLNELEKIFLETHYPDIYTREEIASKLHLTEARVQVWFQ
NRRAKFRKQERHAIYIMKDKS 
 
Selected sequences 
>PhdPA1 >PhdPA8 >PhdPB1 >PhdPB6  
ATTAATTTGT TGCATAATTT TTAAATTATC CTTAATTATC  
>PhdPA2 >PhdPA9 >PhdPB2 >PhdPB7  
GGTTAATTAC TTAATAATTG ATCAATAAAA TTTAATTAAT  
>PhdPA3 >PhdPA10 >PhdPB3 >PhdPB10  
CCTATTAGC CCTAATTGG TCCGCTAATTT TACCTAATTA  
>PhdPA4 >PhdPA11 >PhdPB4 >PhdPB11  
GCTCATTAGG GAAATAATTA CGGAATTAAG GCCATGGAT  
>PhdPA6 >PhdPA12 >PhdPB5   
GCTGCTAATT CGATTAATTA CTAATTATA   
 
Pph13 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KQRRYRTTFNTLQLQELERAFQRTHYPDVFFREELAVRIDLTEARVQVW
FQNRRAKWRKQEKIGGLGGDYKEGA 
347 
 
Selected sequences 
>Pph13C1 >Pph13C6 >Pph13C11 >Pph13D4 >Pph13D9 
CTAATAATTA CATATAATTA GTCCTAATTA AGTAATTACA ACTAATTAAA 
>Pph13C2 >Pph13C7 >Pph13C12 >Pph13D5 >Pph13D11 
GTGATAATTG CATTTAATTA GCCAATTACC GTCAATTAAA ATTAATTAAA 
>Pph13C3 >Pph13C8 >Pph13D1 >Pph13D6  
TCTAATTTAA CCTGATTAGT AATAATTAGC ACTAATTATA  
>Pph13C4 >Pph13C9 >Pph13D2 >Pph13D7  
GCCATAATTA AACAATTATG AACAATTAGC GTTAATTAAT  
>Pph13C5 >Pph13C10 >Pph13D3 >Pph13D8  
CCGAATTAGT TCCAATTACT AGCCTAATTA CAGTGTTAAT  
 
Ptx1 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
QRRQRTHFTSQQLQELEHTFSRNRYPDMSTREEIAMWTNLTEARVRVW
FKNRRAKWRKRERNAMNAAVAAAD 
 
Selected sequences 
>PtxG1 >PtxG8 >PtxH1 >PtxH6 >PtxH11 
CATCTAATCC GGGGATTAAC GCTAATCCTC CGTTAATCCC ACTTAATCCC 
>PtxG2 >PtxG9 >PtxH2 >PtxH7  
TTTAATCCCT TGGGATTAAC CTCTTAATCC GGTTAATCCC  
>PtxG4 >PtxG10 >PtxH3 >PtxH8  
AGAGGATTAG CAATTAATCC CTTACTGTTT TCTTAATCCC  
>PtxG6 >PtxG11 >PtxH4 >PtxH9  
CAGGATTAGT AGGCTAATCC CGTTAATCTC CGTTAATCCC  
>PtxG7 >PtxG12 >PtxH5 >PtxH10  
CTTAATCCTA TCGTAATCCC CCTTAATCCC CGTTAATCCC  
 
Repo 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KKKTRTTFTAYQLEELERAFERAPYPDVFAREELAIKLNLSESRVQVWFQ
NRRAKWRKHEPPRKTGYIKTST 
 
Selected sequences 
>RepoE2 >RepoE9 > Repo2A5 > Repo2B1 > Repo2B8 
CCTTTAATTA CTAATTAATG TAATTACAT GTCAATTAAA GTTAATTAAA 
>RepoE3 >RepoE10 > Repo2A6 > Repo2B2 > Repo2B9 
AGGGTAATTA TTGGGTACAA TCTAATTAAA CCTAATTAAA CCAATTAAAA 
>RepoE4 >RepoE11 > Repo2A7 > Repo2B3 > Repo2B10 
348 
AGCTAATTA TGCGCATCGA TCAATAAATA GGGCTAATTA TAGTTAATTA 
>RepoE5 >RepoE12 > Repo2A8 > Repo2B4 > Repo2B11 
CTGTTAATTA TCCTGACAGT CGCGTAATTA CCACTAATTA TATTTAATTA 
>RepoE6 > Repo2A2 > Repo2A9 > Repo2B5  
GCAAACCCCT AGCAATTTAA TAGCTAATTA CACTTAATTA  
>RepoE7 > Repo2A3 > Repo2A11 > Repo2B6  
TCAATTAAGA CCAATTACTA GATTTAATTG AGTTTAATTA  
>RepoE8 > Repo2A4 > Repo2A12 > Repo2B7  
CTTTTAATTA GCTATAATTA CCATTAATTA TCATTAATTA  
 
Ro 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
QRRQRTTFSTEQTLRLEVEFHRNEYISRSRRFELAETLRLTETQIKIWFQN
RRAKDKRIEKAQIDQHYRN 
 
Selected sequences 
>RoG1 >RoG6 >RoG11 >RoH4 >RoH9 
GGTAATTACC CTAATAATTA TAGTTAATTA TCGCTAATTA GCTAATTAAT 
>RoG2 >RoG7 >RoG12 >RoH5 >RoH10 
AGCAATTAGC CTTTAATTA GTGTTAATTA GCTAATTAAT GCGGTAATTA 
>RoG3 >RoG8 >RoH1 >RoH6 >RoH11 
TTACTAATGA TTACTAATGA GTCAATTAAA GCTAATTAAT GGCAATTAAG 
>RoG4 >RoG9 >RoH2 >RoH7  
TGTAATTAAA CCACTAATTA ACTAATTAAA GCTAATTAAT  
>RoG5 >RoG10 >RoH3 >RoH8  
GTCAATTAGG GTGCTAATTA TCGTAATGA GTCTTAATTA  
 
Rx 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
HRRNRTTFTTYQLHELERAFEKSHYPDVYSREELAMKVNLPEVRVQVW
FQNRRAKWRRQEKSESLRLGLTHFT 
 
Selected sequences 
>RxF2 >RxF9 > Rx2C5 > Rx2C12 > Rx2D8 
GGTAATTAGC TGCCAATATA TACTTAATTA GTCCAGATTG GCTAATTAAA 
>RxF3 >RxF11 > Rx2C6 > Rx2D1 > Rx2D9 
CTACTAATTA TTGGGTACAA CCAATTAGTG AGCAATTAAA ATTAATTAGC 
>RxF4 >RxF12 > Rx2C7 > Rx2D2 > Rx2D10 
CTACTAATTA GCTAATTAAT CCTAATTATG GCTAATTAGA GCTAATTAAC 
>RxF5 >Rx2C1 > Rx2C8 > Rx2D3 > Rx2D11 
CTAATTAACC TAATTATGA GTGTTAATTA AATAATTAGA CCCAATTAAT 
349 
>RxF6 > Rx2C2 > Rx2C9 > Rx2D4  
CTACTAACAT ACTAATTAGA GTCAATTAAT ACCAATTAAG  
>RxF7 > Rx2C3 > Rx2C10 > Rx2D5  
GCCAATTAAC CTTAATTAAC ATCAATTATG GCTAATTAAG  
>RxF8 > Rx2C4 > Rx2C11 > Rx2D6  
GTCAATTAAA TATCAACCCC GTCAATTAGC GTCAATTAAA  
 
Scr 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
TKRQRTSYTRYQTLELEKEFHFNRYLTRRRRIEIAHALCLTERQIKIWFQN
RRMKWKKEHKMASMNIVPYHMG 
 
Selected sequences 
>ScrE04 >ScrF01 >ScrF11 >ScrG7 >ScrH3 
CCTTAATGA GGAAAGTGGA TCATTAATGA CTGTTAATTA ACGTTAATGA 
>ScrE05 >ScrF02 >ScrF12 >ScrG8 >ScrH4 
TACATAATGA CGATAATGA TCGTTAATGA CACTAATTA CTATTAATGA 
>ScrE06 >ScrF04 >ScrG1 >ScrG9 >ScrH7 
TTGGGTACAA GACTTAATGA GCAATTAAAG CCGTTAATTA TTGGGTACAA 
>ScrE08 >ScrF06 >ScrG2 >ScrG10 >ScrH9 
CTACTAATTA ACGCTAATGA GAATTAATGA GTCCAGATTG GTACTAATGA 
>ScrE09 >ScrF07 >ScrG3 >ScrG12 >ScrH10 
ATAGGTCCGT TACACACAGC GGTTTAATGA GCGCTAATGA TATTTAATGA 
>ScrE11 >ScrF09 >ScrG5 >ScrH1 >ScrH11 
AGTGCTTCAC GGAAATACGC CCACTAATTA TGTTAATGA TCACTAATGA 
>ScrE12 >ScrF10 >ScrG6 >ScrH2  
TCCTTAATGA CTACTAACTT GCAATTAACG GACATAATGA  
 
Six4 (-) 
Promoter-Stringency UV5-10mM 
Amino Acid 
Sequence 
DGEETVYCFKEKSRNALKDCYLTNRYPTPDEKKTLAKKTGLTLTQVSN
WFKNRRQRDRTPQQR 
 
Selected sequences 
>5Six4E1 >5Six4E6 >5Six4E11 >5Six4F4 >5Six4F10 
GTATCAAATC GGTATCAAGA GGTATCATAC GGTGTCACAG GTCTCAAATA 
>5Six4E2 >5Six4E7 >5Six4E12 >5Six4F5 >5Six4F11 
GTCTCAAAGC CATTGTACTA GGTGTCAGAC GGTATCATTA GTATCACAAA 
>5Six4E3 >5Six4E8 >5Six4F1 >5Six4F6  
GTATCAAATG GTATCATCTT GGTGTCATGT GGTGTCATCA  
>5Six4E4 >5Six4E9 >5Six4F2 >5Six4F7  
350 
GGTGTCAGAT TTCTCAAAAG GTATCACTTA GGTATCAAAA  
>5Six4E5 >5Six4E10 >5Six4F3 >5Six4F9  
GTCTCATTTA GGTGTCAACT GGTGTCAATT GTGAGCATGT  
 
Slou 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
PRRARTAFTYEQLVSLENKFKTTRYLSVCERLNLALSLSLTETQVKIWFQ
NRRTKWKKQNPGMDVNSPT 
 
Selected sequences 
>SlouE1 >SlouE6 >SlouE11 >SlouF4 >SlouF9 
AATGTCTCAT TACAATTAGC GGTCTAATGA GTTAATTAGT ACCAATTAAA 
>SlouE2 >SlouE7 >SlouE12 >SlouF5 >SlouF10 
AGCCATTAAG GTTAATTATT TTTCTAATGA CCCAATTAAG CGTAATTAAA 
>SlouE3 >SlouE8 >SlouF1 >SlouF6 >SlouF11 
CTCATTAAAA ACCGATTAAA GGGCTAATTA GACAATTATA GCCAATTATC 
>SlouE4 >SlouE9 >SlouF2 >SlouF7  
CGAGTAATGA GATTATTAAA CCTCTAATTG ATCAATTAAG  
>SlouE5 >SlouE10 >SlouF3 >SlouF8  
CGTCAATTAC CAATTAATTG CTATAATTAG CTACTAAAGT  
 
So 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
DGEETSYCFKEKSRSVLRDWYSHNPYPSPREKRDLAEATGLTTTQVSNW
FKNRRQRDRAAEHKDGSTDKQHL 
 
Selected sequences 
>SoE1 >SoE8 >SoF5 >So2E1 >So2E8 
GTATCACAGT GTATCAGATC ATATCCCTCA GATCGTGATA ATACGTCAGT 
>SoE2 >SoE9 >SoF6 >So2E2 >So2E9 
AACGATGATA TCTAGTGATA TCGGAATGAA AATATTGATA CATATCACAA 
>SoE3 >SoE11 >SoF7 >So2E3 >So2E10 
AGTATCAATA GTATCAAAAC GTATCATTTA CATATCACTG AAACATGATA 
>SoE4 >SoE12 >SoF8 >So2E4 >So2E11 
GGTCATCACT CAGGATGATA CGCAGCACAT TGGCATGATA TGTGATGATA 
>SoE5 >SoF2 >SoF9 >So2E5 >So2E12 
AGTATCATTC GATGATGATA GCGCATGAGA GGTATCACAC CACAATGATA 
>SoE6 >SoF3 >SoF10 >So2E6  
AGAAATGATA TCACGCCGAG ATCAGTCCTT AAGGATGATA  
>SoE7 >SoF4 >SoF11 >So2E7  
GTATCACAAT GTATCATTTT GTATCACTTA GGCAGTGATA  
351 
 
Tin 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KRKPRVLFSQAQVLELECRFRLKKYLTGAEREIIAQKLNLSATQVKIWFQ
NRRYKSKRGDIDCEGIAKHLKLK 
 
Selected sequences 
>TinA2 >TinA7 >TinB1 >TinB7  
GGCTCAAGTA CGCACTTGAC CCCACTTGAG CTTCGCAGTA  
>TinA3 >TinA8 >TinB3 >TinB8  
GGTACTTGAC AGTACTTAAG AACACTTAAG GTCCAGATTG  
>TinA4 >TinA9 >TinB4 >TinB9  
CCACTTGACG TCCACTTAAG CCACTTGAA TCCACTTCAA  
>TinA5 >TinA10 >TinB5 >TinB10  
ATCTCAAGTG CCCACTTAAA GCCACTTGAG CTTCGCAGTA  
>TinA6 >TinA11 >TinB6 >TinB11  
CCACTTGAAT CCACTTGTGG TGCACTTGAG GTCCAGATTG  
 
Tup 
Promoter-Stringency UV5m-5mM 
Amino Acid 
Sequence 
PTRVRTVLNEKQLHTLRTCYNANPRPDALMKEQLVEMTSLSPRVIRVWF
QNKRCKDKKKTIQMKLQMQQEKEG 
 
Selected sequences 
>TupE1 >TupE6 >TupE11 >TupF5 >TupF10 
ATCAATTACC CACCATTATA ACCTTAATGG GATAGATC CTATCATAAC 
>TupE2 >TupE7 >TupE12 >TupF6 >TupF11 
CTAATTAGCG TTTAATTATC ACCTTAATGG ATCCATTAAG CGTCTCACGA 
>TupE3 >TupE8 >TupF1 >TupF7  
ACACTAATGT ATGATACCAT TGCATGCATC GCGATAAGTG  
>TupE4 >TupE9 >TupF2 >TupF8  
TTATTAATGG ACCACTTAAC TGCAATTAAG ATCAATTAAG  
>TupE5 >TupE10 >TupF4 >TupF9  
TTCTATTAAG TTCAATTATG TTCCATTTAG TGACCTCAGT  
 
Ubx 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
RRRGRQTYTRYQTLELEKEFHTNHYLTRRRRIEMAHALCLTERQIKIWF
QNRRMKLKKEIQAIKELNEQEKQA 
 
Selected sequences 
>UbxC02 >UbxC07 >UbxD02 >UbxD08  
TAATTAATTA TGCAATAAAA GCGTTAATTA TCCTTAATGA  
352 
>UbxC03 >UbxC08 >UbxD04 >UbxD09  
AATTTTATTA GGCAATTAAG GCCTTAATTA GCCTTAATTA  
>UbxC04 >UbxC11 >UbxD05 >UbxD10  
GCTTTAATTA GTATTAATGA GACAATTAAA CTTTTTATGA  
>UbxC05 >UbxC12 >UbxD06 >UbxD11  
GCTTTAATTA AATTTAATGG CCGTTAATTA GGTAATTAAC  
>UbxC06 >UbxD01 >UbxD07 >UbxD12  
CTATTAATTA TCTTAATGA GCCCATTAAA TGCAATTAAA  
 
Unc4 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KRRRSRTNFNSWQLEELERAFSASHYPDIFMREALAMRLDLKESRVAV
WFQNRRAKVRKREHTKKGPGRPAH 
 
Selected sequences 
>Unc4C1 >Unc4C6 >Unc4C11 >Unc4D4 >Unc4D9 
TCTAATTAGA TTCTATTAAG AGCAATTAAC GTCAATTAAG TCCTGACAGT 
>Unc4C2 >Unc4C7 >Unc4C12 >Unc4D5 >Unc4D10 
TCTGTAATTA TCAATTAAAA TTCAATTAGG GTCAATTAAC GTCAATTAAC 
>Unc4C3 >Unc4C8 >Unc4D1 >Unc4D6 >Unc4D11 
GCGAATTAAG GTCTTAATTG GCACTAATTA TCCAATTAAG ACTAATTAAG 
>Unc4C4 >Unc4C9 >Unc4D2 >Unc4D7  
GCTAATTATG TTCAATTAGG GTACAACCAA ACCAATTAAA  
>Unc4C5 >Unc4C10 >Unc4D3 >Unc4D8  
CTTAATTATC ATCAATTACA ACCAATTATT ACCAATTAAC  
 
Unpg 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KSRRRRTAFTSEQLLELEREFHAKKYLSLTERSQIATSLKLSEVQVKIWFQ
NRRAKWKRVKAGLTSHGLGRNGT 
 
Selected sequences 
>UnpgC1 >UnpgC6 >UnpgC11 >UnpgD5 >UnpgD11 
GGTCATTAGT CTAATTACGC ACTAATTATC ACCAATTAAT CTAATTAATA 
>UnpgC2 >UnpgC7 >UnpgD1 >UnpgD6  
TACGTAATTA AGCAATTAAG CGCCTAATTA CTAATTTGGA  
>UnpgC3 >UnpgC8 >UnpgD2 >UnpgD8  
CGCTAATTAG CTCATTAAA ATAATTAGCG GCTAATTAAT  
>UnpgC4 >UnpgC9 >UnpgD3 >UnpgD9  
AAGATAATTG ATCAATTAAA TCAATTAAG TGTAATTATC  
>UnpgC5 >UnpgC10 >UnpgD4 >UnpgD10  
353 
CGTAATTAG GCAATTAAGG GCCAATTAAG CTAATTAAGG  
 
Vis 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
LRKRRGNLPKSSVKILKRWLYEHRYNAYPSDAEKFTLSQEANLTVLQVC
NWFINARRRILPEMIRREGNDPLHFT 
 
Selected sequences 
>VisG1b >VisG8b >VisG3 >VisG10 >VisH5 
TAAATGACAC CTGTCATCGA ATTATGACAC TACTGTCAAA AGTCCCGCTG 
>VisG2b >VisG9b >VisG4 >VisG11 >VisH6 
GTACTTGACA CGATGTTGTA GGCGTTGACA AGCTGTCACT GAACGCACTT 
>VisG3b >VisG10b >VisG5 >VisG12 >VisH8 
GCACCCCCAC TCCTGACAGT TAAGTGACAA GCTGTCATTA CGATGTTGTA 
>VisG4b >VisG11b >VisG6 >VisH1 >VisH9 
GAGGTGACAT GGTCTCTGCG GCTTGTCATC TATCCTTTAG TCGGGATGTG 
>VisG5b >VisG12b >VisG7 >VisH2 >VisH10 
CGCTGTCATT ATCAGTCCTT TGTTTTGACA AAGTTGACAT TCCTGACAGT 
>VisG6b >VisG1 >VisG8 >VisH3 >VisH11 
TGGTGTCAAC CAAATGACA GGAAGTGACA AGGGTTAAGA AAAGTGAACT 
>VisG7b >VisG2 >VisG9 >VisH4  
CAAGTTGACA GCTCTGACAG CGTGTCAAAC TCACGCCGAG  
 
Vnd 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KRKRRVLFTKAQTYELERRFRQQRYLSAPEREHLASLIRLTPTQVKIWFQ
NHRYKTKRAQNEKGYEGHPGLLH 
 
Selected sequences 
>VndE2 >VndE9 >VndF2 >VndF7 >VndF12 
GTCTCAAGTG ATCTCAAGTG TTTTCAAGTG CACTCAAGTG CATTCAAGTG 
>VndE3 >VndE10 >VndF3 >VndF8  
CTCTCAAGTA TTTTTAAGTA GTACCTGGAT TTTTCAAGTG  
>VndE5 >VndE11 >VndF4 >VndF9  
TATTGAAGTA GTCTCAAGTG CTCTTAAGTA TTTTCAAGTA  
>VndE7 >VndE12 >VndF5 >VndF10  
TGGTCAAGTA TATTGAAGTA TTATCAAGAG GTTTCAAGTG  
>VndE8 >VndF1 >VndF6 >VndF11  
ATCTCAAGTA TGTTCAAGAG GTCTCAAGTA CGTCCTCAAC  
 
Zen 
Promoter-Stringency UV5m-10mM 
354 
Amino Acid 
Sequence 
LKRSRTAFTSVQLVELENEFKSNMYLYRTRRIEIAQRLSLCERQVKIWFQ
NRRMKFKKDIQGHREPKSNAKLA 
 
Selected sequences 
>ZenC1 >ZenC7 >ZenC12 >ZenD6  
GCCTTAATTA CATGCAATTT TCACGCCGAG TCCTTAATGA  
>ZenC3 >ZenC8 >ZenD2 >ZenD7  
GACTAATTA TACCTAATGA TCCCTAATGA TTTTTAATTA  
>ZenC4 >ZenC9 >ZenD3 >ZenD9  
GGGCTAATTA CGTTTAATGA GGCTTAATGA TACATAATGA  
>ZenC5 >ZenC10 >ZenD4 >ZenD11  
ATAATAATGA TCCCTAATGA TACCTAATGA TGCTAATGA  
>ZenC6 >ZenC11 >ZenD5   
CGTCTCGCGA GCGCTAATGA GTGCTAATTA   
 
Zen2 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
SKRSRTAFSSLQLIELEREFHLNKYLARTRRIEISQRLALTERQVKIWFQN
RRMKLKKSTNRKGAIGALTTS 
 
Selected sequences 
>Zen2A1 >Zen2A10 >Zen2B8 >Zen2E6 >Zen2F3 
GTACAAGAGG TTAGTAATTA CTAGCTTACG TGCTAAATTA TTACTAATGA 
>Zen2A2 >Zen2A11 >Zen2B9 >Zen2E7 >Zen2F4 
ATTATAATGA ATCCGAAGTG GCCTTAATTA GCACTAACGA GCCACACGCG 
>Zen2A3 >Zen2B1 >Zen2B10 >Zen2E8 >Zen2F5 
GCGATCGGTG GCATAACATC GTTACGCGTG GTATTGCAAG TTGCTAATTA 
>Zen2A4 >Zen2B2 >Zen2B11 >Zen2E9 >Zen2F6 
ACCGTAATTA ACTCTGTGAG GAGTTAATGA GCAATTAAGG CAGCTAATTA 
>Zen2A5 >Zen2B3 >Zen2E1 >Zen2E10 >Zen2F7 
CCCCAAAGTG ATACTAATTA ATAATTAAGT GCCTTAATTA TGTTAATGA 
>Zen2A6 >Zen2B4 >Zen2E2 >Zen2E11 >Zen2F8 
CTACTAATTG GTCATTAGTA CGTTTAAATG GCAATTAAAA CACCCGTGTG 
>Zen2A7 >Zen2B5 >Zen2E3 >Zen2E12 >Zen2F9 
TGAGTAATGA GTACTGTGTG TATTTAATTA AACACCTGTG CGAATCAGCG 
>Zen2A8 >Zen2B6 >Zen2E4 >Zen2F1 >Zen2F10 
CTGATAATGA TGGCATTACG TCAATTATGA TCCGTAATGA AGTTCCTGTG 
>Zen2A9 >Zen2B7 >Zen2E5 >Zen2F2 >Zen2F11 
CCCGTAATTA CTTGATCGTG GTCATTAAAA TTCGCCGACG GTGTTAATTA 
 
CG11085 
355 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
KPRRRRTAFTHAQLAYLERKFRCQKYLSVADRSDVAETLNLSETQVKT
WYQNRRTKWKRQNQLRLEQLRHQA 
 
Selected sequences 
>CG11085G1 >CG11085G6 >CG11085G11 >CG11085H4 >CG11085H9 
TCCCATTAAG TCCCATTAAG AGCAATTAGG ACCAATTAAC ATCAGTCCTT 
>CG11085G2 >CG11085G7 >CG11085G12 >CG11085H5 >CG11085H10 
CCACTAATTA TGTAATTAAA TCTGTTGAGT ATGTTGGTAT ATGTTGGTAT 
>CG11085G3 >CG11085G8 >CG11085H1 >CG11085H6 >CG11085H11 
CCCAATTAAA GGCTATTAGA AGTTAAGTTC AACATTTAAT GTCAATTAAT 
>CG11085G4 >CG11085G9 >CG11085H2 >CG11085H7  
CGCAATTAAA GCCGATTAAG ATCAATTAGC GTCCAGATTG  
>CG11085G5 >CG11085G10 >CG11085H3 >CG11085H8  
CCCTATTAAA ACTCCCAGTG TGTGACCATC GTCCAAGCGC  
 
CG11294 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
QRRNRTTFTPQQLQELEALFQKTHYPDVFLREEVALRISLSEARVQVWF
QNRRAKWRKQARLQLLQDAWRMRC 
 
Selected sequences 
>CG11294A1 >CG11294A11 >CG11294B4 >CG11294B9  
CTTAATTATC TAACTAATTA GCTAATTAAT GCTAATTAAT  
>CG11294A3 >CG11294A12 >CG11294B5 >CG11294B10  
TTTAATTAGC TAATTAGA ATCAATTAAG GCTAATTAAT  
>CG11294A6 >CG11294B1 >CG11294B6 >CG11294B11  
CCCCTATTT CTAATTAATA CCTAATTAAA GCCATACCAC  
>CG11294A9 >CG11294B2 >CG11294B7   
GTCAATTAGC CTAATTAGGT ATTAATTATG   
>CG11294A10 >CG11294B3 >CG11294B8   
GTAGCCAATG TGCTAATTAA GCTAATTAAC   
 
CG11617 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
SRATKRLFTPDIKRMLKDWLIRRRENPYPSREEKKQLAAETGLTYTQICN
WFANWRRKLKNSEREKAKKSWGHLIK 
 
Selected sequences 
>LagG2 >LagG9 >LagH2 >LagH8  
TTTTTTTACA CGAATTTACA CTGTTTTACA TAAGTTGACA  
>LagG3 >LagG10 >LagH3 >LagH10  
356 
CGATTTAACA TCATTTAACA AGATTTAACA ATCAGTCCTT  
>LagG5 >LagG11 >LagH4 >LagH11  
AATTTTAACA CATTTTGACA TTTTTTTACA GATTTTAACA  
>LagG6 >LagG12 >LagH5   
GATTTTAACA ATGTCAAAAA GTTTAACA   
>LagG8 >LagH1 >LagH6   
ATGTTTAACA GAATTTAACA AAAAATAACA   
 
CG12361 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
RGMMRRAVFSDSQRKGLEKRFQQQKYISKPDRKKLAERLGLKDSQVKI
WFQNRRMKWRNSKERELLASGGSRD 
 
Selected sequences 
>CG12361A1 >CG12361A6 >CG12361A11 >CG12361B4 >CG12361B11 
ATGTTTATGA TCCTTAATGA GTGATAAAAA CCAATAAAAT ATCAGTCCTT 
>CG12361A2 >CG12361A7 >CG12361A12 >CG12361B5  
TTATAAATTA CCCATAAACC GGTATTATTA GTAATTAAAA  
>CG12361A3 >CG12361A8 >CG12361B1 >CG12361B6  
CAGCCTCATCA GTGATAAAAT GGTATTATTA CAAGCATGTT  
>CG12361A4 >CG12361A9 >CG12361B2 >CG12361B7  
TAATTGATGA TGTCATTAAA GTAATCAAAG TCACGCCGAG  
>CG12361A5 >CG12361A10 >CG12361B3 >CG12361B10  
TCATTTAATA GGCAATTAAG CTAATAAACG CTACTAGATC  
 
CG13424 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
RKKRPRTAFSAAQIKALETEFERGKYLSVAKRTALAKQLQLTETQIKIWF
QNRRTKWKRKYTSDVETLASHYYA 
 
Selected sequences 
>CG13424E1 >CG13424E11 >CG13424F9 >CG13424C7 >CG13424D4 
TCAATTAGGC CTAATTAATA AGTTGACCAC AGCTATTAAG GGCTGAGTC 
>CG13424E2 >CG13424E12 >CG13424F10 >CG13424C8 >CG13424D5 
GCTAATTAAA CTGTTAATGA AGGGTCCCGC CAGTTAATAG ACTGCAAAAG 
>CG13424E3 >CG13424F2 >CG13424F11 >CG13424C9 >CG13424D7 
TGTTTAATTA TAACTAATGG GGTATACGAC GATACTTCAA ACTGCAAAAG 
>CG13424E4 >CG13424F3 >CG13424F12 >CG13424C10 >CG13424D8 
GACAATTATA TGCAATTACC CCACTATATT ACAAAGTTCA AGTGCTTCAC 
>CG13424E5 >CG13424F4 >CG13424C1 >CG13424C11 >CG13424D9 
TTATCTCCAA GCCTATTAAA CTAATTAACC CAAGACATTG ACTAGCCGTG 
357 
>CG13424E7 >CG13424F5 >CG13424C2 >CG13424C12 >CG13424D10 
CATGCTATGA TGTCTAATGA GCCTAAGAGA CCAATTAGGA CGAAATCCA 
>CG13424E8 >CG13424F6 >CG13424C3 >CG13424D1 >CG13424D11 
GAGCAGCATC TGTTATAATG GCCCCATTCT GCAATTAGTA AGGGTTAAGA 
>CG13424E9 >CG13424F7 >CG13424C5 >CG13424D2  
CCCATTAATG CCAATTATGC CGATTAATTA ATAATTAGGA  
>CG13424E10 >CG13424F8 >CG13424C6 >CG13424D3  
TCAGCCG TCAATTAAAC CTACTAATTG TCACGCCGAG  
 
CG15696 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
GRLPRIPFTPQQLQALENAYKESNYLSAEDANKLADSLELTNTRVKIWFQ
NRRARERREKREKDESCDSTFSS 
 
Selected sequences 
>CG15696G1 >CG15696G10 >CG15696H7 >156962G4 >156962G12 
CCCTTAATTA ATTAATAATA CCTAATTAAT CCTAATAATA CCAATTTAA 
>CG15696G2 >CG15696G11 >CG15696H8 >156962G5  
CCTCATTAAA CCCAATTGAG ATCAATTAAC CTTAATTACG  
>CG15696G3 >CG15696G12 >CG15696H9 >156962G6  
ACCAATTGAC GTTAATTAGC GTTAATTAAC CCGCTAATTA  
>CG15696G5 >CG15696H1 >CG15696H10 >156962G7  
TGTTTTATTA ACAAAGTTCA CCTAATTAAG TTCAATTACG  
>CG15696G6 >CG15696H2 >CG15696H11 >156962G8  
CCAATTAGAG CTCAATCAAC TCCAATTAAC CGCAATAAAA  
>CG15696G7 >CG15696H3 >156962G1 >156962G9  
CCAATTACAA GCCATCAAG AGTAATTACA TCAATCAAT  
>CG15696G8 >CG15696H4 >156962G2 >156962G10  
CTCAATCTAG ACCAATCAAG TGGGTAATTG GCTAATTAAT  
>CG15696G9 >CG15696H5 >156962G3 >156962G11  
TCTAATTAGA TTCAATTAAA CATAATCAAA ACCAATAAAA  
 
CG18599 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
NKRVRTIFTPEQLECLEAEFERQQYMVGPERLYLAHTLKLTEAQVKVWF
QNRRIKWRKHHLELTQQRLALIRQ 
 
Selected sequences 
>CG18599C1 >CG18599C7 >CG18599D2 >CG18599F1 >CG18599F7 
ATCAATTAAA AATTAATTA CTCATTATAA CCGTTAATTA GCTTAATGA 
>CG18599C2 >CG18599C8 >CG18599D3 >CG18599F2 >CG18599F9 
358 
TTGCTAATGA CCCCTAATTG CCGCGTCCG TTAATAATGA AATTCTGTCA 
>CG18599C3 >CG18599C9 >CG18599D5 >CG18599F3 >CG18599F11 
ATGCTAATTA TGATTAATGA GCCACGTGT CCGCTAATTA GTTATAATGA 
>CG18599C4 >CG18599C10 >CG18599D9 >CG18599F4 >CG18599F12 
TAATTAATTA TATCTAATTA CCCGTAATTA GCGTTAATTA AGCCTAATTA 
>CG18599C5 >CG18599C11 >CG18599D10 >CG18599F5  
CCTTTAATTA CCACTAATGA TTAATCACTC CACTAATTA  
>CG18599C6 >CG18599C12 >CG18599D11 >CG18599F6  
TTAATTAAAA CCGCTAATTA TACATAATGA CTAATTAGTA  
 
CG32105 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
PKRPRTILTSQQRKQFKASFDQSPKPCRKVREALAKDTGLSVRVVQVWF
QNQRAKMKKIQRKAKQNGGSGGGS 
 
Selected sequences 
>CG32105G2 >CG32105G7 >CG32105G12 >CG32105H5 >CG32105H11 
GCTAATTAAA ACCAATTAGA CTTAATTAAA GCTAATTAAT TTTAATTAAG 
>CG32105G3 >CG32105G8 >CG32105H1 >CG32105H6  
GTTAATTAGT TTAATATAAC CTTAATTAAA CTACCAACTT  
>CG32105G4 >CG32105G9 >CG32105H2 >CG32105H7  
GCAATTAGAC TGTCATTAAA GTAATTAATA GCTAATTAAT  
>CG32105G5 >CG32105G10 >CG32105H3 >CG32105H9  
ACTAATTATT TCAATTATAG ATTAATTAGA CTACTAAATT  
>CG32105G6 >CG32105G11 >CG32105H4 >CG32105H10  
GCAATTAATG CTTCACTGAA CTAATTTGGA GCTAATTAAT  
 
CG32532 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
RRRHRTTFTQEQLAELEAAFAKSHYPDIYCREELARTTKLNEARIQVWF
QNRRAKYRKQEKQLQKALAPS 
 
Selected sequences 
>CG32432G1 >CG32432G6 >CG32432G11 >CG32432H4 >CG32432H9 
TGTAATTAGC TCTAATTATT GTCAATTAAT ACCAATTAAT ATCAATTAAG 
>CG32432G2 >CG32432G7 >CG32432G12 >CG32432H5 >CG32432H10 
CCAATTATCA GCTTAATGA ACTAATTAAG TTTAATTATA GTTAATTAAC 
>CG32432G3 >CG32432G8 >CG32432H1 >CG32432H6 >CG32432H11 
TTAATTATCT GGTAATTACC CCAATTAACG GTTAATTAGC TACATAATGA 
>CG32432G4 >CG32432G9 >CG32432H2 >CG32432H7  
GCAAATTAAA GCAATTAGTA ACCAATTAGG TCAATTAGGA  
359 
>CG32432G5 >CG32432G10 >CG32432H3 >CG32432H8  
TAGGTAATTA CCAATTAGAT CTTAATTAAA GCCAATTAAT  
 
CG33980 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
RRHSRTIFTSYQLEKLEEAFKEAHYPDVYAREMLSLKTELPEDRIQVWFQ
NRRAKWRKTEKVWGGSTIMAEYG 
 
Selected sequences 
>CG33980A1 >CG33980A6 >CG33980A11 >CG33980B5  
TTTAATTACA GGCAATTAAC GAACACTACT TAAACTCTCC  
>CG33980A2 >CG33980A7 >CG33980A12 >CG33980B6  
TCTAATTATG GCCAATTAAC GCCAATTAAC ACTAATTAAA  
>CG33980A3 >CG33980A8 >CG33980B2 >CG33980B7  
CTCGTCAAG GTTAATTAAA TCTAATTAGA GCTAATTAGA  
>CG33980A4 >CG33980A9 >CG33980B3 >CG33980B8  
GCTAATTAAC AGGTCAGATA GTTAATTAC ATCAGTCCTT  
>CG33980A5 >CG33980A10 >CG33980B4 >CG33980B10  
GCTAATTAAC CGACTGGAGA CCTAATTATA GCTAATTAAT  
 
CG34031 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
DRKPRQAYSASQLERLENEFNLDKYLSVSKRVELSKSLSLTEVQVKTWF
QNRRTKWKKQLTSRLKIAHRHG 
 
Selected sequences 
>CG34031E1 >CG34031E10 >CG34031F8 >CG34031A6 >CG34031B5 
AACAATTACA AGGGTTAGA CAGTGTTAAT GACAATTAGA CCTATTTAAA 
>CG34031E2 >CG34031E11 >CG34031F9 >CG34031A7 >CG34031B6 
GCAATTAAAG AATGATCGTC TATTCTAAGA GCAATTAAAC GTCTATTAAA 
>CG34031E3 >CG34031E12 >CG34031F10 >CG34031A8 >CG34031B7 
GCTAATTAAC ACGTAACGA AAGAGTCCTA AACTATAAAA TCCCTAACGA 
>CG34031E4 >CG34031F1 >CG34031F11 >CG34031A9 >CG34031B8 
ATTTTTATTG GTCCAGATTG TTGGGTACAA GAACCTACTT ACTGCAAAAG 
>CG34031E5 >CG34031F2 >CG34031A1 >CG34031A10 >CG34031B9 
AACATTTAAT AGGAATTGGA CTAATTAATA GTGTTAATTG CTTCACTGAA 
>CG34031E6 >CG34031F3 >CG34031A2 >CG34031A11 >CG34031B10 
ATTTTAATAG AGCAATTAAC ATCTATTAAG AACAATTAAG ATCAGTCCTT 
>CG34031E7 >CG34031F4 >CG34031A3 >CG34031A12 >CG34031B11 
GCTTTTATAG GACCATTAAG CCAATTAAAC ACCTATTAAA GCGCTAATGA 
>CG34031E8 >CG34031F6 >CG34031A4 >CG34031B2  
360 
ACTATTAAAG GAGTTGTAGA GCAATTAAAC TGCAATTAAG  
>CG34031E9 >CG34031F7 >CG34031A5 >CG34031B3  
AGGGTACAA GAGTTGTAGA TGCAATTAAA ATCAATTAAC  
 
CG4136 
Promoter-Stringency UV5-10mM 
Amino Acid 
Sequence 
KRRHGRTIFTSSQLEELEKAFKEAHYPDVSARELLSMKTGLAEDRIQVW
YQNRRAKWRKTEKCWGHSTKMAEYG 
 
Selected sequences 
>5CG4136G1 >5CG4136G6 >5CG4136G11 >5CG4136H4 >5CG4136H9 
AGCTAATTA GCCTAATTG GCTCATTAGG GGATAATTAA AACAATTACA 
>5CG4136G2 >5CG4136G7 >5CG4136G12 >5CG4136H5 >5CG4136H10 
GTAAATTAAC GAATTAATGA ACTCATTAAC GCTTAATTG TTTAATTAAA 
>5CG4136G3 >5CG4136G8 >5CG4136H1 >5CG4136H6 >5CG4136H11 
GTCTATTAAG CCGATAATTA CTACTAATTG GCTCTAATTA CTTAATTATC 
>5CG4136G4 >5CG4136G9 >5CG4136H2 >5CG4136H7  
TATAATTAGC TCCTATTAAA CAACTAATTA GGTTTAATTA  
>5CG4136G5 >5CG4136G10 >5CG4136H3 >5CG4136H8  
ACTAATTAAG AGTAATTAGG CTTAATTACG CCGCTGTATG  
 
CG4328 
Promoter-Stringency UV5-10mM 
Amino Acid 
Sequence 
PKRPRTILNTQQRRAFKASFEVSPKPCRKVRENLAKDTGLSLRIVQVWFQ
NQRAKVKKIQKKAKQEPPSKGAS 
 
Selected sequences 
>5CG4328E1 >5CG4328E7 >5CG4328F1 >5CG4328F9 >5CG43282A5 
GCAATAAGCA ATCAATAAAT CACAATTAGA TTAATTATCG CTTAATAAAT 
>5CG4328E2 >5CG4328E8 >5CG4328F2 >5CG4328F10 >5CG43282A6 
GAATATATTA GCTATAATTA CCAATTATAC TCAATAATGA CGTATATGAA 
>5CG4328E3 >5CG4328E9 >5CG4328F4 >5CG4328F11 >5CG43282A7 
TTTCATAATGT CGTCATTATT GCCAATTACA TTTAATTATT GCAATAAATT 
>5CG4328E4 >5CG4328E10 >5CG4328F5 >5CG43282A1 >5CG43282A8 
ATCGTTATTG CCATTAATA GTTAATTATT ACTCATAATT TCAATTATCA 
>5CG4328E5 >5CG4328E11 >5CG4328F6 >5CG43282A2 >5CG43282A10 
GCAATATCTA CGTAATATAA TGCAATATAT ATCAATAATA TTAATATGAG 
>5CG4328E6 >5CG4328E12 >5CG4328F7 >5CG43282A3 >5CG43282A11 
CCTCAATTATG CCTAATTAAG AGCAATATAG ATATTTATTA GCAATTAAAG 
 
CG7056 
Promoter-Stringency UV5m-10mM 
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Amino Acid 
Sequence 
RKGGQIRFTSQQTKNLEARFASSKYLSPEERRHLALQLKLTDRQVKTWF
QNRRAKWRRANLSKRSASAQGPI 
 
Selected sequences 
>CG7065A1 >CG7065A9 >CG7065B5 >CG7065B11 >CG7056G6 
ATTTTGATAA TACTGAAGTA GTTTCGATTA CATTAATAAC TATTTAATTA 
>CG7065A4 >CG7065A10 >CG7065B6 >CG7056G1 >CG7056G7 
CCTTTAATAA TATTTAATGA CATTGTACTA ATATTAATTA GGTAATTAGA 
>CG7065A5 >CG7065A11 >CG7065B7 >CG7056G2 >CG7056G8 
ACTCTAATTA GAACCTACTT TAACCAATAA CTTTGAAGTA CTTTTAATAA 
>CG7065A6 >CG7065B1 >CG7065B8 >CG7056G3 >CG7056G10 
TGCTCAACAA AAGTCAATTA CATTGTACTA ACCCTAATTG ATCTTATTAC 
>CG7065A7 >CG7065B3 >CG7065B9 >CG7056G4 >CG7056G11 
AAATGAATTG AGCACAACAA GTTTTAATAA AATCAATTAC AGACCAATTG 
>CG7065A8 >CG7065B4 >CG7065B10 >CG7056G5 >CG7056G12 
TGGTTAATTA TTATCTCCAA TTCTGACCAT ATTTGAATTG GGACGAAGTA 
 
CG9876 
Promoter-Stringency UV5m-10mM 
Amino Acid 
Sequence 
PRRNRTTFSSAQLTALEKVFERTHYPDAFVREELATKVHLSEARVQVWF
QNRRAKFRRNERSVGSRTLLDTA 
 
Selected sequences 
>CG9876A1 >CG9876A6 >CG9876B2 >CG9876B7 >CG9876B12 
ACAATTAGCA AGTTATTAAG CCAATTAGTG TTTAATTAAT TGCAATTATC 
>CG9876A2 >CG9876A7 >CG9876B3 >CG9876B8  
ACTCATTACG CCAATTAGTG CAATAATTAG TCTAATTATC  
>CG9876A3 >CG9876A8 >CG9876B4 >CG9876B9  
TGACTAATTA CTATTAATTA ACTAATTAGA GCTAATTAAC  
>CG9876A4 >CG9876A9 >CG9876B5 >CG9876B10  
CTCGTAATTG AGACCAAGCA TTTAATTAAG ACTAATTAAC  
>CG9876A5 >CG9876A10 >CG9876B6 >CG9876B11  
GTTAATTGA ACTTATTAAC TTTAATTACA ATTAATTATG  
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Table A.3 
Master alignment of selected binding sites.  Sequences that were identified for each factor to contain an 
overrepresented motif based on CONSENSUS analysis were aligned at the common Ade at binding site 
position 3 that is shared by all Asn51 containing homeodomains.
>Vis:VisG1b:-:5:1 
aaaTGACAc- 
>Vis:VisG2b:-:6:2 
actTGACA-- 
>Vis:VisG4b:-:5:4 
aggTGACAt- 
>Vis:VisG5b:+:4:5 
-aaTGACAgc 
>Vis:VisG6b:+:4:6 
-gtTGACAcc 
>Vis:VisG7b:-:6:7 
agtTGACA-- 
>Vis:VisG8b:+:2:8 
cgaTGACAg- 
>Vis:VisG10b:-:4:10 
tccTGACAgt 
>Vis:VisG1:-:5:13 
aaaTGACA-- 
>Vis:VisG2:-:5:14 
ctcTGACAg- 
>Vis:VisG3:-:5:15 
ttaTGACAc- 
>Vis:VisG4:-:6:16 
cgtTGACA-- 
>Vis:VisG5:-:5:17 
aagTGACAa- 
>Vis:VisG6:+:4:18 
-gaTGACAag 
>Vis:VisG7:-:6:19 
tttTGACA-- 
>Vis:VisG8:-:6:20 
aagTGACA-- 
>Vis:VisG9:+:3:21 
gttTGACAcg 
>Vis:VisG10:+:4:22 
-ttTGACAgt 
>Vis:VisG11:+:4:23 
-agTGACAgc 
>Vis:VisG12:+:3:24 
taaTGACAgc 
>Vis:VisH2:-:5:26 
agtTGACAt- 
>Vis:VisH10:-:4:33 
tccTGACAgt 
>Achi:AchiG1:-:1:1 
-CTTGACA-- 
>Achi:AchiG2:+:3:2 
aTGTGACA-- 
>Achi:AchiG3:-:4:3 
-CATGACAgc 
>Achi:AchiG4:+:4:4 
aTCTGACA-- 
>Achi:AchiG5:+:3:5 
gCATGACAg- 
>Achi:AchiG6:+:3:6 
gTTTGACAt- 
>Achi:AchiG8:-:4:8 
-TATGACAgg 
>Achi:AchiG9:-:3:9 
tTTTGACAac 
>Achi:AchiG10:+:4:10 
aTCTGACA-- 
>Achi:AchiH1:-:2:11 
aTTTGATAt- 
>Achi:AchiH2:-:4:12 
-TCTGACAgc 
>Achi:AchiH3:+:3:13 
aAATGACA-- 
>Achi:AchiH4:-:4:14 
-ACTGACAga 
>Achi:AchiH6:-:3:16 
tTTTGACAgc 
>Achi:AchiH11:-:3:19 
cTTTGACAgc 
>Achi:achi2F1:+:3:20 
gAATGACAa- 
>Achi:achi2F2:-:4:21 
-TTTGACAac 
>Achi:achi2F3:-:2:22 
gATTGACAg- 
>Achi:achi2F4:-:4:23 
-TTTGACAgc 
>Achi:achi2F6:+:4:25 
aGATGACA-- 
>Achi:achi2F8:-:3:26 
-TTTGACAgg 
>Achi:achi2F11:-
:4:29 
-TTTGACAgc 
>Achi:achi2F12:-
:3:30 
gTTTGACAgg 
>Hth:hthC2:+:5:1 
ttgTGACAg- 
>Hth:hthC3:-:4:2 
-ttTGACAta 
>Hth:hthC4:-:2:3 
cctTGACGt- 
>Hth:hthC5:-:3:4 
ctgTGACAgg 
>Hth:hthC6:+:4:5 
ctgTGACGt- 
>Hth:hthC8:-:1:6 
-gaTGACA-- 
>Hth:hthC9:-:4:7 
-gcTGACAgt 
>Hth:hthC10:+:6:8 
accTGACG-- 
>Hth:hthC11:+:5:9 
cgaTGACAg- 
>Hth:hthC12:-:1:10 
gttTGACA-- 
>Hth:hthD1:-:3:11 
cagTGACAgg 
>Hth:hthD2:-:4:12 
-ttTGACAgc 
>Hth:hthD3:+:5:13 
attTGACAt- 
>Hth:hthD4:+:5:14 
aggTGACAg- 
>Hth:hthD6:-:4:16 
-aaTGACAgc 
>Hth:hthD9:-:1:19 
caaTGACA-- 
>Hth:hthD11:+:6:21 
tcgTGACA-- 
>Six4:5Six4E1:+:1:1 
ATTTGATAC- 
>Six4:5Six4E2:+:1:2 
CTTTGAGAC- 
>Six4:5Six4E3:+:1:3 
ATTTGATAC- 
>Six4:5Six4E4:+:2:4 
ATCTGACACc 
>Six4:5Six4E5:+:1:5 
AAATGAGAC- 
>Six4:5Six4E6:+:2:6 
TCTTGATACc 
>Six4:5Six4E8:+:1:8 
AGATGATAC- 
>Six4:5Six4E9:+:1:9 
TTTTGAGAA- 
>Six4:5Six4E10:+:2:1
0 
AGTTGACACc 
>Six4:5Six4E11:+:2:1
1 
GTATGATACc 
>Six4:5Six4E12:+:2:1
2 
GTCTGACACc 
>Six4:5Six4F1:+:2:13 
ACATGACACc 
>Six4:5Six4F2:+:1:14 
AAGTGATAC- 
>Six4:5Six4F3:+:2:15 
AATTGACACc 
>Six4:5Six4F4:+:2:16 
CTGTGACACc 
>Six4:5Six4F5:+:2:17 
TAATGATACc 
>Six4:5Six4F6:+:2:18 
TGATGACACc 
>Six4:5Six4F7:+:2:19 
TTTTGATACc 
>Six4:5Six4F10:+:1:2
1 
ATTTGAGAC- 
>Six4:5Six4F11:+:1:2
2 
TTGTGATAC- 
>Optix:11617C4:+:1:3 
AAGTGATA-- 
>Optix:11617C6:+:1:5 
ATGTGATA-- 
>Optix:11617C7:+:1:6 
CAGTGATA-- 
>Optix:11617C8:+:1:7 
TTGCGATA-- 
>Optix:11617C9:-:1:8 
TAGCGATG-- 
>Optix:11617C11:+:1:
10 
TAGTGATA-- 
>Optix:11617D8:+:1:1
7 
AAATGATA-- 
>Optix:11617D9:+:1:1
8 
TAGTGATA-- 
>Optix:11617D10:+:1:
19 
AAGTGATA-- 
>Optix:11617D11:+:1:
20 
TAGTGATA-- 
>Optix:11617D12:+:1:
21 
AGATGATA-- 
>Optix:OptixE8:+:1:2
9 
AAGTGATA-- 
>Optix:Optix2A2:+:1:
34 
CCATGATA-- 
>Optix:Optix2A3:+:1:
35 
ATGTGATA-- 
>Optix:Optix2A4:+:1:
36 
AGCTGATA-- 
>Optix:Optix2A5:+:1:
37 
ATCTGATA-- 
>Optix:Optix2A6:+:1:
38 
AGCTGATA-- 
>Optix:Optix2A10:+:1
:41 
CCGCGATA-- 
>Optix:Optix2A11:+:1
:42 
GATTGATA-- 
>Optix:Optix2A12:+:1
:43 
CCTTGATA-- 
>Optix:Optix2B1:+:1:
44 
TCGCGATA-- 
>Optix:Optix2B3:+:1:
46 
TTGCGATA-- 
>Optix:Optix2B4:+:1:
47 
GATTGATA-- 
>Optix:Optix2B5:+:1:
48 
AAGTGATA-- 
>Optix:Optix2B6:+:1:
49 
AAGTGATA-- 
>Optix:Optix2B7:+:1:
50 
TTATGATA-- 
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>Optix:Optix2B8:+:1:
51 
TTCTGATA-- 
>So:SoE1:-:2:1 
cTGTGATAc- 
>So:SoE2:+:4:2 
cGATGATA-- 
>So:SoE3:-:3:3 
tATTGATAct 
>So:SoE5:-:3:5 
gAATGATAct 
>So:SoE6:+:4:6 
aAATGATA-- 
>So:SoE7:-:2:7 
tTGTGATAc- 
>So:SoE8:-:2:8 
aTCTGATAc- 
>So:SoE9:+:4:9 
tAGTGATA-- 
>So:SoE11:-:2:10 
tTTTGATAc- 
>So:SoE12:+:4:11 
gGATGATA-- 
>So:SoF2:+:4:12 
tGATGATA-- 
>So:SoF4:-:2:14 
aAATGATAc- 
>So:SoF5:-:2:15 
gAGGGATAt- 
>So:SoF7:-:2:17 
aAATGATAc- 
>So:SoF9:+:4:19 
gCATGAGA-- 
>So:SoF11:-:2:21 
aAGTGATAc- 
>So:So2E1:+:4:22 
tCGTGATA-- 
>So:So2E2:+:4:23 
tATTGATA-- 
>So:So2E3:-:3:24 
cAGTGATAtg 
>So:So2E4:+:4:25 
gCATGATA-- 
>So:So2E5:-:3:26 
gTGTGATAcc 
>So:So2E6:+:4:27 
gGATGATA-- 
>So:So2E7:+:4:28 
cAGTGATA-- 
>So:So2E9:-:3:30 
tTGTGATAtg 
>So:So2E10:+:4:31 
aCATGATA-- 
>So:So2E11:+:4:32 
tGATGATA-- 
>So:So2E12:+:4:33 
cAATGATA-- 
>Exd:ExdE1:+:1:1 
GTTTGACAt- 
>Exd:ExdE3:+:1:3 
CTTTGACAt- 
>Exd:ExdE5:+:2:5 
TTTTGACA-- 
>Exd:ExdE6:+:2:6 
ATTTGACA-- 
>Exd:ExdE7:+:1:7 
CTTTGATGa- 
>Exd:ExdE8:+:1:8 
GATTGATGa- 
>Exd:ExdE9:+:2:9 
AGTTGACA-- 
>Exd:ExdE10:+:1:10 
TTTTGACGa- 
>Exd:ExdE12:+:2:12 
TTTTGACA-- 
>Exd:ExdF1:+:1:13 
AGTTGACAt- 
>Exd:ExdF2:+:1:14 
TTTTGATGg- 
>Exd:ExdF3:+:1:15 
CTTTGATGa- 
>Exd:ExdF4:+:2:16 
ATTTGACA-- 
>Exd:ExdF5:+:2:17 
GTTTGACA-- 
>Exd:ExdF6:+:1:18 
GTTTGATGa- 
>Exd:ExdF7:+:2:19 
TTTTGACA-- 
>Exd:ExdF9:+:2:20 
CTTTGACA-- 
>onecut:5onectG1:+:4
:1 
agCTGATTA- 
>onecut:5onectG2:-
:3:2 
-cTTGATTTc 
>onecut:5onectG3:-
:2:3 
ccTTGATTGc 
>onecut:5onectG4:-
:2:4 
taTTGATTAa 
>onecut:5onectG8:+:4
:8 
ctATGATTA- 
>onecut:5onectG10:-
:2:9 
taTTGATTAa 
>onecut:5onectG11:-
:3:10 
-aTTGATTTg 
>onecut:5onectG12:-
:3:11 
-tCTGATTGa 
>onecut:5onectH1:+:4
:12 
agTTGATTG- 
>onecut:5onectH2:-
:3:13 
-aTTGATTTg 
>onecut:5onectH4:-
:3:15 
-cTTGATTTg 
>onecut:5onectH5:+:5
:16 
tcTTGATTT- 
>onecut:5onectH7:-
:3:18 
-gTTGATTTg 
>onecut:5onectH10:-
:3:21 
-tTTGATTGg 
>onecut:5onectH11:-
:2:22 
cgTTGATTAg 
>Vnd:VndE2:+:1:1 
TCTCAAGTG- 
>Vnd:VndE3:+:1:2 
TCTCAAGTA- 
>Vnd:VndE5:+:1:3 
ATTGAAGTA- 
>Vnd:VndE7:+:1:4 
GGTCAAGTA- 
>Vnd:VndE8:+:1:5 
TCTCAAGTA- 
>Vnd:VndE9:+:1:6 
TCTCAAGTG- 
>Vnd:VndE10:+:1:7 
TTTTAAGTA- 
>Vnd:VndE11:+:1:8 
TCTCAAGTG- 
>Vnd:VndE12:+:1:9 
ATTGAAGTA- 
>Vnd:VndF1:+:1:10 
GTTCAAGAG- 
>Vnd:VndF2:+:1:11 
TTTCAAGTG- 
>Vnd:VndF4:+:1:13 
TCTTAAGTA- 
>Vnd:VndF5:+:1:14 
TATCAAGAG- 
>Vnd:VndF6:+:1:15 
TCTCAAGTA- 
>Vnd:VndF7:+:1:16 
ACTCAAGTG- 
>Vnd:VndF8:+:1:17 
TTTCAAGTG- 
>Vnd:VndF9:+:1:18 
TTTCAAGTA- 
>Vnd:VndF10:+:1:19 
TTTCAAGTG- 
>Vnd:VndF12:+:1:21 
ATTCAAGTG- 
>Tin:TinA2:-:3:1 
gCTCAAGTA- 
>Tin:TinA3:+:3:2 
-GTCAAGTAc 
>Tin:TinA4:+:2:3 
cGTCAAGTGg 
>Tin:TinA5:-:3:4 
tCTCAAGTG- 
>Tin:TinA6:+:2:5 
aTTCAAGTGg 
>Tin:TinA7:+:3:6 
-GTCAAGTGc 
>Tin:TinA8:+:3:7 
-CTTAAGTAc 
>Tin:TinA9:+:3:8 
-CTTAAGTGg 
>Tin:TinA10:+:3:9 
-TTTAAGTGg 
>Tin:TinA11:+:2:10 
cCACAAGTGg 
>Tin:TinB1:+:3:11 
-CTCAAGTGg 
>Tin:TinB3:+:3:12 
-CTTAAGTGt 
>Tin:TinB4:+:2:13 
-TTCAAGTGg 
>Tin:TinB5:+:3:14 
-CTCAAGTGg 
>Tin:TinB6:+:3:15 
-CTCAAGTGc 
>Tin:TinB9:+:3:18 
-TTGAAGTGg 
>Bap:BapA2:-:1:1 
GCTTAAGTGG 
>Bap:BapA3:-:1:2 
TCTTAAGTGG 
>Bap:BapA12:-:1:10 
AGTTAAGTGG 
>Bap:BapB1:-:1:11 
GTTTAAGTGG 
>Bap:BapB5:-:1:14 
TGTTAAGTGG 
>Bap:BapB6:-:1:15 
TCTTAAGTGG 
>Bap:BapB7:-:1:16 
ACTTAAGTAC 
>Bap:BapB9:-:1:18 
TGTTAAGTGG 
>Bap:BapB11:-:1:20 
CGTTAAGTGG 
>Bap:Bap2C1:+:1:21 
CTTTAAGTGT 
>Bap:Bap2C2:-:1:22 
ACTTAAGTAC 
>Bap:Bap2C3:-:1:23 
TTTTAAGTGT 
>Bap:Bap2C4:-:1:24 
CTGTAAGTGT 
>Bap:Bap2C6:-:1:26 
GCTTAAGTGC 
>Bap:Bap2C7:-:1:27 
ACTTAAGAAC 
>Bap:Bap2C8:-:1:28 
TCTTAAGTAC 
>Bap:Bap2C9:-:1:29 
ATTTAAGTGA 
>Bap:Bap2C10:-:1:30 
TATTAAGTAC 
>Bap:Bap2C12:-:1:31 
TTTTAAGTGA 
>Bap:Bap2D2:-:1:32 
CTTTAAGTAC 
>Bap:Bap2D3:-:1:33 
GGTTAAGTGG 
>Bap:Bap2D10:-:1:38 
ATTTAAGTGA 
>Bap:Bap2D11:-:1:39 
ACTTAAGTAC 
>CG7056:CG7065A1:+:3
:1 
tTTTGATAA- 
>CG7056:CG7065A4:+:3
:2 
cTTTAATAA- 
>CG7056:CG7065A5:+:3
:3 
cTCTAATTA- 
>CG7056:CG7065A6:+:3
:4 
gCTCAACAA- 
>CG7056:CG7065A7:+:3
:5 
aATGAATTG- 
>CG7056:CG7065A8:+:3
:6 
gGTTAATTA- 
>CG7056:CG7065A9:+:3
:7 
aCTGAAGTA- 
>CG7056:CG7065A10:+:
3:8 
aTTTAATGA- 
>CG7056:CG7065B1:+:3
:10 
aGTCAATTA- 
>CG7056:CG7065B5:+:3
:13 
tTTCGATTA- 
>CG7056:CG7065B6:+:3
:14 
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aTTGTACTA- 
>CG7056:CG7065B7:+:3
:15 
aACCAATAA- 
>CG7056:CG7065B8:+:3
:16 
aTTGTACTA- 
>CG7056:CG7065B9:+:3
:17 
tTTTAATAA- 
>CG7056:CG7065B11:+:
2:19 
cATTAATAAc 
>Ubx:UbxC02:+:3:1 
aATTAATTA- 
>Ubx:UbxC03:+:3:2 
aTTTTATTA- 
>Ubx:UbxC04:+:3:3 
cTTTAATTA- 
>Ubx:UbxC05:+:3:4 
cTTTAATTA- 
>Ubx:UbxC06:+:3:5 
tATTAATTA- 
>Ubx:UbxC07:-:3:6 
-TTTTATTGc 
>Ubx:UbxC08:-:3:7 
-CTTAATTGc 
>Ubx:UbxC11:+:3:8 
tATTAATGA- 
>Ubx:UbxC12:+:3:9 
aTTTAATGG- 
>Ubx:UbxD01:+:2:10 
tCTTAATGA- 
>Ubx:UbxD02:+:3:11 
cGTTAATTA- 
>Ubx:UbxD04:+:3:12 
cCTTAATTA- 
>Ubx:UbxD05:-:3:13 
-TTTAATTGt 
>Ubx:UbxD06:+:3:14 
cGTTAATTA- 
>Ubx:UbxD07:-:3:15 
-TTTAATGGg 
>Ubx:UbxD08:+:3:16 
cCTTAATGA- 
>Ubx:UbxD09:+:3:17 
cCTTAATTA- 
>Ubx:UbxD10:+:3:18 
tTTTTATGA- 
>Ubx:UbxD11:-:3:19 
-GTTAATTAc 
>Ubx:UbxD12:-:3:20 
-TTTAATTGc 
>C15:C15A1:-:3:1 
aTTTAAAGA- 
>C15:C15A2:+:3:2 
-GTTAATTGg 
>C15:C15A3:+:3:3 
-GTTAATGGg 
>C15:C15A4:+:3:4 
-CTTAAACGa 
>C15:C15A5:+:3:5 
-CTTAACGAg 
>C15:C15A6:-:1:6 
-GTTTAACA- 
>C15:C15A7:+:1:7 
cGTTAAACA- 
>C15:C15A8:-:3:8 
cGTTAACGA- 
>C15:C15A9:-:3:9 
tCTTAATTG- 
>C15:C15A10:-:3:10 
cGTTAATGA- 
>C15:C15A11:+:3:11 
-CTTAAATGa 
>C15:C15A12:-:3:12 
aTTTAATTG- 
>C15:C15B1:+:3:13 
-GTTAATTGg 
>C15:C15B2:+:3:14 
-AATAATGGg 
>C15:C15B4:+:3:15 
-TTTAATTAg 
>C15:C15B6:-:2:16 
aTCTTATTAc 
>C15:C15B8:+:3:18 
-ATTAATTAg 
>C15:C15B9:+:3:19 
-TTTAAATAg 
>C15:C15B11:+:3:21 
-GTTAATTGc 
>Mirr:MirrE1:+:1:1 
TTGTAACA-- 
>Mirr:MirrE2:+:1:2 
CAGTAACA-- 
>Mirr:MirrE3:+:1:3 
TAAATACA-- 
>Mirr:MirrE4:+:1:4 
AGCAAACA-- 
>Mirr:MirrE5:+:1:5 
CTATAACA-- 
>Mirr:MirrE6:+:1:6 
TAATAACA-- 
>Mirr:MirrE7:+:1:7 
TCGTGACA-- 
>Mirr:MirrE8:+:1:8 
AAGTTACA-- 
>Mirr:MirrE9:+:1:9 
AACTTACA-- 
>Mirr:MirrE10:+:1:10 
AAAAAACA-- 
>Mirr:MirrE11:+:1:11 
AGAAAACA-- 
>Mirr:MirrE12:+:1:12 
AAAAAACA-- 
>Mirr:MirrF2:+:1:14 
TACTTACA-- 
>Mirr:MirrF3:+:1:15 
AGAAAACA-- 
>Mirr:MirrF4:+:1:16 
GAAAAACA-- 
>Mirr:MirrF5:+:1:17 
TGAAAACA-- 
>Mirr:MirrF6:+:1:18 
GCCTGACA-- 
>Mirr:MirrF7:+:1:19 
AATTTACA-- 
>Mirr:MirrF8:+:1:20 
TCAAAACA-- 
>Mirr:MirrF9:+:1:21 
AGAAAACA-- 
>Mirr:MirrF10:+:1:22 
ACAAAACA-- 
>Mirr:MirrF11:+:1:23 
AAATAACA-- 
>Mirr:Mirr2C2:+:1:24 
CAGAAACA-- 
>Mirr:Mirr2C3:+:1:25 
AACAAACA-- 
>Mirr:Mirr2C4:+:1:26 
GTACTACA-- 
>Mirr:Mirr2C5:+:1:27 
TTCGAACA-- 
>Mirr:Mirr2C7:+:1:28 
ATTTAACA-- 
>Mirr:Mirr2C8:+:1:29 
TTGTAACA-- 
>Mirr:Mirr2C9:+:1:30 
AGAAAACA-- 
>Mirr:Mirr2C11:+:1:3
2 
TGAAAACA-- 
>Mirr:Mirr2C12:+:1:3
3 
GATATACA-- 
>Mirr:Mirr2D1:+:1:34 
CTCTTACA-- 
>Mirr:Mirr2D2:+:1:35 
AAATTACA-- 
>Mirr:Mirr2D3:+:1:36 
ATATAACA-- 
>Mirr:Mirr2D4:+:1:37 
GTTAAACA-- 
>Mirr:Mirr2D5:+:1:38 
CATAAACA-- 
>Mirr:Mirr2D7:+:1:40 
TGAAAACA-- 
>Mirr:Mirr2D8:+:1:41 
AGTTTACA-- 
>Mirr:Mirr2D9:+:1:42 
AGAAAACA-- 
>Mirr:Mirr2D10:+:1:4
3 
CAATAACA-- 
>Mirr:Mirr2D11:+:1:4
4 
GAATAACA-- 
>Ara:AraG1:+:1:1 
GTATTACA-- 
>Ara:AraG2:-:1:2 
TAAGTACA-- 
>Ara:AraG4:+:1:3 
AGTTTACA-- 
>Ara:AraG5:+:1:4 
TAATTACA-- 
>Ara:AraG7:+:1:6 
GGAAAACA-- 
>Ara:AraG8:+:1:7 
GTATTACA-- 
>Ara:AraG11:+:1:9 
GATATACA-- 
>Ara:AraG12:+:1:10 
TTAGAACA-- 
>Ara:AraH3:+:1:11 
GAATAACA-- 
>Ara:AraH5:+:1:12 
ACATAACA-- 
>Ara:AraH6:+:1:13 
TGTAAACA-- 
>Ara:AraH7:-:1:14 
GCTGAACA-- 
>Ara:AraH8:+:1:15 
CAAAAACA-- 
>Ara:AraH9:+:1:16 
ACATAACA-- 
>Ara:AraH10:+:1:17 
CAAAAACA-- 
>Ara:AraH11:+:1:18 
CTTTTACA-- 
>Ara:Ara2G1:+:1:19 
CCCAAACA-- 
>Ara:Ara2G2:+:1:20 
AATTAACA-- 
>Ara:Ara2G3:+:1:21 
AAGTTACA-- 
>Ara:Ara2G4:+:1:22 
AGAGAACA-- 
>Ara:Ara2G5:+:1:23 
TATAAACA-- 
>Ara:Ara2G6:+:1:24 
GAAAAACA-- 
>Ara:Ara2G7:+:1:25 
TAATAACA-- 
>Ara:Ara2G8:+:1:26 
GTAGAACA-- 
>Ara:Ara2G10:+:1:27 
TGAAAACA-- 
>Ara:Ara2G12:+:1:29 
AATTAACA-- 
>Ara:Ara2H1:+:1:30 
AAAAAACA-- 
>Ara:Ara2H2:+:1:31 
CCAAAACA-- 
>Ara:Ara2H4:+:1:33 
AAATTACA-- 
>Ara:Ara2H6:+:1:34 
GAAAAACA-- 
>Ara:Ara2H8:+:1:35 
ACATTACA-- 
>Ara:Ara2H9:+:1:36 
ACAAAACA-- 
>Ara:Ara2H10:+:1:37 
AGAAAACA-- 
>Ara:Ara2H11:+:1:38 
GAATTACA-- 
>Caup:CaupA2:+:1:1 
TATTAACA-- 
>Caup:CaupA3:+:1:2 
CTTTTACA-- 
>Caup:CaupA4:+:1:3 
CAAAAACA-- 
>Caup:CaupA5:+:1:4 
GTTGTACA-- 
>Caup:CaupA6:+:1:5 
CTATTACA-- 
>Caup:CaupA7:+:1:6 
CATTAACA-- 
>Caup:CaupA8:+:1:7 
AGTTAACA-- 
>Caup:CaupA9:+:1:8 
AAAGAACA-- 
>Caup:CaupA10:+:1:9 
CTTTAACA-- 
>Caup:CaupA11:+:1:10 
AAATGACA-- 
>Caup:CaupA12:+:1:11 
CTAAAACA-- 
>Caup:CaupB1:+:1:12 
TAATAACA-- 
>Caup:CaupB2:+:1:13 
TTGTGACA-- 
>Caup:CaupB3:+:1:14 
CGGAAACA-- 
>Caup:CaupB4:+:1:15 
GGTTAACA-- 
>Caup:CaupB5:+:1:16 
TAATAACA-- 
>Caup:CaupB9:+:1:19 
CAGCAACA-- 
>Caup:CaupB10:+:1:20 
CTGTAACA-- 
>Caup:CaupB11:+:1:21 
AAAAAACA-- 
>CG11617:LagG2:+:3:1 
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TTTTTACA-- 
>CG11617:LagG3:+:3:2 
ATTTAACA-- 
>CG11617:LagG5:+:3:3 
TTTTAACA-- 
>CG11617:LagG6:+:3:4 
TTTTAACA-- 
>CG11617:LagG8:+:3:5 
GTTTAACA-- 
>CG11617:LagG9:+:3:6 
AATTTACA-- 
>CG11617:LagG10:+:3:
7 
ATTTAACA-- 
>CG11617:LagG11:+:3:
8 
TTTTGACA-- 
>CG11617:LagG12:-
:2:9 
TTTTGACAt- 
>CG11617:LagH1:+:3:1
0 
ATTTAACA-- 
>CG11617:LagH2:+:3:1
1 
GTTTTACA-- 
>CG11617:LagH3:+:3:1
2 
ATTTAACA-- 
>CG11617:LagH4:+:3:1
3 
TTTTTACA-- 
>CG11617:LagH5:+:1:1
4 
GTTTAACA-- 
>CG11617:LagH6:+:3:1
5 
AAATAACA-- 
>CG11617:LagH8:+:3:1
6 
AGTTGACA-- 
>CG11617:LagH11:+:3:
18 
TTTTAACA-- 
>Ct:5CtE1:+:1:1 
TGCTAAAC-- 
>Ct:5CtE2:+:1:2 
GTCTGAAC-- 
>Ct:5CtE3:+:1:3 
GGTTAAAC-- 
>Ct:5CtE4:+:1:4 
CGTTAATC-- 
>Ct:5CtE5:+:1:5 
CATTGAAC-- 
>Ct:5CtE6:+:1:6 
GATTAAAC-- 
>Ct:5CtE7:+:1:7 
TCTTGAAC-- 
>Ct:5CtE9:+:1:9 
AGTTAAAC-- 
>Ct:5CtE10:+:1:10 
TGCTAATC-- 
>Ct:5CtE11:+:1:11 
GTTCAAAG-- 
>Ct:5CtE12:+:1:12 
GCTCGAGC-- 
>Ct:5CtF1:+:1:13 
TCCTGAAC-- 
>Ct:5CtF3:+:1:15 
AATTGAAC-- 
>Ct:5CtF5:+:1:17 
TTCTGAAC-- 
>Ct:5CtF6:+:1:18 
CCTTGAAC-- 
>Ct:5CtF7:+:1:19 
ACTTAAAC-- 
>Ct:5CtF8:+:1:20 
GGTTGAAC-- 
>Ct:5CtF9:+:1:21 
GCTAAAAC-- 
>Ct:5CtF10:+:1:22 
TCTTGAAC-- 
>Ct:5CtF11:+:1:23 
TCCTGAAC-- 
>CG15696:CG15696G1:-
:3:1 
cCTTAATTA- 
>CG15696:CG15696G2:+
:3:2 
-TTTAATGAg 
>CG15696:CG15696G3:+
:3:3 
-GTCAATTGg 
>CG15696:CG15696G5:-
:3:4 
gTTTTATTA- 
>CG15696:CG15696G6:+
:2:5 
cTCTAATTGg 
>CG15696:CG15696G7:+
:2:6 
tTGTAATTGg 
>CG15696:CG15696G8:+
:3:7 
-CTAGATTGa 
>CG15696:CG15696G9:-
:1:8 
-TCTAATTAg 
>CG15696:CG15696G10:
+:3:9 
-TATTATTAa 
>CG15696:CG15696G11:
+:3:10 
-CTCAATTGg 
>CG15696:CG15696G12:
-:1:11 
-GTTAATTAg 
>CG15696:CG15696H2:+
:3:13 
-GTTGATTGa 
>CG15696:CG15696H3:+
:2:14 
-CTTGATGGc 
>CG15696:CG15696H4:+
:3:15 
-CTTGATTGg 
>CG15696:CG15696H5:+
:3:16 
-TTTAATTGa 
>CG15696:CG15696H7:+
:3:17 
-ATTAATTAg 
>CG15696:CG15696H8:+
:3:18 
-GTTAATTGa 
>CG15696:CG15696H9:+
:3:19 
-GTTAATTAa 
>CG15696:CG15696H10:
+:3:20 
-CTTAATTAg 
>CG15696:CG15696H11:
+:3:21 
-GTTAATTGg 
>CG15696:156962G1:+:
3:22 
-TGTAATTAc 
>CG15696:156962G2:-
:3:23 
gGGTAATTG- 
>CG15696:156962G3:+:
3:24 
-TTTGATTAt 
>CG15696:156962G4:+:
3:25 
-TATTATTAg 
>CG15696:156962G5:-
:1:26 
-CTTAATTAc 
>CG15696:156962G6:-
:3:27 
cGCTAATTA- 
>CG15696:156962G7:-
:1:28 
-TTCAATTAc 
>CG15696:156962G8:+:
3:29 
-TTTTATTGc 
>CG15696:156962G9:+:
2:30 
-ATTGATTGa 
>CG15696:156962G10:+
:3:31 
-ATTAATTAg 
>CG15696:156962G11:+
:3:32 
-TTTTATTGg 
>CG15696:156962G12:+
:2:33 
-TTAAATTGg 
>CG4328:5CG4328E1:+:
2:1 
tGCTTATTGc 
>CG4328:5CG4328E2:-
:3:2 
aATATATTA- 
>CG4328:5CG4328E3:+:
3:3 
aCATTATGAa 
>CG4328:5CG4328E4:-
:3:4 
tCGTTATTG- 
>CG4328:5CG4328E5:+:
2:5 
tAGATATTGc 
>CG4328:5CG4328E6:+:
4:6:mod 
cctCAATTAT 
>CG4328:5CG4328E7:+:
3:7 
-ATTTATTGa 
>CG4328:5CG4328E8:-
:3:8 
cTATAATTA- 
>CG4328:5CG4328E9:+:
3:9 
-AATAATGAc 
>CG4328:5CG4328E10:+
:1:10 
tATTAATGG- 
>CG4328:5CG4328E11:+
:3:11 
-TTATATTAc 
>CG4328:5CG4328E12:+
:3:12 
-CTTAATTAg 
>CG4328:5CG4328F1:+:
3:13 
-TCTAATTGt 
>CG4328:5CG4328F2:+:
2:14 
gTATAATTGg 
>CG4328:5CG4328F4:+:
3:15 
-TGTAATTGg 
>CG4328:5CG4328F5:+:
3:16 
-AATAATTAa 
>CG4328:5CG4328F6:+:
3:17 
-ATATATTGc 
>CG4328:5CG4328F7:+:
3:18 
-CTATATTGc 
>CG4328:5CG4328F9:+:
2:19 
cGATAATTAa 
>CG4328:5CG4328F10:+
:2:20 
tCATTATTGa 
>CG4328:5CG4328F11:+
:3:21 
-AATAATTAa 
>CG4328:5CG43282A1:+
:3:22 
-AATTATGAg 
>CG4328:5CG43282A2:+
:3:23 
-TATTATTGa 
>CG4328:5CG43282A3:-
:3:24 
tATTTATTA- 
>CG4328:5CG43282A5:+
:3:25 
-ATTTATTAa 
>CG4328:5CG43282A6:-
:2:26 
cGTATATGAa 
>CG4328:5CG43282A7:+
:2:27 
aATTTATTGc 
>CG4328:5CG43282A8:+
:2:28 
tGATAATTGa 
>CG4328:5CG43282A10:
-:2:29 
tTAATATGAg 
>CG4328:5CG43282A11:
+:2:30 
cTTTAATTGc 
>CG12361:CG12361A1:+
:3:1 
tGTTTATGA- 
>CG12361:CG12361A2:+
:3:2 
tATAAATTA- 
>CG12361:CG12361A4:+
:3:4 
aATTGATGA- 
>CG12361:CG12361A5:-
:1:5 
aTTAAATGA- 
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>CG12361:CG12361A6:+
:3:6 
cCTTAATGA- 
>CG12361:CG12361A7:-
:2:7 
gGTTTATGGg 
>CG12361:CG12361A8:-
:2:8 
aTTTTATCAc 
>CG12361:CG12361A9:-
:3:9 
-TTTAATGAc 
>CG12361:CG12361A10:
-:3:10 
-CTTAATTGc 
>CG12361:CG12361A11:
-:2:11 
tTTTTATCAc 
>CG12361:CG12361A12:
+:3:12 
gTATTATTA- 
>CG12361:CG12361B1:+
:3:13 
gTATTATTA- 
>CG12361:CG12361B2:-
:2:14 
cTTTGATTAc 
>CG12361:CG12361B3:-
:2:15 
cGTTTATTAg 
>CG12361:CG12361B4:-
:2:16 
aTTTTATTGg 
>CG12361:CG12361B5:-
:2:17 
tTTTAATTAc 
>Cad:CadE1:-:3:1 
cACAAATTA- 
>Cad:CadE2:+:2:2 
tGTTGATTAg 
>Cad:CadE3:+:2:3 
aAGTTATTAc 
>Cad:CadE4:-:3:4 
aATTAATAG- 
>Cad:CadE5:-:3:5 
cTTAAATGA- 
>Cad:CadE6:-:4:6 
gATTTATTT- 
>Cad:CadE8:+:2:7 
aTTTTATAAg 
>Cad:CadE9:-:3:8 
cAGTAATTA- 
>Cad:CadE11:+:3:10 
-CTTAATTGc 
>Cad:CadE12:+:2:11 
-TTTTATTAg 
>Cad:CadF1:-:3:12 
cCGTAATTA- 
>Cad:CadF2:+:2:13 
cATTTATTGg 
>Cad:CadF3:+:2:14 
cTTTAATGGc 
>Cad:CadF4:-:3:15 
gTTTAATAA- 
>Cad:CadF5:-:3:16 
tATTTATTA- 
>Cad:CadF6:-:3:17 
aTTTTATTA- 
>Cad:CadF7:+:2:18 
tGTTTATTGc 
>Cad:CadF8:+:3:19 
-TTTTATTGa 
>Cad:CadF9:+:2:20 
gTTTTATGAt 
>Cad:CadF11:+:2:22 
aCTTTATTAc 
>Cad:Cad2E1:+:2:23 
cCTTTATTGg 
>Cad:Cad2E2:-:3:24 
aCATTATTA- 
>Cad:Cad2E3:+:3:25 
-ATTTATTAg 
>Cad:Cad2E4:-:3:26 
tATTTATTA- 
>Cad:Cad2E7:-:3:28 
cTCTAATTG- 
>Cad:Cad2E8:+:2:29 
aGTTTATTGg 
>Cad:Cad2E9:+:2:30 
tAATGATTGc 
>Cad:Cad2E10:-:3:31 
cTTAAATTA- 
>Cad:Cad2F1:-:3:34 
tTCTAATTA- 
>Cad:Cad2F2:+:2:35 
tGTTTATGAg 
>Cad:Cad2F3:-:3:36 
gATTTATAA- 
>Cad:Cad2F4:-:3:37 
cCATAATTA- 
>Cad:Cad2F5:+:2:38 
tTTTTATTGc 
>Cad:Cad2F6:-:3:39 
tTTTTATTG- 
>Cad:Cad2F7:+:2:40 
aATTTATGGg 
>Cad:Cad2F9:-:3:41 
tTTTTATGA- 
>Cad:Cad2F10:+:2:42 
aTTATATGGg 
>Cad:Cad2F11:+:2:43 
tTTTTATTGc 
>H2:H20C1:-:4:1:mod 
tttTTATATA 
>H2:H20C2:+:4:2 
tcTTAATGA- 
>H2:H20C3:+:3:3 
acATTATTGa 
>H2:H20C4:+:3:4 
ggTTAATGAt 
>H2:H20C5:+:3:5 
taGATATTAc 
>H2:H20C7:+:3:6 
ccTTTATGGg 
>H2:H20C8:+:3:7 
cgTTGATTAa 
>H2:H20C9:-:4:8:mod 
agtCAATAAA 
>H2:H20C10:+:3:9 
gaTTAATTAt 
>H2:H20C11:-
:4:10:mod 
ggaTAATTAA 
>H2:H20C12:+:3:11 
ggGTAATTAg 
>H2:H20D1:+:3:12 
ctATTATTAa 
>H2:H20D2:+:3:13 
tgAATATTGa 
>H2:H20D3:+:3:14 
gcTTAATTGa 
>H2:H20D4:-:4:15:mod 
agaTAATAAT 
>H2:H20D5:-:4:16:mod 
ctgTAATAAA 
>H2:H20D6:-:4:17 
accTCATAAT 
>H2:H20D7:+:3:18 
aaTTTATTAa 
>H2:H20D8:-:4:19:mod 
atcTAATTAA 
>H2:H20D9:-:4:20:mod 
tgcTAATAAA 
>H2:H20D10:+:3:21 
cgTTTATTAa 
>H2:H20D11:+:3:22 
atTTTATGAg 
>H2:5H202H2:+:3:23 
caTTTATTGg 
>H2:5H202H3:+:3:24 
tgTTTATGAa 
>H2:5H202H4:-
:4:25:mod 
cgtTAATAAA 
>H2:5H202H5:-:3:26 
-cTTTTTGGc 
>H2:5H202H6:+:4:27 
atTTTATTA- 
>H2:5H202H7:+:3:28 
ctTTAATGAg 
>H2:5H202H8:-:1:29 
ttATTATGG- 
>H2:5H202H9:-
:4:30:mod 
catTAATAAA 
>H2:5H202H10:+:3:31 
agGTAATTAc 
>H2:5H202H11:+:3:32 
gtTTAATGAc 
>AbdB:abdb2:+:2:1 
GGTTTATAG- 
>AbdB:abdb3:+:1:2 
GTTTTATTGt 
>AbdB:abdb4:+:2:3 
TTTTTATGG- 
>AbdB:abdb5:+:2:4 
GATTAATGG- 
>AbdB:abdb6:+:2:5 
GCTTTATGT- 
>AbdB:abdb7:+:1:6 
GGTTTACAAc 
>AbdB:abdb8:+:2:7 
GTTTAATGT- 
>AbdB:abdb10:+:2:8 
GATTTATGT- 
>AbdB:abdb11:+:2:9 
ATATTATGA- 
>AbdB:abdb12:+:2:10 
CATTTATTA- 
>AbdB:abdb13:+:1:11 
TTTTTATAAc 
>AbdB:abdb14:+:2:12 
TATTAATTA- 
>AbdB:abdb15:+:1:13 
GTTTTATGA- 
>AbdB:abdb17:+:2:14 
GTTTTATGG- 
>AbdB:abdb18:+:2:15 
CTTTAACGA- 
>AbdB:abdb19:+:2:16 
CTTTTATTA- 
>AbdB:abdb20:+:2:17 
CTTTTACGA- 
>AbdB:abdb21:+:2:18 
GATTTATTA- 
>AbdB:abdb22:+:2:19 
GATTTATTA- 
>AbdB:abdb23:+:2:20 
CTTTAATTA- 
>AbdB:abdb24:+:2:21 
GTTTTATGA- 
>Lim3:Lim3C1:-:3:1 
cCCTGATTA- 
>Lim3:Lim3C2:-:1:2 
-ATTTATTAa 
>Lim3:Lim3C3:-:3:3 
gCTTAATCA- 
>Lim3:Lim3C4:+:2:4 
gAATAATTAt 
>Lim3:Lim3C5:+:2:5 
tAATGATTAt 
>Lim3:Lim3C7:-:3:6 
aACAAATTA- 
>Lim3:Lim3C8:+:3:7 
-TCTGATGAa 
>Lim3:Lim3C10:+:2:8 
tAAAAATTAa 
>Lim3:Lim3C11:+:3:9 
-CTAAATGAa 
>Lim3:Lim3C12:+:3:10 
-ATAAATTAg 
>Lim3:Lim3D1:+:3:11 
-TTTAATGAa 
>Lim3:Lim3D3:+:2:13 
aTCTAATGAg 
>Lim3:Lim3D4:+:1:14 
-GGTAATTG- 
>Lim3:Lim3D5:+:3:15 
-CTTAATTGa 
>Lim3:Lim3D6:+:3:16 
-TGTAATTGa 
>Lim3:Lim3D7:+:2:17 
tCTTAATTGa 
>Lim3:Lim3D8:-:1:18 
-ACTAATTAa 
>Lim3:Lim3D9:-:1:19 
-ATTAATCAa 
>Lim3:Lim3D10:+:1:20 
gGCTAATTA- 
>Lim3:Lim3D11:+:2:21 
aTCTAATTAg 
>Awh:AwhC1:-:2:1 
atTTGATTAc 
>Awh:AwhC2:-:2:2 
ggCTGATTGg 
>Awh:AwhC3:-:3:3 
-tTTAATGAa 
>Awh:AwhC4:+:1:4 
--CTGATTAc 
>Awh:AwhC5:+:4:5 
atTTGATTA- 
>Awh:AwhC7:-:2:7 
aaTTAAGTAg 
>Awh:AwhC8:+:1:8 
--CTAATTAc 
>Awh:AwhC9:+:1:9 
--ATAATTAt 
>Awh:AwhC10:-:2:10 
taTTAATGAa 
>Awh:AwhC12:+:4:12 
acTTGATTA- 
>Awh:AwhD1:-:2:13 
cgCTAATGAg 
>Awh:AwhD2:+:4:14 
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gtCTAATTA- 
>Awh:AwhD3:-:2:15 
acCTAATTAc 
>Awh:AwhD5:+:4:16 
caCTAATTA- 
>Awh:AwhD6:-:2:17 
ctTTAATTAc 
>Awh:AwhD7:+:4:18 
ttTTAATTA- 
>Awh:AwhD8:-:1:19 
cgCTAATTG- 
>Awh:AwhD9:+:4:20 
agTTAATTA- 
>Awh:AwhD10:+:4:21 
taCTAATGA- 
>Awh:AwhD11:+:4:22 
acCTAATGA- 
>Awh:Awh2A1:+:4:23 
ccTTAATTT- 
>Awh:Awh2A2:-:2:24 
atTTGATTAg 
>Awh:Awh2A3:+:1:25 
--TTAATTAt 
>Awh:Awh2A4:+:4:26 
ttTTGATTA- 
>Awh:Awh2A8:+:4:27 
ccTAAATGA- 
>Awh:Awh2A9:-:3:28 
-tTTAATTAg 
>Awh:Awh2A10:-:2:29 
tgCTAATTGg 
>Awh:Awh2A11:+:2:30 
-cATAATTA- 
>Awh:Awh2A12:+:1:31 
--TTAATTAg 
>Awh:Awh2B1:+:4:32 
agTTAATTA- 
>Awh:Awh2B2:+:4:33 
agATAATTA- 
>Awh:Awh2B3:-:2:34 
-cTTAATTAt 
>Awh:Awh2B4:+:4:35 
aaCTAATTA- 
>Awh:Awh2B5:+:4:36 
caCTAATTT- 
>Awh:Awh2B6:+:4:37 
tcCTAATTA- 
>Awh:Awh2B7:-:3:38 
-tTTAATTAg 
>Awh:Awh2B8:+:4:39 
taTTAATTA- 
>Awh:Awh2B9:+:4:40 
ccCTAATGA- 
>Awh:Awh2B10:+:4:41 
agTTAATGA- 
>Awh:Awh2B11:+:4:42 
ctCTAATTG- 
>Dll:DllC1:-:3:1 
--tTAATTGT 
>Dll:DllC2:-:5:2:mod 
TGATAATgga 
>Dll:DllC3:-:2:3 
-tgTAATAGC 
>Dll:DllC4:-:2:4 
-gtTAATTTC 
>Dll:DllC5:+:3:5 
-taTAATTTT 
>Dll:DllC6:-:2:6 
-ccTAATTTG 
>Dll:DllC7:-:2:7 
-ttTAATGGC 
>Dll:DllC8:-:2:8 
-acAAATTGT 
>Dll:DllC9:-:3:9 
--aTAATTAC 
>Dll:DllC10:-:4:10 
---TAATTAC 
>Dll:DllC11:-:4:11 
---TAATTAC 
>Dll:DllC12:-:2:12 
-tcTAATGAT 
>Dll:DllD1:-:2:13 
-ctTAATAAC 
>Dll:DllD2:+:3:14 
-caTAATTTT 
>Dll:DllD3:+:2:15 
--cTGATAGG 
>Dll:DllD4:+:4:16 
ggtTAATTAC 
>Dll:DllD5:-:2:17 
-tcTAATTGC 
>Dll:DllD6:-:2:18 
-taTAATTGC 
>Dll:DllD7:-:2:19 
-cgTAATTGG 
>Dll:DllD8:-:4:20 
---TAATTAT 
>Dll:DllD9:+:3:21 
-agTAATTAC 
>Dll:DllD10:+:2:22 
--cTAATTAC 
>Dll:DllD11:-:4:23 
---TAATTAG 
>CG4136:5CG4136G1:+:
3:1 
agCTAATTA- 
>CG4136:5CG4136G2:-
:3:2 
-gTTAATTTa 
>CG4136:5CG4136G3:-
:3:3 
-cTTAATAGa 
>CG4136:5CG4136G4:-
:3:4 
-gCTAATTAt 
>CG4136:5CG4136G5:-
:3:5 
-cTTAATTAg 
>CG4136:5CG4136G6:+:
3:6 
gcCTAATTG- 
>CG4136:5CG4136G7:+:
4:7 
aaTTAATGA- 
>CG4136:5CG4136G8:+:
4:8 
cgATAATTA- 
>CG4136:5CG4136G9:-
:3:9 
-tTTAATAGg 
>CG4136:5CG4136G10:-
:3:10 
-cCTAATTAc 
>CG4136:5CG4136G11:-
:3:11 
-cCTAATGAg 
>CG4136:5CG4136G12:-
:3:12 
-gTTAATGAg 
>CG4136:5CG4136H1:+:
4:13 
taCTAATTG- 
>CG4136:5CG4136H2:+:
4:14 
aaCTAATTA- 
>CG4136:5CG4136H3:+:
2:15 
-cTTAATTAc 
>CG4136:5CG4136H4:-
:4:16 
--TTAATTAt 
>CG4136:5CG4136H5:+:
3:17 
gcTTAATTG- 
>CG4136:5CG4136H6:+:
4:18 
ctCTAATTA- 
>CG4136:5CG4136H7:+:
4:19 
gtTTAATTA- 
>CG4136:5CG4136H9:-
:3:21 
-tGTAATTGt 
>CG4136:5CG4136H10:-
:3:22 
-tTTAATTAa 
>CG4136:5CG4136H11:+
:2:23 
-cTTAATTAt 
>Al:AlE5:+:3:2 
--tTAATTAA 
>Al:AlE2:-:3:1 
-gcTAATTAA 
>Al:AlE6:-:4:3 
tgcTAATTAA 
>Al:AlE7:-:4:4 
gcaTAATTAA 
>Al:AlE8:-:4:5 
gacTAATTAA 
>Al:AlE9:+:3:6 
--tTAATTAA 
>Al:AlE10:-:4:7 
ttcTAATTAA 
>Al:AlE11:-:3:8 
-taTAATTAA 
>Al:AlE12:-:4:9 
tgcTAATTAA 
>Al:AlF2:-:4:11 
gacTAATTAA 
>Al:AlF3:-:4:12 
cgcTAATTGA 
>Al:AlF4:-:4:13 
tcaTAATTAA 
>Al:AlF5:-:4:14 
cgcTAATTGG 
>Al:AlF6:-:4:15 
accTAATTAA 
>Al:AlF7:-:1:16 
---TAATTAA 
>Al:AlF8:+:3:17 
--gTAATTAG 
>Al:AlF9:-:4:18 
gtcTAATTAA 
>Al:AlF10:-:4:19 
ggcTAATTAA 
>Al:AlF11:-:4:20 
cccTAATTGA 
>Al:AlF12:-:3:21 
-gtTAATTAA 
>CG11294:CG11294A1:+
:2:1 
-cTTAATTAt 
>CG11294:CG11294A3:+
:2:2 
-tTTAATTAg 
>CG11294:CG11294A9:+
:2:4 
-gTCAATTAg 
>CG11294:CG11294A11:
+:4:6 
aaCTAATTA- 
>CG11294:CG11294A12:
-:1:7 
-tCTAATTA- 
>CG11294:CG11294B1:-
:2:8 
taTTAATTAg 
>CG11294:CG11294B2:-
:2:9 
acCTAATTAg 
>CG11294:CG11294B3:-
:4:10 
--TTAATTAg 
>CG11294:CG11294B4:-
:3:11 
-aTTAATTAg 
>CG11294:CG11294B5:+
:2:12 
-aTCAATTAa 
>CG11294:CG11294B6:-
:3:13 
-tTTAATTAg 
>CG11294:CG11294B7:+
:2:14 
-aTTAATTAt 
>CG11294:CG11294B8:-
:3:15 
-gTTAATTAg 
>CG11294:CG11294B9:-
:3:16 
-aTTAATTAg 
>CG11294:CG11294B10:
-:3:17 
-aTTAATTAg 
>Lim1:LimC10:+:2:9 
-gTTAATTAg 
>Lim1:LimC11:+:2:10 
-gTTAATTGa 
>Lim1:LimC12:+:1:11 
--TTAATTAg 
>Lim1:LimD1:+:3:12 
taCTAATTA- 
>Lim1:LimD2:+:2:13 
-aTTAATTAg 
>Lim1:LimD3:-:4:14 
--TTAATTAc 
>Lim1:LimD4:-:4:15 
--TTAATTAt 
>Lim1:LimD10:-:3:20 
-aTTAATTAg 
>Lim1:LimD11:-:4:21 
--TTAATTAa 
>Lim1:Lim1C2a:-:4:23 
--CTAATTAt 
>Lim1:Lim1C9a:-:4:28 
--TTAATTAg 
>Lim1:Lim1C10a:+:2:2
9 
-gTTAATTAc 
>Lim1:Lim1D2a:-:4:32 
--TTAATTAg 
>Lim1:Lim1D4a:+:3:33 
aaTTAATTAt 
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>Lim1:Lim1D6a:-:4:34 
--TTAATTAa 
>Lim1:Lim1D9a:-:3:35 
-tTTAATTAg 
>Lim1:Lim1D10a:-
:4:36 
--TTAATTAg 
>Lim1:Lim1D11a:+:2:3
7 
-tTTAATTAc 
>Hbn:HbnA1:+:1:1:mod 
-aaTAATTAA 
>Hbn:HbnA4:+:2:2 
-aGTAATTAc 
>Hbn:HbnA5:+:2:3:mod 
-tgTAATTGA 
>Hbn:HbnA6:+:2:4:mod 
-caTAATTGA 
>Hbn:HbnA7:+:3:5 
gaTTAATTAa 
>Hbn:HbnA8:-:4:6:mod 
ctcTAATTGA 
>Hbn:HbnA9:-:4:7:mod 
cctTAATTAA 
>Hbn:HbnA10:-:3:8 
-cTTAATTTg 
>Hbn:HbnB2:+:4:9 
gaCTAATTA- 
>Hbn:HbnB3:-:3:10 
-tTTAATTGt 
>Hbn:HbnB4:-:3:11 
-aTTAATTGt 
>Hbn:HbnB5:-:3:12 
-tTTAATTAa 
>Hbn:HbnB6:+:2:13 
-cTTAATTAt 
>Hbn:HbnB7:-:3:14 
-tTTAATTGg 
>Hbn:HbnB9:-:3:15 
-tTTAATTAa 
>Hbn:HbnB10:-:3:16 
-gTTAATTAg 
>Hbn:HbnB11:-:2:17 
-aTTAATTGg 
>Repo:RepoE2:-:3:1 
cTTTAATTA- 
>Repo:RepoE3:-:3:2 
gGGTAATTA- 
>Repo:RepoE4:-:2:3 
aGCTAATTA- 
>Repo:RepoE5:-:3:4 
tGTTAATTA- 
>Repo:RepoE7:+:2:6 
tCTTAATTGa 
>Repo:RepoE8:-:3:7 
tTTTAATTA- 
>Repo:RepoE9:+:2:8 
cATTAATTAg 
>Repo:Repo2A2:+:3:12 
-TTAAATTGc 
>Repo:Repo2A3:+:2:13 
tAGTAATTGg 
>Repo:Repo2A4:-:3:14 
cTATAATTA- 
>Repo:Repo2A5:+:1:15 
aTGTAATTA- 
>Repo:Repo2A6:+:3:16 
-TTTAATTAg 
>Repo:Repo2A7:+:2:17 
tATTTATTGa 
>Repo:Repo2A8:-:3:18 
gCGTAATTA- 
>Repo:Repo2A9:-:3:19 
aGCTAATTA- 
>Repo:Repo2A11:-
:3:20 
aTTTAATTG- 
>Repo:Repo2A12:-
:3:21 
cATTAATTA- 
>Repo:Repo2B1:+:3:22 
-TTTAATTGa 
>Repo:Repo2B2:+:3:23 
-TTTAATTAg 
>Repo:Repo2B3:-:3:24 
gGCTAATTA- 
>Repo:Repo2B4:-:3:25 
cACTAATTA- 
>Repo:Repo2B5:-:3:26 
aCTTAATTA- 
>Repo:Repo2B6:-:3:27 
gTTTAATTA- 
>Repo:Repo2B7:-:3:28 
cATTAATTA- 
>Repo:Repo2B8:+:3:29 
-TTTAATTAa 
>Repo:Repo2B9:+:2:30 
tTTTAATTGg 
>Repo:Repo2B10:-
:3:31 
aGTTAATTA- 
>Repo:Repo2B11:-
:3:32 
aTTTAATTA- 
>CG32105:CG32105G2:+
:2:1 
-TTTAATTAG 
>CG32105:CG32105G3:+
:2:2 
-ACTAATTAA 
>CG32105:CG32105G4:+
:1:3 
gTCTAATTGC 
>CG32105:CG32105G5:+
:2:4 
-AATAATTAG 
>CG32105:CG32105G6:+
:1:5 
cATTAATTGC 
>CG32105:CG32105G7:+
:2:6 
-TCTAATTGG 
>CG32105:CG32105G8:+
:1:7 
gTTATATTAA 
>CG32105:CG32105G9:+
:2:8 
-TTTAATGAC 
>CG32105:CG32105G10:
+:1:9 
cTATAATTGA 
>CG32105:CG32105G12:
+:2:11 
-TTTAATTAA 
>CG32105:CG32105H1:+
:2:12 
-TTTAATTAA 
>CG32105:CG32105H2:+
:1:13 
tATTAATTAC 
>CG32105:CG32105H3:-
:1:14 
-ATTAATTAG 
>CG32105:CG32105H4:+
:1:15 
tCCAAATTAG 
>CG32105:CG32105H5:+
:2:16 
-ATTAATTAG 
>CG32105:CG32105H7:+
:2:18 
-ATTAATTAG 
>CG32105:CG32105H9:+
:1:19 
aATTTAGTAG 
>CG32105:CG32105H10:
+:2:20 
-ATTAATTAG 
>CG32105:CG32105H11:
-:1:21 
-TTTAATTAA 
>CG33980:CG33980A1:-
:1:1 
-TTTAATTAC 
>CG33980:CG33980A2:+
:1:2 
-CATAATTAG 
>CG33980:CG33980A4:+
:1:4 
-GTTAATTAG 
>CG33980:CG33980A5:+
:1:5 
-GTTAATTAG 
>CG33980:CG33980A6:+
:1:6 
-GTTAATTGC 
>CG33980:CG33980A7:+
:1:7 
-GTTAATTGG 
>CG33980:CG33980A8:+
:1:8 
-TTTAATTAA 
>CG33980:CG33980A12:
+:1:12 
-GTTAATTGG 
>CG33980:CG33980B2:-
:1:13 
-TCTAATTAG 
>CG33980:CG33980B4:+
:1:15 
-TATAATTAG 
>CG33980:CG33980B6:+
:1:17 
-TTTAATTAG 
>CG33980:CG33980B7:+
:1:18 
-TCTAATTAG 
>CG33980:CG33980B10:
+:1:20 
-ATTAATTAG 
>Exex:ExexE1:-:3:1 
-tCTAATTAa 
>Exex:ExexE2:+:2:2:m
od 
-ctTAATTGG 
>Exex:ExexE3:+:3:3 
ggGTAATTAa 
>Exex:ExexE4:+:4:4 
gaGTAATTA- 
>Exex:ExexE5:+:2:5 
-cTTAATTAt 
>Exex:ExexE6:+:4:6 
caGTAATTA- 
>Exex:ExexE7:+:4:7 
cgTTAATTA- 
>Exex:ExexE8:-:4:8 
--GTAATAAg 
>Exex:ExexE9:-:3:9 
-aGTAATTAg 
>Exex:ExexE10:+:4:10 
gtGTAATTA- 
>Exex:ExexE11:+:4:11 
ggCTAATTA- 
>Exex:ExexE12:+:4:12 
gaGTAATTA- 
>Exex:ExexF1:+:2:13 
-gGTAATTAg 
>Exex:ExexF2:-
:4:14:mod 
ttcTAATTGA 
>Exex:ExexF3:-
:4:15:mod 
agtTAATTAC 
>Exex:ExexF4:+:2:16 
-tGTAATTAa 
>Exex:ExexF5:-
:4:17:mod 
actTAATCAC 
>Exex:ExexF6:+:2:18 
-tCTAATTAa 
>Exex:ExexF7:+:2:19 
-aCTAATTAg 
>Exex:ExexF8:+:4:20 
ggCTAATTA- 
>Exex:ExexF9:+:2:21 
-ttTAATTGC 
>Exex:ExexF10:+:4:22 
atGTAATTA- 
>Exex:ExexF11:+:3:23 
cgCTAATTAa 
>Rx:RxF2:+:3:1 
-GCTAATTAc 
>Rx:RxF3:-:3:2 
tACTAATTA- 
>Rx:RxF4:-:3:3 
tACTAATTA- 
>Rx:RxF5:+:2:4 
gGTTAATTAg 
>Rx:RxF7:-:1:6:mod 
-gtTAATTGG 
>Rx:RxF8:-:1:7:mod 
-ttTAATTGA 
>Rx:RxF12:-:1:10 
-GCTAATTAa 
>Rx:Rx2C1:+:1:11 
tCATAATTA- 
>Rx:Rx2C2:-:1:12 
-ACTAATTAg 
>Rx:Rx2C3:+:3:13 
-GTTAATTAa 
>Rx:Rx2C5:-:3:15 
aCTTAATTA- 
>Rx:Rx2C6:+:2:16 
cACTAATTGg 
>Rx:Rx2C7:-:1:17 
-CCTAATTAt 
>Rx:Rx2C8:-:3:18 
tGTTAATTA- 
>Rx:Rx2C9:-:1:19:mod 
-atTAATTGA 
>Rx:Rx2C10:-
:1:20:mod 
-caTAATTGA 
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>Rx:Rx2C11:-
:1:21:mod 
-gcTAATTGA 
>Rx:Rx2D1:-:1:23:mod 
-ttTAATTGC 
>Rx:Rx2D2:-:1:24 
-GCTAATTAg 
>Rx:Rx2D3:-:1:25 
-AATAATTAg 
>Rx:Rx2D4:-:1:26:mod 
-ctTAATTGG 
>Rx:Rx2D5:-:1:27 
-GCTAATTAa 
>Rx:Rx2D6:-:1:28:mod 
-ttTAATTGA 
>Rx:Rx2D8:-:1:29 
-GCTAATTAa 
>Rx:Rx2D9:+:3:30 
-GCTAATTAa 
>Rx:Rx2D10:-:1:31 
-GCTAATTAa 
>Rx:Rx2D11:-
:1:32:mod 
-atTAATTGG 
>Ro:RoG1:+:3:1 
-GGTAATTAc 
>Ro:RoG2:-:1:2:mod 
-gcTAATTGC 
>Ro:RoG3:-:3:3 
tACTAATGA- 
>Ro:RoG4:+:3:4 
-TTTAATTAc 
>Ro:RoG5:-:1:5:mod 
-ccTAATTGA 
>Ro:RoG6:-:3:6 
tAATAATTA- 
>Ro:RoG7:-:2:7 
cTTTAATTA- 
>Ro:RoG8:-:3:8 
tACTAATGA- 
>Ro:RoG9:-:3:9 
cACTAATTA- 
>Ro:RoG10:-:3:10 
tGCTAATTA- 
>Ro:RoG11:-:3:11 
aGTTAATTA- 
>Ro:RoG12:-:3:12 
tGTTAATTA- 
>Ro:RoH1:-:1:13:mod 
-ttTAATTGA 
>Ro:RoH2:-:1:14 
-ACTAATTAa 
>Ro:RoH3:-:2:15 
tCGTAATGA- 
>Ro:RoH4:-:3:16 
cGCTAATTA- 
>Ro:RoH5:-:1:17 
-GCTAATTAa 
>Ro:RoH6:-:1:18 
-GCTAATTAa 
>Ro:RoH7:-:1:19 
-GCTAATTAa 
>Ro:RoH8:-:3:20 
tCTTAATTA- 
>Ro:RoH9:-:1:21 
-GCTAATTAa 
>Ro:RoH10:-:3:22 
cGGTAATTA- 
>Ro:RoH11:-:1:23:mod 
-ctTAATTGC 
>Pph13:Pph13C1:+:3:1 
tAATAATTA- 
>Pph13:Pph13C2:+:3:2 
tGATAATTG- 
>Pph13:Pph13C3:+:1:3 
-TCTAATTTa 
>Pph13:Pph13C4:+:3:4 
cCATAATTA- 
>Pph13:Pph13C5:-:3:5 
-ACTAATTCg 
>Pph13:Pph13C6:+:3:6 
aTATAATTA- 
>Pph13:Pph13C7:+:3:7 
aTTTAATTA- 
>Pph13:Pph13C8:-:3:8 
-ACTAATCAg 
>Pph13:Pph13C9:+:1:9
:mod 
-caTAATTGT 
>Pph13:Pph13C10:+:1:
10:mod 
-agTAATTGG 
>Pph13:Pph13C11:+:3:
11 
tCCTAATTA- 
>Pph13:Pph13C12:+:1:
12:mod 
-ggTAATTGG 
>Pph13:Pph13D1:+:1:1
3 
-AATAATTAg 
>Pph13:Pph13D2:+:1:1
4:mod 
-gcTAATTGT 
>Pph13:Pph13D3:+:3:1
5 
gCCTAATTA- 
>Pph13:Pph13D4:+:1:1
6 
-AGTAATTAc 
>Pph13:Pph13D5:+:1:1
7:mod 
-ttTAATTGA 
>Pph13:Pph13D6:+:1:1
8 
-ACTAATTAt 
>Pph13:Pph13D7:-
:3:19 
-ATTAATTAa 
>Pph13:Pph13D9:+:1:2
1 
-ACTAATTAa 
>Pph13:Pph13D11:+:1:
22 
-ATTAATTAa 
>Inv:InvC1:+:2:1 
gGTTAATTAt 
>Inv:InvC2:-:1:2 
-ACTAATTAa 
>Inv:InvC3:+:2:3 
tGCTAATTAt 
>Inv:InvC5:-:3:4 
cACTAATTA- 
>Inv:InvC7:+:3:6 
-TATAATTAc 
>Inv:InvC8:-:1:7 
-TCTAATTAa 
>Inv:InvC11:+:1:10 
cTCTAATTA- 
>Inv:InvC12:+:3:11 
-TTTAATTAg 
>Inv:InvD1:+:2:12 
aTTTAATTGg 
>Inv:InvD2:+:2:13 
cTCTAATTGa 
>Inv:InvD3:+:2:14 
tTTTAATTGa 
>Inv:InvD4:+:2:15 
tTCTAATTAg 
>Inv:InvD5:+:2:16 
tACTAATTAc 
>Inv:InvD7:+:2:18 
aACTAATTGg 
>Inv:InvD8:+:2:19 
tTTTAATTGa 
>Inv:InvD11:+:3:22 
-GTTAATTAc 
>CG9876:CG9876A1:-
:2:1 
tGCTAATTGt 
>CG9876:CG9876A2:+:1
:2:mod 
-cgTAATGAG 
>CG9876:CG9876A3:+:3
:3 
gACTAATTA- 
>CG9876:CG9876A4:+:3
:4 
tCGTAATTG- 
>CG9876:CG9876A5:+:1
:5 
-GTTAATTGa 
>CG9876:CG9876A6:+:1
:6 
-AGTTATTAa 
>CG9876:CG9876A7:-
:2:7 
cACTAATTGg 
>CG9876:CG9876A8:+:3
:8 
tATTAATTA- 
>CG9876:CG9876A10:+:
1:10 
-ACTTATTAa 
>CG9876:CG9876B2:-
:2:11 
cACTAATTGg 
>CG9876:CG9876B3:+:2
:12 
cAATAATTAg 
>CG9876:CG9876B4:+:1
:13 
-ACTAATTAg 
>CG9876:CG9876B5:+:1
:14 
-TTTAATTAa 
>CG9876:CG9876B6:+:1
:15 
-TTTAATTAc 
>CG9876:CG9876B7:-
:3:16 
-ATTAATTAa 
>CG9876:CG9876B8:+:1
:17 
-TCTAATTAt 
>CG9876:CG9876B9:+:1
:18 
-GCTAATTAa 
>CG9876:CG9876B10:+:
1:19 
-ACTAATTAa 
>CG9876:CG9876B11:+:
1:20 
-ATTAATTAt 
>CG9876:CG9876B12:-
:3:21 
-GATAATTGc 
>En:eng1:-:2:1 
cGCTAATTAg 
>En:eng2:+:3:2 
aTTTAATTA- 
>En:eng3:-:2:3 
cACTAATGAg 
>En:eng4:+:3:4 
gGGTAATTA- 
>En:eng5:-:2:5 
tGATAATTGc 
>En:eng7:+:3:6 
tGCTAATTA- 
>En:eng8:-:2:7 
gGTTAATTGa 
>En:eng9:+:3:8 
cGTTAATTA- 
>En:eng10:+:3:9 
aGGTAATTA- 
>En:eng11:+:3:10 
gGCTAATTA- 
>En:eng12:-:1:11 
tTTTAATTG- 
>En:eng13:-:2:12 
tTTTAATTGg 
>En:eng14:+:3:13 
aACTAATTA- 
>En:eng15:+:3:14 
tCTTAATTG- 
>En:eng16:+:3:15 
cGATAATTG- 
>En:eng17:+:3:16 
gACTAATTA- 
>En:eng18:-:2:17 
tTTTAATTGg 
>En:eng19:-:3:18 
-CTTAATTGa 
>En:eng20:+:3:19 
cGTTAATGA- 
>En:eng21:+:1:20 
-GCTAATTAa 
>En:eng22:-:2:21 
gTTTAATTGg 
>En:eng23:-:2:22 
-CTTAATTGa 
>En:eng24:+:3:23 
gGCTAATTA- 
>CG32532:CG32432G1:+
:3:1 
-gCTAATTAc 
>CG32532:CG32432G2:+
:2:2 
tgATAATTGg 
>CG32532:CG32432G3:-
:1:3 
--TTAATTAt 
>CG32532:CG32432G4:+
:3:4 
-tTTAATTTg 
>CG32532:CG32432G5:-
:4:5 
agGTAATTA- 
>CG32532:CG32432G6:-
:2:6 
-tCTAATTAt 
>CG32532:CG32432G7:-
:3:7 
gcTTAATGA- 
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>CG32532:CG32432G8:+
:3:8 
-gGTAATTAc 
>CG32532:CG32432G9:+
:2:9 
taCTAATTGc 
>CG32532:CG32432G10:
+:2:10 
atCTAATTGg 
>CG32532:CG32432G11:
+:3:11 
-aTTAATTGa 
>CG32532:CG32432G12:
+:3:12 
-cTTAATTAg 
>CG32532:CG32432H1:+
:2:13 
cgTTAATTGg 
>CG32532:CG32432H2:+
:3:14 
-cCTAATTGg 
>CG32532:CG32432H3:+
:3:15 
-tTTAATTAa 
>CG32532:CG32432H4:+
:3:16 
-aTTAATTGg 
>CG32532:CG32432H5:-
:2:17 
-tTTAATTAt 
>CG32532:CG32432H6:-
:2:18 
-gTTAATTAg 
>CG32532:CG32432H7:+
:2:19 
tcCTAATTGa 
>CG32532:CG32432H8:+
:3:20 
-aTTAATTGg 
>CG32532:CG32432H9:+
:3:21 
-cTTAATTGa 
>CG32532:CG32432H10:
+:3:22 
-gTTAATTAa 
>CG32532:CG32432H11:
-:4:23 
acATAATGA- 
>Unpg:UnpgC1:-:3:1 
-ACTAATGAc 
>Unpg:UnpgC2:+:3:2 
aCGTAATTA- 
>Unpg:UnpgC3:+:2:3 
cGCTAATTAg 
>Unpg:UnpgC4:+:3:4 
aGATAATTG- 
>Unpg:UnpgC5:+:1:5 
-CGTAATTAg 
>Unpg:UnpgC6:-:2:6 
gCGTAATTAg 
>Unpg:UnpgC7:-:3:7 
-CTTAATTGc 
>Unpg:UnpgC8:-:2:8 
-TTTAATGAg 
>Unpg:UnpgC9:-:3:9 
-TTTAATTGa 
>Unpg:UnpgC10:-:2:10 
cCTTAATTGc 
>Unpg:UnpgC11:+:1:11 
-ACTAATTAt 
>Unpg:UnpgD1:+:3:12 
gCCTAATTA- 
>Unpg:UnpgD2:-:2:13 
cGCTAATTAt 
>Unpg:UnpgD3:-:2:14 
-CTTAATTGa 
>Unpg:UnpgD4:-:3:15 
-CTTAATTGg 
>Unpg:UnpgD5:-:3:16 
-ATTAATTGg 
>Unpg:UnpgD6:-:2:17 
tCCAAATTAg 
>Unpg:UnpgD8:-:3:18 
-ATTAATTAg 
>Unpg:UnpgD9:+:1:19 
-TGTAATTAt 
>Unpg:UnpgD10:-:2:20 
cCTTAATTAg 
>Unpg:UnpgD11:-:2:21 
tATTAATTAg 
>PhdP:PhdPA1:+:2:1 
-aTTAATTtg 
>PhdP:PhdPA2:+:3:2 
ggTTAATTac 
>PhdP:PhdPA3:-:3:3 
-gCTAATAgg 
>PhdP:PhdPA4:+:2:4:m
od 
-cctAATGAG 
>PhdP:PhdPA8:+:4:6 
gcATAATTt- 
>PhdP:PhdPA9:+:4:7 
taATAATTg- 
>PhdP:PhdPA10:+:2:8 
-cCTAATTgg 
>PhdP:PhdPA11:+:4:9 
aaATAATTa- 
>PhdP:PhdPA12:+:4:10 
gaTTAATTa- 
>PhdP:PhdPB1:-:4:11 
-gATAATTta 
>PhdP:PhdPB2:-:4:12 
-tTTTATTga 
>PhdP:PhdPB3:+:5:13 
cgCTAATTt- 
>PhdP:PhdPB4:-:4:14 
-cTTAATTcc 
>PhdP:PhdPB5:+:1:15 
--CTAATTat 
>PhdP:PhdPB6:+:2:16 
-cTTAATTat 
>PhdP:PhdPB7:+:2:17 
-tTTAATTaa 
>PhdP:PhdPB10:+:4:18 
acCTAATTa- 
>CG7056:CG7056G1:+:3
:20 
tATTAATTA- 
>CG7056:CG7056G2:+:3
:21 
tTTGAAGTA- 
>CG7056:CG7056G3:+:3
:22 
cCCTAATTG- 
>CG7056:CG7056G4:+:2
:23 
aATCAATTAc 
>CG7056:CG7056G5:+:3
:24 
tTTGAATTG- 
>CG7056:CG7056G6:+:3
:25 
aTTTAATTA- 
>CG7056:CG7056G7:-
:3:26 
-TCTAATTAc 
>CG7056:CG7056G8:+:3
:27 
tTTTAATAA- 
>CG7056:CG7056G10:+:
2:28 
aTCTTATTAc 
>CG7056:CG7056G11:+:
3:29 
gACCAATTG- 
>CG7056:CG7056G12:+:
3:30 
gACGAAGTA- 
>Oc:OcA2:+:4:2 
gcTTAAGCC- 
>Oc:OcA3:+:3:3 
cgATAATCCc 
>Oc:OcA4:-:3:4 
-tTTAAGCCc 
>Oc:OcA5:-:3:5 
-aATAATCCt 
>Oc:OcA6:+:4:6 
atATAATCC- 
>Oc:OcA9:-:4:9 
--CTAATCCg 
>Oc:OcA10:-:2:10 
ccTTAATCCt 
>Oc:OcA11:-:3:11 
-gTTAATCTg 
>Oc:OcB1:-:3:12 
-aTTAATCCa 
>Oc:OcB2:+:4:13 
tcATAATCC- 
>Oc:OcB3:-:3:14 
-cGTAATCCt 
>Oc:OcB4:-:3:15 
-cTTAATCGc 
>Oc:OcB5:-:3:16 
-cTTAATCCa 
>Oc:OcB6:-:3:17 
-tATAATCCc 
>Oc:OcB7:+:4:18 
agTTAATCC- 
>Oc:OcB8:-:3:19 
-aCTAATCCa 
>Oc:OcB9:-:2:20 
-aTTAATCCt 
>Oc:OcB10:-:3:21 
-cTTAATCCg 
>Oc:OcB11:-:3:22 
-gTTAATCCg 
>Bcd:bcd1:-:2:1 
tGTTAATCCg 
>Bcd:bcd2:+:3:2 
-TCTAATCCa 
>Bcd:bcd3:-:2:3 
cGTTAATCTc 
>Bcd:bcd4:-:3:4 
gTTTAATCC- 
>Bcd:bcd5:-:3:5 
cTATAATCC- 
>Bcd:bcd6:-:2:6 
tCTTAATCCc 
>Bcd:bcd7:-:2:7 
gCTTAATCCg 
>Bcd:bcd8:-:3:8 
gGTTAATCC- 
>Bcd:bcd9:-:3:9 
aGATAATCC- 
>Bcd:bcd10:-:2:10 
aGCTTATCC- 
>Bcd:bcd11:-:3:11 
gGGTAATCC- 
>Bcd:bcd13:-:2:12 
tGTTAATCC- 
>Bcd:bcd14:+:3:13 
-TATAATCCc 
>Bcd:bcd15:-:2:14 
gCGTAATCCa 
>Bcd:bcd16:+:1:15 
gCTTAAGCC- 
>Bcd:bcd17:-:1:16 
-GGTTATCCg 
>Bcd:bcd18:-:2:17 
tGTTAATCCc 
>Bcd:bcd20:-:3:18 
gCTTAATCC- 
>Bcd:bcd21:-:3:19 
tACTAATCC- 
>Bcd:bcd22:-:3:20 
tCCTAATCC- 
>Bcd:bcd23:-:2:21 
gGTTAATCCg 
>Bcd:bcd24:+:3:22 
-TCTAATCCa 
>Ptx1:PtxG1:+:4:1 
atCTAATCC- 
>Ptx1:PtxG2:+:2:2 
-tTTAATCCc 
>Ptx1:PtxG4:-:4:3 
--CTAATCCt 
>Ptx1:PtxG6:-:3:4 
-aCTAATCCt 
>Ptx1:PtxG7:+:2:5 
-cTTAATCCt 
>Ptx1:PtxG8:-:3:6 
-gTTAATCCc 
>Ptx1:PtxG9:-:3:7 
-gTTAATCCc 
>Ptx1:PtxG10:+:4:8 
aaTTAATCC- 
>Ptx1:PtxG11:+:4:9 
ggCTAATCC- 
>Ptx1:PtxG12:+:3:10 
tcGTAATCCc 
>Ptx1:PtxH1:+:2:11 
-gCTAATCCt 
>Ptx1:PtxH2:+:4:12 
tcTTAATCC- 
>Ptx1:PtxH4:+:3:14 
cgTTAATCTc 
>Ptx1:PtxH5:+:3:15 
ccTTAATCCc 
>Ptx1:PtxH6:+:3:16 
cgTTAATCCc 
>Ptx1:PtxH7:+:3:17 
ggTTAATCCc 
>Ptx1:PtxH8:+:3:18 
tcTTAATCCc 
>Ptx1:PtxH9:+:3:19 
cgTTAATCCc 
>Ptx1:PtxH10:+:3:20 
cgTTAATCCc 
>Ptx1:PtxH11:+:3:21 
acTTAATCCc 
>Gsc:GscA1:+:2:1 
tCGTAATCGg 
>Gsc:GscA2:-:3:2 
aAGTAATCC- 
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>Gsc:GscA3:+:2:3 
gACTAATCTt 
>Gsc:GscA4:+:3:4 
-AATAATCCt 
>Gsc:GscA5:+:2:5 
tACTAATCTt 
>Gsc:GscA6:+:3:6 
-GATAATCTg 
>Gsc:GscA7:+:3:7 
-AGTAATCCt 
>Gsc:GscA8:+:3:8 
-CTTAATCGc 
>Gsc:GscA9:-:3:9 
tCGTAATCC- 
>Gsc:GscA10:-:3:10 
cGTTAATCT- 
>Gsc:GscA11:+:3:11 
-CATAATCCt 
>Gsc:GscA12:-:3:12 
cAATAATCC- 
>Gsc:GscB1:-:3:13 
cGTTAATCT- 
>Gsc:GscB3:+:2:14 
tGTTAATCCc 
>Gsc:GscB4:+:3:15 
-CTTAATCTc 
>Gsc:GscB5:+:3:16 
-CTTAATCCg 
>Gsc:GscB6:+:3:17 
-TTTAATCCg 
>Gsc:GscB7:-:3:18 
cCCTAATCC- 
>Gsc:GscB8:+:2:19 
tGTTAATCCc 
>Gsc:GscB9:+:2:20 
tCCTAATCCa 
>Gsc:GscB10:+:3:21 
-ACTAATCCa 
>Gsc:GscB11:+:1:22 
cATTAATCC- 
>Oct:oct1:+:3:1 
cGATAATGA- 
>Oct:oct2:+:3:2 
gTTTAATGA- 
>Oct:oct3:+:3:3 
tTTTAATAA- 
>Oct:oct4:+:3:4 
aCATAATTT- 
>Oct:oct5:+:2:5 
cTATAATTAg 
>Oct:oct6:+:3:6 
aGATAATTT- 
>Oct:oct7:+:3:7 
aTATAATAA- 
>Oct:oct8:+:3:8 
cATTAATCA- 
>Oct:oct10:-:3:9 
-TTTAATCAc 
>Oct:oct11:-:3:10 
-CCTAATGAg 
>Oct:oct13:+:3:11 
aGCTAATTA- 
>Oct:oct14:+:3:12 
cATTAATTT- 
>Oct:oct15:+:3:13 
gGTAAATGA- 
>Oct:oct16:-:3:14 
-TTTAATGAg 
>Oct:oct17:+:3:15 
cCCTAATTA- 
>Oct:oct18:-:3:16 
-GTTAATGAg 
>Oct:oct19:+:3:17 
tCATAATCA- 
>Oct:oct20:+:3:18 
gTTTAATTG- 
>Oct:oct21:+:3:19 
aGATAATTC- 
>Oct:oct22:+:3:20 
gTTTAATTT- 
>Oct:oct23:+:3:21 
cTTTAATTT- 
>Oct:oct24:+:3:22 
tGATAATTA- 
>Bsh:BshE1:+:1:1 
-CCTAATGGG 
>Bsh:BshE2:+:1:2 
-TTTAATCGA 
>Bsh:BshE3:+:1:3 
-CTTAATGAC 
>Bsh:BshE4:+:1:4 
-TGTAATTGG 
>Bsh:BshE6:+:1:5 
-ATTAATTGC 
>Bsh:BshE8:+:1:7 
-CTTAATGAT 
>Bsh:BshE11:+:1:10 
-TTTAATCGA 
>Bsh:BshE12:+:1:11 
-CTTAATCGA 
>Bsh:BshF1:+:1:12 
-TCTAATGAG 
>Bsh:BshF4:+:1:14 
-TCTAATGAG 
>Bsh:BshF6:+:1:15 
-GTTAATTGC 
>Bsh:BshF7:+:1:16 
-ATTAATTAG 
>Bsh:BshF8:+:1:17 
-ATTAATTAG 
>Bsh:BshF9:+:1:18 
-CTTAACGAG 
>Bsh:BshF10:+:1:19 
-TATAATTGG 
>Bsh:BshF11:+:1:20 
-TGTAATTGG 
>Tup:TupE1:-:3:1 
-GGTAATTGa 
>Tup:TupE2:-:2:2 
cGCTAATTAg 
>Tup:TupE3:-:2:3:mod 
CACTAATGt- 
>Tup:TupE4:+:3:4 
tATTAATGG- 
>Tup:TupE5:-:3:5 
-CTTAATAGa 
>Tup:TupE6:-:3:6 
-TATAATGGt 
>Tup:TupE7:-:3:7 
-GATAATTAa 
>Tup:TupE9:-:3:9 
-GTTAAGTGg 
>Tup:TupE10:-:3:10 
-CATAATTGa 
>Tup:TupE11:+:3:11 
cCTTAATGG- 
>Tup:TupE12:+:3:12 
cCTTAATGG- 
>Tup:TupF2:-:3:14 
-CTTAATTGc 
>Tup:TupF4:-:3:15 
-CTAAATGGa 
>Tup:TupF6:-:3:17 
-CTTAATGGa 
>Tup:TupF7:+:3:18 
cGATAAGTG- 
>Tup:TupF8:-:3:19 
-CTTAATTGa 
>NK7:NK7E1:+:3:1 
aTATAATGA- 
>NK7:NK7E2:+:3:2 
aATTAAGTG- 
>NK7:NK7E3:+:3:3 
aATTAAGTG- 
>NK7:NK7E4:-:3:4 
-TTTAAATAc 
>NK7:NK7E6:+:3:5 
aAATAATTA- 
>NK7:NK7E7:+:2:6 
gAGTAAATGa 
>NK7:NK7E8:+:3:7 
aACTAATTG- 
>NK7:NK7E10:-:3:8 
-GTTAAGTGg 
>NK7:NK7F1:+:3:10 
aGCTAATTG- 
>NK7:NK7F4:+:3:13 
cGCTAATGA- 
>NK7:NK7F6:-:1:15 
tTTTAATTG- 
>NK7:NK7F7:+:3:16 
cCTTAATAG- 
>NK7:NK7F8:-:3:17 
-CTTAATTGc 
>NK7:NK7F9:-:3:18 
-CTTAATTGg 
>NK7:NK7F10:+:3:19 
gCTTAATTA- 
>NK7:NK7F11:+:3:20 
gACTAATTA- 
>NK7:NK72A2:-:2:21 
gTTTAATGAt 
>NK7:NK72A3:+:3:22 
aCTTAAGTG- 
>NK7:NK72A5:-:3:24 
-TTTAATGGa 
>NK7:NK72A6:-:3:25 
-CTTAATAGc 
>NK7:NK72A7:-:3:26 
-TATAATTGt 
>NK7:NK72A8:-:2:27 
tTTTAATTAa 
>NK7:NK72A9:+:3:28 
aCATAATAG- 
>NK7:NK72A10:+:3:29 
aGATAATGA- 
>NK7:NK72A11:-:2:30 
tATTGATAGc 
>NK7:NK72A12:+:3:31 
cATTAAATG- 
>NK7:NK72B2:+:3:32 
gGTTAAATA- 
>NK7:NK72B4:+:3:34 
aATTAAGTG- 
>NK7:NK72B5:-:2:35 
tATTAATAGt 
>NK7:NK72B6:-:3:36 
-ATTGATGGt 
>NK7:NK72B7:+:3:37 
tATTAATGA- 
>NK7:NK72B8:-:3:38 
-CTTAATTAc 
>NK7:NK72B9:+:3:39 
cACTAATTA- 
>NK7:NK72B10:-:3:40 
-TTTAATAGg 
>NK7:NK72B11:-:2:41 
cCTTAATTGg 
>CG13424:CG13424E1:+
:2:1 
gCCTAATTGa 
>CG13424:CG13424E2:+
:3:2 
-TTTAATTAg 
>CG13424:CG13424E3:-
:3:3 
gTTTAATTA- 
>CG13424:CG13424E4:+
:3:4 
-TATAATTGt 
>CG13424:CG13424E9:+
:2:8 
cATTAATGGg 
>CG13424:CG13424E11:
+:2:10 
tATTAATTAg 
>CG13424:CG13424E12:
-:3:11 
tGTTAATGA- 
>CG13424:CG13424F2:-
:3:12 
aACTAATGG- 
>CG13424:CG13424F3:+
:3:13 
-GGTAATTGc 
>CG13424:CG13424F4:+
:3:14 
-TTTAATAGg 
>CG13424:CG13424F5:-
:3:15 
gTCTAATGA- 
>CG13424:CG13424F7:+
:2:17 
gCATAATTGg 
>CG13424:CG13424F8:+
:2:18 
gTTTAATTGa 
>CG13424:CG13424C1:+
:2:23 
gGTTAATTAg 
>CG13424:CG13424C5:-
:3:26 
gATTAATTA- 
>CG13424:CG13424C6:-
:3:27 
tACTAATTG- 
>CG13424:CG13424C7:+
:3:28 
-CTTAATAGc 
>CG13424:CG13424C8:-
:3:29 
aGTTAATAG- 
>CG13424:CG13424C12:
+:2:33 
tCCTAATTGg 
>CG13424:CG13424D1:+
:2:34 
tACTAATTGc 
>CG13424:CG13424D2:+
:2:35 
tCCTAATTAt 
>Hgtx:HgtxC1:+:3:1 
-ATTAATAGg 
>Hgtx:HgtxC2:-:1:2 
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-AGTAATTGa 
>Hgtx:HgtxC3:-:2:3 
aGCTAATTA- 
>Hgtx:HgtxC4:+:3:4 
-GATAATTGg 
>Hgtx:HgtxC5:-:3:5 
tTGTAATTA- 
>Hgtx:HgtxC6:+:1:6 
tTTTAATGA- 
>Hgtx:HgtxC7:-:3:7 
aTGTAATTA- 
>Hgtx:HgtxC8:+:3:8 
-GTTAATTGa 
>Hgtx:HgtxC9:+:3:9 
-CATAATGAg 
>Hgtx:HgtxD1:+:3:11 
-GATAATTGc 
>Hgtx:HgtxD2:+:3:12 
-TCTAATTAc 
>Hgtx:HgtxD3:+:3:13 
-AATAATGAa 
>Hgtx:HgtxD4:+:2:14 
aATTAATTAa 
>Hgtx:HgtxD5:-:3:15 
tTTTAATTA- 
>Hgtx:HgtxD6:-:3:16 
cTTTAATTA- 
>Hgtx:HgtxD7:+:2:17 
-TTTAATGAg 
>Hgtx:HgtxD8:-:3:18 
cTTTAATTA- 
>Hgtx:HgtxD9:-:3:19 
tTTTAATGA- 
>Hgtx:HgtxD10:-:3:20 
aGTTAATGA- 
>Hgtx:HgtxD11:-:3:21 
gTTTAATTA- 
>Ems:emsA1:+:2:1 
-TATAATTAa 
>Ems:emsA2:+:1:2 
cATAAATGG- 
>Ems:emsA3:-:3:3 
aTTTTATGA- 
>Ems:emsA5:+:2:5 
tATTAGTGAa 
>Ems:emsA6:+:3:6 
-AGTAATGAc 
>Ems:emsA7:+:3:7 
-ATTAATGGa 
>Ems:emsA8:+:3:8 
-GTTAATCAc 
>Ems:emsA9:-:3:9 
cATAAATGA- 
>Ems:emsA10:+:3:10 
-TTTAATTAg 
>Ems:emsA11:+:2:11 
cAATAATTGg 
>Ems:emsA12:-:3:12 
cATAAATTA- 
>Ems:emsB2:+:3:14 
-TATAATTGg 
>Ems:emsB3:+:3:15 
-TTTAATGGa 
>Ems:emsB5:-:3:16 
tTCTAATGA- 
>Ems:emsB6:-:3:17 
gCCTAATGA- 
>Ems:emsB7:-:3:18 
cACTAATTA- 
>Ems:emsB8:-:3:19 
gTCTAATGA- 
>Ems:emsB9:+:2:20 
cTCTAATTGg 
>Ems:emsB10:+:2:21 
cTCTAATTAg 
>Ems:emsB11:+:2:22 
cGCTAATTAg 
>Otp:OTPG1:+:1:1 
-TTCAATTAt 
>Otp:OTPG2:-:2:2 
tTCTAATTTg 
>Otp:OTPG3:-:3:3 
-ATTAATTGc 
>Otp:OTPG4:+:2:4 
gTTTAATCA- 
>Otp:OTPG5:+:3:5 
tTGTAATTA- 
>Otp:OTPG6:-:2:6 
aATTAATGGt 
>Otp:OTPG8:+:4:7 
cGCTAATTT- 
>Otp:OTPG9:-:2:8 
gTTTAATGAg 
>Otp:OTPG10:-:1:9 
cTTTAATGA- 
>Otp:OTPG11:+:1:10 
-TTTAATTAa 
>Otp:OTPG12:+:1:11 
-CCTAATTAg 
>Otp:OTPH1:+:2:12 
cCTTAATTAa 
>Otp:OTPH2:-:2:13 
cTGTAATTAg 
>Otp:OTPH3:+:2:14 
gCATAATTA- 
>Otp:OTPH4:-:3:15 
-GTTAATGAa 
>Otp:OTPH5:-:2:16 
cCTTAATTGa 
>Otp:OTPH6:-:3:17 
-TTTAATTAa 
>Otp:OTPH7:-:3:18 
-TCTAATTAa 
>Otp:OTPH10:+:3:19 
aACTAATTA- 
>Otp:OTPH11:-:2:20 
gTCTAATTAa 
>Ftz:FtzG1:+:3:1 
tCATAATTG- 
>Ftz:FtzG3:-:3:3 
-GTTAATGGg 
>Ftz:FtzG4:+:3:4 
tCTTAATTA- 
>Ftz:FtzG6:+:3:6 
tACTAATGA- 
>Ftz:FtzG7:+:3:7 
tATAAATGA- 
>Ftz:FtzG8:+:3:8 
tTTTAATTG- 
>Ftz:FtzG9:+:3:9 
gCCTAATGA- 
>Ftz:FtzG10:+:3:10 
aGTTAATTA- 
>Ftz:FtzG11:-:3:11 
-GTTAATGAt 
>Ftz:FtzG12:+:3:12 
gCTTAATTA- 
>Ftz:FtzH1:+:3:13 
gCTTAATGG- 
>Ftz:FtzH3:+:3:15 
cGTTAATTA- 
>Ftz:FtzH5:+:3:16 
aGTTAATGA- 
>Ftz:FtzH7:+:3:18 
tGTTAATTA- 
>Ftz:FtzH8:+:3:19 
gGTTAATTA- 
>Ftz:FtzH9:+:3:20 
tTTTAATGA- 
>Ftz:FtzH10:+:3:21 
tATTAATTA- 
>Ftz:FtzH11:+:3:22 
tGTTAATGA- 
>Antp:AntpA02:-:3:1 
cCTTAATTA- 
>Antp:AntpA03:-:3:2 
aTTTAATTA- 
>Antp:AntpA04:-:3:3 
gCTTAATGA- 
>Antp:AntpA05:-:3:4 
tGTTAATGA- 
>Antp:AntpA07:-:3:6 
gTTTAATGA- 
>Antp:AntpA08:-:3:7 
gCTTAATGA- 
>Antp:AntpA10:-:3:8 
tACTAATTA- 
>Antp:AntpA11:-:3:9 
cCTTAATGG- 
>Antp:AntpB01:-:3:11 
tCATAATTA- 
>Antp:AntpB02:-:3:12 
tGTTAATTA- 
>Antp:AntpB04:-:3:13 
aTTTAATTA- 
>Antp:AntpB06:-:3:14 
gTTTAATGA- 
>Antp:AntpB07:-:3:15 
tTTTAATGA- 
>Antp:AntpB09:-:3:17 
gTTTAATTA- 
>Antp:AntpB11:-:3:18 
tTTTAATGA- 
>Antp:AntpB12:-:3:19 
cTTTAATGA- 
>Zen2:Zen2A2:+:2:2 
TTATAATGA- 
>Zen2:Zen2A4:+:2:4 
CCGTAATTA- 
>Zen2:Zen2A6:+:2:6 
TACTAATTG- 
>Zen2:Zen2A7:+:2:7 
GAGTAATGA- 
>Zen2:Zen2A8:+:2:8 
TGATAATGA- 
>Zen2:Zen2A9:+:2:9 
CCGTAATTA- 
>Zen2:Zen2A10:+:2:10 
TAGTAATTA- 
>Zen2:Zen2B3:+:2:14 
TACTAATTA- 
>Zen2:Zen2B4:-:2:15 
TACTAATGAc 
>Zen2:Zen2B9:+:2:20 
CCTTAATTA- 
>Zen2:Zen2B11:+:2:22 
AGTTAATGA- 
>Zen2:Zen2E1:-:2:23 
ACTTAATTAt 
>Zen2:Zen2E3:+:2:25 
ATTTAATTA- 
>Zen2:Zen2E4:-:2:26 
TCATAATTGa 
>Zen2:Zen2E5:-:2:27 
TTTTAATGAc 
>Zen2:Zen2E6:+:2:28 
GCTAAATTA- 
>Zen2:Zen2E7:+:2:29 
CACTAACGA- 
>Zen2:Zen2E9:-:2:31 
CCTTAATTGc 
>Zen2:Zen2E10:+:2:32 
CCTTAATTA- 
>Zen2:Zen2E11:-:2:33 
TTTTAATTGc 
>Zen2:Zen2F1:+:2:35 
CCGTAATGA- 
>Zen2:Zen2F3:+:2:37 
TACTAATGA- 
>Zen2:Zen2F5:+:2:39 
TGCTAATTA- 
>Zen2:Zen2F6:+:2:40 
AGCTAATTA- 
>Zen2:Zen2F7:+:1:41 
TGTTAATGA- 
>Zen2:Zen2F11:+:2:45 
TGTTAATTA- 
>Slou:SlouE2:+:3:2 
-CTTAATGGc 
>Slou:SlouE3:+:2:3 
tTTTAATGAg 
>Slou:SlouE4:-:3:4 
gAGTAATGA- 
>Slou:SlouE5:-:2:5 
cGTCAATTAc 
>Slou:SlouE6:+:3:6 
-GCTAATTGt 
>Slou:SlouE7:-:1:7 
-GTTAATTAt 
>Slou:SlouE8:+:3:8 
-TTTAATCGg 
>Slou:SlouE9:+:3:9 
-TTTAATAAt 
>Slou:SlouE10:+:1:10 
aATTAATTG- 
>Slou:SlouE11:-:3:11 
gTCTAATGA- 
>Slou:SlouE12:-:3:12 
tTCTAATGA- 
>Slou:SlouF1:-:3:13 
gGCTAATTA- 
>Slou:SlouF2:-:3:14 
cTCTAATTG- 
>Slou:SlouF3:-:2:15 
cTATAATTAg 
>Slou:SlouF4:-:1:16 
-GTTAATTAg 
>Slou:SlouF5:+:3:17 
-CTTAATTGg 
>Slou:SlouF6:+:3:18 
-TATAATTGt 
>Slou:SlouF7:+:3:19 
-CTTAATTGa 
>Slou:SlouF8:+:1:20 
cTTTAGTAG- 
>Slou:SlouF9:+:3:21 
-TTTAATTGg 
>Slou:SlouF10:+:3:22 
-TTTAATTAc 
>Slou:SlouF11:+:3:23 
-GATAATTGg 
>Btn:BtnE1:+:3:1 
-TTTAATGGc 
>Btn:BtnE2:-:3:2 
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cAGTAATGA- 
>Btn:BtnE3:-:3:3 
aCTTGATTA- 
>Btn:BtnE4:+:3:4 
-ATTAATGTa 
>Btn:BtnE5:+:3:5 
-CTTAATGGg 
>Btn:BtnE6:-:3:6 
cTGTAATTA- 
>Btn:BtnE7:+:3:7 
-GGTAATGAc 
>Btn:BtnE8:+:3:8 
-CTTAACGAc 
>Btn:BtnE9:-:3:9 
gCCTAATTA- 
>Btn:BtnE10:+:3:10 
-TATAATTGc 
>Btn:BtnE11:-:1:11 
-GATAATTAa 
>Btn:BtnE12:-:3:12 
tCGTAATGA- 
>Btn:BtnF1:+:3:13 
-TATAATGAt 
>Btn:BtnF2:-:1:14 
-CTTAATTAa 
>Btn:BtnF3:+:3:15 
-ATTAATGAc 
>Btn:BtnF4:-:3:16 
aTATAATGA- 
>Btn:BtnF5:+:3:17 
-GATAATTAg 
>Btn:BtnF6:+:3:18 
-ATTAATTAc 
>Btn:BtnF7:+:3:19 
-CTTAATGAc 
>Btn:BtnF8:-:3:20 
aCTTAATGA- 
>Btn:BtnF9:-:3:21 
cCTTAATGA- 
>Btn:BtnF10:-:3:22 
cGTTAATGA- 
>Btn:BtnF11:-:3:23 
aGTTAATGA- 
>Dfd:dfd1:+:3:1 
-CTTAATGAa 
>Dfd:dfd2:+:3:2 
-ATTAATGAc 
>Dfd:dfd3:+:3:3 
-TTTAATGAt 
>Dfd:dfd4:+:3:4 
-ATTAATGAc 
>Dfd:dfd5:+:2:5 
tGTTAATGAc 
>Dfd:dfd6:+:3:6 
-CTTAATTAg 
>Dfd:dfd7:+:3:7 
-ATTAATTAt 
>Dfd:dfd8:+:3:8 
-CTTAATTAg 
>Dfd:dfd9:+:3:9 
-ATTAATGGg 
>Dfd:dfd10:-:3:10 
tTTTAATGA- 
>Dfd:dfd11:+:3:11 
-TTTAATAGc 
>Dfd:dfd12:-:3:12 
cACTAATGA- 
>Dfd:dfd13:-:2:13 
tCGTAATGA- 
>Dfd:dfd14:-:3:14 
gCTTAATGG- 
>Dfd:dfd15:-:3:15 
tCGTAATTA- 
>Dfd:dfd16:+:2:16 
-AGTAATGAg 
>Dfd:dfd17:+:3:17 
-CTTAATGAa 
>Dfd:dfd18:+:3:18 
-CCTAATGAc 
>Dfd:dfd19:-:3:19 
aCCTAATGA- 
>Dfd:dfd20:-:3:20 
gGATAATGA- 
>Dfd:dfd21:-:3:21 
gACTAATGA- 
>Dfd:dfd22:+:3:22 
-GTTAATGAt 
>Dfd:dfd23:-:3:23 
cGTTAATGA- 
>Dfd:dfd24:-:3:24 
aATTAATGA- 
>Scr:ScrE04:+:1:1 
CCTTAATGA- 
>Scr:ScrE05:+:2:2 
ACATAATGA- 
>Scr:ScrE08:+:2:4 
TACTAATTA- 
>Scr:ScrE12:+:2:7 
CCTTAATGA- 
>Scr:ScrF02:+:1:9 
CGATAATGA- 
>Scr:ScrF04:+:2:10 
ACTTAATGA- 
>Scr:ScrF06:+:2:11 
CGCTAATGA- 
>Scr:ScrF11:+:2:15 
CATTAATGA- 
>Scr:ScrF12:+:2:16 
CGTTAATGA- 
>Scr:ScrG1:-:2:17 
CTTTAATTGc 
>Scr:ScrG2:+:2:18 
AATTAATGA- 
>Scr:ScrG3:+:2:19 
GTTTAATGA- 
>Scr:ScrG5:+:2:20 
CACTAATTA- 
>Scr:ScrG6:-:2:21 
CGTTAATTGc 
>Scr:ScrG7:+:2:22 
TGTTAATTA- 
>Scr:ScrG8:+:1:23 
CACTAATTA- 
>Scr:ScrG9:+:2:24 
CGTTAATTA- 
>Scr:ScrG12:+:2:26 
CGCTAATGA- 
>Scr:ScrH1:+:1:27 
TGTTAATGA- 
>Scr:ScrH2:+:2:28 
ACATAATGA- 
>Scr:ScrH3:+:2:29 
CGTTAATGA- 
>Scr:ScrH4:+:2:30 
TATTAATGA- 
>Scr:ScrH9:+:2:32 
TACTAATGA- 
>Scr:ScrH10:+:2:33 
ATTTAATGA- 
>Scr:ScrH11:+:2:34 
CACTAATGA- 
>Zen:ZenC1:+:2:1 
CCTTAATTA- 
>Zen:ZenC3:+:1:2 
GACTAATTA- 
>Zen:ZenC4:+:2:3 
GGCTAATTA- 
>Zen:ZenC5:+:2:4 
TAATAATGA- 
>Zen:ZenC8:+:2:7 
ACCTAATGA- 
>Zen:ZenC9:+:2:8 
GTTTAATGA- 
>Zen:ZenC10:+:2:9 
CCCTAATGA- 
>Zen:ZenC11:+:2:10 
CGCTAATGA- 
>Zen:ZenD2:+:2:12 
CCCTAATGA- 
>Zen:ZenD3:+:2:13 
GCTTAATGA- 
>Zen:ZenD4:+:2:14 
ACCTAATGA- 
>Zen:ZenD5:+:2:15 
TGCTAATTA- 
>Zen:ZenD6:+:2:16 
CCTTAATGA- 
>Zen:ZenD7:+:2:17 
TTTTAATTA- 
>Zen:ZenD9:+:2:18 
ACATAATGA- 
>Zen:ZenD11:+:1:19 
TGCTAATGA- 
>Pb:Pb1:+:3:1 
-TCTAATGAc 
>Pb:Pb2:+:3:2 
-GTTAATTAc 
>Pb:Pb3:+:3:3 
-TTTAATTAc 
>Pb:Pb4:+:3:4 
-GTTAATGAc 
>Pb:pBG2:-:3:5 
tCCTAATTA- 
>Pb:pBG3:+:2:6 
-TTTAATGAg 
>Pb:pBG4:+:3:7 
-TATAATTAc 
>Pb:pBG5:-:3:8 
tGTTAATTA- 
>Pb:pBG6:+:3:9 
-ATTAATTAc 
>Pb:pBG7:-:3:10 
aCATAATGA- 
>Pb:pBG8:-:3:11 
gACTAATGA- 
>Pb:pBG9:-:3:12 
cGTTAATGA- 
>Pb:pBG11:+:3:13 
-CTTAATGAg 
>Pb:pBG12:-:1:14 
-GCTAATTAa 
>Pb:pBH1:+:3:15 
-TTTAATTAc 
>Pb:pBH3:+:3:16 
-TATAATTAc 
>Pb:pBH4:-:1:17 
-GATAATTAt 
>Pb:pBH6:-:3:19 
tGCTAATGA- 
>Pb:pBH7:-:1:20 
-GCTAATTAa 
>Pb:pBH8:-:3:21 
gGTTAATGA- 
>Pb:pBH9:+:1:22 
cATTAATGA- 
>Pb:pBH10:+:3:23 
-TCTAATGAg 
>Pb:pBH11:+:3:24 
-TCTAATTAc 
>Pb:pBH12:-:3:25 
tGCTAATTA- 
>Lab:LabE1:+:1:1 
cgTTAATGA- 
>Lab:LabE2:-:4:2 
ccTTAATTA- 
>Lab:LabE3:-:4:3 
ggCTAATTA- 
>Lab:LabE4:+:3:4 
-aTTAATTAt 
>Lab:LabE6:-:4:6 
atTTAATTA- 
>Lab:LabE7:+:3:7 
-aTTAATTAg 
>Lab:LabE8:-:4:8 
agTTAATTA- 
>Lab:LabE9:-:4:9 
taCTAATTA- 
>Lab:LabE10:+:4:10 
--TTAAAGAa 
>Lab:LabF1:+:3:12 
-cTTAATGAc 
>Lab:LabF5:-:4:16 
tgTTAATTA- 
>Lab:LabF9:+:3:20 
-aTTAATGAc 
>Lab:LabF11:-:4:22 
gtCTAATGA- 
>Lab:LabH6:-:4:25 
tgTTAATTA- 
>Lab:LabH7:-:4:26 
tcTTAATTA- 
>Lab:LabH12:-:4:31 
acATAATGA- 
>AbdA:AbdAG02:-:3:1 
-tTTAATTAc 
>AbdA:AbdAG03:+:4:2 
cgTTAATGA- 
>AbdA:AbdAG04:+:4:3 
ttTTAATTA- 
>AbdA:AbdAG06:+:1:5 
--TTAATTAc 
>AbdA:AbdAG07:+:4:6 
tcTTTATTA- 
>AbdA:AbdAG10:+:3:9 
caCTAATTA- 
>AbdA:AbdAG11:+:2:10 
-cATAATTA- 
>AbdA:AbdAG12:+:4:11 
ttTTAATTA- 
>AbdA:AbdAH03:-:3:14 
-tTTAATGAc 
>AbdA:AbdAH04:+:4:15 
ttTTTATGA- 
>AbdA:AbdAH05:+:4:16 
taCTAATTC- 
>AbdA:AbdAH06:-:3:17 
-tTTAATTGc 
>AbdA:AbdAH07:-:4:18 
--TTAAAGAa 
>AbdA:AbdAH08:+:4:19 
atTTAATTA- 
>AbdA:AbdAH09:+:4:20 
cgCTAATGA- 
>AbdA:AbdAH10:+:4:21 
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gtTTAATGA- 
>AbdA:AbdAH11:-:3:22 
-cTTAATTGc 
>AbdA:AbdAH12:+:4:23 
tcTTAATTAc 
>Ap:ApA2:-:2:1 
gGTTAATGAt 
>Ap:ApA3:+:3:2 
gACTAATTG- 
>Ap:ApA4:+:3:3 
gGTTAATTA- 
>Ap:ApA5:+:3:4 
aAATAATGA- 
>Ap:ApA6:-:2:5 
cGCTAATTAg 
>Ap:ApA7:+:3:6 
tGCTAATTG- 
>Ap:ApA8:+:1:7 
-GCTAATTAa 
>Ap:ApA9:-:2:8 
tCATAATTGg 
>Ap:ApA10:-:2:9 
cCTTAATTAg 
>Ap:ApA11:+:1:10 
-ACAAATTAa 
>Ap:ApB3:+:3:12 
cCTTAATGA- 
>Ap:ApB4:-:2:13 
aCTTAATTAg 
>Ap:ApB5:-:3:14 
-TTTAATGAg 
>Ap:ApB6:+:1:15 
-ACTAATTAa 
>Ap:ApB7:+:3:16 
cGTTAATGA- 
>Ap:ApB8:+:3:17 
cGCTAATTA- 
>Ap:ApB9:+:3:18 
gACTAATTA- 
>Ap:ApB10:+:2:19 
cGCTAATGA- 
>Ap:ApB11:-:2:20 
tGCTAATTAg 
>Ind:IndC1:+:2:1 
GATTAATTA- 
>Ind:IndC2:+:1:2 
CGCTAATGA- 
>Ind:IndC3:+:2:3 
ACCTAATGA- 
>Ind:IndC4:-:1:4 
TATTAAGTG- 
>Ind:IndC5:-:1:5 
CTCTAATTA- 
>Ind:IndC7:+:2:7 
CGTTAATGA- 
>Ind:IndC8:+:2:8 
GATTAATGA- 
>Ind:IndC9:+:2:9 
CGTTAATGA- 
>Ind:IndC10:-:2:10 
TACTAATTAc 
>Ind:IndC11:-:2:11 
TATTAATTAc 
>Ind:IndC12:-:2:12 
TGTTAATGAg 
>Ind:IndD1:-:2:13 
CCTTAATTAg 
>Ind:IndD3:-:2:14 
TTCTAATTAc 
>Ind:IndD4:+:2:15 
CACTAATGA- 
>Ind:IndD5:+:2:16 
TGCTAATTA- 
>Ind:IndD6:+:2:17 
TCCTAATTA- 
>Ind:IndD7:+:2:18 
CACTAATGA- 
>Ind:IndD8:-:2:19 
TATTAATTGc 
>Ind:IndD9:+:2:20 
CACTAATTA- 
>Ind:IndD10:+:2:21 
CCCTAATTA- 
>Ind:IndD11:-:2:22 
TGCTAATTAg 
>CG18599:CG18599C1:-
:3:1 
-tTTAATTGa 
>CG18599:CG18599C2:+
:4:2 
tgCTAATGA- 
>CG18599:CG18599C3:+
:4:3 
tgCTAATTA- 
>CG18599:CG18599C4:+
:4:4 
aaTTAATTA- 
>CG18599:CG18599C5:+
:4:5 
ctTTAATTA- 
>CG18599:CG18599C6:+
:1:6 
--TTAATTAa 
>CG18599:CG18599C7:+
:3:7 
aaTTAATTA- 
>CG18599:CG18599C8:+
:4:8 
ccCTAATTG- 
>CG18599:CG18599C9:+
:4:9 
gaTTAATGA- 
>CG18599:CG18599C10:
+:4:10 
atCTAATTA- 
>CG18599:CG18599C11:
+:4:11 
caCTAATGA- 
>CG18599:CG18599C12:
+:4:12 
cgCTAATTA- 
>CG18599:CG18599D2:-
:2:13 
ttATAATGAg 
>CG18599:CG18599D9:+
:4:16 
ccGTAATTA- 
>CG18599:CG18599D10:
+:1:17 
--TTAATCAc 
>CG18599:CG18599D11:
+:4:18 
acATAATGA- 
>CG18599:CG18599F1:+
:4:19 
cgTTAATTA- 
>CG18599:CG18599F2:+
:4:20 
taATAATGA- 
>CG18599:CG18599F3:+
:4:21 
cgCTAATTA- 
>CG18599:CG18599F4:+
:4:22 
cgTTAATTA- 
>CG18599:CG18599F5:+
:3:23 
caCTAATTA- 
>CG18599:CG18599F6:+
:1:24 
--CTAATTAg 
>CG18599:CG18599F7:+
:3:25 
gcTTAATGA- 
>CG18599:CG18599F11:
+:4:27 
ttATAATGA- 
>CG18599:CG18599F12:
+:4:28 
gcCTAATTA- 
>Lbe:IbeG2:-:3:1 
-CATAATCAt 
>Lbe:IbeG3:+:3:2 
aTCTAAGTA- 
>Lbe:IbeG4:+:3:3 
gGTTAACCA- 
>Lbe:IbeG5:+:2:4 
tCCTAATCAc 
>Lbe:IbeG6:+:2:5 
cGTTAAATGa 
>Lbe:IbeG7:-:3:6 
-GGTAATTAc 
>Lbe:IbeG8:+:3:7 
cTATAAGTA- 
>Lbe:IbeG9:-:3:8 
-TGTAACAAg 
>Lbe:IbeG10:-:3:9 
-GTTAACCAg 
>Lbe:IbeG11:+:3:10 
gCCTAATTA- 
>Lbe:IbeG12:+:4:11 
gATTAACTA- 
>Lbe:IbeH1:+:3:12 
cACTAACAA- 
>Lbe:IbeH2:-:3:13 
-ACTAACGAg 
>Lbe:IbeH3:+:3:14 
aCATAATCA- 
>Lbe:IbeH4:+:3:15 
cTTTAACAA- 
>Lbe:IbeH5:+:1:16 
-GCTAATTAa 
>Lbe:IbeH6:-:3:17 
-GTTAATTGg 
>Lbe:IbeH7:-:3:18 
-GTTAATTAg 
>Lbe:IbeH8:-:1:19 
-GATAACAA- 
>Lbe:IbeH9:-:3:20 
-GTTAATTGg 
>Lbe:IbeH10:-:3:21 
-TTTAACGAg 
>Lbe:IbeH11:-:3:22 
-CTTAACGAg 
>Lbl:LblC1:-:3:1 
-GATAATTAt 
>Lbl:LblC2:-:3:2 
-TATAATTAc 
>Lbl:LblC3:+:3:3 
gGATAATTG- 
>Lbl:LblC4:+:3:4 
cACTAATCA- 
>Lbl:LblC5:+:1:5 
-GCTAATTAt 
>Lbl:LblC6:+:3:6 
tGCTAATTG- 
>Lbl:LblC7:+:1:7 
-GTTAATTAa 
>Lbl:LblC8:+:3:8 
aACTAACGA- 
>Lbl:LblC9:-:3:9 
-CTTAATCAg 
>Lbl:LblC10:-:2:10 
-GATAATTGg 
>Lbl:LblC11:-:2:11 
-GTTAACAAg 
>Lbl:LblC12:-:3:12 
-CTTAACGAg 
>Lbl:LblD1:-:3:13 
-TTTAATTGg 
>Lbl:LblD2:-:3:14 
-CTTAACGAg 
>Lbl:LblD3:-:3:15 
-CTTAATTGg 
>Lbl:LblD4:-:3:16 
-GATAATTGg 
>Lbl:LblD5:+:3:17 
gACTAATGA- 
>Lbl:LblD6:+:3:18 
tGCTAATCA- 
>Lbl:LblD7:+:1:19 
-GCTAATTAa 
>Lbl:LblD8:+:1:20 
-GCTAATTAa 
>Lbl:LblD9:+:3:21 
gACTAATGA- 
>Lbl:LblD10:-:3:22 
-CTTAACGAg 
>Lbl:LblD11:+:3:23 
gACTAATGA- 
>Eve:Eve-G2:+:2:2 
aATTAAGTAa 
>Eve:Eve-G3:+:2:3 
tAATAATCGa 
>Eve:Eve-G4:-:3:4 
tTCTAATCA- 
>Eve:Eve-G5:-:3:5 
aGTAAATTA- 
>Eve:Eve-G6:-:3:6 
tTCTAACGA- 
>Eve:Eve-G7:+:3:7 
-TATAATGAt 
>Eve:Eve-G8:+:2:8 
tACTAACGAc 
>Eve:Eve-G9:-:3:9 
gGCTAATTG- 
>Eve:Eve-G10:+:2:10 
gTCTAATTGa 
>Eve:Eve-G11:+:3:11 
-GTTAATGTg 
>Eve:Eve-G12:+:3:12 
-CATAATGAg 
>Eve:Eve-H1:-:1:13 
-GTTAATTAa 
>Eve:Eve-H2:+:3:14 
-GTTAATGGg 
>Eve:Eve-H3:+:3:15 
-TTTAATGAc 
>Eve:Eve-H4:-:3:16 
gTTTAATGA- 
>Eve:Eve-H5:-:3:17 
gGCTAATTA- 
>Eve:Eve-H6:-:3:18 
tGCTAATTA- 
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>Eve:Eve-H7:-:3:19 
cACTAATTA- 
>Eve:Eve-H8:+:2:20 
tACTAATTAc 
>Eve:Eve-H9:-:3:21 
tGCTAATGA- 
>Eve:Eve-H10:+:3:22 
-ATTAATGAg 
>Eve:Eve-H11:+:3:23 
-GTTAATGAc 
>E5:E5C1:-:3:1 
-CCTAATTGa 
>E5:E5C2:-:2:2 
aTTTAATTAa 
>E5:E5C3:-:2:3 
tGTAAATTAg 
>E5:E5C4:-:1:4 
gCTTAATGG- 
>E5:E5C5:+:1:5 
-ATAAATTAa 
>E5:E5C6:+:3:6 
tGTTAATAA- 
>E5:E5C7:+:3:7 
cCGTAATTA- 
>E5:E5C8:+:2:8 
gCTTAAGTA- 
>E5:E5C9:-:3:9 
-GCTAATTGa 
>E5:E5C10:+:3:10 
cTGTAATGA- 
>E5:E5C11:+:3:11 
tTATAATTA- 
>E5:E5C12:-:2:12 
tTCTAATTAa 
>E5:E5D2:+:3:14 
gTATAATGA- 
>E5:E5D3:-:1:15 
cACTATTGA- 
>E5:E5D4:+:3:16 
tGTTAATTG- 
>E5:E5D5:+:3:17 
aGCTAATGA- 
>E5:E5D7:+:3:19 
gGCTAATTA- 
>E5:E5D8:+:3:20 
tATTAATTA- 
>E5:E5D9:+:3:21 
aTCTAATTA- 
>E5:E5D10:+:3:22 
cACTAATGA- 
>E5:E5D11:+:3:23 
gACTAATGA- 
>E5:E52C1:+:3:24 
gACTAATAG- 
>E5:E52C2:-:2:25 
gGTTAATGGg 
>E5:E52C3:+:3:26 
gGCTAAATA- 
>E5:E52C4:-:2:27 
aCGTAATGAa 
>E5:E52C5:-:3:28 
-CTTAATAGt 
>E5:E52C6:+:3:29 
aTTAAATGA- 
>E5:E52C7:+:3:30 
aCTTAATAA- 
>E5:E52C8:+:3:31 
cAATAATGA- 
>E5:E52C10:-:3:33 
-ACTAATGAa 
>E5:E52C11:+:3:34 
gGGTAATTA- 
>E5:E52C12:+:3:35 
gTTTAATGA- 
>E5:E52D1:+:3:36 
aTGTAATGA- 
>E5:E52D2:+:3:37 
tTTTAATTA- 
>E5:E52D3:+:3:38 
gCATAATTA- 
>E5:E52D4:+:3:39 
cGTTAATAG- 
>E5:E52D5:+:3:40 
aACTAATTA- 
>E5:E52D6:-:2:41 
tCTTAATTGa 
>E5:E52D7:+:3:42 
cATTAATGA- 
>E5:E52D8:+:3:43 
cAATAATTA- 
>E5:E52D9:+:3:44 
aTCTAATGA- 
>E5:E52D10:+:3:45 
cGGTAATTA- 
>E5:E52D11:-:3:46 
-GCTAATTAc 
>BH1:B1HG8:+:1:8 
-GCTAATTGA 
>BH1:B1HG9:+:1:9 
-GTTAATTGA 
>BH1:B1HG10:+:2:10 
tGTTAAACGG 
>BH1:B1HH9:-:2:20 
-CTTAATTGC 
>BH1:BH12E2:+:2:22 
tTCTAAACGG 
>BH1:BH12E3:-:2:23 
-GTTAATTGG 
>BH1:BH12E4:+:2:24 
gGCTAATTGA 
>BH1:BH12E5:+:2:25 
aGTTAATAGG 
>BH1:BH12E6:-:2:26 
-GTTAATTGT 
>BH1:BH12E7:-:2:27 
-GTTAATTGA 
>BH1:BH12E8:-:2:28 
-CATAATTGC 
>BH1:BH12E9:+:2:29 
tGTTAAACGG 
>BH1:BH12E10:+:2:30 
tCTTAAACGG 
>BH1:BH12E11:+:2:31 
tCTTAAACGG 
>BH1:BH12E12:+:2:32 
aGATAATTGC 
>BH1:BH12F1:+:2:33 
gGATAATTGA 
>BH1:BH12F2:+:2:34 
aCTTAAACGT 
>BH1:BH12F3:+:1:35 
-GATAATTAA 
>BH1:BH12F4:+:2:36 
cTTTAAACGG 
>BH1:BH12F6:-:2:38 
-ATTAAATGT 
>BH1:BH12F11:+:2:42 
tTCTAATTGA 
>BH2:BH2E1:+:1:1 
-GATAAACGG 
>BH2:BH2E2:+:1:2 
-TTTAATTGC 
>BH2:BH2E4:+:1:3 
-CTTAATAGT 
>BH2:BH2E5:+:1:4 
-ACTAAATGG 
>BH2:BH2E6:+:1:5 
-TTTAATAGG 
>BH2:BH2E7:+:1:6 
-CTTAATGGC 
>BH2:BH2E9:+:1:8 
-CTTAAAAGG 
>BH2:BH2E10:+:1:9 
-ATTAATTGG 
>BH2:BH2E11:+:1:10 
-GATAAATGA 
>BH2:BH2E12:+:1:11 
-TCTAATGGG 
>BH2:BH2F1:+:1:12 
-GATAATTGG 
>BH2:BH2F2:+:1:13 
-CTTAAATGA 
>BH2:BH2F3:+:1:14 
-TGTAATTGG 
>BH2:BH2F4:+:1:15 
-CATAATTGG 
>BH2:BH2F5:+:1:16 
-GATAATTGG 
>BH2:BH2F6:+:1:17 
-TATAATTGC 
>BH2:BH2F7:+:1:18 
-GTTAATTGA 
>BH2:BH2F8:+:1:19 
-GTTAATTGC 
>BH2:BH2F9:+:1:20 
-GTTAATTGA 
>BH2:BH2F10:+:1:21 
-CTTAATTGA 
>BH2:BH2F11:+:1:22 
-CTTAATTGG 
>CG11085:CG11085G1:+
:1:1 
-CTTAATGGG 
>CG11085:CG11085G3:+
:1:3 
-TTTAATTGG 
>CG11085:CG11085G4:+
:1:4 
-TTTAATTGC 
>CG11085:CG11085G5:+
:1:5 
-TTTAATAGG 
>CG11085:CG11085G6:+
:1:6 
-CTTAATGGG 
>CG11085:CG11085G7:+
:1:7 
-TTTAATTAC 
>CG11085:CG11085G8:+
:1:8 
-TCTAATAGC 
>CG11085:CG11085G9:+
:1:9 
-CTTAATCGG 
>CG11085:CG11085G11:
+:1:11 
-CCTAATTGC 
>CG11085:CG11085H2:+
:1:14 
-GCTAATTGA 
>CG11085:CG11085H4:+
:1:16 
-GTTAATTGG 
>CG11085:CG11085H6:+
:1:18 
-ATTAAATGT 
>CG11085:CG11085H11:
+:1:23 
-ATTAATTGA 
>CG34031:CG34031E1:+
:3:1 
-TGTAATTGt 
>CG34031:CG34031E2:+
:2:2 
cTTTAATTGc 
>CG34031:CG34031E3:+
:3:3 
-GTTAATTAg 
>CG34031:CG34031E4:-
:3:4 
tTTTTATTG- 
>CG34031:CG34031E5:+
:3:5 
-ATTAAATGt 
>CG34031:CG34031E6:-
:3:6 
tTTTAATAG- 
>CG34031:CG34031E7:-
:3:7 
cTTTTATAG- 
>CG34031:CG34031E8:+
:2:8 
cTTTAATAGt 
>CG34031:CG34031F3:+
:3:15 
-GTTAATTGc 
>CG34031:CG34031F4:+
:3:16 
-CTTAATGGt 
>CG34031:CG34031A1:+
:2:23 
tATTAATTAg 
>CG34031:CG34031A2:+
:3:24 
-CTTAATAGa 
>CG34031:CG34031A3:+
:2:25 
gTTTAATTGg 
>CG34031:CG34031A4:+
:2:26 
gTTTAATTGc 
>CG34031:CG34031A5:+
:3:27 
-TTTAATTGc 
>CG34031:CG34031A6:+
:3:28 
-TCTAATTGt 
>CG34031:CG34031A7:+
:2:29 
gTTTAATTGc 
>CG34031:CG34031A8:+
:3:30 
-TTTTATAGt 
>CG34031:CG34031A10:
-:3:32 
tGTTAATTG- 
>CG34031:CG34031A11:
+:3:33 
-CTTAATTGt 
>CG34031:CG34031A12:
+:3:34 
-TTTAATAGg 
>CG34031:CG34031B2:+
:3:35 
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-CTTAATTGc 
>CG34031:CG34031B3:+
:3:36 
-GTTAATTGa 
>CG34031:CG34031B5:+
:3:37 
-TTTAAATAg 
>CG34031:CG34031B6:+
:3:38 
-TTTAATAGa 
>Hmx:HMXA2:+:4:1 
tgTTAATTG- 
>Hmx:HMXA3:+:4:2 
agATAATTG- 
>Hmx:HMXA4:+:4:3 
cgCTAATTG- 
>Hmx:HMXA5:-:4:4 
--TTAAATGg 
>Hmx:HMXA6:+:4:5 
taTTAATTG- 
>Hmx:HMXA7:+:4:6 
ccTTAATTG- 
>Hmx:HMXA8:+:4:7 
tgTTAATTG- 
>Hmx:HMXA12:+:1:10 
--TTAATTG- 
>Hmx:HMXE1:+:4:11 
cgTTAATTA- 
>Hmx:HMXE2:+:4:12 
acTTAATCG- 
>Hmx:HMXE3:+:4:13 
ctCTAATTG- 
>Hmx:HMXE4:+:4:14 
acTTAATCG- 
>Hmx:HMXE5:+:4:15 
taTTAATCG- 
>Hmx:HMXE6:+:4:16 
acTTAATTA- 
>Hmx:HMXE7:+:4:17 
agTTAATTA- 
>Hmx:HMXE8:+:4:18 
caCTAATTA- 
>Hmx:HMXE9:+:4:19 
gtTTAATTG- 
>Hmx:HMXE10:+:4:20 
atTTAATTG- 
>Hmx:HMXF4:-:3:25 
-cTTAATTGc 
>Hmx:HMXF8:-:3:28 
-cTTAATTGc 
>Unc4:Unc4C1:-:1:1 
-TCTAATTAg 
>Unc4:Unc4C2:-:3:2 
cTGTAATTA- 
>Unc4:Unc4C3:+:3:3 
-CTTAATTCg 
>Unc4:Unc4C4:-:1:4 
-GCTAATTAt 
>Unc4:Unc4C5:-:1:5 
-CTTAATTAt 
>Unc4:Unc4C6:+:3:6 
-CTTAATAGa 
>Unc4:Unc4C7:+:2:7 
tTTTAATTGa 
>Unc4:Unc4C8:-:3:8 
tCTTAATTG- 
>Unc4:Unc4C9:+:3:9 
-CCTAATTGa 
>Unc4:Unc4C10:+:3:10 
-TGTAATTGa 
>Unc4:Unc4C11:+:3:11 
-GTTAATTGc 
>Unc4:Unc4C12:+:3:12 
-CCTAATTGa 
>Unc4:Unc4D1:-:3:13 
cACTAATTA- 
>Unc4:Unc4D3:+:3:15 
-AATAATTGg 
>Unc4:Unc4D4:+:3:16 
-CTTAATTGa 
>Unc4:Unc4D5:+:3:17 
-GTTAATTGa 
>Unc4:Unc4D6:+:3:18 
-CTTAATTGg 
>Unc4:Unc4D7:+:3:19 
-TTTAATTGg 
>Unc4:Unc4D8:+:3:20 
-GTTAATTGg 
>Unc4:Unc4D10:+:3:22 
-GTTAATTGa 
>Unc4:Unc4D11:+:3:23 
-CTTAATTAg 
>Odsh:OdshC1:-:4:1 
ttGTAATTA- 
>Odsh:OdshC2:+:2:2 
-tTTAATTTc 
>Odsh:OdshC3:+:2:3 
tgCTAATTAt 
>Odsh:OdshC4:-:3:4 
taCTAATTAa 
>Odsh:OdshC5:-:4:5 
aaCTAATTG- 
>Odsh:OdshC7:-:3:6 
agCTAATTA- 
>Odsh:OdshC8:-:2:7 
-cCTAATTAc 
>Odsh:OdshC9:+:2:8 
ccTTAATTGc 
>Odsh:OdshC10:+:3:9 
-gGTAATTAc 
>Odsh:OdshC11:-:4:10 
atTTAATTA- 
>Odsh:OdshC12:+:3:11 
-cCTAATTGt 
>Odsh:OdshD1:+:3:12 
-aTTAATTGt 
>Odsh:OdshD2:+:2:13 
atTTAATTGg 
>Odsh:OdshD3:-:3:14 
tgCTAATTAa 
>Odsh:OdshD4:-:4:15 
acTTAATTA- 
>Odsh:OdshD5:-:2:16 
-cCTAATTAa 
>Odsh:OdshD6:-:2:17 
-tCTAATTAa 
>Odsh:OdshD7:-:4:18 
cgCTAATTA- 
>Odsh:OdshD8:+:3:19 
-aCTAATTGa 
>Odsh:OdshD9:+:3:20 
-tGTAATTGa 
>Odsh:OdshD10:-:2:21 
-cTTAATTAa 
>Odsh:OdshD11:+:3:22 
-gGTAATTGa 
>Dr:DrA2:+:1:1 
CCTCAATTA- 
>Dr:DrA3:+:1:2 
AAGCAATTA- 
>Dr:DrA4:+:1:3 
GGCCAATTA- 
>Dr:DrA5:+:1:4 
AACTAATTA- 
>Dr:DrA6:+:1:5 
CTCCAATTA- 
>Dr:DrA7:+:1:6 
CACCAATTA- 
>Dr:DrA8:+:1:7 
GAGCAATTA- 
>Dr:DrA9:+:1:8 
GGGTAATTA- 
>Dr:DrA10:+:1:9 
GACTAATTA- 
>Dr:DrA11:+:1:10 
CGCTAATTA- 
>Dr:DrB2:+:1:11 
CTCCAATTA- 
>Dr:DrB3:+:1:12 
GGCCAATTA- 
>Dr:DrB4:+:1:13 
AAACAATTA- 
>Dr:DrB5:+:1:14 
AACCAATTA- 
>Dr:DrB6:+:1:15 
GAGCAATTA- 
>Dr:DrB7:+:1:16 
GACCAATTA- 
>Dr:DrB8:+:1:17 
CTCCAATTA- 
>Dr:DrB9:+:1:18 
GAGTAATTA- 
>Dr:DrB10:+:1:19 
CAGCAATTA- 
>Dr:DrB11:+:1:20 
CCCCAATTA- 
>Dr:DrB12:+:1:21 
GTCCAATTA
377 
 
Table A.4 
Mutual Information product comparing full 60 amino acid homeodomains and 
when ignoring positions 11 through 39 that are less likely to contact DNA directly. 
 
MI Joint Rank Product 
 
MI Row-wise ranks 
 
MI(b,a):  
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1 8 2 17 10 42 3 22 44 49 40 32 33 16 18 31 
2 3 34 26 9 44 8 18 41 46 20 13 37 31 16 2 
3 5 10 7 17 41 1 9 28 47 23 25 19 30 18 12 
4 28 22 13 16 47 4 3 23 52 27 20 43 31 18 11 
5 16 17 21 31 45 1 8 48 24 12 35 25 13 29 4 
6 18 28 22 8 60 41 20 43 23 3 17 55 31 25 1 
7 16 30 20 22 52 2 11 34 46 25 32 26 17 31 21 
8 20 18 13 7 48 5 10 44 46 33 43 6 36 17 28 
9 22 13 10 11 47 6 8 43 48 28 29 20 35 18 16 
10 9 20 15 3 44 6 25 38 49 14 32 33 8 22 30 
 
 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
1 57 48 25 6 43 41 23 20 28 54 50 26 11 4 24 
2 53 32 19 21 40 28 11 27 25 52 47 43 23 4 7 
3 55 31 29 2 33 38 11 49 26 53 50 40 27 13 34 
4 55 41 24 12 42 10 19 32 33 54 45 37 17 14 29 
5 56 22 23 14 30 36 32 44 37 55 43 41 9 28 46 
6 53 40 2 11 47 27 9 33 21 54 4 10 15 13 36 
7 57 40 35 5 9 18 28 33 29 54 50 44 14 8 37 
8 55 35 19 1 16 22 39 38 34 54 49 45 9 8 24 
9 57 31 12 2 32 19 40 33 17 53 46 41 21 9 39 
10 54 50 34 4 43 36 23 13 29 55 52 27 21 1 17 
 
 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 
1 27 1 29 45 55 19 21 47 13 51 34 15 36 37 56 
2 42 15 24 48 54 17 14 36 30 49 38 1 33 50 51 
3 32 24 14 46 56 8 15 43 35 44 45 6 39 51 52 
4 46 25 1 38 56 8 9 39 15 40 48 5 35 49 50 
5 11 26 20 51 58 39 38 33 42 52 49 7 34 50 53 
6 50 6 5 35 44 24 7 37 19 52 58 56 30 34 39 
7 27 41 15 51 56 23 12 38 39 48 47 4 36 49 53 
8 11 25 30 50 56 23 14 32 41 52 42 12 29 47 53 
9 15 37 27 50 56 30 5 45 38 49 44 7 36 51 54 
10 37 2 16 48 57 12 7 47 28 45 35 26 31 39 56 
 
 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 
1 7 39 58 52 30 59 38 59 5 46 14 53 35 12 9 
2 22 45 58 56 39 59 29 59 6 57 12 55 35 5 10 
3 16 42 58 57 21 59 37 60 4 48 3 54 36 20 22 
4 30 36 58 57 34 60 26 59 21 51 6 53 44 2 7 
5 5 3 54 57 6 60 47 59 19 18 10 40 2 15 27 
6 51 29 49 48 59 45 57 45 12 32 38 42 26 14 16 
7 3 24 58 55 6 60 10 59 1 43 7 45 42 13 19 
8 3 26 57 58 2 59 37 60 4 40 27 51 21 15 31 
9 3 24 58 55 1 59 42 60 4 34 14 52 23 26 25 
10 11 40 58 53 24 59 41 59 10 46 19 51 42 5 18 
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MI Column-wise ranks 
 
MI(b,a):  
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1 6 5 8 6 6 8 8 8 7 9 8 7 6 6 9 
2 8 9 9 9 9 9 9 9 8 8 9 9 9 9 8 
3 7 7 7 8 5 6 7 7 5 6 7 6 8 8 7 
4 9 8 6 7 8 7 5 5 9 7 6 8 7 7 5 
5 4 4 4 4 2 3 4 4 1 3 4 4 2 4 2 
6 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
7 2 3 3 3 7 1 3 1 3 2 2 3 1 3 3 
8 3 2 2 2 3 4 2 3 2 4 3 1 4 2 4 
9 1 1 1 1 1 2 1 2 4 1 1 2 3 1 1 
10 5 6 5 5 4 5 6 6 6 5 5 5 5 5 6 
 
 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
1 9 9 6 7 8 8 8 6 7 8 6 6 6 6 6 
2 6 7 9 9 9 9 9 8 9 6 9 9 9 9 8 
3 8 5 8 6 5 7 6 9 6 7 7 8 8 8 9 
4 7 6 7 8 7 5 7 7 8 9 5 7 7 7 7 
5 1 3 4 4 4 4 4 5 4 4 2 3 4 4 5 
6 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
7 5 4 3 3 1 3 1 2 3 3 4 4 2 3 3 
8 2 2 2 1 2 2 3 3 2 2 3 2 1 2 1 
9 4 1 1 2 3 1 2 1 1 1 1 1 3 1 2 
10 3 8 5 5 6 6 5 4 5 5 8 5 5 5 4 
 
 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 
1 6 6 8 8 5 8 7 9 5 8 6 8 6 6 8 
2 9 9 9 9 6 9 9 8 9 9 8 9 9 9 7 
3 7 8 7 6 8 7 8 6 8 6 7 6 8 8 5 
4 8 7 5 5 7 6 6 5 7 4 9 5 7 7 6 
5 4 3 4 4 3 4 4 4 4 7 5 4 4 4 3 
6 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
7 3 4 1 3 2 2 2 2 3 2 3 2 3 2 4 
8 1 1 3 2 4 1 3 1 2 3 2 3 1 1 1 
9 2 2 2 1 1 3 1 3 1 1 1 1 2 3 2 
10 5 5 6 7 9 5 5 7 6 5 4 7 5 5 9 
 
 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 
1 6 7 9 4 7 10 8 10 6 7 8 6 6 7 7 
2 9 9 10 7 9 8 9 8 9 9 9 9 9 9 9 
3 7 8 7 10 6 6 7 6 7 6 7 8 7 8 8 
4 8 6 6 6 8 3 5 3 8 8 5 7 8 6 5 
5 4 1 1 5 4 2 4 2 4 2 4 1 1 4 4 
6 10 10 5 9 10 1 10 1 10 10 10 10 10 10 10 
7 3 4 4 2 3 4 1 4 1 4 1 2 4 1 2 
8 1 3 3 8 2 5 2 5 3 3 3 3 3 2 3 
9 2 2 2 1 1 7 3 7 2 1 2 4 2 3 1 
10 5 5 8 3 5 9 6 9 5 5 6 5 5 5 6 
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Joint Rank Product = (row rank)*(col rank) 
 
Color Key: products equal to 1 (i.e. top element in row as well as column) are red. Products <=4 are purple. 
Products <= 9 are blue 
I choose 1, 4, and 9 as cut offs because rowRank_1*colRank_1 = 1, rowRank_2*colRank2 = 4 etc. 
1 4 9 
 
Joint Rank Product = (row rank)*(col rank) 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1 48 10 136 60 252 24 176 352 343 360 256 231 96 108 279 
2 24 306 234 81 396 72 162 369 368 160 117 333 279 144 16 
3 35 70 49 136 205 6 63 196 235 138 175 114 240 144 84 
4 252 176 78 112 376 28 15 115 468 189 120 344 217 126 55 
5 64 68 84 124 90 3 32 192 24 36 140 100 26 116 8 
6 180 280 220 80 600 410 200 430 230 30 170 550 310 250 10 
7 32 90 60 66 364 2 33 34 138 50 64 78 17 93 63 
8 60 36 26 14 144 20 20 132 92 132 129 6 144 34 112 
9 22 13 10 11 47 12 8 86 192 28 29 40 105 18 16 
10 45 120 75 15 176 30 150 228 294 70 160 165 40 110 180 
 
 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
1 513 432 150 42 344 328 184 120 196 432 300 156 66 24 144 
2 318 224 171 189 360 252 99 216 225 312 423 387 207 36 56 
3 440 155 232 12 165 266 66 441 156 371 350 320 216 104 306 
4 385 246 168 96 294 50 133 224 264 486 225 259 119 98 203 
5 56 66 92 56 120 144 128 220 148 220 86 123 36 112 230 
6 530 400 20 110 470 270 90 330 210 540 40 100 150 130 360 
7 285 160 105 15 9 54 28 66 87 162 200 176 28 24 111 
8 110 70 38 1 32 44 117 114 68 108 147 90 9 16 24 
9 228 31 12 4 96 19 80 33 17 53 46 41 63 9 78 
10 162 400 170 20 258 216 115 52 145 275 416 135 105 5 68 
 
 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 
1 162 6 232 360 275 152 147 423 65 408 204 120 216 222 448 
2 378 135 216 432 324 153 126 288 270 441 304 9 297 450 357 
3 224 192 98 276 448 56 120 258 280 264 315 36 312 408 260 
4 368 175 5 190 392 48 54 195 105 160 432 25 245 343 300 
5 44 78 80 204 174 156 152 132 168 364 245 28 136 200 159 
6 500 60 50 350 440 240 70 370 190 520 580 560 300 340 390 
7 81 164 15 153 112 46 24 76 117 96 141 8 108 98 212 
8 11 25 90 100 224 23 42 32 82 156 84 36 29 47 53 
9 30 74 54 50 56 90 5 135 38 49 44 7 72 153 108 
10 185 10 96 336 513 60 35 329 168 225 140 182 155 195 504 
 
 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 
1 42 273 522 208 210 590 304 590 30 322 112 318 210 84 63 
2 198 405 580 392 351 472 261 472 54 513 108 495 315 45 90 
3 112 336 406 570 126 354 259 360 28 288 21 432 252 160 176 
4 240 216 348 342 272 180 130 177 168 408 30 371 352 12 35 
5 20 3 54 285 24 120 188 118 76 36 40 40 2 60 108 
6 510 290 245 432 590 45 570 45 120 320 380 420 260 140 160 
7 9 96 232 110 18 240 10 236 1 172 7 90 168 13 38 
8 3 78 171 464 4 295 74 300 12 120 81 153 63 30 93 
9 6 48 116 55 1 413 126 420 8 34 28 208 46 78 25 
10 55 200 464 159 120 531 246 531 50 230 114 255 210 25 108 
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Joint Rank Product Summary 
 1 32       
 2 42       
Expected based 
on qualitative 
code 3 6       
5,6,7 4 33       
55,2,3 5 6 58 47 15    
51 6        
47,54,43 7 54* 6 56 42 20 46  
47,50,54 8 19 46 50* 12 28   
47,50,54 9 50* 19 37 46 42 7 29 
 10 29       
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Ranking the joint rank product by row. 
 
Purpose: find row rank of 'missed' qualitative code AA residues (shown in red) 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1 8 2 19 9 37 3 26 49 47 50 38 35 14 15 41 
2 3 36 28 9 50 8 19 46 45 18 13 41 32 16 2 
3 5 11 7 19 30 1 9 29 34 20 26 16 35 21 12 
4 41 27 12 16 54 5 3 17 59 30 19 49 35 20 11 
5 21 23 27 39 29 2 10 52 6 11 43 31 8 34 4 
6 20 31 24 10 60 44 22 46 25 3 19 55 34 28 1 
7 17 33 24 27 60 2 18 19 45 22 26 30 11 35 25 
8 28 21 15 8 51 10 10 49 39 49 48 4 51 20 44 
9 18 13 9 10 33 11 6 47 56 20 22 28 50 16 14 
10 9 23 16 3 36 6 28 45 51 15 31 33 8 20 37 
 
 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
1 57 54 22 6 48 46 27 17 28 54 42 24 12 3 20 
2 39 26 20 21 44 29 11 24 27 37 52 48 23 4 7 
3 57 22 33 2 25 41 10 58 23 53 50 48 31 14 45 
4 55 40 24 13 45 9 22 36 43 60 37 42 18 14 33 
5 18 22 30 18 36 44 40 55 45 55 28 38 11 33 57 
6 53 43 2 13 49 30 11 36 23 54 4 12 17 15 39 
7 59 48 39 9 5 23 15 27 32 49 54 53 15 13 42 
8 43 31 23 1 18 25 46 45 30 42 53 37 5 9 13 
9 58 24 11 2 49 17 46 25 15 37 31 29 41 8 44 
10 32 54 35 4 49 43 22 11 27 50 55 25 18 1 14 
 
 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 
1 25 1 36 50 40 23 21 53 11 52 29 17 33 34 56 
2 47 15 24 53 40 17 14 33 31 54 35 1 34 55 43 
3 32 28 13 42 59 8 17 37 43 40 47 6 46 55 39 
4 52 26 1 31 56 8 10 32 15 23 58 4 39 48 46 
5 16 25 26 54 50 47 46 41 49 60 58 9 42 53 48 
6 50 8 7 38 48 26 9 40 21 52 58 56 33 37 42 
7 31 50 9 47 43 21 13 29 44 36 46 4 40 38 55 
8 6 14 37 41 57 12 24 18 35 55 36 21 16 26 27 
9 23 43 38 36 40 48 3 54 27 35 30 5 42 55 51 
10 39 2 17 53 58 13 7 52 34 44 26 38 29 40 57 
 
 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 
1 6 39 58 30 31 59 43 59 5 45 16 44 31 13 10 
2 22 51 60 49 42 56 30 56 6 59 12 58 38 5 10 
3 15 49 54 60 18 51 38 52 4 44 3 56 36 24 27 
4 38 34 50 47 44 29 21 28 24 57 6 53 51 2 7 
5 5 2 17 59 6 36 51 35 24 11 14 14 1 20 32 
6 51 32 27 47 59 5 57 5 14 35 41 45 29 16 18 
7 5 36 56 41 12 58 7 57 1 52 3 33 51 8 20 
8 2 33 56 60 3 58 32 59 7 47 34 54 29 17 40 
9 4 34 52 39 1 59 53 60 6 26 20 57 31 44 19 
10 12 41 56 30 23 59 47 59 10 46 21 48 42 5 19 
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Ignoring positions 11 through 39 
 
MI(b,a): 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1 0.12 0.15 0.11 0.12 0.05 0.14 0.10 0.04 0.03 0.06 0 0 0 0 0 
2 0.08 0.04 0.04 0.07 0.02 0.07 0.06 0.03 0.02 0.06 0 0 0 0 0 
3 0.12 0.11 0.11 0.09 0.05 0.15 0.11 0.07 0.04 0.09 0 0 0 0 0 
4 0.08 0.09 0.12 0.11 0.03 0.14 0.15 0.09 0.02 0.08 0 0 0 0 0 
5 0.25 0.25 0.24 0.20 0.14 0.45 0.30 0.09 0.23 0.28 0 0 0 0 0 
6 0.01 0.00 0.01 0.01 0.00 0.00 0.01 0.00 0.01 0.01 0 0 0 0 0 
7 0.34 0.25 0.32 0.31 0.04 0.47 0.37 0.24 0.14 0.30 0 0 0 0 0 
8 0.34 0.34 0.36 0.41 0.13 0.44 0.39 0.21 0.17 0.26 0 0 0 0 0 
9 0.35 0.39 0.45 0.43 0.16 0.46 0.46 0.23 0.14 0.32 0 0 0 0 0 
10 0.16 0.13 0.14 0.19 0.06 0.17 0.12 0.09 0.04 0.14 0 0 0 0 0 
 
 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
 
 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 
1 0 0 0 0 0 0 0 0 0 0.02 0.07 0.11 0.07 0.06 0.01 
2 0 0 0 0 0 0 0 0 0 0.02 0.03 0.08 0.04 0.02 0.02 
3 0 0 0 0 0 0 0 0 0 0.05 0.04 0.12 0.06 0.03 0.03 
4 0 0 0 0 0 0 0 0 0 0.05 0.03 0.14 0.06 0.03 0.02 
5 0 0 0 0 0 0 0 0 0 0.04 0.09 0.31 0.19 0.08 0.04 
6 0 0 0 0 0 0 0 0 0 0.00 0.00 0.00 0.00 0.00 0.00 
7 0 0 0 0 0 0 0 0 0 0.13 0.13 0.44 0.24 0.12 0.03 
8 0 0 0 0 0 0 0 0 0 0.09 0.22 0.39 0.30 0.17 0.05 
9 0 0 0 0 0 0 0 0 0 0.13 0.23 0.46 0.26 0.10 0.04 
10 0 0 0 0 0 0 0 0 0 0.05 0.10 0.11 0.10 0.08 0.01 
 
 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 
1 0.12 0.06 0.00 0.02 0.08 0.00 0.06 0.00 0.13 0.03 0.11 0.02 0.07 0.12 0.12 
2 0.05 0.02 0.00 0.01 0.03 0.00 0.04 0.00 0.08 0.01 0.07 0.01 0.03 0.08 0.07 
3 0.10 0.05 0.00 0.00 0.09 0.00 0.06 0.00 0.12 0.04 0.12 0.01 0.06 0.09 0.09 
4 0.07 0.06 0.00 0.01 0.07 0.00 0.08 0.00 0.10 0.02 0.14 0.02 0.04 0.16 0.14 
5 0.32 0.35 0.03 0.01 0.31 0.00 0.11 0.00 0.24 0.25 0.30 0.16 0.36 0.26 0.22 
6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.01 0.01 0.01 
7 0.44 0.30 0.00 0.02 0.43 0.00 0.37 0.00 0.50 0.17 0.41 0.16 0.19 0.36 0.32 
8 0.56 0.31 0.01 0.01 0.58 0.00 0.24 0.00 0.45 0.24 0.30 0.11 0.33 0.36 0.28 
9 0.53 0.34 0.01 0.04 0.69 0.00 0.23 0.00 0.47 0.27 0.39 0.08 0.34 0.33 0.33 
10 0.15 0.08 0.00 0.02 0.12 0.00 0.08 0.00 0.16 0.05 0.13 0.03 0.08 0.17 0.13 
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Row-wise ranks 
 
MI(b,a): 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1 5 1 11 7 21 2 12 22 24 20 32 32 32 32 32 
2 2 15 12 6 20 5 9 19 22 10 32 32 32 32 32 
3 4 8 6 10 19 1 7 15 23 14 32 32 32 32 32 
4 14 10 7 8 21 3 2 11 26 13 32 32 32 32 32 
5 11 12 15 18 21 1 7 23 16 9 32 32 32 32 32 
6 6 11 8 2 31 18 7 20 9 1 32 32 32 32 32 
7 10 16 12 13 26 2 8 17 22 15 32 32 32 32 32 
8 11 10 8 5 24 4 6 21 22 17 32 32 32 32 32 
9 11 9 7 8 22 4 6 20 23 16 32 32 32 32 32 
10 4 11 8 1 22 3 13 17 25 7 32 32 32 32 32 
 
 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
1 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 
2 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 
3 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 
4 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 
5 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 
6 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 
7 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 
8 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 
9 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 
10 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 
 
 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 
1 32 32 32 32 32 32 32 32 32 25 14 10 16 17 28 
2 32 32 32 32 32 32 32 32 32 23 17 1 14 24 25 
3 32 32 32 32 32 32 32 32 32 21 22 5 18 25 26 
4 32 32 32 32 32 32 32 32 32 19 22 4 17 23 24 
5 32 32 32 32 32 32 32 32 32 26 24 6 19 25 27 
6 32 32 32 32 32 32 32 32 32 26 29 27 13 15 17 
7 32 32 32 32 32 32 32 32 32 24 23 4 18 25 27 
8 32 32 32 32 32 32 32 32 32 26 20 7 15 23 27 
9 32 32 32 32 32 32 32 32 32 24 21 5 18 25 27 
10 32 32 32 32 32 32 32 32 32 23 16 14 15 18 28 
 
 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 
1 4 19 29 26 13 30 18 30 3 23 9 27 15 8 6 
2 11 21 29 27 18 30 13 30 4 28 8 26 16 3 7 
3 9 20 29 28 12 30 17 31 3 24 2 27 16 11 13 
4 15 18 29 28 16 31 12 30 9 25 5 27 20 1 6 
5 4 3 28 29 5 31 22 30 14 13 8 20 2 10 17 
6 25 12 24 23 30 21 28 21 3 14 16 19 10 4 5 
7 3 14 29 28 5 31 7 30 1 20 6 21 19 9 11 
8 2 13 28 29 1 30 18 31 3 19 14 25 12 9 16 
9 2 13 29 28 1 30 19 31 3 17 10 26 12 15 14 
10 6 19 29 27 12 30 20 30 5 24 10 26 21 2 9 
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Column-wise ranks 
 
MI(b,a): 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1 6 5 8 6 6 8 8 8 7 9 10 10 10 10 10 
2 8 9 9 9 9 9 9 9 8 8 10 10 10 10 10 
3 7 7 7 8 5 6 7 7 5 6 10 10 10 10 10 
4 9 8 6 7 8 7 5 5 9 7 10 10 10 10 10 
5 4 4 4 4 2 3 4 4 1 3 10 10 10 10 10 
6 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
7 2 3 3 3 7 1 3 1 3 2 10 10 10 10 10 
8 3 2 2 2 3 4 2 3 2 4 10 10 10 10 10 
9 1 1 1 1 1 2 1 2 4 1 10 10 10 10 10 
10 5 6 5 5 4 5 6 6 6 5 10 10 10 10 10 
 
 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
1 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
2 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
3 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
4 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
5 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
6 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
7 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
8 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
9 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
 
 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 
1 10 10 10 10 10 10 10 10 10 8 6 8 6 6 8 
2 10 10 10 10 10 10 10 10 10 9 8 9 9 9 7 
3 10 10 10 10 10 10 10 10 10 6 7 6 8 8 5 
4 10 10 10 10 10 10 10 10 10 4 9 5 7 7 6 
5 10 10 10 10 10 10 10 10 10 7 5 4 4 4 3 
6 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
7 10 10 10 10 10 10 10 10 10 2 3 2 3 2 4 
8 10 10 10 10 10 10 10 10 10 3 2 3 1 1 1 
9 10 10 10 10 10 10 10 10 10 1 1 1 2 3 2 
10 10 10 10 10 10 10 10 10 10 5 4 7 5 5 9 
 
 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 
1 6 7 9 4 7 10 8 10 6 7 8 6 6 7 7 
2 9 9 10 7 9 8 9 8 9 9 9 9 9 9 9 
3 7 8 7 10 6 6 7 6 7 6 7 8 7 8 8 
4 8 6 6 6 8 3 5 3 8 8 5 7 8 6 5 
5 4 1 1 5 4 2 4 2 4 2 4 1 1 4 4 
6 10 10 5 9 10 1 10 1 10 10 10 10 10 10 10 
7 3 4 4 2 3 4 1 4 1 4 1 2 4 1 2 
8 1 3 3 8 2 5 2 5 3 3 3 3 3 2 3 
9 2 2 2 1 1 7 3 7 2 1 2 4 2 3 1 
10 5 5 8 3 5 9 6 9 5 5 6 5 5 5 6 
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Ignoring positions 11 through 39: 
Joint Rank Product = (row rank)*(col rank) 
 
Joint Rank Product = (row rank)*(col rank) 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1 30 5 88 42 126 16 96 176 168 180 320 320 320 320 320 
2 16 135 108 54 180 45 81 171 176 80 320 320 320 320 320 
3 28 56 42 80 95 6 49 105 115 84 320 320 320 320 320 
4 126 80 42 56 168 21 10 55 234 91 320 320 320 320 320 
5 44 48 60 72 42 3 28 92 16 27 320 320 320 320 320 
6 60 110 80 20 310 180 70 200 90 10 320 320 320 320 320 
7 20 48 36 39 182 2 24 17 66 30 320 320 320 320 320 
8 33 20 16 10 72 16 12 63 44 68 320 320 320 320 320 
9 11 9 7 8 22 8 6 40 92 16 320 320 320 320 320 
10 20 66 40 5 88 15 78 102 150 35 320 320 320 320 320 
 
 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
1 320 320 320 320 320 320 320 320 320 320 320 320 320 320 320 
2 320 320 320 320 320 320 320 320 320 320 320 320 320 320 320 
3 320 320 320 320 320 320 320 320 320 320 320 320 320 320 320 
4 320 320 320 320 320 320 320 320 320 320 320 320 320 320 320 
5 320 320 320 320 320 320 320 320 320 320 320 320 320 320 320 
6 320 320 320 320 320 320 320 320 320 320 320 320 320 320 320 
7 320 320 320 320 320 320 320 320 320 320 320 320 320 320 320 
8 320 320 320 320 320 320 320 320 320 320 320 320 320 320 320 
9 320 320 320 320 320 320 320 320 320 320 320 320 320 320 320 
10 320 320 320 320 320 320 320 320 320 320 320 320 320 320 320 
 
 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 
1 320 320 320 320 320 320 320 320 320 200 84 80 96 102 224 
2 320 320 320 320 320 320 320 320 320 207 136 9 126 216 175 
3 320 320 320 320 320 320 320 320 320 126 154 30 144 200 130 
4 320 320 320 320 320 320 320 320 320 76 198 20 119 161 144 
5 320 320 320 320 320 320 320 320 320 182 120 24 76 100 81 
6 320 320 320 320 320 320 320 320 320 260 290 270 130 150 170 
7 320 320 320 320 320 320 320 320 320 48 69 8 54 50 108 
8 320 320 320 320 320 320 320 320 320 78 40 21 15 23 27 
9 320 320 320 320 320 320 320 320 320 24 21 5 36 75 54 
10 320 320 320 320 320 320 320 320 320 115 64 98 75 90 252 
 
 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 
1 24 133 261 104 91 300 144 300 18 161 72 162 90 56 42 
2 99 189 290 189 162 240 117 240 36 252 72 234 144 27 63 
3 63 160 203 280 72 180 119 186 21 144 14 216 112 88 104 
4 120 108 174 168 128 93 60 90 72 200 25 189 160 6 30 
5 16 3 28 145 20 62 88 60 56 26 32 20 2 40 68 
6 250 120 120 207 300 21 280 21 30 140 160 190 100 40 50 
7 9 56 116 56 15 124 7 120 1 80 6 42 76 9 22 
8 2 39 84 232 2 150 36 155 9 57 42 75 36 18 48 
9 4 26 58 28 1 210 57 217 6 17 20 104 24 45 14 
10 30 95 232 81 60 270 120 270 25 120 60 130 105 10 54 
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Summary ignoring positions 11 through 39: 
 
Joint Rank Product Summary 
 Nuc  AA's         
 1  2         
 2  42         
Expected based 
on qualitative 
code 3  6         
5,6,7 4  59         
55,2,3 5  6 58 47       
51 6           
47,54,43 7  54* 6 56 52 42 46 59   
47,50,54 8  46 50* 54*       
47,50,54 9  50* 46 42 7 54* 3 4 6 9 
 10  4         
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Table A.5 
Fly factors used to predict the human homeodomains and confidence scores. 
Confidence 
Score 
Human HD 
Query 
fly HD 
Ref 
Similarity 
Score 
#Key 
Residue 
matches 
Ref. Key 
Residues 
(5,47,50,54
&55) 
#Sites 
Contributed by 
Ref 
1 ALX3    RVQAK  
  Pph13 316 5 RVQAK 21 
  Hbn 311 5 RVQAK 17 
  Al 310 5 RVQAK 20 
       
1 ALX4    RVQAK  
  Rx 315 5 RVQAK 27 
  Al 314 5 RVQAK 20 
  Pph13 311 5 RVQAK 21 
       
 ARGFX    RVRFK  
 No predictions made     
       
1 ARX    RVQAK  
  Al 349 5 RVQAK 20 
  Pph13 348 5 RVQAK 21 
  Hbn 333 5 RVQAK 17 
       
1 BARHL1    RTQTK  
  BH2 320 5 RTQTK 21 
  BH1 310 5 RTQTK 21 
       
1 BARHL2    RTQTK  
  BH2 314 5 RTQTK 21 
  BH1 304 5 RTQTK 21 
       
3 BARX1    RTQMK  
  Bsh 254 5 RTQMK 16 
       
3 BARX2    RTQMK  
  Bsh 242 5 RTQMK 16 
       
2 BSX    RTQMK  
  Bsh 339 5 RTQMK 16 
       
2 CDX1    RIQAK  
  Cad 303 5 RIQAK 38 
       
2 CDX2    RIQAK  
  Cad 308 5 RIQAK 38 
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2 CDX4    RIQAK  
  Cad 284 5 RIQAK 38 
       
2 CRX    RVKAK  
  Oc 327 5 RVKAK 19 
       
 CUTL1    RNHSR  
 No predictions made     
       
4 CUTL2    RNHSR  
  Ct 203 4 RNHMR 20 
       
2 DBX1    RIQMK  
  CG12
361 
334 5 RIQMK 16 
       
2 DBX2    RIQMK  
  CG12
361 
306 5 RIQMK 16 
       
2 DLX1    RIQSK  
  Dll 332 5 RIQSK 23 
       
2 DLX2    RIQSK  
  Dll 316 5 RIQSK 23 
       
2 DLX3    RIQSK  
  Dll 304 5 RIQSK 23 
       
2 DLX4    RIQSK  
  Dll 320 5 RIQSK 23 
       
2 DLX5    RIQSK  
  Dll 313 5 RIQSK 23 
       
2 DLX6    RIQSK  
  Dll 321 5 RIQSK 23 
       
3 DMBX1    RVKAK  
  Gsc 260 5 RVKAK 22 
  Ptx1 252 5 RVKAK 20 
  Oc 243 5 RVKAK 19 
       
1 DRGX    RVQAK  
  Al 312 5 RVQAK 20 
  CG11
294 
308 5 RVQAK 15 
  Pph13 295 5 RVQAK 21 
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1 EMX1    RVQTK  
  E5 311 5 RVQTK 43 
  Ems 300 5 RVQTK 20 
       
1 EMX2    RVQTK  
  E5 323 5 RVQTK 43 
  Ems 307 5 RVQTK 20 
       
3 EN1    RIQAK  
  En 283 5 RIQAK 23 
  Inv 272 5 RIQAK 16 
       
3 EN2    RIQAK  
  En 287 5 RIQAK 23 
  Inv 276 5 RIQAK 16 
       
3 ESX1    RVQAK  
  Hbn 265 5 RVQAK 17 
  Repo 264 5 RVQAK 28 
  Rx 260 5 RVQAK 27 
       
2 EVX1    RVQMK  
  Eve 354 5 RVQMK 22 
       
2 EVX2    RVQMK  
  Eve 358 5 RVQMK 22 
       
2 GBX1    RIQAK  
  Unpg 338 5 RIQAK 21 
       
2 GBX2    RIQAK  
  Unpg 337 5 RIQAK 21 
       
2 GSC    RVKAK  
  Gsc 300 5 RVKAK 22 
       
2 GSCL    RVKAK  
  Gsc 282 5 RVKAK 22 
       
2 GSX1    RIQVK  
  Ind 300 5 RIQVK 21 
       
2 GSX2    RIQVK  
  Ind 299 5 RIQVK 21 
       
 HESX1    RIQAK  
 No predictions made     
       
3 HHEX    QTQAK  
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  CG70
56 
267 5 QTQAK 26 
       
2 HLX    RVQMK  
  H2 308 5 RVQMK 32 
       
 HMBOX1    RNAKE  
 No predictions made     
       
2 HMX1    RIQNK  
  Hmx 346 5 RIQNK 20 
       
3 HMX2    RTQNK  
  Hmx 321 4 RIQNK 20 
       
2 HMX3    RIQNK  
  Hmx 345 5 RIQNK 20 
       
 HNF1A    RNAKE  
 No predictions made     
       
 HNF1B    RNAKE  
 No predictions made     
       
2 HOXA1    RIQMK  
  Lab 315 5 RIQMK 16 
       
3 HOXA10    RIQMK  
  AbdB 259 5 RIQMK 21 
  Antp 248 5 RIQMK 16 
  Scr 248 5 RIQMK 25 
  AbdA 247 5 RIQMK 18 
       
4 HOXA11    RIQMK  
  AbdB 251 5 RIQMK 21 
  Scr 218 5 RIQMK 25 
  Ftz 213 5 RIQMK 18 
       
 HOXA13    RIQVK  
 No predictions made     
       
2 HOXA2    RVQMK  
  Pb 365 5 RVQMK 24 
       
3 HOXA3    RIQMK  
  Scr 279 5 RIQMK 25 
  Dfd 278 5 RIQMK 24 
  Ftz 273 5 RIQMK 18 
       
1 HOXA4    RIQMK  
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  Dfd 355 5 RIQMK 24 
  Scr 351 5 RIQMK 25 
  Antp 334 5 RIQMK 16 
       
1 HOXA5    RIQMK  
  Scr 361 5 RIQMK 25 
  Antp 360 5 RIQMK 16 
  Dfd 342 5 RIQMK 24 
       
1 HOXA6    RIQMK  
  Antp 375 5 RIQMK 16 
  Scr 351 5 RIQMK 25 
  AbdA 341 5 RIQMK 18 
       
1 HOXA7    RIQMK  
  Antp 390 5 RIQMK 16 
  Scr 372 5 RIQMK 25 
  AbdA 356 5 RIQMK 18 
       
3 HOXA9    RIQMK  
  AbdB 272 5 RIQMK 21 
  Scr 260 5 RIQMK 25 
  Antp 254 5 RIQMK 16 
       
2 HOXB1    RIQMK  
  Lab 303 5 RIQMK 16 
       
 HOXB13    RIQVK  
 No predictions made     
       
2 HOXB2    RVQMK  
  Pb 365 5 RVQMK 24 
       
3 HOXB3    RIQMK  
  Dfd 280 5 RIQMK 24 
  Scr 276 5 RIQMK 25 
  Ftz 275 5 RIQMK 18 
       
1 HOXB4    RIQMK  
  Dfd 355 5 RIQMK 24 
  Scr 351 5 RIQMK 25 
  Antp 334 5 RIQMK 16 
       
1 HOXB5    RIQMK  
  Scr 361 5 RIQMK 25 
  Antp 360 5 RIQMK 16 
  Dfd 342 5 RIQMK 24 
       
1 HOXB6    RIQMK  
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  Antp 374 5 RIQMK 16 
  Scr 353 5 RIQMK 25 
  AbdA 345 5 RIQMK 18 
       
1 HOXB7    RIQMK  
  Antp 385 5 RIQMK 16 
  Scr 353 5 RIQMK 25 
  AbdA 345 5 RIQMK 18 
       
1 HOXB8    RIQMK  
  Antp 342 5 RIQMK 16 
  AbdA 315 5 RIQMK 18 
  Ubx 310 5 RIQMK 20 
       
3 HOXB9    RIQMK  
  AbdB 267 5 RIQMK 21 
  Scr 258 5 RIQMK 25 
  Antp 255 5 RIQMK 16 
       
3 HOXC10    RIQMK  
  AbdB 254 5 RIQMK 21 
  Dfd 250 5 RIQMK 24 
  Antp 248 5 RIQMK 16 
       
3 HOXC11    RIQMK  
  AbdB 265 5 RIQMK 21 
       
4 HOXC12    RIQMK  
  AbdB 232 5 RIQMK 21 
  Zen2 207 5 RIQMK 26 
  Ftz 202 5 RIQMK 18 
       
 HOXC13    RIQVK  
 No predictions made     
       
1 HOXC4    RIQMK  
  Dfd 359 5 RIQMK 24 
  Scr 349 5 RIQMK 25 
  Antp 332 5 RIQMK 16 
       
1 HOXC5    RIQMK  
  Scr 346 5 RIQMK 25 
  Antp 340 5 RIQMK 16 
  Dfd 322 5 RIQMK 24 
       
1 HOXC6    RIQMK  
  Antp 370 5 RIQMK 16 
  Scr 343 5 RIQMK 25 
  AbdA 341 5 RIQMK 18 
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1 HOXC8    RIQMK  
  Antp 334 5 RIQMK 16 
  AbdA 307 5 RIQMK 18 
  Ubx 302 5 RIQMK 20 
       
3 HOXC9    RIQMK  
  AbdB 277 5 RIQMK 21 
  Scr 268 5 RIQMK 25 
  Antp 262 5 RIQMK 16 
       
2 HOXD1    RIQMK  
  Lab 306 5 RIQMK 16 
       
3 HOXD10    RIQMK  
  AbdB 257 5 RIQMK 21 
  AbdA 247 5 RIQMK 18 
  Scr 246 5 RIQMK 25 
       
4 HOXD11    RIQMK  
  AbdB 254 5 RIQMK 21 
  Ftz 221 5 RIQMK 18 
  Scr 221 5 RIQMK 25 
       
3 HOXD12    RIQMK  
  AbdB 229 5 RIQMK 21 
       
 HOXD13    RIQVK  
 No predictions made     
       
3 HOXD3    RIQMK  
  Scr 277 5 RIQMK 25 
  Dfd 276 5 RIQMK 24 
  Ftz 273 5 RIQMK 18 
       
1 HOXD4    RIQMK  
  Dfd 357 5 RIQMK 24 
  Scr 353 5 RIQMK 25 
  Antp 336 5 RIQMK 16 
       
1 HOXD8    RIQMK  
  Antp 339 5 RIQMK 16 
  AbdA 322 5 RIQMK 18 
  Ubx 307 5 RIQMK 20 
       
3 HOXD9    RIQMK  
  AbdB 281 5 RIQMK 21 
  Scr 265 5 RIQMK 25 
  AbdA 256 5 RIQMK 18 
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3 IRX1    KTARR  
  Mirr 309 4 RTARR 41 
  Ara 300 4 RTARR 34 
  Caup 300 4 RTARR 19 
       
1 IRX2    RTARR  
  Ara 330 5 RTARR 34 
  Caup 330 5 RTARR 19 
  Mirr 329 5 RTARR 41 
       
3 IRX3    KTARR  
  Mirr 302 4 RTARR 41 
  Ara 301 4 RTARR 34 
  Caup 301 4 RTARR 19 
       
1 IRX4    RTARR  
  Mirr 352 5 RTARR 41 
  Ara 335 5 RTARR 34 
  Caup 335 5 RTARR 19 
       
1 IRX5    RTARR  
  Ara 330 5 RTARR 34 
  Caup 330 5 RTARR 19 
  Mirr 329 5 RTARR 41 
       
1 IRX6    RTARR  
  Mirr 344 5 RTARR 41 
  Ara 340 5 RTARR 34 
  Caup 340 5 RTARR 19 
       
2 ISL1    RVQCK  
  Tup 353 5 RVQCK 16 
       
2 ISL2    RVQCK  
  Tup 355 5 RVQCK 16 
       
4 ISX    RIQAK  
  Unpg 204 5 RIQAK 21 
       
1 LBX1    RTQAK  
  Lbe 332 5 RTQAK 22 
  Lbl 327 5 RTQAK 23 
       
3 LBX2    RTQAK  
  Lbl 287 5 RTQAK 23 
  Lbe 280 5 RTQAK 22 
       
2 LHX1    RVQSK  
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  Lim1 330 5 RVQSK 18 
       
2 LHX2    RVQAK  
  Ap 345 5 RVQAK 19 
       
2 LHX3    RVQAK  
  Lim3 339 5 RVQAK 20 
       
2 LHX4    RVQAK  
  Lim3 337 5 RVQAK 20 
       
2 LHX5    RVQSK  
  Lim1 330 5 RVQSK 18 
       
3 LHX8    RVQAR  
  Awh 253 5 RVQAR 40 
       
2 LHX9    RVQAK  
  Ap 345 5 RVQAK 19 
       
1 LMX1A    RVQAK  
  CG43
28 
317 5 RVQAK 30 
  CG32
105 
308 5 RVQAK 19 
       
1 LMX1B    RVQAK  
  CG43
28 
317 5 RVQAK 30 
  CG32
105 
308 5 RVQAK 19 
       
2 MEIS1    RNIRR  
  Hth 366 5 RNIRR 17 
       
2 MEIS2    RNIRR  
  Hth 371 5 RNIRR 17 
       
 MEIS3    DNIRR  
 No predictions made     
       
2 MEIS3P2    RNIRR  
  Hth 335 5 RNIRR 17 
       
2 MEOX1    RVQMK  
  Btn 295 5 RVQMK 23 
       
3 MIXL1    RVQAK  
  CG11
294 
234 5 RVQAK 15 
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  Pph13 231 5 RVQAK 21 
  CG32
532 
229 5 RVQAK 23 
       
 MKX    RNARR  
 No predictions made     
       
2 MNX1    RIQMK  
  Exex 339 5 RIQMK 23 
       
2 MSX1    RIQAK  
  Dr 333 5 RIQAK 21 
       
2 MSX2    RIQAK  
  Dr 335 5 RIQAK 21 
       
 NANOG    RTQMR  
 No predictions made     
       
 NANOGP1    RTQMR  
 No predictions made     
       
 NANOGP8    RTQMR  
 No predictions made     
       
2 NKX2-1    RIQYK  
  Vnd 326 5 RIQYK 19 
       
2 NKX2-2    RIQYK  
  Vnd 363 5 RIQYK 19 
       
3 NKX2-3    RIQYK  
  Vnd 293 5 RIQYK 19 
  Bap 276 5 RIQYK 23 
  Tin 255 5 RIQYK 16 
       
2 NKX2-4    RIQYK  
  Vnd 326 5 RIQYK 19 
       
3 NKX2-5    RIQYK  
  Vnd 289 5 RIQYK 19 
  Bap 268 5 RIQYK 23 
  Tin 250 5 RIQYK 16 
       
3 NKX2-6    RIQYK  
  Vnd 283 5 RIQYK 19 
  Bap 257 5 RIQYK 23 
  Tin 252 5 RIQYK 16 
       
2 NKX2-8    RIQYK  
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  Vnd 337 5 RIQYK 19 
       
2 NKX3-1    RIQYK  
  Bap 306 5 RIQYK 23 
       
2 NKX3-2    RIQYK  
  Bap 333 5 RIQYK 23 
       
2 NKX6-1    RVQTK  
  Hgtx 368 5 RVQTK 20 
       
2 NKX6-2    RVQTK  
  Hgtx 371 5 RVQTK 20 
       
4 NOBOX    RVQAK  
  Al 235 5 RVQAK 20 
  CG41
36 
228 5 RVQAK 22 
  PhdP 222 5 RVQAK 17 
       
2 ONECUT1    RNMRR  
  onecu
t 
316 5 RNMRR 15 
       
2 ONECUT2    RNMRR  
  onecu
t 
297 5 RNMRR 15 
       
2 OTP    RVQAK  
  Otp 372 5 RVQAK 20 
       
2 OTX1    RVKAK  
  Oc 360 5 RVKAK 19 
       
2 OTX2    RVKAK  
  Oc 364 5 RVKAK 19 
       
2 PBX1    RNGIR  
  Exd 350 5 RNGIR 17 
       
2 PBX2    RNGIR  
  Exd 351 5 RNGIR 17 
       
2 PBX3    RNGIR  
  Exd 346 5 RNGIR 17 
       
2 PBX4    RNGIR  
  Exd 329 5 RNGIR 17 
       
3 PDX1    RIQMK  
398 
  Scr 279 5 RIQMK 25 
  Dfd 271 5 RIQMK 24 
  Antp 271 5 RIQMK 16 
       
2 PITX2    RVKAK  
  Ptx1 374 5 RVKAK 20 
       
2 PITX3    RVKAK  
  Ptx1 374 5 RVKAK 20 
       
2 PKNOX1    RNIRR  
  Hth 285 5 RNIRR 17 
       
2 PKNOX2    RNIRR  
  Hth 301 5 RNIRR 17 
       
3 PROP1    RVQAK  
  CG32
532 
281 5 RVQAK 23 
  Al 271 5 RVQAK 20 
  Pph13 251 5 RVQAK 21 
       
1 PRRX1    RVQAK  
  CG98
76 
329 5 RVQAK 20 
  Pph13 301 5 RVQAK 21 
       
1 PRRX2    RVQAK  
  CG98
76 
335 5 RVQAK 20 
  Pph13 302 5 RVQAK 21 
       
 Predicted    RNIHK  
 No predictions made     
       
2 RAX    RVQAK  
  Rx 388 5 RVQAK 27 
       
2 RAXL1    RVQAK  
  Rx 374 5 RVQAK 27 
       
 RHOXF1    RVKAR  
 No predictions made     
       
 RHOXF2    VIEAK  
 No predictions made     
       
 SATB1    RKQYY  
 No predictions made     
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 SATB2    RKQYH  
 No predictions made     
       
3 SHOX    RVQAK  
  PhdP 280 5 RVQAK 17 
  CG11
294 
276 5 RVQAK 15 
  Otp 275 5 RVQAK 20 
       
3 SHOX2    RVQAK  
  PhdP 280 5 RVQAK 17 
  CG11
294 
276 5 RVQAK 15 
  Otp 275 5 RVQAK 20 
       
2 SIX1    SNKQR  
  So 361 5 SNKQR 27 
       
2 SIX2    SNKQR  
  So 365 5 SNKQR 27 
       
2 SIX3    TNKQR  
  Optix 372 5 TNKQR 27 
       
2 SIX4    VNKQR  
  Six4 306 5 VNKQR 20 
       
2 SIX5    VNKQR  
  Six4 307 5 VNKQR 20 
       
2 SIX6    TNKQR  
  Optix 367 5 TNKQR 27 
       
1 TGIF1    RNIRR  
  Vis 299 5 RNIRR 22 
  Achi 298 5 RNIRR 23 
       
1 TGIF2    RNIRR  
  Vis 311 5 RNIRR 22 
  Achi 310 5 RNIRR 23 
       
4 TGIF2LX    KNIRR  
  Vis 239 4 RNIRR 22 
  Achi 238 4 RNIRR 23 
  Hth 211 4 RNIRR 17 
       
4 TGIF2LY    KNIRR  
  Vis 234 4 RNIRR 22 
  Achi 233 4 RNIRR 23 
  Hth 206 4 RNIRR 17 
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2 TLX1    RTQTK  
  C15 345 5 RTQTK 19 
       
2 TLX2    RTQTK  
  C15 328 5 RTQTK 19 
       
2 TLX3    RTQTK  
  C15 347 5 RTQTK 19 
       
 VAX1    RSNFK  
 No predictions made     
       
2 VAX2    RVQTK  
  Ems 247 5 RVQTK 20 
  E5 235 5 RVQTK 43 
       
 VENTX    RTQMK  
 No predictions made     
       
1 VSX1    RVQAK  
  CG33
980 
328 5 RVQAK 13 
  CG41
36 
296 5 RVQAK 22 
  Rx 291 5 RVQAK 27 
       
1 VSX2    RVQAK  
  CG33
980 
341 5 RVQAK 13 
  CG41
36 
306 5 RVQAK 22 
  Rx 303 5 RVQAK 27 
 
 
 
